About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Estrone
- Company
- Khyber Medical University Peshawar
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 311 recruiting
Efficacy results: Not yet reported
311 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 6, 2026
Find a Clinical Trial Near Me
See recruiting studies for Estrone and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01072825
A European Network for the Investigation of Gender Incongruence
University Hospital, Ghent 125 participants Est. completion 2030-12-31 4 sitesOther conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual PersonsView official trial listing → -
Recruiting NCT NCT02081924
Reproductive Hormones During Sustained Administration of Kisspeptin
Not yet reported Imperial College London 76 participants Est. completion 2027-11-30 1 siteOther conditions: Fertility Disorders, Hypothalamic DysfunctionView official trial listing → -
Recruiting NCT NCT02476786
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 siteOther conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the BreastView official trial listing → -
Recruiting NCT NCT02535221
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
Not yet reported Peking University 234 participants Est. completion 2026-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT02819882
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Spanish Breast Cancer Research Group 1867 participants Est. completion 2026-06 40 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT03011684
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
Not yet reported University of California, San Francisco 309 participants Est. completion 2028-03-31 1 siteOther conditions: InfertilityView official trial listing → -
Recruiting NCT NCT03299179
The Effects of the Female Hormones on Cerebral Perfusion
University Ghent 62 participants Est. completion 2027-12-31 1 siteOther conditions: Cerebral Perfusion, Contraception, Menstrual CycleView official trial listing → -
Recruiting NCT NCT03401047
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Not yet reported University of Virginia 37 participants Est. completion 2025-12-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Recruiting NCT NCT03424005
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 1132 participants Est. completion 2030-09-30 53 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT03621904
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Radboud University Medical Center 150 participants Est. completion 2027-09-01 1 siteOther conditions: Endometrial Cancer Stage III, Endometrial Cancer Stage IV, Endometrial Cancer RecurrentView official trial listing → -
Recruiting NCT NCT03624244
Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
Not yet reported Centre Leon Berard 40 participants Est. completion 2031-01 22 sitesOther conditions: Low Grade Endometrial Stromal SarcomaView official trial listing → -
Recruiting NCT NCT03675893
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
Not yet reported Dana-Farber Cancer Institute 110 participants Est. completion 2031-08-01 3 sites Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Recruiting NCT NCT03875378
Transdermal Estrogen in Women With Anorexia Nervosa
Not yet reported Pouneh K. Fazeli, MD 66 participants Est. completion 2028-12-31 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT04043520
Bioenergetic Effects of Aging and Menopause (BEAM)
Not yet reported University of Colorado, Denver 57 participants Est. completion 2024-08-31 1 site Stand-aloneOther conditions: Menopause, Obesity, Abdominal, Aging, Weight GainView official trial listing → -
Recruiting NCT NCT04074720
Prospective Breast Cancer Biospecimen Collection
Thomas Jefferson University 200 participants Est. completion 2028-07-01 1 siteOther conditions: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the BreastView official trial listing → -
Recruiting NCT NCT04111978
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Not yet reported Swiss GO Trial Group 540 participants Est. completion 2032-07-01 53 sitesOther conditions: Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC), Low-grade Serous Ovarian Carcinoma (LGSOC), Ovarian Endometrioid CarcinomaView official trial listing → -
Recruiting NCT NCT04113993
Bazedoxifene -Treatment for Women With Schizophrenia
Not yet reported The Alfred 160 participants Est. completion 2026-12-31 1 siteOther conditions: Schizophrenia, Schizophreniform Disorders, Schizo Affective DisorderView official trial listing → -
Recruiting NCT NCT04174352
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2027-12 2 sites Stand-aloneOther conditions: ERα+ Breast Cancer, ESR1 Gene MutationView official trial listing → -
Recruiting NCT NCT04263298
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
Not yet reported Herui Yao 210 participants Est. completion 2030-05-01 13 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT04288427
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
Not yet reported Beth Israel Deaconess Medical Center 120 participants Est. completion 2026-11-30 1 site Stand-aloneOther conditions: Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease, Prostate Hypertrophy, Prostate Pain, Lower Urinary Tract Symptoms, Urinary Obstruction, Urinary Tract DiseaseView official trial listing → -
Recruiting NCT NCT04312399
Hormone Replacement Trial Against ALzheimers' Disease
Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 siteOther conditions: Postmenopausal Symptoms, Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT04356664
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Not yet reported, Not yet reported Hopital Foch 180 participants Est. completion 2026-06-18 1 siteOther conditions: Endometriosis, Adenomyosis, Infertility, FemaleView official trial listing → -
Recruiting NCT NCT04439370
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
University of Minnesota 160 participants Est. completion 2026-12-30 1 siteOther conditions: Hypertension, Menopause, Premature, Menopause, Blood PressureView official trial listing → -
Recruiting NCT NCT04476485
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04478305
Affect of Duavive on Mood & Anxiety Symptoms
Not yet reported St. Joseph's Healthcare Hamilton 30 participants Est. completion 2025-12 1 siteOther conditions: Menopause, Depression, Anxiety, Sleep, Menopause Related ConditionsView official trial listing → -
Recruiting NCT NCT04596592
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
University of Colorado, Denver 90 participants Est. completion 2026-07-31 1 siteOther conditions: Transgenderism, Gender Dysphoria, Insulin SensitivityView official trial listing → -
Recruiting NCT NCT04601116
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Not yet reported Aarhus University Hospital 3360 participants Est. completion 2035-01-01 1 siteOther conditions: Breast Cancer Female, Estrogen Receptor Positive TumorView official trial listing → -
Recruiting NCT NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Not yet reported Pfizer 320 participants Est. completion 2029-08-10 44 sitesOther conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT04685148
Maternal Mental Health Trial
Not yet reported, Not yet reported Vibe G Frøkjær, MD, PhD 220 participants Est. completion 2030-12-31 1 siteOther conditions: Major Depressive Disorder, Postpartum DepressionView official trial listing → -
Recruiting NCT NCT04783857
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Not yet reported University of Minnesota 171 participants Est. completion 2027-06-02 1 siteOther conditions: Smoking, Smoking Cessation, Smoking ReductionView official trial listing → -
Recruiting NCT NCT04802759
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 316 participants Est. completion 2029-05-30 32 sites Stand-aloneOther conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast CancerView official trial listing → -
Recruiting NCT NCT04812912
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
Memorial Sloan Kettering Cancer Center 120 participants Est. completion 2027-03-18 7 sitesOther conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal CarcinomaView official trial listing → -
Recruiting NCT NCT04824014
4FMFES-PET Imaging of ER+ Advanced Breast Cancers
Not yet reported Centre de recherche du Centre hospitalier universitaire de Sherbrooke 150 participants Est. completion 2026-12-31 1 siteOther conditions: ER+ Breast CancerView official trial listing → -
Recruiting NCT NCT04838249
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
University of Leipzig 80 participants Est. completion 2026-05 1 siteOther conditions: Transsexualism, Transgenderism, Adiposity, Eating Behavior, Arterial Stiffness, MicroangiopathyView official trial listing → -
Recruiting NCT NCT04872166
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
Not yet reported Edgewood Oncology Inc. 112 participants Est. completion 2027-05 6 sitesOther conditions: Advanced Solid Tumor, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT04965766
Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 139 participants Est. completion 2030-04-11 11 sitesOther conditions: Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sitesOther conditions: ER+ Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05044962
Kuwa Free! - Live Free!
Not yet reported University of Alabama at Birmingham 700 participants Est. completion 2027-03-31 1 site Stand-aloneOther conditions: HIV Infections, Contraception, Drug-drug InteractionView official trial listing → -
Recruiting NCT NCT05113368
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Not yet reported Sarah K. Lynam MD 31 participants Est. completion 2027-02 1 siteOther conditions: Ovarian Cancer, Serous Ovarian CancerView official trial listing → -
Recruiting NCT NCT05169762
Feminizing Treatment in Transgender Women and Non-binary Persons
Odense University Hospital 100 participants Est. completion 2035-09-01 1 siteOther conditions: TransgenderismView official trial listing → -
Recruiting NCT NCT05181033
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
Not yet reported National University Hospital, Singapore 120 participants Est. completion 2027-08 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05187832
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Not yet reported Kind Pharmaceuticals LLC 61 participants Est. completion 2026-11 1 siteOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05190094
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Not yet reported International Cancer Research Group, United Arab Emirates 80 participants Est. completion 2026-06 7 sitesOther conditions: Hormonal Receptors Positive, HER2 Negative, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05221021
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Not yet reported Walter Reed National Military Medical Center 152 participants Est. completion 2027-01-30 1 siteOther conditions: Overactive Bladder SyndromeView official trial listing → -
Recruiting NCT NCT05280028
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 siteOther conditions: Menopausal SyndromeView official trial listing → -
Recruiting NCT NCT05282277
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 siteOther conditions: Depression, Psychosis, AnhedoniaView official trial listing → -
Recruiting NCT NCT05283421
Improving Diagnostics in Cervical Dysplasia
Not yet reported University of Aarhus 150 participants Est. completion 2026-08-16 1 siteOther conditions: Cervical CancerView official trial listing → -
Recruiting NCT NCT05293366
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
Federico II University 100 participants Est. completion 2027-01-27 1 siteOther conditions: Long Covid-19View official trial listing → -
Recruiting NCT NCT05304962
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Not yet reported Regor Pharmaceuticals Inc. 64 participants Est. completion 2027-03-31 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05305924
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2027-12-01 1 siteOther conditions: ER-Positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05307705
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Not yet reported Eli Lilly and Company 260 participants Est. completion 2026-12 50 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05316935
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Not yet reported, Not yet reported Xiaojun Chen 80 participants Est. completion 2028-03-30 2 sitesOther conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone ResistanceView official trial listing → -
Recruiting NCT NCT05318755
China Gender-affirming Hormone Therapy Study
Peking University Third Hospital 240 participants Est. completion 2028-12-31 1 siteOther conditions: Transgender, Gender IncongruenceView official trial listing → -
Recruiting NCT NCT05325632
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 53 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: HER2-positive Breast CancerView official trial listing → -
Recruiting NCT NCT05333328
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
Not yet reported Gangnam Severance Hospital 418 participants Est. completion 2033-01 2 sitesOther conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer, Premenopausal Breast Cancer, Node-positive Breast CancerView official trial listing → -
Recruiting NCT NCT05343572
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
Not yet reported Hugh Taylor 90 participants Est. completion 2027-12 1 siteOther conditions: Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation FailureView official trial listing → -
Recruiting NCT NCT05362760
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Not yet reported Prof. Wolfgang Janni 300 participants Est. completion 2029-04 54 sitesOther conditions: Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05379556
LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19
Federico II University 100 participants Est. completion 2027-01-27 1 siteOther conditions: Long Covid-19View official trial listing → -
Recruiting NCT NCT05386108
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Not yet reported, Not yet reported Stemline Therapeutics, Inc. 73 participants Est. completion 2026-12 86 sitesOther conditions: Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms, Breast Diseases, Central Nervous System Neoplasms, Brain Diseases, Central Nervous System DiseasesView official trial listing → -
Recruiting NCT NCT05457972
Postpartum Vaginal Estrogen for Breastfeeding Patients
Not yet reported University Hospitals Cleveland Medical Center 100 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Breastfeeding, Postpartum Sexual Dysfunction, Vaginal AtrophyView official trial listing → -
Recruiting NCT NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sitesOther conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05472792
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Not yet reported UNC Lineberger Comprehensive Cancer Center 90 participants Est. completion 2032-04-15 1 siteOther conditions: Breast Cancer, Quality of LifeView official trial listing → -
Recruiting NCT NCT05473273
Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.
ART Fertility Clinics LLC 40 participants Est. completion 2026-12-30 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Recruiting NCT NCT05515354
Smoking Cessation and Menstrual Cycle Phase
Not yet reported Centre for Addiction and Mental Health 1200 participants Est. completion 2026-12-31 1 siteSubstance use disorder Other conditions: Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use DisorderView official trial listing → -
Recruiting NCT NCT05524584
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Not yet reported University of California, Irvine 20 participants Est. completion 2031-12-31 1 siteOther conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05536128
Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor
Not yet reported Seoul National University Hospital 64 participants Est. completion 2025-12-31 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05541367
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
Tongji Hospital 80 participants Est. completion 2026-12-31 1 siteOther conditions: Breast Cancer, TNBC - Triple-Negative Breast Cancer, Estrogen-receptor-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05564377
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Not yet reported National Cancer Institute (NCI) 2900 participants Est. completion 2030-07-01 483 sitesOther conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Malignant Solid Neoplasm, Malignant Female Reproductive System Neoplasm, Metastatic HER2-Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Unresectable HER2-Negative Breast Carcinoma, Unresectable Malignant Solid NeoplasmView official trial listing → -
Recruiting NCT NCT05573126
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Not yet reported, Not yet reported Ellipses Pharma 95 participants Est. completion 2028-02 14 sitesOther conditions: Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05586724
Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy
Not yet reported Angelica Lindén Hirschberg 520 participants Est. completion 2027-12 1 siteOther conditions: Menopausal SymptomsView official trial listing → -
Recruiting NCT NCT05586802
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Not yet reported Georgios Papadakis 150 participants Est. completion 2027-04-30 1 siteOther conditions: Klinefelter SyndromeView official trial listing → -
Recruiting NCT NCT05594095
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Not yet reported Fudan University 620 participants Est. completion 2026-12-01 1 siteOther conditions: Breast Neoplasm, Breast Cancer, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05601440
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Not yet reported Canadian Cancer Trials Group 484 participants Est. completion 2028-06-30 10 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05601700
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
Not yet reported Ente Ospedaliero Ospedali Galliera 132 participants Est. completion 2029-09-22 19 sitesOther conditions: Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of OvaryView official trial listing → -
Recruiting NCT NCT05608252
VS-6766+Abema+Fulv in Met HR+/HER- BC
Not yet reported, Not yet reported Adrienne G. Waks 63 participants Est. completion 2028-12-31 3 sitesOther conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05646862
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Not yet reported Hoffmann-La Roche 420 participants Est. completion 2029-03-30 210 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05672901
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
Not yet reported Stratpharma AG 100 participants Est. completion 2026-09 3 sitesOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Recruiting NCT NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Not yet reported Totus Medicines 241 participants Est. completion 2027-12 18 sitesOther conditions: HR+/HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05696626
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Not yet reported LeonaBio 600 participants Est. completion 2028-04 224 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05704036
Estrogen Supplementation and Bone Health in Women With CF
Not yet reported Johns Hopkins University 75 participants Est. completion 2027-01 1 site Stand-aloneOther conditions: Cystic Fibrosis, HypoestrogenismView official trial listing → -
Recruiting NCT NCT05716516
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
Not yet reported Dartmouth-Hitchcock Medical Center 36 participants Est. completion 2027-05 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05735080
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Not yet reported, Not yet reported Incyclix Bio 150 participants Est. completion 2027-09 18 sitesOther conditions: Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Ovarian Cancer, CCNE1 Amplification, Solid Tumor, Advanced Cancer, Metastatic CancerView official trial listing → -
Recruiting NCT NCT05746793
At High-risk for Pre-eclampsia After Assisted Reproductive Technology
CRG UZ Brussel 1050 participants Est. completion 2027-10-01 1 siteOther conditions: Pre-EclampsiaView official trial listing → -
Recruiting NCT NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Not yet reported, Not yet reported Eli Lilly and Company 880 participants Est. completion 2030-07 65 sitesOther conditions: Breast Cancer, Solid Tumors, AdultView official trial listing → -
Recruiting NCT NCT05774951
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Not yet reported AstraZeneca 4300 participants Est. completion 2036-05-29 709 sitesOther conditions: Breast Cancer, Early Breast CancerView official trial listing → -
Recruiting NCT NCT05787470
State of Hormones Impact Nociceptive Expression
University of Alabama at Birmingham 120 participants Est. completion 2027-07-31 1 siteOther conditions: Pain, Gender IdentityView official trial listing → -
Recruiting NCT NCT05816655
Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Not yet reported Korea University Guro Hospital 202 participants Est. completion 2029-06-30 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT05837325
Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?
ART Fertility Clinics LLC 300 participants Est. completion 2026-12-31 1 siteOther conditions: Infertility, Female, InfertilityView official trial listing → -
Recruiting NCT NCT05862272
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Not yet reported Sumitomo Pharma Switzerland GmbH 1000 participants Est. completion 2030-09 120 sitesOther conditions: Uterine Fibroids, EndometriosisView official trial listing → -
Recruiting NCT NCT05867251
Study of AVZO-021 in Patients With Advanced Solid Tumors
Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 430 participants Est. completion 2030-01-31 13 sites Stand-aloneOther conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, CCNE1 Amplification, Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Endometrial Cancer, TNBC - Triple-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05872204
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Not yet reported Universitaire Ziekenhuizen KU Leuven 100 participants Est. completion 2028-01 12 sitesObstructive sleep apnea Other conditions: Low Grade Serous Ovarian CarcinomaView official trial listing → -
Recruiting NCT NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Not yet reported NRG Oncology 3960 participants Est. completion 2034-07 1261 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05899010
MIcronized PROgesterone in Frozen Embryo Transfer Cycles
Not yet reported Fundación Santiago Dexeus Font 1020 participants Est. completion 2028-04 1 siteOther conditions: InfertilityView official trial listing → -
Recruiting NCT NCT05901428
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
Not yet reported Fudan University 1736 participants Est. completion 2032-06 1 siteOther conditions: Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05916196
[18F]FES PET/.CT in Uterine Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 30 participants Est. completion 2028-08-01 1 site Stand-aloneOther conditions: Uterine CancerView official trial listing → -
Recruiting NCT NCT05933395
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Not yet reported Dartmouth-Hitchcock Medical Center 135 participants Est. completion 2031-10 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05934708
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
Not yet reported University of Southern California 30 participants Est. completion 2026-08 1 site Stand-aloneOther conditions: Inflammatory ResponseView official trial listing → -
Recruiting NCT NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Not yet reported Fudan University 265 participants Est. completion 2028-01 1 siteOther conditions: Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05953090
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Not yet reported Stratpharma AG 2000 participants Est. completion 2028-12 14 sites Stand-aloneOther conditions: Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)View official trial listing → -
Recruiting NCT NCT05960370
Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle
Instituto Bernabeu 206 participants Est. completion 2025-06-15 1 siteOther conditions: Infertility Due to NonimplantationView official trial listing → -
Recruiting NCT NCT05969795
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
Not yet reported ART Fertility Clinics LLC 342 participants Est. completion 2026-09-30 3 sitesOther conditions: Pregnancy Related, Infertility, FemaleView official trial listing → -
Recruiting NCT NCT05982496
18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Not yet reported Università Vita-Salute San Raffaele 119 participants Est. completion 2029-12-01 1 site Stand-aloneOther conditions: Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI, Axillary Lymphadenopathy, Luminal A Breast CancerView official trial listing → -
Recruiting NCT NCT05989347
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Not yet reported Yale University 20 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Breast Cancer, Hyperinsulinism, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT06006091
The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)
Not yet reported International Peace Maternity and Child Health Hospital 858 participants Est. completion 2027-08-01 1 siteOther conditions: Letrozole, Infertility, FemaleView official trial listing → -
Recruiting NCT NCT06028555
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
Center for Epidemiology and Health Research, Germany 101000 participants Est. completion 2028-10-31 1 siteOther conditions: Contraception, Birth ControlView official trial listing → -
Recruiting NCT NCT06067503
Biomarkers to Detect Endocrine Therapy Resistance
Not yet reported University of Wisconsin, Madison 8 participants Est. completion 2026-12 1 siteOther conditions: Metastatic Cancer, Breast Cancer, Lobular Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06072807
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Not yet reported Weill Medical College of Cornell University 20 participants Est. completion 2027-12 1 siteOther conditions: Breast Cancer, Brain MetastasesView official trial listing → -
Recruiting NCT NCT06086704
Study of 18F-FFNP Breast PET/MRI
Not yet reported University of Wisconsin, Madison 53 participants Est. completion 2030-08-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06101303
Endometriosis Pain
Washington University School of Medicine 120 participants Est. completion 2029-09-01 1 siteOther conditions: Pelvic Pain, EndometriosisView official trial listing → -
Recruiting NCT NCT06107673
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)
Not yet reported Hebei Medical University Fourth Hospital 144 participants Est. completion 2028-12-01 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Not yet reported BeOne Medicines 433 participants Est. completion 2029-12 61 sitesOther conditions: Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT06127979
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
Not yet reported Memorial Sloan Kettering Cancer Center 42 participants Est. completion 2028-11 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Not yet reported Peking Union Medical College 39 participants Est. completion 2028-07-10 2 sitesOther conditions: Salivary Gland Carcinoma, Precision TherapyView official trial listing → -
Recruiting NCT NCT06159608
Sex Differences in the Vascular Effects of E-cigarette Use
Not yet reported Anna Stanhewicz, PhD 80 participants Est. completion 2026-12 1 siteOther conditions: E-cigarette UseView official trial listing → -
Recruiting NCT NCT06176261
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Not yet reported Nancy Lin, MD 58 participants Est. completion 2029-01-01 3 sites Stand-aloneOther conditions: Breast Cancer, Breast Cancer Female, Metastatic Triple-Negative Breast Carcinoma, ER Positive Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER-negative Breast CancerView official trial listing → -
Recruiting NCT NCT06179303
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Not yet reported University of Washington 60 participants Est. completion 2028-06-01 3 sitesOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable HER2-Negative Breast Carcinoma, Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06186271
International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)
Center for Epidemiology and Health Research, Germany 68100 participants Est. completion 2029-06 1 siteOther conditions: ContraceptionView official trial listing → -
Recruiting NCT NCT06197295
Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity
Not yet reported Mackay Memorial Hospital 200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Urinary Bladder, Overactive, Effect of DrugView official trial listing → -
Recruiting NCT NCT06201234
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
Not yet reported GBG Forschungs GmbH 176 participants Est. completion 2028-12-31 36 sitesOther conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 MutationView official trial listing → -
Recruiting NCT NCT06202261
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 154 participants Est. completion 2027-10 2 sites Stand-aloneOther conditions: Metastatic Breast Cancer, Recurrent Breast Cancer, Advanced MalignanciesView official trial listing → -
Recruiting NCT NCT06208410
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
Not yet reported, Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 306 participants Est. completion 2027-02-26 1 siteOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT06218303
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 site Stand-aloneOther conditions: Ductal Carcinoma in SituView official trial listing → -
Recruiting NCT NCT06222957
The Effects of HER2 Receptor Signaling on Human Brown Fat Activity
Copenhagen University Hospital, Rigshospitalet 30 participants Est. completion 2026-03-01 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06239376
Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients
Not yet reported Mỹ Đức Hospital 222 participants Est. completion 2027-05-30 1 siteOther conditions: Adenomyosis, IVF, Frozen Embryo TransferView official trial listing → -
Recruiting NCT NCT06245681
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Medical University of Vienna 40 participants Est. completion 2028-10-20 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Recruiting NCT NCT06247267
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
Walter Reed National Military Medical Center 75 participants Est. completion 2025-08 1 siteOther conditions: Hypogonadism, Gender Identity DysphoriaView official trial listing → -
Recruiting NCT NCT06260033
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Not yet reported City of Hope Medical Center 18 participants Est. completion 2026-10-29 2 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, Metastatic Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06264882
Cardiometabolic Consequences of the Loss of Ovarian Function
Not yet reported University of Colorado, Denver 100 participants Est. completion 2028-08-31 1 siteOther conditions: Menopause, Estrogen Deficiency, Aging, AdiposityView official trial listing → -
Recruiting NCT NCT06280560
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Fundación IVI 60 participants Est. completion 2026-12-30 1 siteOther conditions: Endometrial ReceptivityView official trial listing → -
Recruiting NCT NCT06291675
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
Medical University of Vienna 50 participants Est. completion 2033-03-03 1 siteOther conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic ChangeView official trial listing → -
Recruiting NCT NCT06307184
Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
Instituto Valenciano de Infertilidade de Lisboa 530 participants Est. completion 2026-12 1 siteOther conditions: Frozen Embryo TransferView official trial listing → -
Recruiting NCT NCT06334315
Oral Contraceptive Pill (OCP) Pharmacogenomics
Not yet reported Yale University 700 participants Est. completion 2028-05 2 sitesOther conditions: Contraception, Pharmacogenomic Drug InteractionView official trial listing → -
Recruiting NCT NCT06343870
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
Not yet reported University of Sao Paulo General Hospital 140 participants Est. completion 2027-04-30 1 siteOther conditions: Menopause, Testosterone Deficiency, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT06357442
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
University of Colorado, Denver 34 participants Est. completion 2026-07-01 1 siteOther conditions: Primary Ovarian Insufficiency, Hypogonadotropic Hypogonadism, Hormone Replacement TherapyView official trial listing → -
Recruiting NCT NCT06361940
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Not yet reported Medical College of Wisconsin 100 participants Est. completion 2029-12 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06366347
ALPINE: Maintenance Letrozole/Abemaciclib
Not yet reported Dana-Farber Cancer Institute 32 participants Est. completion 2029-03-01 6 sitesOther conditions: Endometrial Cancer, Recurrent Endometrial Cancer, TP53View official trial listing → -
Recruiting NCT NCT06372119
Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)
Not yet reported Mỹ Đức Hospital 790 participants Est. completion 2026-04 2 sitesOther conditions: Embryo Transfer, Irregular Menstruation, Letrozole, Hormone Replacement TherapyView official trial listing → -
Recruiting NCT NCT06380751
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
Not yet reported AstraZeneca 788 participants Est. completion 2031-12-30 306 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06382948
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Not yet reported MedSIR 300 participants Est. completion 2028-04 104 sites Stand-aloneOther conditions: Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene MutationView official trial listing → -
Recruiting NCT NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 15 participants Est. completion 2027-04 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06439524
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
Not yet reported Main Line Health 110 participants Est. completion 2028-12-01 1 siteOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06439693
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Not yet reported Dana-Farber Cancer Institute 72 participants Est. completion 2033-03-30 1 siteOther conditions: Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IV Breast CancerView official trial listing → -
Recruiting NCT NCT06450301
Senescent Endometrial Cells in Patients with Thin Endometrial Lining
Trio Fertility 100 participants Est. completion 2027-06 1 siteOther conditions: Asherman's Syndrome, Thin Endometrial Lining, Cell SenescenceView official trial listing → -
Recruiting NCT NCT06452394
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Not yet reported Swiss Cancer Institute 50 participants Est. completion 2028-12-31 8 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06455969
Adaptions and Resiliency to Multi-Stressor OpeRations
Not yet reported Bradley Nindl 120 participants Est. completion 2027-08 1 site Stand-aloneOther conditions: Musculoskeletal Injury, Hypogonadism, Hormonal ContraceptionView official trial listing → -
Recruiting NCT NCT06479720
Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
Not yet reported Mackay Memorial Hospital 300 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Effect of Drug, Urinary Bladder, OveractiveView official trial listing → -
Recruiting NCT NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Not yet reported Stemline Therapeutics, Inc. 4220 participants Est. completion 2032-10 567 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06497894
No More Sleepless Nights in Perimenopause
Not yet reported Insel Gruppe AG, University Hospital Bern 54 participants Est. completion 2027-01-30 1 siteOther conditions: Insomnia, MenopauseView official trial listing → -
Recruiting NCT NCT06500208
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
Not yet reported Shanghai Jiao Tong University School of Medicine 48 participants Est. completion 2026-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06502548
Endometriosis Transcriptomic Cell Atlas
Not yet reported University Hospital, Toulouse 92 participants Est. completion 2027-09 1 siteOther conditions: Endometriosis, InfertilityView official trial listing → -
Recruiting NCT NCT06515470
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Not yet reported Biotheryx, Inc. 82 participants Est. completion 2027-12-31 6 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06520982
Early Neurovascular Adaptations in Aging Women
Not yet reported University of Missouri-Columbia 64 participants Est. completion 2028-06-30 1 siteOther conditions: Women, Sympathetic Nervous System, Aging, Blood FlowView official trial listing → -
Recruiting NCT NCT06525155
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Not yet reported Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 32 participants Est. completion 2025-02 1 siteOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT06530459
The MUSE Study for Menopausal Arthralgia
Not yet reported, Not yet reported National University Hospital, Singapore 100 participants Est. completion 2028-04 1 siteOther conditions: Arthralgia, Menopause, Perimenopausal Disorder, Joint Pain, Postmenopausal DisorderView official trial listing → -
Recruiting NCT NCT06533865
Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea
Not yet reported Massachusetts General Hospital 114 participants Est. completion 2029-04 2 sitesOther conditions: FHA (Functional Hypothalamic Amenorrhea)View official trial listing → -
Recruiting NCT NCT06534125
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
Not yet reported Emory University 150 participants Est. completion 2027-12-31 4 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06544473
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 siteOther conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT06555068
A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 528 participants Est. completion 2028-08 1 siteOther conditions: Advanced Unresectable or Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06570460
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Not yet reported Aarhus University Hospital 50 participants Est. completion 2026-12-31 1 siteOther conditions: Turner Syndrome, Hypogonadism; Ovarian, Hormone Replacement Therapy, Estrogen Replacement Therapy, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT06572930
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
ART Fertility Clinics LLC 150 participants Est. completion 2026-12-01 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Recruiting NCT NCT06583408
The REgistry of Very Early Estrogen and AnovuLation
Mayo Clinic 100000 participants Est. completion 2029-08-01 2 sitesOther conditions: Hypothalamic Amenorrhea, Functional, Hypothalamic Amenorrhea, Functional Hypogonadotropic HypogonadismView official trial listing → -
Recruiting NCT NCT06607757
Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
Not yet reported GBG Forschungs GmbH 120 participants Est. completion 2026-08-31 25 sitesOther conditions: CCCA Assessed by Ki67 Drop Below <2.7% From BaselineView official trial listing → -
Recruiting NCT NCT06618703
Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
Not yet reported University Hospital, Angers 230 participants Est. completion 2030-10 3 sitesOther conditions: Endocrine; Deficiency, Hypothalamo-Pituitary Disorder, Radiotherapy Side EffectView official trial listing → -
Recruiting NCT NCT06624644
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Not yet reported, Not yet reported Linnaeus Therapeutics, Inc. 135 participants Est. completion 2031-02 9 sites Stand-aloneOther conditions: Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma, Unresectable MelanomaView official trial listing → -
Recruiting NCT NCT06624839
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Not yet reported University of Maryland, Baltimore 120 participants Est. completion 2028-01 2 sites Stand-aloneOther conditions: Human Papilloma Virus, Anal Dysplasia, HIVView official trial listing → -
Recruiting NCT NCT06625775
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Not yet reported TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392 participants Est. completion 2028-11 44 sitesOther conditions: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Lung Cancer, Metastatic Colorectal Cancer, Advanced Lung Cancer, HR-positive, HER2-negative Advanced Breast Cancer, HER2-positive Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06644794
Progesterone-modified Natural Cycle for FET
Not yet reported Shandong University of Traditional Chinese Medicine 336 participants Est. completion 2028-12-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Recruiting NCT NCT06656819
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
University of Texas Southwestern Medical Center 50 participants Est. completion 2027-12-31 1 siteOther conditions: HealthyView official trial listing → -
Recruiting NCT NCT06663072
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Not yet reported University of Chicago 25 participants Est. completion 2026-11 1 siteOther conditions: Metastatic Pancreatic Neuroendocrine TumorView official trial listing → -
Recruiting NCT NCT06666439
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Julia Foldi 20 participants Est. completion 2029-10-31 1 siteOther conditions: Metastatic Invasive Lobular Carcinoma (mILC)View official trial listing → -
Recruiting NCT NCT06679491
Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes
Not yet reported Universite de La Reunion 60 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Menstrual Cycle, Resistance Training, Neuromuscular Function, Female Athlete, Women Health, Oral Contraceptive Pill, Muscle Strenght, Hormones, Periodized TrainingView official trial listing → -
Recruiting NCT NCT06683248
The Effects of Night Shift Work on Health Across the Menstrual Cycle
Not yet reported Uppsala University 60 participants Est. completion 2025-12-31 1 siteOther conditions: Sleep Deprivation, Menstrual Cycle, Brain Health, Metabolism, Microbiota, Immune SystemView official trial listing → -
Recruiting NCT NCT06686537
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
Not yet reported University of Colorado, Denver 20 participants Est. completion 2027-12 2 sitesOther conditions: Infertility, Female, ObesityView official trial listing → -
Recruiting NCT NCT06690866
Negative Emotionality and Epigenetics During Puberty
International Research Training Group 2804 100 participants Est. completion 2026-04 1 siteOther conditions: Puberty, Healthy, StressView official trial listing → -
Recruiting NCT NCT06704516
COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
Not yet reported University of Oxford 10 participants Est. completion 2026-01-01 1 siteMASLD Other conditions: MenopauseView official trial listing → -
Recruiting NCT NCT06726148
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals 280 participants Est. completion 2028-09-25 33 sitesOther conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung CancerView official trial listing → -
Recruiting NCT NCT06734533
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive(HR+) Metastatic Breast Cancer(MBC) .
Hunan Cancer Hospital 80 participants Est. completion 2025-12-30 1 siteOther conditions: HR+ Breast CancerView official trial listing → -
Recruiting NCT NCT06736704
SNV4818 in Participants With Advanced Solid Tumors
Not yet reported, Not yet reported Pikavation Therapeutics, Inc. 320 participants Est. completion 2027-06 12 sitesOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT06737380
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Not yet reported LiveKidney.Bio 10 participants Est. completion 2026-07 1 siteOther conditions: SLE, Lupus, Systemic Lupus Erthematosus, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)View official trial listing → -
Recruiting NCT NCT06738966
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
Not yet reported Shanghai Best-Link Bioscience, LLC 9 participants Est. completion 2027-12-26 2 sites Stand-aloneOther conditions: Breast Cancer, Ovarian Cancer, Endometrial CancerView official trial listing → -
Recruiting NCT NCT06745466
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
Not yet reported University of Delaware 30 participants Est. completion 2027-10 1 site Stand-aloneOther conditions: Estrogen, PremenopauseView official trial listing → -
Recruiting NCT NCT06756932
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
Not yet reported BeOne Medicines 120 participants Est. completion 2027-07-30 14 sitesOther conditions: Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06757634
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Not yet reported Celcuity Inc 1180 participants Est. completion 2033-07-30 203 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06758128
Genetic and Immunity in Heart Failure
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 215 participants Est. completion 2026-09-30 2 sitesHeart failureView official trial listing → -
Recruiting NCT NCT06784193
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Not yet reported Olema Pharmaceuticals, Inc. 180 participants Est. completion 2027-08-30 25 sites Stand-aloneOther conditions: Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC), Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Breast Cancer, Fulvestrant, PalazestrantView official trial listing → -
Recruiting NCT NCT06785129
Endometriosis and Migraine
Washington University School of Medicine 120 participants Est. completion 2030-01-01 1 siteOther conditions: Migraine, EndometriosisView official trial listing → -
Recruiting NCT NCT06798571
Role of Menopause in Thermoregulation
Not yet reported Penn State University 24 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Menopause, AgingView official trial listing → -
Recruiting NCT NCT06807580
Progesterone in Gender Affirming Hormone Therapy Study
Not yet reported Emory University 40 participants Est. completion 2027-02 1 siteOther conditions: Transgender WomenView official trial listing → -
Recruiting NCT NCT06840093
Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial
Not yet reported University of Iowa 84 participants Est. completion 2027-06-30 1 site Stand-aloneOther conditions: Postoperative Restriction, Midurethral Sling, Mesh, Stress Urinary IncontinenceView official trial listing → -
Recruiting NCT NCT06851754
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 185 participants Est. completion 2031-12-31 1 site Stand-aloneOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Recruiting NCT NCT06852365
Combined Oral Contraceptive Pill and Resistance Starch
Not yet reported University of Pennsylvania 100 participants Est. completion 2028-04 1 siteMetabolic syndrome Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Recruiting NCT NCT06856174
Menopausal HT for Women Living With HIV (HoT)
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 105 participants Est. completion 2027-09-20 23 sitesOther conditions: HIV Infection, MenopauseView official trial listing → -
Recruiting NCT NCT06856200
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
Not yet reported Fudan University 36 participants Est. completion 2026-06 1 siteOther conditions: Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine TherapyView official trial listing → -
Recruiting NCT NCT06866119
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
Massachusetts General Hospital 45 participants Est. completion 2029-06-30 1 siteOther conditions: Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications, Endothelial Function (FMD), Estrogen Replacement TherapyView official trial listing → -
Recruiting NCT NCT06869486
Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors
Universidad Autonoma de Baja California 300 participants Est. completion 2026-12-31 1 siteOther conditions: Insomnia, Cardiorespiratory Fitness, Metabolic DiseaseView official trial listing → -
Recruiting NCT NCT06873971
Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause
Not yet reported University of Nove de Julho 60 participants Est. completion 2026-12-31 1 siteOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Recruiting NCT NCT06896617
Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)
Not yet reported Fundacion Clinic per a la Recerca Biomédica 334 participants Est. completion 2026-12-20 1 siteOther conditions: Infertilities, Embryo TransferView official trial listing → -
Recruiting NCT NCT06905210
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Not yet reported Eurofarma Laboratorios S.A. 531 participants Est. completion 2027-03 1 siteOther conditions: Acne Vulgaris, Acne Vulgaris on the FaceView official trial listing → -
Recruiting NCT NCT06933407
Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women
Szeged University 80 participants Est. completion 2030-01-01 1 siteOther conditions: Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence (UI), Urinary Bladder, Overactive, Incontinence, Overactive Bladder, Stress Urinary Incontinence, Stress Urinary Incontinence (SUI)View official trial listing → -
Recruiting NCT NCT06936930
Reproductive and Mental Health of Patients With Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 600 participants Est. completion 2027-12-31 1 siteOther conditions: Aplastic Anemia, Reproductive HealthView official trial listing → -
Recruiting NCT NCT06953076
Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 111 participants Est. completion 2027-05-02 1 siteOther conditions: Uterine Bleeding, Uterine Leiomyomas, Uterine Hemorrhage, Uterine NeoplasmsView official trial listing → -
Recruiting NCT NCT06954961
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
Not yet reported InventisBio Co., Ltd 640 participants Est. completion 2028-12-31 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06964906
Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2030-12-31 1 siteOther conditions: ER+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT06969326
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
Not yet reported Women and Infants Hospital of Rhode Island 48 participants Est. completion 2026-12-01 1 siteOther conditions: Postoperative Bleeding, Gender Dysphoria, HysterectomyView official trial listing → -
Recruiting NCT NCT06970912
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
Not yet reported Peking University People's Hospital 393 participants Est. completion 2029-12-31 1 siteOther conditions: Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer, ctDNA Monitoring, Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT06974604
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Not yet reported Brown University 60 participants Est. completion 2029-05-31 1 siteOther conditions: Breast Neoplasms, Lung NeoplasmsView official trial listing → -
Recruiting NCT NCT06975111
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites Stand-aloneOther conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, CardiovascularView official trial listing → -
Recruiting NCT NCT06979596
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sitesOther conditions: Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Not yet reported Relay Therapeutics, Inc. 540 participants Est. completion 2031-12-31 243 sitesOther conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06993506
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 500 participants Est. completion 2027-10-31 19 sitesOther conditions: HER2-negative Breast Cancer, Recurrence, MetastasisView official trial listing → -
Recruiting NCT NCT06995482
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
Not yet reported Kashiv BioSciences, LLC 40 participants Est. completion 2026-06 2 sitesOther conditions: Healthy Postmenopausal WomenView official trial listing → -
Recruiting NCT NCT06997029
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Not yet reported Bristol-Myers Squibb 234 participants Est. completion 2028-12-14 21 sitesOther conditions: Advanced Solid Tumor, Advanced Breast Cancer, Advanced Ovarian CancerView official trial listing → -
Recruiting NCT NCT06998108
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
Not yet reported BeBetter Med Inc 330 participants Est. completion 2026-06-30 1 siteOther conditions: HR+/HER2- Locally Advanced, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT06998407
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Not yet reported, Not yet reported Avenzo Therapeutics, Inc. 380 participants Est. completion 2030-08 16 sites Stand-aloneOther conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07010146
Role of Estrogen on Skeletal Outcomes in FHA
Not yet reported University of Virginia 150 participants Est. completion 2030-05-31 2 sitesOther conditions: Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)View official trial listing → -
Recruiting NCT NCT07013643
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Not yet reported AstraZeneca 50 participants Est. completion 2027-07-09 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Recruiting NCT NCT07015476
Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea
IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-11 1 siteOther conditions: AmenorrheaView official trial listing → -
Recruiting NCT NCT07022340
Hemodynamics After Resistance Training
Not yet reported University of Michigan 50 participants Est. completion 2026-12 1 siteOther conditions: PerimenopauseView official trial listing → -
Recruiting NCT NCT07024173
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Not yet reported Shandong Suncadia Medicine Co., Ltd. 240 participants Est. completion 2027-12 2 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07029399
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Not yet reported NiKang Therapeutics, Inc. 361 participants Est. completion 2027-12-31 18 sitesOther conditions: HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC), CCNE1 Amplified Advanced Solid Tumors, HR+ HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07030426
Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery
Not yet reported Sarah Wozney 180 participants Est. completion 2029-09-30 2 sitesOther conditions: Pelvic Organ Prolapse (POP)View official trial listing → -
Recruiting NCT NCT07032506
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
Not yet reported Weill Medical College of Cornell University 320 participants Est. completion 2031-12-31 3 sitesOther conditions: Intrauterine AdhesionView official trial listing → -
Recruiting NCT NCT07037082
Understanding Cycles to Improve Women's Health
University Hospital, Montpellier 320 participants Est. completion 2029-07-01 1 siteOther conditions: Woman of Reproductive Age, Socioeconomic FactorsView official trial listing → -
Recruiting NCT NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Not yet reported Tanta University 150 participants Est. completion 2026-11-20 1 siteOther conditions: Gynecologic DiseaseView official trial listing → -
Recruiting NCT NCT07053982
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Not yet reported University Hospital, Toulouse 20 participants Est. completion 2028-03 1 site Stand-aloneOther conditions: EndometriosisView official trial listing → -
Recruiting NCT NCT07061093
Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study
Ospedale Policlinico San Martino 96 participants Est. completion 2026-01-31 1 siteOther conditions: Cardiovascular System Diseases (&Amp; [Cardiac])View official trial listing → -
Recruiting NCT NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Not yet reported Pfizer 400 participants Est. completion 2030-11-04 202 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07065643
Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric Restriction
Not yet reported University of Aberdeen 75 participants Est. completion 2027-12 1 siteOther conditions: Overweight and Obese Adults, HealthyView official trial listing → -
Recruiting NCT NCT07083635
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Not yet reported Chulalongkorn University 40 participants Est. completion 2026-12 1 siteOther conditions: Menstruation Disturbances, Metrorrhagia, Uterine Hemorrhage, Contraception BehaviorView official trial listing → -
Recruiting NCT NCT07084714
Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms
Not yet reported University of Colorado, Colorado Springs 35 participants Est. completion 2026-08 1 site Stand-aloneOther conditions: Premenstrual Syndrome, Menstrual Cycle, Menstrual Distress (Dysmenorrhea), Menstrual Bleeding, HeavyView official trial listing → -
Recruiting NCT NCT07100106
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Not yet reported, Not yet reported Genentech, Inc. 285 participants Est. completion 2028-08-31 64 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07100782
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
Not yet reported University of Michigan 130 participants Est. completion 2028-09 1 siteOther conditions: Endometriosis, Pelvic PainView official trial listing → -
Recruiting NCT NCT07109726
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Not yet reported, Not yet reported Terremoto Biosciences Inc. 205 participants Est. completion 2029-02-28 20 sitesOther conditions: Breast Cancer, Endometrial Cancer, Ovarian Cancer, Lung Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Solid Tumor, Cervical CancerView official trial listing → -
Recruiting NCT NCT07110883
A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors
Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 400 participants Est. completion 2028-10-31 2 sites Stand-aloneOther conditions: Advanced Solid TumorView official trial listing → -
Recruiting NCT NCT07115082
Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
Not yet reported, Not yet reported Yan Hongli 50 participants Est. completion 2026-03-30 1 siteOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Recruiting NCT NCT07117630
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Not yet reported Fudan University 60 participants Est. completion 2027-12 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07138222
IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
Peter MacCallum Cancer Centre, Australia 80 participants Est. completion 2027-12 6 sitesOther conditions: Melanoma (Skin Cancer)View official trial listing → -
Recruiting NCT NCT07148921
Perception of Pain During Gender Affirming Hormone Therapy
Medical University of Vienna 40 participants Est. completion 2026-03 1 siteOther conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex HormonesView official trial listing → -
Recruiting NCT NCT07160504
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Not yet reported University of Aarhus 90 participants Est. completion 2026-12-31 1 siteOther conditions: Vagina AtrophyView official trial listing → -
Recruiting NCT NCT07171970
IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women
Not yet reported Mỹ Đức Hospital 600 participants Est. completion 2028-01-15 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome (PCOS), In Vitro Maturation of Oocytes, Fresh Embryo TransferView official trial listing → -
Recruiting NCT NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Not yet reported Eli Lilly and Company 800 participants Est. completion 2033-05 361 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Recruiting NCT NCT07180160
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Not yet reported Wenjin Yin 123 participants Est. completion 2028-03 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07187947
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500 participants Est. completion 2035-12-31 1 siteCardiovascular disease Other conditions: Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Health StatusView official trial listing → -
Recruiting NCT NCT07191717
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
Not yet reported Jonsson Comprehensive Cancer Center 42 participants Est. completion 2031-04-30 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma, Localized Estrogen Receptor-Positive Breast Carcinoma, Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07198724
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
Not yet reported, Not yet reported Kristina A. Fanucci 65 participants Est. completion 2038-06-01 1 site Stand-aloneOther conditions: Metastatic Breast Cancer, HER2 Low Breast Carcinoma, HER2-negative Breast Cancer, Breast Cancer, Breast Cancer FemaleView official trial listing → -
Recruiting NCT NCT07207070
A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.
Not yet reported Risen (Suzhou) Pharma Tech Co., Ltd. 312 participants Est. completion 2030-05-31 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07209449
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 75 participants Est. completion 2028-10-01 7 sitesOther conditions: Endometrial CancerView official trial listing → -
Recruiting NCT NCT07222215
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
Not yet reported Kristina A. Fanucci 297 participants Est. completion 2030-10-01 1 site Stand-aloneOther conditions: Estrogen-receptor-positive Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2- Breast Cancer, ESR1 Gene Mutation, ER Wildtype, Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT07222267
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Not yet reported BeOne Medicines 86 participants Est. completion 2037-01-13 31 sites Stand-aloneOther conditions: Breast Cancer, Advanced Solid TumorView official trial listing → -
Recruiting NCT NCT07226349
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Not yet reported BeOne Medicines 105 participants Est. completion 2028-11-01 23 sitesOther conditions: Advanced Solid TumorView official trial listing → -
Recruiting NCT NCT07242131
Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS
Not yet reported Ege University 150 participants Est. completion 2026-06-01 1 siteOther conditions: Polycystic Ovary Syndrome (PCOS)View official trial listing → -
Recruiting NCT NCT07242352
Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC
Not yet reported Women's Cancer Study Group GmbH 1520 participants Est. completion 2033-09-30 33 sitesOther conditions: Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07254429
COMPASS - COpenhagen MenoPAuSe Study
Not yet reported Martin Blomberg Jensen 192 participants Est. completion 2028-05 1 siteOther conditions: Menopausal Osteoporosis, Bone MarkersView official trial listing → -
Recruiting NCT NCT07262138
Active Surveillance in Older Women With ER+ Breast Cancer
University of Pittsburgh 50 participants Est. completion 2030-12-31 1 siteOther conditions: Early Stage Estrogen Receptor (ER) Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07268183
How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
Hospices Civils de Lyon 180 participants Est. completion 2027-01-06 1 siteOther conditions: Prolactinoma, MacroprolactinomaView official trial listing → -
Recruiting NCT NCT07278323
Frozen Shoulder and Hormone Replacement Therapy
Not yet reported University of California, San Francisco 60 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Adhesive Capsulitis of the Shoulder, Frozen ShoulderView official trial listing → -
Recruiting NCT NCT07287098
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Not yet reported Eli Lilly and Company 600 participants Est. completion 2029-12 88 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Recruiting NCT NCT07287917
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Not yet reported, Not yet reported Aminex Therapeutics, Inc. 92 participants Est. completion 2028-12-29 20 sitesOther conditions: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals 205 participants Est. completion 2031-05-09 15 sitesOther conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate CancerView official trial listing → -
Recruiting NCT NCT07314073
[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Not yet reported Asan Medical Center 85 participants Est. completion 2029-12-31 1 siteOther conditions: Stage III Breast CancerView official trial listing → -
Recruiting NCT NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Not yet reported Pfizer 260 participants Est. completion 2030-04-14 13 sites Stand-aloneOther conditions: Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer, Metastatic Colorectal Adenocarcinoma, Triple Negative Breast CancerView official trial listing → -
Recruiting NCT NCT07338955
Validating and Assessing Reliability
Bahria University 385 participants Est. completion 2026-01-20 1 siteOther conditions: Upper Limb DisabilityView official trial listing → -
Recruiting NCT NCT07340190
A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2028-04-07 6 sitesOther conditions: Advanced MalignanciesView official trial listing → -
Recruiting NCT NCT07340541
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Not yet reported UNC Lineberger Comprehensive Cancer Center 700 participants Est. completion 2031-06-02 6 sites Stand-aloneOther conditions: Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-positive Breast Cancer, Hormone Receptor Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07347600
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 500 participants Est. completion 2029-12-31 30 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Recruiting NCT NCT07358468
Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study
Mỹ Đức Hospital 384 participants Est. completion 2027-12-01 2 sitesOther conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine PeristalsisView official trial listing → -
Recruiting NCT NCT07361263
Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency
Not yet reported University Hospital, Basel, Switzerland 28 participants Est. completion 2027-02 1 site Stand-aloneOther conditions: AVP Deficiency, Diabetes InsipidusView official trial listing → -
Recruiting NCT NCT07368998
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Not yet reported Hoffmann-La Roche 80 participants Est. completion 2031-10-31 34 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07389733
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
Not yet reported, Not yet reported Shandong Suncadia Medicine Co., Ltd. 180 participants Est. completion 2028-12 2 sitesOther conditions: Advanced Unresectable or Metastatic Breast Cancer of AdultsView official trial listing → -
Recruiting NCT NCT07400419
Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2028-04-01 1 siteOther conditions: Muscle Mass and StrengthView official trial listing → -
Recruiting NCT NCT07400523
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 446 participants Est. completion 2031-02-10 4 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07405801
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Not yet reported Hoffmann-La Roche 80 participants Est. completion 2030-02-26 58 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07406412
Hormonal Regulation of Cardiometabolic Health Study
University of Jyvaskyla 120 participants Est. completion 2028-12-15 7 sitesOther conditions: Menopause SurgicalView official trial listing → -
Recruiting NCT NCT07419594
Estradiol and Intrusive Memories
Not yet reported Charite University, Berlin, Germany 273 participants Est. completion 2028-02-29 1 site Stand-aloneOther conditions: PTSD, Intrusive Memories, Intrusion Symptom, Trauma, IntrusionView official trial listing → -
Recruiting NCT NCT07421895
A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
The Third Xiangya Hospital of Central South University 600 participants Est. completion 2032-12-31 1 siteOther conditions: Retained Products of Conception, RPOCView official trial listing → -
Recruiting NCT NCT07421908
Investigating the Association Between Diagnostic and Therapeutic Management Models and Prognosis of Intrauterine Adhesions Based on a Large-Scale Prospective Cohort Study
Not yet reported The Third Xiangya Hospital of Central South University 5000 participants Est. completion 2035-03-01 1 site Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Recruiting NCT NCT07422506
A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
Not yet reported The Third Xiangya Hospital of Central South University 580 participants Est. completion 2035-01-01 1 site Stand-aloneOther conditions: Missed Abortion, Early Pregnancy FailureView official trial listing → -
Recruiting NCT NCT07425990
FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles
Not yet reported University of Novi Sad 120 participants Est. completion 2027-03 1 siteOther conditions: Infertility Female, Frozen Embryo Transfer (FET)View official trial listing → -
Recruiting NCT NCT07426822
Rash & Diarrhea Prophylaxis With Capivasertib
Not yet reported Maryam Lustberg 108 participants Est. completion 2029-04 1 siteOther conditions: Metastatic HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07427394
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
Not yet reported AstraZeneca 24 participants Est. completion 2027-12-28 6 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT07446400
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2026-11-07 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Recruiting NCT NCT07467772
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2028-04 1 site Stand-aloneObstructive sleep apnea Other conditions: Uterine Sarcoma, Endometrial Stromal Sarcoma, ESS, Perivascular Epithelioid Cell Tumors, Uterine PEComa, Estrogen Receptor Positive Tumor, uLMSView official trial listing → -
Recruiting NCT NCT07498478
Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
Not yet reported TransThera Sciences (Nanjing), Inc. 94 participants Est. completion 2027-12-31 13 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07499804
Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 siteOther conditions: IVF, Infertility, FemaleView official trial listing → -
Recruiting NCT NCT07499817
Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes
Not yet reported Beni-Suef University 100 participants Est. completion 2026-04-30 1 siteOther conditions: Embryo Transfer, IVF, InfertilityView official trial listing → -
Recruiting NCT NCT07539090
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
Not yet reported Deciphera Pharmaceuticals, LLC 24 participants Est. completion 2026-10 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Recruiting NCT NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Not yet reported IDEAYA Biosciences 160 participants Est. completion 2030-06-30 11 sitesObstructive sleep apnea Other conditions: ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC), Castration-resistant Prostate Cancer (CRPC)View official trial listing → -
Recruiting NCT NCT07541079
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Not yet reported Genentech, Inc. 300 participants Est. completion 2034-06-30 2 sitesOther conditions: Early Breast CancerView official trial listing → -
Recruiting NCT NCT07568509
Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
Not yet reported Massachusetts General Hospital 20 participants Est. completion 2027-04 1 siteOther conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, HypopituitarismView official trial listing → -
Recruiting NCT NCT07580846
ATENEA Study: Adherence to Creatine-Based Nutritional Supplementation in Estrogen-Depleted Women
Margan Biotech 100 participants Est. completion 2026-10-01 4 sitesOther conditions: Menopause, Estrogen DeficiencyView official trial listing → -
Recruiting NCT NCT07580950
The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic Amenorrhea
Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2028-06-30 1 siteOther conditions: Functional Hypothalamic AmenorrheaView official trial listing → -
Recruiting NCT NCT07604272
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males
Not yet reported Northwestern University 30 participants Est. completion 2028-07 1 siteOther conditions: Inguinal Hernia Unilateral, Inguinal Hernia Bilateral, Inguinal Hernia Without Obstruction or Gangrene, Inguinal Hernia, Without Mention of Obstruction or GangreneView official trial listing → -
Recruiting NCT NCT07604571
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2032-06-08 7 sitesOther conditions: Advanced HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07612215
Elacestrant in Advanced Triple Positive Breast Cancer
Not yet reported, Not yet reported NYU Langone Health 50 participants Est. completion 2030-05 1 site Stand-aloneOther conditions: ER Positive, HER2 Positive Breast CancerView official trial listing → -
Recruiting NCT NCT07616427
Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2033-05-20 3 sitesOther conditions: HR+/HER2+ Early Breast CancerView official trial listing → -
Recruiting NCT NCT07616453
Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 45 participants Est. completion 2033-05-05 1 siteOther conditions: HR+/HER2- Early Breast CancerView official trial listing → -
Recruiting NCT NCT07617454
Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women
Not yet reported Mette Hansen 30 participants Est. completion 2027-08-01 1 site Stand-aloneOther conditions: Menopause Related Conditions, Exercise TrainingView official trial listing → -
Recruiting NCT NCT07620587
The Role of Estradiol and Progesterone on Appetite Regulation and Energy Balance
Not yet reported Wilfrid Laurier University 60 participants Est. completion 2028-08-31 1 siteOther conditions: Energy Balance, Physiology - Regulation of Appetite and Food IntakeView official trial listing → -
Recruiting NCT NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Not yet reported AstraZeneca 150 participants Est. completion 2029-02-28 89 sitesOther conditions: ER-Positive HER2-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT07649356
Significance of Estrogen Status for Muscle Function, Physical Fitness, and Physiological Health Parameters - a Comparison of Age-matched Groups of Women Before and After Menopause.
Mette Hansen 30 participants Est. completion 2027-08-01 1 siteOther conditions: Muscle Mass and Strength, MenopauseView official trial listing → -
Recruiting NCT NCT07666555
A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.
Not yet reported Fudan University 98 participants Est. completion 2029-12-30 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07675213
Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles
Mỹ Đức Hospital 442 participants Est. completion 2027-12-01 1 siteOther conditions: Infertility, Endometrial Peristalsis, Uterine Contraction, Endometrial Waves, Frozen Embryo Transfer (FET), Uterine Peristalsis, Hormone Replacement Therapy (HRT)View official trial listing → -
Recruiting NCT NCT07686718
To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.
Lancaster University 50 participants Est. completion 2027-08-01 1 siteOther conditions: Premenstrual Dysphoric Disorder ( PMDD)View official trial listing → -
Recruiting NCT NCT07697781
Office Hysteroscopy in Postmenopausal Women: A Randomized Trial of Cervical Preparation Strategies
Not yet reported Faculty of Medicine of Tunis 120 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Postmenopausal Women, Intrauterine Diseases, Endometrial Pathology, Postmenopausal Bleeding, Abnormal Uterine Bleeding (AUB)View official trial listing → -
Recruiting NCT NCT07697924
CURENDO (Cord-blood Uterine Regeneration Endometrium): Platelet-rich Plasma Therapy Derived From Umbilical Cord Blood for the Treatment of Endometrial Pathologies (Asherman Syndrome / Endometrial Atrophy / Thin Endometrium)
Not yet reported Fundación IVI 35 participants Est. completion 2029-12 1 siteOther conditions: Asherman SyndromeView official trial listing → -
Recruiting NCT NCT07704658
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Not yet reported Rigel Pharmaceuticals 12 participants Est. completion 2027-08-30 2 sitesOther conditions: NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced MalignanciesView official trial listing → -
Recruiting NCT NCT07792408
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
Not yet reported Vertex Pharmaceuticals Incorporated 148 participants Est. completion 2027-03-20 1 siteOther conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)View official trial listing → -
Recruiting NCT NCT07794150
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
Not yet reported Corium Innovations, Inc. 250 participants Est. completion 2027-05-31 2 sitesOther conditions: Menopause, Healthy Female ParticipantsView official trial listing → -
Recruiting NCT NCT07795736
Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury
University of Calgary 200 participants Est. completion 2028-11-01 2 sitesOther conditions: Growth Hormone Deficiency, Traumatic Brain InjuryView official trial listing → -
Recruiting NCT NCT07796880
Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2033-03-15 1 siteOther conditions: Hormone Receptor-Positive Breast Cancer, HER2 Low Breast Carcinoma, Early-Stage Breast CancerView official trial listing → -
Recruiting NCT NCT07831499
Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health
Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-07-15 1 siteOther conditions: Menopause, Healthy Adult, Brain, PostmenopausalView official trial listing → -
Terminated NCT NCT00000175
The Effects of Sex Hormones on Cognition and Mood in Older Adults
Not yet reported National Institute on Aging (NIA) Est. completion 2005-06 1 siteOther conditions: Cognition Disorders, Mood DisordersView official trial listing → -
Completed NCT NCT00000176
Alzheimer's Disease Prevention Trial
Not yet reported National Institute on Aging (NIA) Est. completion 2007-09 22 sitesOther conditions: Alzheimer Disease, Memory DisordersView official trial listing → -
Completed NCT NCT00000177
Estrogen Hormone Protocol
Not yet reported National Institute on Aging (NIA) 120 participants Est. completion 1999-01 25 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00000380
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
Not yet reported University of Washington Est. completion 2007-07Other conditions: Sleep DisordersView official trial listing → -
Completed NCT NCT00000399
Bone Estrogen Strength Training
Not yet reported University of Arizona 300 participants Est. completion 2001-01 1 siteOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00000419
Safety of Estrogens in Lupus: Hormone Replacement Therapy
Not yet reported NYU Langone Health 350 participants Est. completion 2002-08 16 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00000420
Safety of Estrogens in Lupus: Birth Control Pills
Not yet reported NYU Langone Health 350 participants Est. completion 2003-08 15 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00000421
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
Not yet reported NYU Langone Health 154 participants Est. completion 2003-08 3 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT00000430
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 240 participants Est. completion 2004-09 1 siteOther conditions: Osteopenia, OsteoporosisView official trial listing → -
Completed NCT NCT00000466
Postmenopausal Estrogen/Progestin Interventions (PEPI)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-10Cardiovascular disease Other conditions: Bone Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial Ischemia, Osteoporosis, Thrombosis, PostmenopauseView official trial listing → -
Completed NCT NCT00000482
Coronary Drug Project
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1985-03Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial IschemiaView official trial listing → -
Completed NCT NCT00000483
Coronary Drug Project Mortality Surveillance
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1985-03Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial IschemiaView official trial listing → -
Completed NCT NCT00000549
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-07Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, PostmenopauseView official trial listing → -
Completed NCT NCT00000555
Women's Angiographic Vitamin and Estrogen Trial (WAVE)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-05Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, PostmenopauseView official trial listing → -
Completed NCT NCT00000601
Postmenopausal Hormone Therapy in Unstable Angina
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2000-06Cardiovascular disease Other conditions: Angina, Unstable, Coronary Disease, Heart Diseases, PostmenopauseView official trial listing → -
Completed NCT NCT00000605
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-07Cardiovascular disease Other conditions: Coronary Arteriosclerosis, Coronary Disease, Heart Diseases, Myocardial Ischemia, PostmenopauseView official trial listing → -
Completed NCT NCT00000611
Women's Health Initiative (WHI)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI)Cardiovascular disease Other conditions: Bone Diseases, Breast Neoplasms, Colonic Neoplasms, Coronary Disease, Heart Diseases, Myocardial Ischemia, Osteoporosis, PostmenopauseView official trial listing → -
Completed NCT NCT00000612
Soy Estrogen Alternative Study (SEA)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1998-12Cardiovascular disease Other conditions: Endometrial Hyperplasia, Heart Diseases, Menopausal Complaints, Uterine Diseases, MenopauseView official trial listing → -
Completed NCT NCT00000897
A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants 6 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00001221
Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 160 participants Est. completion 2003-09 1 siteOther conditions: Gonadal Dysgenesis, Turner's SyndromeView official trial listing → -
Completed NCT NCT00001253
The Effects of Estrogen on Cognition in Girls With Turner Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 950 participants Est. completion 2004-03 1 siteOther conditions: Gonadal Dysgenesis, Turner's SyndromeView official trial listing → -
Completed NCT NCT00001259
A Treatment Study for Premenstrual Syndrome (PMS)
Not yet reported National Institute of Mental Health (NIMH) 60 participants Est. completion 2020-02-06 1 siteOther conditions: Premenstrual Syndrome, Menstruation DisturbancesView official trial listing → -
Completed NCT NCT00001275
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1134 participants Est. completion 2017-02-08 1 siteOther conditions: Amenorrhea, Hypoaldosteronism, Hypogonadism, Infertility, Premature Ovarian FailureView official trial listing → -
Completed NCT NCT00001285
Effects of Sex Hormones on Circadian Rhythm in Men and Women
National Institute of Mental Health (NIMH) 73 participants Est. completion 2000-06 1 siteOther conditions: Bipolar Disorder, Circadian Rhythm, Depressive DisorderView official trial listing → -
Completed NCT NCT00001322
The Effects of Reproductive Hormones on Mood and Behavior
Not yet reported, Not yet reported National Institute of Mental Health (NIMH) 100 participants Est. completion 2020-03-03 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT00001343
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 80 participants Est. completion 2007-10-10 2 sitesOther conditions: Dwarfism, Turner's SyndromeView official trial listing → -
Completed NCT NCT00001454
Hormonal Effects on the Uterus and Endometrium
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 129 participants Est. completion 2015-07-27 1 siteOther conditions: PregnancyView official trial listing → -
Completed NCT NCT00001521
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 66 participants Est. completion 2024-04-01 1 siteOther conditions: Congenital Adrenal Hyperplasia (CAH)View official trial listing → -
Completed NCT NCT00001770
Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)
National Institute of Mental Health (NIMH) 50 participants Est. completion 2003-03 1 siteOther conditions: Depressive Disorder, Mood Disorder, Psychomotor AgitationView official trial listing → -
Completed NCT NCT00001848
The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612 participants Est. completion 2006-01 1 siteOther conditions: Endometriosis, Pelvic PainView official trial listing → -
Completed NCT NCT00001890
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2001-03 1 siteOther conditions: Atherosclerosis, Chlamydia Infections, Cytomegalovirus Infections, Pneumonia, Bacterial, PostmenopauseView official trial listing → -
Completed NCT NCT00001951
Hormone Replacement in Young Women With Premature Ovarian Failure
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 250 participants Est. completion 2006-10 1 siteOther conditions: Healthy, Osteoporosis, Premature Ovarian FailureView official trial listing → -
Completed NCT NCT00002721
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Not yet reported University of New Mexico 18 participants Est. completion 2013-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00002775
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Not yet reported, Not yet reported Herbert Irving Comprehensive Cancer Center 37 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00002855
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00002967
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Not yet reported NSABP Foundation Inc Est. completion 2006-03 108 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00003066
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Not yet reported Herbert Irving Comprehensive Cancer Center 40 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003084
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 75 participants Est. completion 2002-11 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003098
Diet and Estrogen Metabolism in Postmenopausal Women
Not yet reported Jonsson Comprehensive Cancer Center 12 participants Est. completion 2004-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003394
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2003-04 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003584
Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
Not yet reported University of New Mexico 35 participants Est. completion 2000-12 1 siteOther conditions: Kidney CancerView official trial listing → -
Status unknown NCT NCT00003633
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
Not yet reported Herbert Irving Comprehensive Cancer Center 12 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00003717
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Not yet reported St. Barnabas Medical Center 17 participants 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00003771
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
Not yet reported Regional Oncologic Center 1300 participants Est. completion 2004-02 6 sitesOther conditions: Breast Cancer, Menopausal SymptomsView official trial listing → -
Completed NCT NCT00003992
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
Not yet reported National Cancer Institute (NCI) 200 participants Est. completion 2009-03 45 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00004001
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported SWOG Cancer Research Network 770 participants Est. completion 2007-01 16 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004054
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00004105
Combination Chemotherapy in Treating Patients With Advanced Cancer
Not yet reported, Not yet reported NYU Langone Health 1 siteOther conditions: Leukemia, Lymphoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00004274
Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 260 participants 1 siteOther conditions: Turner's SyndromeView official trial listing → -
Completed NCT NCT00004565
Susceptibility to Breast Cancer
National Cancer Institute (NCI) 737 participants Est. completion 2012-05-04 1 siteOther conditions: Breast Cancer, HealthyView official trial listing → -
Completed NCT NCT00004650
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 150 participantsOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00004763
Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Not yet reported National Center for Research Resources (NCRR) 45 participantsOther conditions: HyperandrogenismView official trial listing → -
Completed NCT NCT00005011
Combined Hormone Replacement in Menstrually-Related Mood Disorders
National Institute of Mental Health (NIMH) 22 participants Est. completion 2016-10-28 1 siteOther conditions: Premenstrual Syndrome, DepressionView official trial listing → -
Completed NCT NCT00005048
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported NYU Langone Health 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005108
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2002-01 1 siteOther conditions: Atherosclerosis, Healthy, Vascular DiseaseView official trial listing → -
Completed NCT NCT00005185
Myocardial Infarction and Non-contraceptive Estrogen Use
National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1990-03Cardiovascular disease Other conditions: Heart Diseases, Menopause, PostmenopauseView official trial listing → -
Completed NCT NCT00005446
Endogenous Estrogen and Coronary Heart Disease in Women
NYU Langone HealthCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, PostmenopauseView official trial listing → -
Completed NCT NCT00005466
Stroke and MI in Users of Estrogen/Progestogen
National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1995-07Cardiovascular disease Other conditions: Heart Diseases, Coronary Disease, Cerebrovascular Accident, PostmenopauseView official trial listing → -
Completed NCT NCT00005627
Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00005768
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women
Not yet reported National Center for Research Resources (NCRR) 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00005810
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005822
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Not yet reported Case Comprehensive Cancer Center 21 participants Est. completion 2003-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Eastern Cooperative Oncology Group 19 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00005879
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
Not yet reported University of Kansas Medical Center 199 participants Est. completion 2008-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00005923
The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity
National Center for Research Resources (NCRR) 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00005970
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Not yet reported National Cancer Institute (NCI) 3436 participants Est. completion 2010-01-27 157 sitesOther conditions: Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7View official trial listing → -
Completed NCT NCT00006133
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Not yet reported National Center for Research Resources (NCRR) 970 participants 17 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00006324
Hormonal Birth Control and the Risk of Acquiring HIV
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6360 participants Est. completion 2002-12 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00006399
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Not yet reported National Center for Research Resources (NCRR) 45 participants Est. completion 2004-03 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT00006903
Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Not yet reported Gynecologic Oncology Group 67 participantsOther conditions: Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7View official trial listing → -
Completed NCT NCT00009659
Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 58 participants Est. completion 2001-12 1 siteOther conditions: PostmenopauseView official trial listing → -
Terminated NCT NCT00010153
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00010829
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
Not yet reported National Center for Complementary and Integrative Health (NCCIH) Est. completion 2005-12 1 siteCardiovascular disease Other conditions: Osteoporosis, Breast Cancer, Endometrial CancerView official trial listing → -
Completed NCT NCT00012025
ICI 182780 in Treating Women With Metastatic Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 80 participants Est. completion 2008-08 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00013546
Hormone Replacement Therapy to Treat Turner Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 92 participants Est. completion 2002-12 1 siteOther conditions: Osteoporosis, Turner's SyndromeView official trial listing → -
Completed NCT NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 1 siteOther conditions: Prostate Cancer, ThromboembolismView official trial listing → -
Completed NCT NCT00016107
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
Not yet reported National Cancer Institute (NCI) 72 participants 1 siteOther conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT00018343
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Not yet reported US Department of Veterans Affairs Est. completion 2001-03 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00021372
Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Not yet reported Fox Chase Cancer Center 25 participants Est. completion 2006-09 17 sitesOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00022516
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 1086 participants Est. completion 2016-08 36 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00024167
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Not yet reported M.D. Anderson Cancer Center 265 participants 40 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00025194
Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2006-07 4 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00026039
Women's Estrogen for Stroke Trial (WEST)
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS)Cardiovascular diseaseView official trial listing → -
Completed NCT NCT00026286
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Not yet reported Eastern Cooperative Oncology Group Est. completion 2007-06-15 24 sitesOther conditions: Breast Cancer, Hot Flashes, Menopausal SymptomsView official trial listing → -
Completed NCT NCT00027859
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Eastern Cooperative Oncology Group 98 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00028769
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2011-07 91 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00029159
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
Not yet reported Thomas Jefferson University 200 participants Est. completion 2012-06 2 sitesOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT00029757
Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women
Not yet reported National Center for Research Resources (NCRR) 15 participants 1 siteOther conditions: Menopause, PostmenopauseView official trial listing → -
Completed NCT NCT00030095
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Not yet reported National Cancer Institute (NCI) 2 sitesOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00030654
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Not yet reported Radiation Therapy Oncology Group 21 participants Est. completion 2005-02-04 78 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00033358
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Not yet reported National Cancer Institute (NCI) 52 participants 1 siteOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00038168
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 14 participants Est. completion 2003-01 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00038246
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2004-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00041431
Estrogen, Cytokines and Heart Failure in Women
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-12Cardiovascular diseaseHeart failure Other conditions: Heart Diseases, MenopauseView official trial listing → -
Completed NCT NCT00041899
Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 15 participants Est. completion 2005-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00042289
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 1578 participants Est. completion 2020-09-30 62 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00043069
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Not yet reported Alliance for Clinical Trials in Oncology 71 participants Est. completion 2010-01 114 sites Stand-aloneOther conditions: Osteoporosis, Prostate CancerView official trial listing → -
Completed NCT NCT00044291
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 865 participants Est. completion 2006-01 63 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-dependentView official trial listing → -
Terminated NCT NCT00044837
Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 120 participants 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00044876
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 56 participants Est. completion 2015-10-01 1 siteOther conditions: LeiomyomaView official trial listing → -
Completed NCT NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Not yet reported Nuvance Health Est. completion 2009-10 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2007-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00050011
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Not yet reported Novartis Pharmaceuticals 602 participants Est. completion 2009-01 44 sitesOther conditions: Breast Neoplasms, OsteoporosisView official trial listing → -
Completed NCT NCT00050141
Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121 participants Est. completion 2008-01 23 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00052845
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Not yet reported Alliance for Clinical Trials in Oncology 80 participants Est. completion 2009-04 80 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00056082
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
Not yet reported University of Kansas Medical Center 110 participants Est. completion 2013-07 3 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00056901
Screening Evaluation for Women With Postpartum Depression
National Institute of Mental Health (NIMH) 68 participants Est. completion 2017-12-24 1 siteOther conditions: Postpartum Depression, DepressionView official trial listing → -
Completed NCT NCT00057941
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 148 participants Est. completion 2012-06 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Terminated NCT NCT00059228
Clinical Trial of Estrogen for Postpartum Depression
Not yet reported National Institute of Mental Health (NIMH) 12 participants Est. completion 2016-11-15 1 siteOther conditions: Postpartum Depression, DepressionView official trial listing → -
Completed NCT NCT00060736
The Effects of Estrogen Withdrawal on Mood Symptoms in Women
National Institute of Mental Health (NIMH) 60 participants Est. completion 2016-04-27 1 siteOther conditions: Perimenopausal Depression, Post Menopausal, Healthy, DepressionView official trial listing → -
Completed NCT NCT00065325
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Not yet reported AstraZeneca 694 participants Est. completion 2014-09 117 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00066157
Alzheimer's Disease: Therapeutic Potential of Estrogen
Not yet reported, Not yet reported University of Wisconsin, Madison 42 participants Est. completion 2007-12 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00066703
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 2672 participants Est. completion 2024-10-23 228 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00067509
Emergency Contraception (ECP): Reducing Unintended Pregnancies
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1100 participants Est. completion 2004-05 2 sitesOther conditions: Contraception, PregnancyView official trial listing → -
Completed NCT NCT00068328
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Alliance for Clinical Trials in Oncology 1706 participants Est. completion 2016-12 85 sitesOther conditions: Breast Cancer, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00068419
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Not yet reported Children's Oncology Group 70 participants Est. completion 2010-04-26 1 site Stand-aloneOther conditions: Desmoid TumorView official trial listing → -
Completed NCT NCT00068601
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Not yet reported SWOG Cancer Research Network 257 participants Est. completion 2016-09 34 sitesOther conditions: Breast Cancer, Infertility, Menopausal SymptomsView official trial listing → -
Active, not recruiting NCT NCT00070564
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Not yet reported SWOG Cancer Research Network 3294 participants Est. completion 2027-01 542 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00072293
Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases
Not yet reported ETOP IBCSG Partners Foundation 931 participants Est. completion 2017-03-31 31 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00075764
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
Not yet reported SWOG Cancer Research Network 695 participants Est. completion 2018-10-01 426 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00076050
Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms
Not yet reported University of Miami 248 participants Est. completion 2009-06 1 siteOther conditions: Menopause, Osteoporosis, OsteopeniaView official trial listing → -
Completed NCT NCT00077025
Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer
Not yet reported AstraZeneca 174 participants Est. completion 2013-05 27 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00077168
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
Not yet reported Institute of Cancer Research, United Kingdom 2000 participants 29 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00079248
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 1 siteOther conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, OsteoporosisView official trial listing → -
Withdrawn NCT NCT00080613
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Not yet reported Robert H. Lurie Cancer Center 1 siteOther conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Status unknown NCT NCT00080756
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
Not yet reported City of Hope Medical Center 11 participants Est. completion 2024-10-15 1 siteOther conditions: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast CancerView official trial listing → -
Completed NCT NCT00081705
Estrogen Receptor Variants, HDL, and Atherosclerosis
National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2007-02Cardiovascular disease Other conditions: Atherosclerosis, Coronary Arteriosclerosis, Heart DiseasesView official trial listing → -
Completed NCT NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2008-09 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT00083005
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
Not yet reported National Institutes of Health Clinical Center (CC) 60 participants Est. completion 2007-12 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00083824
Estrogen, HDL, and Coronary Heart Disease in Women
Not yet reported, Not yet reported Tufts University 309 participants Est. completion 2007-02 1 site Stand-aloneCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00084396
Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Not yet reported Washington University School of Medicine 115 participants Est. completion 2016-09 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00084565
Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
Not yet reported Fox Chase Cancer Center Est. completion 2004-11Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00088153
Effects of Anorexia Nervosa on Bone Mass in Adolescents
Not yet reported, Not yet reported Massachusetts General Hospital 110 participants Est. completion 2011-06 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Terminated NCT NCT00089414
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
Not yet reported National Institute of Mental Health (NIMH) 5 participants Est. completion 2010-06 1 siteOther conditions: Premenstrual Syndrome, PMS, Premenstrual Dysphoric Disorder, PMDD, DepressionView official trial listing → -
Completed NCT NCT00090857
Letrozole in Preventing Breast Cancer in Postmenopausal Women
Not yet reported Dana-Farber Cancer Institute 49 participants Est. completion 2013-03 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00093002
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Not yet reported AstraZeneca 179 participants Est. completion 2007-07 31 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00097058
Estrogen Use in Protection From Cognitive Decline
Stanford University 71 participants Est. completion 2014-11 1 siteOther conditions: Aging, MenopauseView official trial listing → -
Terminated NCT NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-DependentView official trial listing → -
Active, not recruiting NCT NCT00099437
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
Not yet reported AstraZeneca 736 participants Est. completion 2026-12-31 106 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00100360
Hormonal Causes of Menstrual-Related Mood Disorders
National Institute of Mental Health (NIMH) 22 participants Est. completion 2016-12-15 1 siteOther conditions: Mood Disorders, DepressionView official trial listing → -
Completed NCT NCT00100451
Aging, Exercise, and Hormonal Influences of Fat Metabolism
Not yet reported US Department of Veterans Affairs Est. completion 2001-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00100854
Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Not yet reported Translational Oncology Research International 108 participants Est. completion 2018-09-05 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00102141
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Not yet reported Bayer 750 participants Est. completion 2005-07Other conditions: Hypertension, PostmenopauseView official trial listing → -
Completed NCT NCT00104572
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
Not yet reported National Institute on Aging (NIA) 44 participants Est. completion 2015-01 1 siteOther conditions: Hypogonadism, Diabetes, Sarcopenia, Osteoporosis, DepressionView official trial listing → -
Completed NCT NCT00108238
Estrogen Alternatives Study
Not yet reported US Department of Veterans Affairs Est. completion 2006-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00108849
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Not yet reported Novo Nordisk A/S 309 participants Est. completion 2007-05 57 sitesOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT00111241
Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
Monash University 115 participants Est. completion 2011-12 1 siteOther conditions: ArthralgiaView official trial listing → -
Completed NCT NCT00113100
Mechanisms of Skin Repair by Topical Estrogen
Not yet reported University of Michigan 152 participants Est. completion 2007-06 1 siteOther conditions: Skin WrinklingView official trial listing → -
Completed NCT NCT00114270
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
Not yet reported University of Virginia Est. completion 2007-06 1 siteOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00115024
EPAT: Estrogen in the Prevention of Atherosclerosis Trial
Not yet reported, Not yet reported National Institute on Aging (NIA) 222 participants Est. completion 1998-11 1 siteOther conditions: Atherosclerosis, PostmenopauseView official trial listing → -
Completed NCT NCT00115505
Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology 307 participants Est. completion 2016-06 227 sitesOther conditions: Breast CarcinomaView official trial listing → -
Withdrawn NCT NCT00117260
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Not yet reported Duramed Research Est. completion 2007-08Other conditions: OsteopeniaView official trial listing → -
Completed NCT NCT00117273
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
Not yet reported Duramed Research 36 participants Est. completion 2006-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 226 participants Est. completion 2009-09 1 siteOther conditions: Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast CancerView official trial listing → -
Terminated NCT NCT00123539
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 334 participants Est. completion 2005-08 1 siteCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Neurologic ManifestationsView official trial listing → -
Status unknown NCT NCT00126464
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
Not yet reported Cedars-Sinai Medical Center 100 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00127075
POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis
Not yet reported Hospices Civils de Lyon 300 participants Est. completion 2012-04 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00128934
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 744 participants Est. completion 2007-12 83 sitesOther conditions: Menstruation Disturbances, Premenstrual SyndromeView official trial listing → -
Completed NCT NCT00131495
Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
Not yet reported Warner Chilcott 814 participants Est. completion 2007-02 1 siteOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Terminated NCT NCT00131924
High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Not yet reported Northwestern University 1 participants Est. completion 2006-01 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00132756
Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Not yet reported, Not yet reported Morton Plant Mease Health Care 30 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00133354
Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys
Not yet reported, Not yet reported Nemours Children's Clinic 53 participants Est. completion 2010-08 1 siteOther conditions: HypopituitarismView official trial listing → -
Completed NCT NCT00134654
Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
Not yet reported Dana-Farber Cancer Institute 48 participants Est. completion 2011-06 3 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00134680
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
Not yet reported Duke University 33 participants Est. completion 2005-07 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00134745
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
Not yet reported Line Cleemann 43 participants Est. completion 2013-03 1 siteOther conditions: Turner SyndromeView official trial listing → -
Completed NCT NCT00136032
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
Not yet reported Massachusetts General Hospital 63 participants Est. completion 2006-11 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT00137371
Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 480 participants Est. completion 2007-09 49 sitesOther conditions: Atrophic Vaginitis, Atrophy, VaginitisView official trial listing → -
Terminated NCT NCT00138125
Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
Not yet reported Translational Oncology Research International 2 participants Est. completion 2009-12 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00140998
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
Not yet reported Nemours Children's Clinic 16 participants Est. completion 2004-06 1 siteOther conditions: Turner Syndrome, Hypogonadism, Premature Ovarian FailureView official trial listing → -
Terminated NCT NCT00141544
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 28 participants Est. completion 2008-03 78 sitesOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT00141557
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 133 participants Est. completion 2008-03 78 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00141570
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 350 participants Est. completion 2007-06 77 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00145522
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
Not yet reported Solvay Pharmaceuticals 135 participants Est. completion 2009-03 11 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00146146
Testosterone and Its Metabolites in GID
Not yet reported Unita Complessa di Ostetricia e Ginecologia 15 participants Est. completion 2008-01 1 siteOther conditions: TranssexualismView official trial listing → -
Completed NCT NCT00146601
Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Not yet reported Dana-Farber Cancer Institute 35 participants Est. completion 2007-07 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00149604
AFTER: Altering Fat Through Estrogen and Raloxifene
Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 siteOther conditions: PostmenopauseView official trial listing → -
Status unknown NCT NCT00150163
Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men
Odense University Hospital 800 participants Est. completion 2008-12 1 siteOther conditions: Bone DiseasesView official trial listing → -
Completed NCT NCT00151060
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2006-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00151073
Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
Not yet reported University of Michigan Rogel Cancer Center 28 participants Est. completion 2007-09 1 siteOther conditions: Hormone-Refractory Prostate CancerView official trial listing → -
Completed NCT NCT00151086
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 33 participants Est. completion 2006-08 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00152282
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
Not yet reported Abbott 105 participants Est. completion 2001-08Other conditions: Amenorrhea, PostmenopauseView official trial listing → -
Completed NCT NCT00152295
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
Not yet reported Abbott 18 participants Est. completion 2001-12Other conditions: PostmenopauseView official trial listing → -
Status unknown NCT NCT00154180
Kronos Early Estrogen Prevention Study (KEEPS)
Not yet reported Kronos Longevity Research Institute 728 participants Est. completion 2012-07 9 sitesOther conditions: Menopause, ArteriosclerosisView official trial listing → -
Completed NCT NCT00160173
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
Not yet reported ASCEND Therapeutics 221 participants Est. completion 2005-09-06 109 sitesOther conditions: Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT00160316
Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Not yet reported Solvay Pharmaceuticals 454 participants Est. completion 2007-12 22 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00160342
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Not yet reported Solvay Pharmaceuticals 1251 participants Est. completion 2007-09 125 sitesOther conditions: Hot Flushes, Menopause, PostmenopauseView official trial listing → -
Completed NCT NCT00161681
Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-08 48 sitesOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT00163033
Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women
Not yet reported Pantarhei Bioscience 49 participants Est. completion 2007-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sitesOther conditions: Adenocarcinoma of the Prostate, Prostate CancerView official trial listing → -
Completed NCT NCT00167648
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer
Not yet reported University of Washington 17 participants Est. completion 2006-12 2 sitesOther conditions: Cancer, Prostate NeoplasmsView official trial listing → -
Completed NCT NCT00167921
Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants 2 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Status unknown NCT NCT00169299
Herbal Alternatives for Menopause Symptoms (HALT Study)
Not yet reported Kaiser Permanente 351 participants Est. completion 2004-09 1 siteOther conditions: Vasomotor Symptoms Associated With MenopauseView official trial listing → -
Completed NCT NCT00171340
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
Not yet reported Novartis Pharmaceuticals 1065 participants Est. completion 2010-02 106 sitesOther conditions: Bone Loss, Breast CancerView official trial listing → -
Status unknown NCT NCT00173550
Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
National Taiwan University Hospital 200 participants 1 siteOther conditions: Menopause, Premature, Hysterectomy, Ovariectomy, Estrogen Replacement Therapy, Attitude, PerceptionView official trial listing → -
Terminated NCT NCT00176644
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
Not yet reported University of Medicine and Dentistry of New Jersey 23 participants Est. completion 2008-12 6 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00179426
Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
Beth Israel Deaconess Medical Center 175 participants Est. completion 2006-06 1 siteOther conditions: Seizure Disorder, EpilepsyView official trial listing → -
Completed NCT NCT00182091
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Not yet reported Massachusetts General Hospital 75 participants Est. completion 2010-12 1 siteOther conditions: Acromegaly, Growth Hormone Deficiency, Pituitary DiseaseView official trial listing → -
Completed NCT NCT00183924
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
Not yet reported University of Southern California 20 participants Est. completion 2008-12 1 siteOther conditions: Prostate AdenocarcinomaView official trial listing → -
Completed NCT NCT00185224
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
Not yet reported Bayer 58 participants Est. completion 2006-03 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00185237
Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch
Not yet reported Bayer 165 participants Est. completion 2006-11Other conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00185328
Efficacy and Tolerability of Angeliq in Thai Women
Not yet reported Bayer 55 participants Est. completion 2006-12Other conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00185419
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
Not yet reported Bayer 842 participants Est. completion 2006-03 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00185458
Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
Not yet reported Bayer 394 participants Est. completion 2008-05 12 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00185484
Efficacy and Safety Oral Contraceptive Study
Not yet reported Bayer 1113 participants Est. completion 2006-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00186121
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
Not yet reported Stanford University 35 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00193050
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
Not yet reported SCRI Development Innovations, LLC 110 participants Est. completion 2009-03 Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00193193
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
Not yet reported SCRI Development Innovations, LLC 100 participants Est. completion 2007-02Other conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00193271
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
Not yet reported SCRI Development Innovations, LLC 30 participants Est. completion 2007-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00193726
Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer
Not yet reported Sudeep Gupta 273 participants Est. completion 2012-03-30 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00195455
Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 133 participants Est. completion 2007-03 6 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00195559
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 526 participants Est. completion 2007-12 51 sitesOther conditions: Premenstrual Syndrome, Menstruation DisturbancesView official trial listing → -
Completed NCT NCT00196313
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Not yet reported Duramed Research 95 participants Est. completion 2008-10 13 sitesOther conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00196326
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
Not yet reported Duramed Research 2235 participants Est. completion 2007-06 55 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00196352
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Not yet reported Duramed Research 320 participants Est. completion 2006-11 11 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00196365
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Not yet reported Duramed Research 97 participants Est. completion 2007-07 18 sitesOther conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00196378
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
Not yet reported Duramed Research 300 participants Est. completion 2006-02 38 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00201864
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2014-02 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00203996
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
Not yet reported University of Chicago 37 participants Est. completion 2008-06 1 site Stand-aloneObstructive sleep apnea Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT00204074
Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.
Not yet reported, Not yet reported University Hospital, Linkoeping Est. completion 2005-07 1 siteOther conditions: MigraineView official trial listing → -
Completed NCT NCT00204438
Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle
Not yet reported University of Saskatchewan 45 participants Est. completion 2002-12 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00204451
Human Ovarian Follicular Dynamics and Emergency Contraception
Not yet reported University of Saskatchewan 40 participants Est. completion 2006-06 1 siteOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT00206414
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
Not yet reported Baylor Breast Care Center 15 participants Est. completion 2006-09 1 siteOther conditions: BREAST CANCERView official trial listing → -
Completed NCT NCT00206544
Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?
Not yet reported The Alfred 51 participants Est. completion 2007-12 1 siteOther conditions: Bipolar Disorder, Mania, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00206570
Clinical Estradiol Trial in Women With Schizophrenia
Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Terminated NCT NCT00210028
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
Not yet reported Institut Claudius Regaud 40 participants Est. completion 2008-08 3 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00212277
Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
Not yet reported Nobelpharma Est. completion 2007-02Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00212342
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
Not yet reported Nobelpharma 100 participants Est. completion 2006-03Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00213096
Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive
Not yet reported Population Council 50 participants Est. completion 2004-02 1 siteOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT00217464
Fulvestrant in Treating Patients With Recurrent Prostate Cancer
Not yet reported Roswell Park Cancer Institute 17 participants Est. completion 2010-03 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00218205
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Not yet reported Department of Veterans Affairs, New Jersey 28 participants Est. completion 2006-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00220324
Pearl Index Study With Low Dose Combined Oral Contraceptive
Not yet reported Bayer 840 participants Est. completion 2005-11 25 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00220454
Effect of Estrogen & Stress for Postmenopausal Women
Not yet reported Seattle Institute for Biomedical and Clinical Research 40 participants Est. completion 2005-03Other conditions: AgingView official trial listing → -
Completed NCT NCT00224094
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
Not yet reported Watson Pharmaceuticals 27 participants 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00227942
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
Not yet reported Hadine Joffe, MD 86 participants Est. completion 2007-11 1 site Stand-aloneOther conditions: Sleep Initiation and Maintenance Disorders, DepressionView official trial listing → -
Completed NCT NCT00229450
Estrogen and Perimenopausal Depression
Not yet reported University of California, Los Angeles 17 participants Est. completion 2004-08 1 site Stand-aloneOther conditions: Depressive Disorder, Major, MenopauseView official trial listing → -
Completed NCT NCT00229697
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
Not yet reported AstraZeneca 317 participants Est. completion 2015-06 55 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00230815
A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction
Not yet reported EMD Serono 62 participants Est. completion 2005-11Other conditions: InfertilityView official trial listing → -
Completed NCT NCT00232505
Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
Not yet reported UNC Lineberger Comprehensive Cancer Center 112 participants Est. completion 2012-08-12 14 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00234403
A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer
Not yet reported AstraZeneca 60 participants Est. completion 2007-10 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00234676
POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
Not yet reported The Parkinson Study Group 23 participants Est. completion 2006-03 6 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00234819
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 325 participants Est. completion 2007-02 7 sitesOther conditions: Vasomotor Symptoms Associated With MenopauseView official trial listing → -
Terminated NCT NCT00236301
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2007-01 1 siteOther conditions: Healthy Symptomatic Menopausal WomenView official trial listing → -
Completed NCT NCT00236769
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1751 participants Est. completion 1999-10Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00236782
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1517 participants Est. completion 1999-03Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00236795
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1494 participants Est. completion 1999-03Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00237042
Managing Temporomandibular Disorder (TMD) Symptoms
Not yet reported University of Washington 252 participants Est. completion 2010-06 1 siteOther conditions: Temporomandibular Joint DisordersView official trial listing → -
Completed NCT NCT00237198
Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
Not yet reported Novartis Pharmaceuticals 47 participants 24 sitesOther conditions: Postmenopausal Women With Advanced Breast CancerView official trial listing → -
Completed NCT NCT00238732
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 650 participants Est. completion 2007-03 63 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Completed NCT NCT00239343
Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer
Not yet reported AstraZeneca 160 participants Est. completion 2007-05 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00240071
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00241449
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sitesOther conditions: Breast Cancer, MetastasisView official trial listing → -
Completed NCT NCT00242710
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
Not yet reported Pfizer 1083 participants Est. completion 2008-09 9 sites Stand-aloneOther conditions: Endometrial Hyperplasia, OsteoporosisView official trial listing → -
Completed NCT NCT00244998
Fulvestrant in Treating Patients With Advanced Prostate Cancer
Not yet reported Roswell Park Cancer Institute 20 participants Est. completion 2012-06 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00245921
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 2000 participants Est. completion 2005-10Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00248963
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 600 participants Est. completion 2004-10Other conditions: Oral ContraceptiveView official trial listing → -
Terminated NCT NCT00249847
Study of PET Scans and Serotonin in Hot Flashes Treatment
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5 participants Est. completion 2008-04 1 site Stand-aloneOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00251082
Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Not yet reported Solvay Pharmaceuticals 391 participants Est. completion 2007-10 18 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00252408
Danish Osteoporosis Prevention Study
Not yet reported University of Aarhus 2000 participants Est. completion 2003-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Withdrawn NCT NCT00252811
A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer
Not yet reported AstraZeneca 60 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00253422
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
Not yet reported Institute of Cancer Research, United Kingdom 698 participants Est. completion 2022-11-28 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00253539
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
Not yet reported The Cleveland Clinic 3 participants Est. completion 2005-04Other conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)View official trial listing → -
Completed NCT NCT00254189
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2004-10Other conditions: OvulationView official trial listing → -
Completed NCT NCT00254865
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 34 participants Est. completion 2003-03Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00255125
Role of Soy Supplementation in Prostate Cancer Development
Not yet reported VA Office of Research and Development 86 participants Est. completion 2009-10 1 siteOther conditions: Prostate NeoplasmView official trial listing → -
Completed NCT NCT00255463
Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study
Not yet reported AstraZeneca 185 participants Est. completion 2005-11 34 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00256698
Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
Not yet reported AstraZeneca 514 participants Est. completion 2012-02 85 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00258063
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2004-09Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00258076
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2004-09Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00261482
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
Not yet reported Janssen Pharmaceutica N.V., Belgium 778 participants Est. completion 2004-12Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00263341
Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
Not yet reported Population Council 1135 participants Est. completion 2014-08 12 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00264407
Neural Changes in the Aging Auditory System
University of Rochester 126 participants Est. completion 2005-02 2 sitesAlcohol use disorder Other conditions: Progesterone, Estrogens, Hearing, PsychoacousticsView official trial listing → -
Completed NCT NCT00265759
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 622 participants Est. completion 2019-11-27 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00266032
Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
Not yet reported Bayer 1166 participants Est. completion 2008-10 35 sitesOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT00267553
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 200 participants Est. completion 2006-06 35 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-DependentView official trial listing → -
Active, not recruiting NCT NCT00268476
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
Not yet reported, Not yet reported Medical Research Council 11992 participants Est. completion 2030-12 120 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00269620
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
Not yet reported University of Pittsburgh 500 participants Est. completion 2006-12 10 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00272740
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer
Not yet reported AstraZeneca 93 participants 8 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00272935
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
Not yet reported Duramed Research 400 participants Est. completion 2007-05 49 sitesOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00274469
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
Not yet reported AstraZeneca 205 participants Est. completion 2017-01-13 41 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00276081
Gabapentin Versus Estrogen for the Treatment of Hot Flashes
Not yet reported University of Rochester 60 participants Est. completion 2004-09 1 siteOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00278915
Faslodex in McCune-Albright Syndrome
Not yet reported AstraZeneca 30 participants Est. completion 2023-07-20 16 sitesOther conditions: Puberty, Precocious, McCune-Albright SyndromeView official trial listing → -
Completed NCT NCT00283608
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
Mayo Clinic 1000 participants Est. completion 2010-03 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00283816
Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
Not yet reported University of Rochester 36 participants Est. completion 2008-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00286364
Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial
Not yet reported Copenhagen University Hospital, Rigshospitalet 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00288002
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Not yet reported GBG Forschungs GmbH 1500 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00290251
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72 participants Est. completion 2010-08 2 sitesOther conditions: LeiomyomaView official trial listing → -
Completed NCT NCT00293059
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Not yet reported Bayer 190 participants Est. completion 2008-05 46 sites Stand-aloneOther conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00294463
Effects of Tibolone Treatment on the Endometrium
Not yet reported Erasmus Medical Center 35 participants Est. completion 2005-03 1 siteOther conditions: Postmenopause, OsteoporosisView official trial listing → -
Completed NCT NCT00298025
A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
Not yet reported EMD Serono 185 participants Est. completion 2004-05Other conditions: Infertile Women Undergoing Assisted Reproductive Technology (ART)View official trial listing → -
Completed NCT NCT00301353
Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women
Not yet reported TNO 300 participants Est. completion 2004-07 3 sitesOther conditions: OsteoporosisView official trial listing → -
Withdrawn NCT NCT00301587
A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2004-12Other conditions: Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nervous System MalformationsView official trial listing → -
Terminated NCT NCT00302731
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Not yet reported Jeanne Drisko, MD, CNS, FACN 21 participants Est. completion 2014-09 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00303524
Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients
Not yet reported AstraZeneca 170 participants Est. completion 2009-02 22 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00303615
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
Not yet reported Legacy Health System 5 participants Est. completion 2007-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT00303784
Prostate Adenocarcinoma TransCutaneous Hormones
Not yet reported University College, London 2200 participants Est. completion 2021-08 32 sitesOther conditions: Anemia, Cardiovascular Complications, Hot Flashes, Osteoporosis, Prostate CancerView official trial listing → -
Completed NCT NCT00305448
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
Not yet reported AstraZeneca 143 participants Est. completion 2012-02 35 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00305825
Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery
Not yet reported University of California, San Francisco 43 participants Est. completion 2016-05-24 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00306618
Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
Not yet reported CASI pharmaceuticals, Inc. 27 participants Est. completion 2008-12 1 siteOther conditions: Recurrent Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT00307632
An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
Not yet reported Janssen-Cilag Farmaceutica Ltda. 580 participants Est. completion 2004-12 12 sitesOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT00307775
Vaginal Estrogen for the Treatment of Faecal Incontinence in Women
Not yet reported London North West Healthcare NHS Trust 43 participants Est. completion 2011-10 1 siteOther conditions: Fecal IncontinenceView official trial listing → -
Completed NCT NCT00307801
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Not yet reported Bayer 231 participants Est. completion 2008-05 36 sites Stand-aloneOther conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00309855
Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
Not yet reported Mayo Clinic 80 participants Est. completion 2008-08 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT00310531
3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Not yet reported Bayer 500 participants Est. completion 2007-06Other conditions: OsteopeniaView official trial listing → -
Completed NCT NCT00310791
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Not yet reported, Not yet reported Boston Children's Hospital 80 participants Est. completion 2010-12 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT00313170
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
Not yet reported AstraZeneca 144 participants Est. completion 2019-03-13 34 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT00315107
Estrogen Treatment in Acromegalic Women
Not yet reported Université de Montréal 30 participants Est. completion 2007-08 1 siteOther conditions: AcromegalyView official trial listing → -
Completed NCT NCT00318318
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20 participants Est. completion 2007-02 1 siteOther conditions: Healthy, Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT00319163
Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 26 participants Est. completion 2006-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00319566
Heart and Estrogen-Progestin Replacement Study (HERS)
Not yet reported University of California, San Francisco 2430 participants Est. completion 2001-07 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00320580
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen
Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 239 participants Est. completion 2003-03Other conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00322348
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women
Not yet reported AstraZeneca 98 participants Est. completion 2009-11 14 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00324259
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Washington University School of Medicine 66 participants Est. completion 2014-08 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT00326404
Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents
Not yet reported The Hospital for Sick Children 130 participants Est. completion 2009-05 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00327769
Faslodex Advanced Breast Cancer Local Chinese Study
Not yet reported AstraZeneca 234 participants Est. completion 2007-09 12 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00328120
Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Not yet reported AstraZeneca 20 participants Est. completion 2010-06 5 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00328497
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
Not yet reported CASI pharmaceuticals, Inc. 31 participants Est. completion 2009-12 1 siteOther conditions: Carcinoid TumorView official trial listing → -
Terminated NCT NCT00328926
Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
Not yet reported EMD Serono 11 participants Est. completion 2012-05 1 siteOther conditions: Hypogonadotropic HypogonadismView official trial listing → -
Completed NCT NCT00331071
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 334 participants Est. completion 2006-03Other conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT00331123
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Not yet reported Warner Chilcott 562 participants Est. completion 2006-07 3 sitesOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT00331214
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Not yet reported Warner Chilcott 533 participants Est. completion 2006-07 3 sitesOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT00332553
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Not yet reported Eli Lilly and Company 150 participants Est. completion 2004-05 1 siteOther conditions: Vasomotor Symptoms, Endometrial SafetyView official trial listing → -
Completed NCT NCT00334295
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
Not yet reported AstraZeneca 35 participants Est. completion 2011-01 9 sitesOther conditions: Endometrial CarcinomaView official trial listing → -
Status unknown NCT NCT00334971
Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women
Not yet reported Massachusetts General Hospital 116 participants Est. completion 2018-01 1 siteOther conditions: Healthy, Fragile X SyndromeView official trial listing → -
Completed NCT NCT00335218
Fat Distribution in Healthy Early Postmenopausal Women
Not yet reported Bayer 67 participants Est. completion 2004-08 3 sitesOther conditions: Healthy, PostmenopauseView official trial listing → -
Completed NCT NCT00338052
Study of Bleeding With Extended Administration of an Oral Contraceptive
Not yet reported Warner Chilcott 207 participants Est. completion 2007-05 23 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00338728
Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer
Not yet reported M.D. Anderson Cancer Center 59 participants Est. completion 2018-11-27 1 siteOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive, PDGFR Positive, Postmenopausal, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT00340652
Effects of Infant Diets on Estrogen Activity and Development
National Institute of Environmental Health Sciences (NIEHS) 157 participants Est. completion 2012-08-22 2 sitesOther conditions: HormoneView official trial listing → -
Completed NCT NCT00340665
Study of Infant Diets on Estrogen Activity and Development
National Institute of Environmental Health Sciences (NIEHS) 239 participants Est. completion 2012-08-22 2 sitesOther conditions: Infant Formula, Estrogen ActivityView official trial listing → -
Completed NCT NCT00342095
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
National Institute of Environmental Health Sciences (NIEHS) 640 participants Est. completion 2007-03-07 6 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00342498
Estrogen Receptor Gene Mutations
National Institute of Environmental Health Sciences (NIEHS) Est. completion 2008-06-17 2 sitesOther conditions: Mutations, HormonesView official trial listing → -
Completed NCT NCT00344383
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 61 participants Est. completion 2004-07Other conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT00350480
Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
Not yet reported Kaiser Permanente 240 participants Est. completion 2005-06 1 siteOther conditions: Uterine Hemorrhage, MenorrhagiaView official trial listing → -
Status unknown NCT NCT00351416
Letrozole Treatment in Normal and GnRH Deficient Women
Not yet reported, Not yet reported Massachusetts General Hospital 15 participants 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT00356447
Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Not yet reported Bayer 249 participants Est. completion 2007-10 9 sitesOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00357006
A Definitive Estrogen Patch Study (ADEPT)
Not yet reported The Alfred 180 participants Est. completion 2013-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)View official trial listing → -
Completed NCT NCT00357110
Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer
Not yet reported AstraZeneca 13 participants Est. completion 2008-10 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00357604
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2006-11 1 siteOther conditions: HIV InfectionsView official trial listing → -
Terminated NCT NCT00358098
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
AHS Cancer Control Alberta 51 participants Est. completion 2013-06 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00361075
Midlife Cholesterol Study
Not yet reported Northwestern University 120 participants Est. completion 2005-05 2 sitesCardiovascular disease Other conditions: Menopause, Postmenopause, PremenopauseView official trial listing → -
Completed NCT NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
Not yet reported The Alfred 54 participants Est. completion 2014-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00365599
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 43 participants Est. completion 2012-08 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00367276
Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.
Not yet reported Bayer 221 participants Est. completion 2004-05Other conditions: HealthyView official trial listing → -
Completed NCT NCT00367536
Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2006-08Other conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00368459
Raloxifene for Women With Alzheimer's Disease
Not yet reported Stanford University 42 participants Est. completion 2012-01 4 sites Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Withdrawn NCT NCT00370019
Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 2011-12-12 1 siteOther conditions: Premature Ovarian FailureView official trial listing → -
Completed NCT NCT00371345
Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer
Not yet reported Bristol-Myers Squibb 92 participants Est. completion 2009-05 23 sitesOther conditions: Breast Cancer, MetastasisView official trial listing → -
Completed NCT NCT00371956
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
Not yet reported Tuen Mun Hospital 114 participants Est. completion 2010-02 1 siteOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00372996
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Not yet reported Pfizer 219 participants Est. completion 2014-06 62 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00375622
Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Not yet reported Rabin Medical Center 60 participants Est. completion 2006-06 1 siteOther conditions: Hereditary Hemorrhagic TelangiectasiaView official trial listing → -
Completed NCT NCT00377988
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 423 participants Est. completion 2008-10Other conditions: Contraception, Female ContraceptionView official trial listing → -
Terminated NCT NCT00379197
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 13 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00380887
Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer 54 participantsOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00384046
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
Not yet reported Warner Chilcott 272 participants Est. completion 2007-07 31 sitesOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Status unknown NCT NCT00386022
The Effects of Aging and Estrogen on the Pituitary
Not yet reported, Not yet reported Massachusetts General Hospital 19 participants Est. completion 2018-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00387829
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
Not yet reported Integra LifeSciences Corporation 347 participants Est. completion 2011-12 36 sitesOther conditions: Spinal Injuries, AdhesionsView official trial listing → -
Completed NCT NCT00390455
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Not yet reported National Cancer Institute (NCI) 295 participants Est. completion 2014-07-02 368 sitesOther conditions: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT00391417
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
Not yet reported BioSante Pharmaceuticals 431 participants Est. completion 2005-04Other conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00391807
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 1683 participants Est. completion 2008-09 66 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00393172
Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]
Not yet reported, Not yet reported University of Minnesota 400 participants Est. completion 2010-03 1 siteOther conditions: Breast Cancer, ObesityView official trial listing → -
Completed NCT NCT00394771
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
Not yet reported Duramed Research 567 participants Est. completion 2008-03 50 sitesOther conditions: Breakthrough BleedingView official trial listing → -
Completed NCT NCT00396799
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2006-11Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00399685
Drug Interaction - Oral Contraceptive
Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2007-08 2 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00401219
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-02Other conditions: Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT00402636
Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)
Not yet reported Deutsches Herzzentrum Muenchen 502 participants Est. completion 2006-10 2 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Withdrawn NCT NCT00402935
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
Case Comprehensive Cancer Center Est. completion 2007-05 1 siteOther conditions: Leukemia, Long-term Effects Secondary to Cancer Therapy in Adults, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00405938
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Not yet reported SCRI Development Innovations, LLC 79 participants Est. completion 2011-06 11 sitesOther conditions: Breast Cancer, Breast NeoplasmsView official trial listing → -
Completed NCT NCT00413062
Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
Not yet reported Organon and Co 2281 participants Est. completion 2008-08Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00413764
Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)
Not yet reported Organon and Co 358 participants Est. completion 2005-11-15Other conditions: Sexual DysfunctionView official trial listing → -
Completed NCT NCT00417430
Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies
Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 20 participants Est. completion 2006-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00423917
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2017-01-15 205 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00424203
Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Not yet reported UNICANCER 40 participants Est. completion 2011-11 17 sitesOther conditions: Breast Cancer, Cognitive/Functional Effects, Depression, Malnutrition, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00425776
Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture
Not yet reported Vejle Hospital 94 participants Est. completion 2010-01 1 siteOther conditions: Breast Cancer, PostmenopauseView official trial listing → -
Completed NCT NCT00426972
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites
Not yet reported Renovo 148 participants Est. completion 2008-10 30 sitesOther conditions: Burn, Trauma, Varicose UlcerView official trial listing → -
Completed NCT NCT00427245
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Not yet reported Anglo Celtic Cooperative Oncology Group 400 participants 66 sitesOther conditions: Breast Cancer, Infertility, Menopausal SymptomsView official trial listing → -
Completed NCT NCT00428311
Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS
Not yet reported Hospital Universitario Ramon y Cajal 50 participants Est. completion 2006-10 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00431093
Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)
Not yet reported Organon and Co 570 participants Est. completion 2005-03Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00431132
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 336 participants Est. completion 2008-11 42 sitesOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT00433589
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 6600 participants Est. completion 2020-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00435175
Acute Metabolic Effects of Estradiol
Not yet reported University of Aarhus 8 participants Est. completion 2006-07 1 siteOther conditions: PostmenopauseView official trial listing → -
Terminated NCT NCT00438321
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
Not yet reported Massachusetts General Hospital 66 participants Est. completion 2010-02-26 1 siteMetabolic syndromeView official trial listing → -
Status unknown NCT NCT00439972
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity
Not yet reported University of Washington 36 participants Est. completion 2011-12 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00442689
Metabolic Syndrome in PCOS: Precursors and Interventions
Not yet reported Northwestern University 97 participants Est. completion 2012-11 1 siteMetabolic syndrome Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00443716
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
Not yet reported Mayo Clinic 60 participants Est. completion 1989-04 1 siteOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00444535
Lapatinib and Bevacizumab for Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2020-06-19 9 sitesOther conditions: Neoplasms, BreastView official trial listing → -
Completed NCT NCT00446030
Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer
Not yet reported Sanofi 127 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00446199
Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
Not yet reported Bayer 735 participants Est. completion 2008-11 76 sitesOther conditions: Vasomotor Symptoms, Hot FlashesView official trial listing → -
Withdrawn NCT NCT00447863
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08Other conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT00449254
Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults
Not yet reported Manhattan Pharmaceuticals 24 participants 3 sitesOther conditions: ObesityView official trial listing → -
Completed NCT NCT00451204
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Not yet reported University of California, Los Angeles 158 participants Est. completion 2014-07 16 sitesOther conditions: Relapsing Remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT00451555
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
Not yet reported Eli Lilly and Company 156 participants Est. completion 2018-10-18 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00454805
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
Not yet reported AstraZeneca 75 participants Est. completion 2016-04 16 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00455156
Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
Not yet reported Premier Research 1200 participants Est. completion 2011-09 15 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00455741
Postmenopausal Women Estrogen and Progesterone Infusion
Not yet reported, Not yet reported Massachusetts General Hospital 20 participants Est. completion 2015-08-22 1 siteOther conditions: Postmenopause, AgingView official trial listing → -
Completed NCT NCT00455962
Effect of Race on Gonadotropin Responses
Not yet reported, Not yet reported Massachusetts General Hospital 23 participants Est. completion 2011-12 1 siteOther conditions: Premenopause, HealthyView official trial listing → -
Terminated NCT NCT00459810
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
Not yet reported OHSU Knight Cancer Institute 21 participants Est. completion 2009-07 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00463450
Efficacy of Gynodian® Depot in Women With Impaired Well-being
Not yet reported Bayer 140 participants Est. completion 2004-04Other conditions: Hormone Replacement TherapyView official trial listing → -
Completed NCT NCT00463489
Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer
Not yet reported Ontario Clinical Oncology Group (OCOG) 338 participants Est. completion 2018-06 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00463788
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer
Not yet reported Merck KGaA, Darmstadt, Germany 181 participants Est. completion 2011-02 46 sitesOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT00464516
Preoperative Estetrol in Breast Cancer
Not yet reported Pantarhei Bioscience 30 participants Est. completion 2010-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00464789
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-05Other conditions: MenopauseView official trial listing → -
Completed NCT NCT00465075
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2007-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00465192
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 230 participants Est. completion 1995-11-30Other conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT00465894
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
Not yet reported University of Alabama at Birmingham 58 participants Est. completion 2011-12Other conditions: Overactive BladderView official trial listing → -
Completed NCT NCT00468715
Bicalutamide in Treating Patients With Metastatic Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-06-24 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00471991
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
Not yet reported Bayer 60 participants Est. completion 2007-12 1 siteOther conditions: Oral ContraceptiveView official trial listing → -
Completed NCT NCT00472004
Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 204 participants Est. completion 2009-12 1 siteOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00474851
The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial
Not yet reported Boston Children's Hospital 53 participants Est. completion 2015-01 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT00475553
Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®
Not yet reported Scott and White Hospital & Clinic 75 participants Est. completion 2008-05 1 siteOther conditions: Breakthrough Bleeding, Breakthrough SpottingView official trial listing → -
Completed NCT NCT00476645
Fulvestrant in Hormone Refractory Prostate Cancer
Not yet reported Stanford University 10 participants Est. completion 2009-12 1 siteOther conditions: Prostatic Neoplasms, Prostate CancerView official trial listing → -
Completed NCT NCT00477633
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 1700 participants Est. completion 2009-02 63 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00479674
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Not yet reported Duke University 41 participants Est. completion 2014-03 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00479778
Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 72 participants Est. completion 2007-07 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00480532
A Study of Continuous Oral Contraceptives and Doxycycline
Not yet reported Oregon Health and Science University 131 participants Est. completion 2011-05 2 sitesOther conditions: Contraceptives, OralView official trial listing → -
Completed NCT NCT00481455
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
Not yet reported CASI pharmaceuticals, Inc. 15 participants Est. completion 2008-10 1 siteOther conditions: Recurrent Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT00481650
Observational Trial With Leios/Alesse
Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-03Other conditions: Contraceptives, Oral, CombinedView official trial listing → -
Completed NCT NCT00484107
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer 200 participants Est. completion 2006-10Other conditions: PostmenopauseView official trial listing → -
Status unknown NCT NCT00490308
The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment
Not yet reported Assaf-Harofeh Medical Center 120 participants Est. completion 2008-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00491595
Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women
Not yet reported University of North Carolina 36 participants Est. completion 2005-07Other conditions: Drug ToxicityView official trial listing → -
Terminated NCT NCT00498901
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
Not yet reported University of Washington 1 participants Est. completion 2008-11 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00499083
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00503841
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Not yet reported Barbara Ann Karmanos Cancer Institute 44 participants Est. completion 2010-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00504816
A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
Not yet reported GlaxoSmithKline 22 participants Est. completion 2008-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00505752
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
Not yet reported Merck KGaA, Darmstadt, Germany 520 participants Est. completion 2008-09 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT00506480
Assessment of Endometrial Receptivity in Recipients of Donated Oocytes
Not yet reported Hadassah Medical Organization 100 participants Stand-aloneOther conditions: Embryo ImplantationView official trial listing → -
Completed NCT NCT00511342
Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)
Not yet reported Organon and Co 110 participants Est. completion 2009-06Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511355
Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)
Not yet reported Organon and Co 121 participants Est. completion 2008-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511433
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
Not yet reported Organon and Co 48 participants Est. completion 2008-01Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00511784
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 440 participants Est. completion 2007-06Other conditions: Contraception, Female Contraception, Fertility ControlView official trial listing → -
Completed NCT NCT00513916
Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women
Not yet reported University of Hawaii Cancer Research Center 100 participants Est. completion 2012-02 1 siteOther conditions: Breast Cancer, Healthy, no Evidence of DiseaseView official trial listing → -
Completed NCT NCT00516698
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Alliance for Clinical Trials in Oncology 140 participants Est. completion 2009-12 180 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00517556
Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea
Not yet reported, Not yet reported Milton S. Hershey Medical Center 38 participants Est. completion 2011-04 1 siteOther conditions: DysmenorrheaView official trial listing → -
Status unknown NCT NCT00519454
Estrogen and Gender Biased Autoimmunity
The Center for Rheumatic Disease, Allergy, & Immunology 75 participants Est. completion 2013-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00522262
Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial
Not yet reported AHS Cancer Control Alberta 320 participants Est. completion 2007-07 2 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00522873
Endometrial Safety Study
Not yet reported Bayer 662 participants Est. completion 2009-08 59 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00534417
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Accelerated Community Oncology Research Network 41 participants Est. completion 2011-09 10 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00534846
The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia
Not yet reported Satakunta Central Hospital 10 participants Est. completion 2009-02 1 siteOther conditions: Breast PainView official trial listing → -
Completed NCT NCT00537836
ZK283197 for Treatment of Vasomotor Symptoms
Not yet reported Bayer 116 participants Est. completion 2008-12 4 sitesOther conditions: Vasomotor SystemView official trial listing → -
Status unknown NCT NCT00541086
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
Not yet reported Gruppo Italiano Mammella (GIM) 3697 participants Est. completion 2020-07 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00541281
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150 participants Est. completion 2006-02 19 sitesOther conditions: Hormone Resistant Prostate Cancer, Metastatic Prostate CancerView official trial listing → -
Terminated NCT NCT00543127
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Not yet reported Spanish Breast Cancer Research Group 870 participants Est. completion 2016-07 53 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00544882
A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 61 participants Est. completion 2008-03-31 4 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT00545077
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
Not yet reported Spanish Breast Cancer Research Group 380 participants Est. completion 2014-07-24 70 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00547001
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
Not yet reported Hartford Hospital 235 participants Est. completion 2009-11 1 siteOther conditions: Hot Flashes, Night SweatsView official trial listing → -
Completed NCT NCT00548977
Genetic Studies Spermatogenic Failure
National Cheng-Kung University Hospital 283 participants Est. completion 2005-02 1 siteOther conditions: Oligospermia, Azoospermia, Male InfertilityView official trial listing → -
Completed NCT NCT00549666
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
Not yet reported Sumitomo Pharma America, Inc. 23 participants Est. completion 2007-12 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT00550303
Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 28 participants Est. completion 2007-11Other conditions: HealthyView official trial listing → -
Terminated NCT NCT00551733
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Not yet reported CTI BioPharma 450 participants Est. completion 2007-12-25 41 sitesOther conditions: Lung CancerView official trial listing → -
Terminated NCT NCT00551785
Surveillance Study of Women Taking Intrinsa®
Center for Epidemiology and Health Research, Germany 328 participants Est. completion 2012-06 1 siteOther conditions: Ovariectomy, Hysterectomy, Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT00554632
Birth Control Pill vs Birth Control Patch Study
Not yet reported University of Vermont 24 participants Est. completion 2005-08Other conditions: Venous ThrombosisView official trial listing → -
Terminated NCT NCT00560924
Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
Not yet reported Novo Nordisk A/S 6 participants Est. completion 2004-03-17 1 siteOther conditions: Menopause, Urinary InfectionsView official trial listing → -
Withdrawn NCT NCT00562341
Effect of Lap-Band Induced Weight Loss on Serum PSA Levels
Maimonides Medical Center Est. completion 2009-12-31 1 siteOther conditions: Obesity, Prostate CancerView official trial listing → -
Completed NCT NCT00563472
Feasibility Study Into the Contraceptive Effect of Estetrol
Not yet reported Pantarhei Bioscience 52 participants Est. completion 2008-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00563576
Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
Not yet reported Columbia University 71 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: MetrorrhagiaView official trial listing → -
Terminated NCT NCT00565916
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
Not yet reported Washington University School of Medicine 22 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Postmenopausal SyndromeView official trial listing → -
Completed NCT NCT00566553
The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women
Not yet reported Mayo Clinic 39 participants Est. completion 2011-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00567164
Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
Not yet reported Bayer 1887 participants Est. completion 2009-11 85 sitesOther conditions: Contraception, Ovulation Inhibition, Contraceptives, OralView official trial listing → -
Completed NCT NCT00569244
SH T00186 in the Treatment of Primary Dysmenorrhea
Not yet reported Bayer 223 participants Est. completion 2009-12 27 sitesOther conditions: Primary DysmenorrheaView official trial listing → -
Completed NCT NCT00569543
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
University of Nebraska 27 participants Est. completion 2012-08-02 2 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00570258
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00570323
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
Not yet reported Mothaffar Rimawi 72 participants Est. completion 2018-12-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00570440
Continuous Use of COCs
Not yet reported FHI 360 362 participants Est. completion 2010-10 2 sitesOther conditions: Pregnancy PreventionView official trial listing → -
Completed NCT NCT00570921
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00572351
The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels
Not yet reported Cedars-Sinai Medical Center 44 participants Est. completion 2007-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00572390
Oestrogen Withdrawal in Hypopituitary Women
Not yet reported University of Aarhus 38 participants Est. completion 2002-02 1 siteOther conditions: HypopituitarismView official trial listing → -
Completed NCT NCT00572819
Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial
Not yet reported Ullevaal University Hospital 100 participants Est. completion 2009-05 1 siteOther conditions: Cervical RipeningView official trial listing → -
Completed NCT NCT00572858
Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women
Cedars-Sinai Medical Center 75 participants Est. completion 2020-10 1 siteOther conditions: Estrogen DeficiencyView official trial listing → -
Terminated NCT NCT00573755
Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
Not yet reported Mayo Clinic 4 participants Est. completion 2013-04 3 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00576225
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
Not yet reported CTI BioPharma Est. completion 2010-04-05 44 sitesOther conditions: NSCLCView official trial listing → -
Completed NCT NCT00580112
An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 127 participants Est. completion 2011-08 33 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00580333
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Not yet reported Massachusetts General Hospital 51 participants Est. completion 2020-06 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00580775
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
Yale University 25 participants Est. completion 2010-12 1 siteOther conditions: Menopausal WomenView official trial listing → -
Active, not recruiting NCT NCT00585507
Efficacy and Safety of 500mg of Fulvestrant
Not yet reported Beth Israel Deaconess Medical Center 40 participants Est. completion 2027-03-15 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00586898
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2009-03 1 site Stand-aloneOther conditions: Prostate, Cancer, Hormonal CyclingView official trial listing → -
Active, not recruiting NCT NCT00587886
Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center 1315 participants Est. completion 2026-12-31 1 siteOther conditions: Cancer, Endometrial Cancer, Ovarian Cancer, Corpus Uteri, EndometriumView official trial listing → -
Completed NCT NCT00589134
The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Not yet reported Yale University 26 participants Est. completion 2009-12 1 siteOther conditions: Exercise Induced HyponatremiaView official trial listing → -
Terminated NCT NCT00592007
Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Not yet reported Lyudmila Bazhenova, M.D. 7 participants Est. completion 2012-04 1 siteOther conditions: Non Small Cell Lung CarcinomaView official trial listing → -
Completed NCT NCT00592579
A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma
Not yet reported CASI pharmaceuticals, Inc. 60 participants Est. completion 2008-09 2 sitesOther conditions: Relapsed Multiple Myeloma, Plateau Phase Multiple MyelomaView official trial listing → -
Completed NCT NCT00592839
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
Not yet reported Duramed Research 157 participants Est. completion 2009-02 17 sitesOther conditions: Nocturnal Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00593294
Oral Contraceptive and Cardiovascular Risk in PCOS
Not yet reported Federico II University 150 participants Est. completion 2007-12 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00600106
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
Not yet reported Cedars-Sinai Medical Center 37 participants Est. completion 2010-03 1 siteOther conditions: Myocardial IschemiaView official trial listing → -
Completed NCT NCT00604825
Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sitesOther conditions: Menopausal and Female Climacteric StatesView official trial listing → -
Completed NCT NCT00608062
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Not yet reported University of Colorado, Denver 155 participants Est. completion 2012-10-25 1 siteOther conditions: Arterial Stiffening, Aging, MenopauseView official trial listing → -
Completed NCT NCT00608972
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Not yet reported Rutgers, The State University of New Jersey 31 participants Est. completion 2015-09-25 7 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00611104
Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
Mayo Clinic 20 participants Est. completion 2014-08-22 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00611975
Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning
Not yet reported Weill Medical College of Cornell University 83 participants Est. completion 2008-09Other conditions: HealthyView official trial listing → -
Completed NCT NCT00612508
Hormonal Contraception and Vaginal Health
Not yet reported Oregon Health and Science University 14 participants Est. completion 2008-05 1 siteOther conditions: Contraceptive Usage, Vaginal Epithelial DisruptionView official trial listing → -
Completed NCT NCT00612560
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
Not yet reported Roswell Park Cancer Institute 28 participants Est. completion 2014-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00617188
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 26 participants Est. completion 2008-07 1 siteOther conditions: Ovarian CancerView official trial listing → -
Status unknown NCT NCT00617500
Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement
Not yet reported Sociedade Hospital Samaritano 278 participants Est. completion 2009-11 2 sitesOther conditions: ClimactericView official trial listing → -
Completed NCT NCT00619866
An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis
Not yet reported AbbVie 155 participants Est. completion 2009-08-28Other conditions: Endometriosis, PainView official trial listing → -
Status unknown NCT NCT00623116
A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
Not yet reported Hospital for Children and Adolescents, Finland 50 participants Est. completion 2025-12 1 siteOther conditions: Kallmann SyndromeView official trial listing → -
Completed NCT NCT00624130
Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers
Not yet reported Bayer 453 participants Est. completion 2005-06 17 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00626340
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Not yet reported University of Pennsylvania 18 participants Est. completion 2008-07 1 siteOther conditions: Menopause, DepressionView official trial listing → -
Status unknown NCT NCT00629278
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
Not yet reported Azienda Ospedaliero-Universitaria di Modena 2500 participants 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00629616
Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer
Not yet reported UNICANCER 116 participants Est. completion 2018-04 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00631124
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
Not yet reported Bayer 103 participants Est. completion 2008-12 2 sites Stand-aloneOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00632723
IRESSA™ (Gefitinib) in Breast Cancer Patients
Not yet reported AstraZeneca 54 participants Est. completion 2005-10Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00633360
The Oral Contraceptive Pill for Premenstrual Worsening of Depression
Not yet reported Massachusetts General Hospital 32 participants Est. completion 2011-05 1 siteOther conditions: Premenstrual Syndrome, DepressionView official trial listing → -
Completed NCT NCT00635713
Second Line Breast Cancer Trial
Not yet reported AstraZeneca 588 participants Est. completion 2004-09Other conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00640224
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
Not yet reported Silva Arslanian 65 participants Est. completion 2015-07 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00647933
An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)
Not yet reported Organon and Co 24 participants Est. completion 2000-12Other conditions: InfertilityView official trial listing → -
Completed NCT NCT00649090
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
Not yet reported Pfizer 1549 participants Est. completion 2007-04 61 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00649896
Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day
Not yet reported Mylan Pharmaceuticals Inc 76 participants Est. completion 2003-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00650442
Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System
Not yet reported Mylan Pharmaceuticals Inc 39 participants Est. completion 2003-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00651469
Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.
Not yet reported Bayer 534 participants Est. completion 2004-07 27 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT00651599
Treatment of Vasomotor Symptoms in Korean Post Menopausal Women
Not yet reported Bayer 90 participants Est. completion 2005-05 4 sitesOther conditions: Vasomotor SymptomsView official trial listing → -
Completed NCT NCT00651846
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
Not yet reported Bayer 43 participants Est. completion 2005-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00653016
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
Not yet reported Janssen-Ortho Inc., Canada 405 participants Est. completion 2003-08Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00653614
Cycle Control and Safety of E2-DRSP
Not yet reported Bayer 635 participants Est. completion 2009-06 25 sitesOther conditions: Contraceptive, Oral, HormonalView official trial listing → -
Completed NCT NCT00656981
Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne
Not yet reported Bayer 541 participants Est. completion 2004-06 22 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT00660803
Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer
AstraZeneca 200 participants Est. completion 2009-04 4 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00661531
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Not yet reported Georgetown University 11 participants Est. completion 2015-06 3 sitesOther conditions: Breast Cancer, Cancer of the Breast, Neoplasms, BreastView official trial listing → -
Completed NCT NCT00662454
Oral Contraceptive Efficacy and Body Weight
Not yet reported Oregon Health and Science University 120 participants Est. completion 2006-05 1 siteOther conditions: Contraception, Body WeightView official trial listing → -
Completed NCT NCT00666822
Compliance to a Hormone Therapy Regimen in Breast Cancer
Case Comprehensive Cancer Center 178 participants Est. completion 2015-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00668252
Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects
Assistance Publique - Hôpitaux de Paris 48 participants Est. completion 2007-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00668538
Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans
Not yet reported University of Southern Denmark 20 participants Est. completion 2008-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00673686
Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D
Not yet reported Bayer 105 participants Est. completion 2005-02 1 siteOther conditions: Contraceptives, OralView official trial listing → -
Terminated NCT NCT00674557
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
Not yet reported Cancer Research UK 111 participants Est. completion 2009-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00675688
Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 3544 participants Est. completion 2006-01Other conditions: Endometrial Hyperplasia, OsteoporosisView official trial listing → -
Status unknown NCT NCT00675779
Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis
Not yet reported Poznan University of Medical Sciences 44 participants Est. completion 2011-03 1 siteOther conditions: Endometriosis, PainView official trial listing → -
Completed NCT NCT00676663
Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer
Not yet reported Syndax Pharmaceuticals 130 participants Est. completion 2012-11-26 38 sitesOther conditions: Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast CancerView official trial listing → -
Completed NCT NCT00680667
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 11 participants Est. completion 2011-04 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00680797
Metabolic Effects of Androgenicity in Aging Men and Women
Not yet reported VA Office of Research and Development 33 participants Est. completion 2016-12-31 1 site Stand-aloneOther conditions: Aging, Insulin ResistanceView official trial listing → -
Terminated NCT NCT00684216
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
Not yet reported, Not yet reported The Netherlands Cancer Institute 10 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00685009
The Women's Health Initiative Memory Study (The WHIMS Study)
National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 siteOther conditions: Dementia SyndromesView official trial listing → -
Status unknown NCT NCT00687648
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported National Cancer Centre, Singapore 70 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00687739
Prevention of Obesity in Women Via Estradiol Regulation
Not yet reported University of Colorado, Denver 79 participants Est. completion 2014-06 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT00688194
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
Not yet reported Gruppo Italiano Mammella (GIM) 396 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00694733
Regulation of Cortisol Metabolism and Fat Patterning
Not yet reported Oregon Health and Science University 140 participants Est. completion 2024-09 1 siteOther conditions: Obesity, Menopausal SyndromeView official trial listing → -
Completed NCT NCT00696111
Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
Not yet reported University of Chicago 18 participants Est. completion 2022-06-30 1 site Stand-aloneObstructive sleep apnea Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00697307
Bioequivalence Study of Patches With Different Release Profiles
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 43 participants Est. completion 2003-07Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00698035
Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients
Not yet reported University of California, San Francisco 76 participants Est. completion 2012-12 1 siteOther conditions: Sexual Dysfunction, PhysiologicalView official trial listing → -
Completed NCT NCT00699751
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases
Not yet reported Bayer 921 participants Est. completion 2014-02-13 134 sitesOther conditions: Hormone Refractory Prostate Cancer, Bone MetastasesView official trial listing → -
Completed NCT NCT00700232
ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls
University Hospital, Tours 120 participants Est. completion 2009-07 1 siteOther conditions: Intrahepatic Cholestasis of PregnancyView official trial listing → -
Completed NCT NCT00701337
Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route
Not yet reported University Hospital, Toulouse 40 participants Est. completion 2010-01 1 siteOther conditions: PostmenopausalView official trial listing → -
Completed NCT NCT00702520
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)
Organon and Co 15 participants Est. completion 2008-01-15Other conditions: Pregnancy, NeonatesView official trial listing → -
Completed NCT NCT00702858
Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer
Not yet reported Legacy Health System 30 participants Est. completion 2011-06Other conditions: Breast Cancer, Joint PainView official trial listing → -
Terminated NCT NCT00705822
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Not yet reported Sanofi 54 participants Est. completion 2009-07 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Completed NCT NCT00706225
Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-07 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00707525
Embryo Aneuploidies and Ovarian Stimulation
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA Est. completion 2010-02 1 siteOther conditions: Embryo AneuploidiesView official trial listing → -
Completed NCT NCT00709189
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53 participants Est. completion 2005-08Other conditions: Female Contraception, Contraception, Therapeutic Equivalency, PharmacokineticsView official trial listing → -
Completed NCT NCT00709332
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-02Other conditions: Drug Interactions, Contraception, PharmacokineticsView official trial listing → -
Completed NCT NCT00709644
Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2005-08Other conditions: Pharmacokinetics, Therapeutic Equivalency, Contraceptives, OralView official trial listing → -
Completed NCT NCT00714233
Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)
Not yet reported University of Rochester 43 participants Est. completion 2007-12Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00722072
Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy
Not yet reported OHSU Knight Cancer Institute 12 participants Est. completion 2012-07 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00722761
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
Not yet reported Massachusetts General Hospital 30 participants Est. completion 2012-04 1 siteOther conditions: Acne VulgarisView official trial listing → -
Terminated NCT NCT00722800
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
Not yet reported Massachusetts General Hospital 4 participants Est. completion 2011-12 1 siteOther conditions: Hidradenitis SuppurativaView official trial listing → -
Completed NCT NCT00725374
A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)
Not yet reported Organon and Co 102 participants Est. completion 2005-04-15Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00727129
Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms
Not yet reported Upsher-Smith Laboratories 495 participants Est. completion 2005-08Other conditions: Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT00728949
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
Not yet reported Eli Lilly and Company 93 participants Est. completion 2015-02 9 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT00729404
Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene
Not yet reported Bayer 17 participants Est. completion 2009-02 3 sitesOther conditions: Contraception, Ovulation InhibitionView official trial listing → -
Completed NCT NCT00729859
CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men
Not yet reported University of Washington 31 participants Est. completion 2010-05Other conditions: HealthyView official trial listing → -
Completed NCT NCT00732693
Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure
Not yet reported University of Edinburgh 42 participants Est. completion 2006-11 2 sitesOther conditions: Premature Ovarian FailureView official trial listing → -
Completed NCT NCT00740025
Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)
Virginia Center for Reproductive Medicine 200 participants Est. completion 2010-01 1 siteOther conditions: PregnancyView official trial listing → -
Completed NCT NCT00740194
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men
Not yet reported, Not yet reported University Hospital, Ghent 20 participants Est. completion 2010-08 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00744328
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Not yet reported Northwestern University 85 participants Est. completion 2013-09 1 siteOther conditions: Postpartum DepressionView official trial listing → -
Completed NCT NCT00745108
Tibolone Endometrium Study (Study 32972)(P06470)
Not yet reported Organon and Co 32 participants Est. completion 2005-07-21Other conditions: Postmenopausal WomenView official trial listing → -
Completed NCT NCT00745173
Study Evaluating Premarin and Bazedoxifene Potential Interaction
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 30 participants Est. completion 2008-10 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00745901
Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females
Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 355 participants Est. completion 2008-10Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT00746096
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Not yet reported Nobelpharma 115 participants Est. completion 2009-09Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT00750100
Low Dose hCG in the Late Follicular Phase
Not yet reported Universitair Ziekenhuis Brussel 70 participants Est. completion 2008-11 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00752635
Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris
Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09Other conditions: Acne VulgarisView official trial listing → -
Terminated NCT NCT00752986
ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial
Not yet reported Genzyme, a Sanofi Company 39 participants Est. completion 2013-09 11 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00754065
To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Not yet reported Bayer 409 participants Est. completion 2011-05-10 59 sites Stand-aloneOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00754325
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
Not yet reported Bristol-Myers Squibb 100 participants Est. completion 2014-01 28 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT00755313
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco 81 participants Est. completion 2014-06-06 1 siteOther conditions: Breast Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Neurotoxicity, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00755885
Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Cancer Research UK 77 participants Est. completion 2016-06-04 6 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00759642
Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Not yet reported University of Kansas Medical Center 33 participants Est. completion 2018-08-20 3 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00764881
Effects of SH T00658ID on Libido
Not yet reported Bayer 217 participants Est. completion 2010-07 32 sites Stand-aloneOther conditions: Contraception, LibidoView official trial listing → -
Completed NCT NCT00766038
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Not yet reported University of Pennsylvania 63 participants Est. completion 2013-12 3 sitesOther conditions: Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT00767520
Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
Not yet reported Bristol-Myers Squibb 155 participants Est. completion 2012-12 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00773695
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00774267
Study Evaluating Changes In Mammographic Breast Density
Pfizer 507 participants Est. completion 2010-04 26 sitesOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00774878
Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer
Not yet reported Sanofi 18 participants Est. completion 2010-11 3 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00775086
Bioequivalence Study of Patches With Different Equilibration Profiles
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 42 participants Est. completion 2004-08Other conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT00775242
Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.
Not yet reported, Not yet reported Centro A.F. de Estudios Tecnologicos, S.A. 103 participants Est. completion 2008-11 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00778609
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
Not yet reported Bayer 449 participants Est. completion 2010-12 63 sites Stand-aloneOther conditions: Oral Contraceptive, Headache, Pelvic PainView official trial listing → -
Completed NCT NCT00781456
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
Not yet reported Duramed Research 109 participants Est. completion 2011-08 22 sitesOther conditions: MigraineView official trial listing → -
Completed NCT NCT00784888
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
Pfizer 344 participants Est. completion 2011-12 16 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
Shalvata Mental Health Center 80 participants 1 siteOther conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic EpisodeView official trial listing → -
Completed NCT NCT00789802
A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC
Not yet reported Washington University School of Medicine 129 participants Est. completion 2011-01 1 siteOther conditions: Contraception, BleedingView official trial listing → -
Completed NCT NCT00799708
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2008-10Other conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00799929
IVF Clinical Trial of Two Different Treatment Protocols.
Not yet reported New Hope Fertility Center 564 participants Est. completion 2014-10 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00803335
The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse
Not yet reported TriHealth Inc. 54 participants Est. completion 2011-05 1 siteOther conditions: Pelvic Organ Prolapse, Vaginal AtrophyView official trial listing → -
Withdrawn NCT NCT00804960
Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?
Not yet reported Center for Human Reproduction Est. completion 2010-04 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00805207
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
Not yet reported Washington University School of Medicine 61 participants Est. completion 2013-03 1 site Stand-aloneObstructive sleep apnea Other conditions: Polycystic Ovary Syndrome (PCOS), ObesityView official trial listing → -
Completed NCT NCT00805415
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
Not yet reported Bayer 209 participants Est. completion 2004-02 2 sites Stand-aloneOther conditions: Ovulation InhibitionView official trial listing → -
Completed NCT NCT00808132
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Not yet reported Pfizer 1886 participants Est. completion 2011-02 178 sitesOther conditions: Menopause, OsteoporosisView official trial listing → -
Completed NCT NCT00811369
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Ontario Clinical Oncology Group (OCOG) 126 participants Est. completion 2013-08 13 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT00816556
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
Not yet reported Maire Mac Bride 63 participants Est. completion 2011-12 1 siteOther conditions: Atrophic VaginitisView official trial listing → -
Terminated NCT NCT00816582
PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
Not yet reported British Columbia Cancer Agency 17 participants Est. completion 2018-07 4 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00818519
GA YAZ ACNE in China Phase III
Not yet reported Bayer 179 participants Est. completion 2010-05 7 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT00820664
A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women
Not yet reported Merck Sharp & Dohme LLC 29 participants Est. completion 2009-05Other conditions: Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT00821496
Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
Not yet reported VIVUS LLC 20 participants Est. completion 2009-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00825617
Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy
Not yet reported University of Aarhus 16 participants Est. completion 2000-06 1 siteOther conditions: Turner SyndromeView official trial listing → -
Withdrawn NCT NCT00826839
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients
Not yet reported Weill Medical College of Cornell University Est. completion 2012-01 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT00827151
Bone Mass Accrual in Adolescent Athletes
Not yet reported Massachusetts General Hospital Est. completion 2015-01 1 siteOther conditions: Amenorrhea, Bone LossView official trial listing → -
Completed NCT NCT00827632
Obesity, Oral Contraception, and Ovarian Suppression
Not yet reported Columbia University 226 participants Est. completion 2008-12 1 siteOther conditions: Ovarian SuppressionView official trial listing → -
Completed NCT NCT00828854
Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing
Not yet reported Syndax Pharmaceuticals 27 participants Est. completion 2009-11-24 6 sitesOther conditions: ER+ Breast CancerView official trial listing → -
Completed NCT NCT00830492
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
Not yet reported Yazd Research & Clinical Center for Infertility 200 participants Est. completion 2008-12 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Completed NCT NCT00830973
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer
Medco Health Solutions, Inc. 184 participants Est. completion 2009-01 1 siteOther conditions: Breast Neoplasms, TamoxifenView official trial listing → -
Completed NCT NCT00834678
Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Not yet reported, Not yet reported Ohio State University Comprehensive Cancer Center 11 participants Est. completion 2014-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00837616
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
Not yet reported Nemours Children's Clinic 41 participants Est. completion 2012-12 3 sitesOther conditions: Turner Syndrome, Hypogonadism, Premature Ovarian FailureView official trial listing → -
Completed NCT NCT00839696
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
University of Wisconsin, Madison 270 participants Est. completion 2010-04 1 siteOther conditions: Breast Cancer RiskView official trial listing → -
Completed NCT NCT00842751
Oral T7 Oral Testosterone in Man
Not yet reported University of Washington 11 participants Est. completion 2009-12 1 siteOther conditions: Healthy Males, Male ContraceptiveView official trial listing → -
Completed NCT NCT00843336
Comparison of Two Internet Supported Natural Family Planning Methods
Not yet reported Marquette University 358 participants Est. completion 2013-12 2 sites Stand-aloneOther conditions: PregnancyView official trial listing → -
Completed NCT NCT00843570
Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment
Not yet reported University of Oxford 159 participants Est. completion 2013-05 2 sitesOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT00844012
Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain
Not yet reported University Magna Graecia 60 participants Est. completion 2010-07 1 siteOther conditions: Endometriosis, Chronic Pelvic PainView official trial listing → -
Completed NCT NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12 Stand-aloneOther conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, SarcomasView official trial listing → -
Terminated NCT NCT00847821
Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene
Wyeth is now a wholly owned subsidiary of Pfizer 185 participants Est. completion 2010-08 22 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00856050
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Not yet reported Dana-Farber Cancer Institute 27 participants Est. completion 2014-03 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT00856492
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Not yet reported SWOG Cancer Research Network 215 participants Est. completion 2015-12 366 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00859508
Study of SyntheCelTM Dura Replacement to Other Dura Replacements
Not yet reported Synthes USA HQ, Inc. 99 participants Est. completion 2009-01 8 sitesOther conditions: Cranial Dura RepairView official trial listing → -
Completed NCT NCT00860964
A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women
Not yet reported Peking Union Medical College 221 participants Est. completion 2006-12 Stand-aloneOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00863655
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Not yet reported Novartis Pharmaceuticals 724 participants Est. completion 2014-12-04 200 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00864214
A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone
Not yet reported Mayo Clinic 40 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT00866437
Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel
Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT00870168
Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer
Not yet reported Centre Jean Perrin 60 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00870220
Initiating Transdermal Estradiol Therapy in Turner's Syndrome
Not yet reported University of Chicago 1 participants Est. completion 2011-03 3 sitesOther conditions: Turner's SyndromeView official trial listing → -
Completed NCT NCT00871858
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer
Not yet reported Institut Bergonié 120 participants Est. completion 2018-07-02 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00873262
Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)
Not yet reported EVE Medical Systems Ltd. 20 participants Est. completion 2010-11 1 siteOther conditions: Premenstrual SyndromeView official trial listing → -
Completed NCT NCT00873483
US Ovulation Inhibition Study in Obese Women
Not yet reported Bayer 173 participants Est. completion 2010-03-03 6 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00877097
Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
Not yet reported Kuopio University Hospital 167 participants Est. completion 2009-02Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00883272
Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women
NYU Langone Health 32 participants Est. completion 2009-06 1 siteOther conditions: Menopause, ThrombophiliaView official trial listing → -
Status unknown NCT NCT00887380
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)
Not yet reported Trans Tasman Radiation Oncology Group 2023 participants Est. completion 2024-12 34 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00889512
The Luveris In Vitro Fertilization Trial
Not yet reported University Reproductive Associates 14 participants Est. completion 2013-11 1 siteOther conditions: Infertility, Hypothalamic Amenorrhea, HyperprolactinemiaView official trial listing → -
Terminated NCT NCT00892268
Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain
Not yet reported University of Arizona 68 participants Est. completion 2009-10Other conditions: Breast Cancer, Menopausal Symptoms, PainView official trial listing → -
Completed NCT NCT00893061
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
Not yet reported Centre Oscar Lambret 44 participants Est. completion 2014-11-26 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00896571
Transdermal Contraceptive Patch - Endometrial Effects Study
Not yet reported Bayer 92 participants Est. completion 2011-08 1 siteOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT00896636
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
Northwestern University 385 participants Est. completion 2022-01 1 siteOther conditions: Breast Cancer, Healthy, no Evidence of DiseaseView official trial listing → -
Status unknown NCT NCT00897065
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Massachusetts General Hospital 957 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00897208
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
Mayo Clinic 316 participants Est. completion 2015-06-30 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00897299
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
Eastern Cooperative Oncology Group 900 participants Est. completion 2005-10-08Other conditions: Breast Cancer, Estrogen Receptor, Her-2, PgrView official trial listing → -
Status unknown NCT NCT00897728
Study of Tumor and Blood Samples From Women With Breast Cancer
Institut Curie 180 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00898976
Biomarkers in Native American Women With Breast Cancer
Alliance for Clinical Trials in Oncology 120 participants Est. completion 2007-05Other conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00899639
Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
Rutgers, The State University of New Jersey Est. completion 2008-05Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00900133
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
Case Comprehensive Cancer Center 60 participants Est. completion 2006-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00900653
Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women
Not yet reported Yonsei University 142 participants Est. completion 2010-07 1 siteOther conditions: Urinary Tract InfectionsView official trial listing → -
Suspended NCT NCT00901290
Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects
Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT00901589
Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women
Not yet reported Aalborg University Hospital 92 participants Est. completion 2009-05 1 siteOther conditions: Postmenopause, PremenopauseView official trial listing → -
Completed NCT NCT00902746
Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis
Not yet reported Nobelpharma 149 participants Est. completion 2012-02Other conditions: DysmenorrheaView official trial listing → -
Terminated NCT NCT00903006
Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
Not yet reported, Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00905684
Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)
Bayer 5446 participants Est. completion 2011-12 13 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT00905723
The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women
Not yet reported Federal University of São Paulo 60 participants 1 site Stand-aloneOther conditions: Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT00908570
Topical Estriol for Vaginal Health
Not yet reported Gynuity Health Projects 104 participants Est. completion 2011-03 2 sitesOther conditions: Vaginal HealthView official trial listing → -
Completed NCT NCT00911716
TC Avastin. ICORG 08-10, V6
Not yet reported Cancer Trials Ireland 106 participants Est. completion 2015-09 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00913926
Effects of Wellnara on Climacteric Symptoms
Bayer 749 participants Est. completion 2009-05 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00914693
EU/LA Pearl Index Study - Transdermal Contraceptive Patch
Not yet reported Bayer 1694 participants Est. completion 2011-09 66 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00915174
Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
Not yet reported Merz Pharmaceuticals GmbH 36 participants Est. completion 2009-11 1 siteOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT00915668
A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2011-03Other conditions: Pharmacokinetics, Drug Interactions, HealthyView official trial listing → -
Completed NCT NCT00915915
Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)
Not yet reported Bayer 108 participants Est. completion 2010-04 2 sitesOther conditions: Contraception, Ovulation InhibitionView official trial listing → -
Completed NCT NCT00918476
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)
Not yet reported Pfizer 14 participants Est. completion 2011-02 1 siteOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00918892
Assessment of Candidate Protein Expression in Breast Cancer Specimens
Case Comprehensive Cancer Center 460 participants Est. completion 2021-09-23 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00919919
Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Not yet reported Rabin Medical Center 60 participants Est. completion 2010-11 1 siteOther conditions: Endometrial Hyperplasia, Endometrial CancerView official trial listing → -
Completed NCT NCT00921115
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Not yet reported University of Kansas Medical Center 42 participants Est. completion 2023-03-20 1 siteOther conditions: Invasive Breast CancerView official trial listing → -
Completed NCT NCT00923572
Yasmin Post Marketing Surveillance
Bayer 777 participants Est. completion 2013-08 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT00924560
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
Not yet reported Duramed Research 1361 participants Est. completion 2012-08 46 sitesOther conditions: Bone Mineral DensityView official trial listing → -
Terminated NCT NCT00925548
STRIDE - STimulating Immune Response In aDvanced brEast Cancer
Not yet reported EMD Serono 16 participants Est. completion 2010-08 29 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00927095
Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
Not yet reported University of North Carolina, Chapel Hill 67 participants Est. completion 2014-07 1 siteOther conditions: Premenstrual Dysphoric DisorderView official trial listing → -
Status unknown NCT NCT00927511
A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)
Not yet reported Regina Elena Cancer Institute 104 participants Est. completion 2012-04 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00932152
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Not yet reported University of Pittsburgh 3 participants Est. completion 2013-01 1 siteOther conditions: Non-small Cell Lung Cancer, Postmenopausal WomenView official trial listing → -
Completed NCT NCT00932321
Study of Safety and Efficacy of an Oral Contraceptive
Not yet reported Warner Chilcott 938 participants Est. completion 2004-11 34 sitesOther conditions: Prevention of PregnancyView official trial listing → -
Completed NCT NCT00933179
FC Patch Low: Metabolism Study
Not yet reported Bayer 30 participants Est. completion 2010-09 1 siteOther conditions: ContraceptionView official trial listing → -
Withdrawn NCT NCT00935558
Dendritic Cell Based Therapy for Breast Cancer Patients
Not yet reported Inge Marie Svane 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00941057
Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Not yet reported Bayer 43 participants Est. completion 2010-01 1 siteOther conditions: Pharmacology, ClinicalView official trial listing → -
Completed NCT NCT00944918
Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)
Not yet reported AstraZeneca 25 participants Est. completion 2011-06 2 sitesOther conditions: Progression-free SurvivalView official trial listing → -
Withdrawn NCT NCT00945360
Aromatase Inhibitors for Treatment of Uterine Leiomyomas
Not yet reported American University of Beirut Medical Center Est. completion 2011-05 1 siteOther conditions: Symptomatic or Large Uterine FibroidsView official trial listing → -
Completed NCT NCT00946192
Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
Not yet reported Massachusetts General Hospital 121 participants Est. completion 2021-04 1 site Stand-aloneOther conditions: Exercise-related AmenorrheaView official trial listing → -
Completed NCT NCT00949598
Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer
Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 177 participants Est. completion 2010-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00954135
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients
Not yet reported University of Turin, Italy 190 participants Est. completion 2010-12 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00956813
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
Not yet reported Alliance for Clinical Trials in Oncology 210 participants Est. completion 2013-05 107 sitesOther conditions: Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00959244
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105
University of Nebraska 100 participants Est. completion 2009-09-25 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00963417
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
Not yet reported ETOP IBCSG Partners Foundation 119 participants Est. completion 2024-10-23 13 sitesOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00963729
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
Not yet reported Imperial College London 756 participants Est. completion 2011-03 5 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00967239
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc 1881 participantsOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00968214
Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27
Alliance for Clinical Trials in Oncology 364 participants Est. completion 2018-09Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00968968
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Not yet reported Novartis Pharmaceuticals 37 participants Est. completion 2018-03-30 116 sitesOther conditions: CancerView official trial listing → -
Completed NCT NCT00973102
Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)
Not yet reported University of Texas Southwestern Medical Center 50 participants Est. completion 2012-05 2 sitesOther conditions: Hemorrhagic ShockView official trial listing → -
Completed NCT NCT00975676
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02
Not yet reported ETOP IBCSG Partners Foundation 123 participants Est. completion 2016-12 24 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00976651
Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium
Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2009-12 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00983957
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
Not yet reported Bristol-Myers Squibb 47 participants Est. completion 2010-02 3 sitesOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00984386
Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing
Not yet reported Renovo 44 participants Est. completion 2005-04 1 siteOther conditions: Cicatrix, Wound-healingView official trial listing → -
Completed NCT NCT00984399
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2024-05-13 5 sites Stand-aloneOther conditions: Atrophic Vaginitis, Breast CancerView official trial listing → -
Completed NCT NCT00984789
Birth Control Patch Study
Not yet reported Bayer 393 participants Est. completion 2010-09 23 sitesOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT00988845
Indole-3-Carbinol Effects on Estrogen Metabolism
Not yet reported University of Wisconsin, Madison 38 participants Est. completion 2014-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00988910
Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being
Bayer 632 participants Est. completion 2010-12 1 siteOther conditions: ContraceptionView official trial listing → -
Withdrawn NCT NCT00993642
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Not yet reported Tulane University Health Sciences Center Est. completion 2010-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00996580
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Not yet reported Teva Women's Health 3597 participants Est. completion 2011-09 94 sitesOther conditions: Pregnancy PreventionView official trial listing → -
Completed NCT NCT00997893
Research Investigation of Soy and Estrogen
Not yet reported University of Illinois at Chicago 96 participants Est. completion 2015-05 1 siteOther conditions: Menopause, Hot FlashesView official trial listing → -
Completed NCT NCT00998257
Regulatory Post Marketing Surveillance Study on YAZ
Bayer 770 participants Est. completion 2011-11 1 siteOther conditions: Contraception, Premenstrual Syndrome, AcneView official trial listing → -
Withdrawn NCT NCT00999479
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
Not yet reported University of Oklahoma Est. completion 2011-10 1 site Stand-aloneOther conditions: EndometriomaView official trial listing → -
Active, not recruiting NCT NCT00999804
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
Not yet reported Baylor Breast Care Center 128 participants Est. completion 2026-01 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00999921
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
Not yet reported Medical College and Hospital Kolkata 256 participants Est. completion 2015-01 1 siteOther conditions: Benign Breast Disease, Fibrocystic Disease of Breast, Fibroadenoma, MastalgiaView official trial listing → -
Withdrawn NCT NCT01004419
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer
Not yet reported University of Wisconsin, Madison Est. completion 2011-05Other conditions: Carcinoma, Non Small Cell LungView official trial listing → -
Completed NCT NCT01004744
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
Not yet reported Columbia University 10 participants Est. completion 2009-08 1 siteOther conditions: Invasive Breast CancerView official trial listing → -
Status unknown NCT NCT01004796
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
University of Wisconsin, MadisonOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01005056
Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
Organon and Co 3838 participants Est. completion 2009-03Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01007071
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
Not yet reported Stanford University 11 participants Est. completion 2012-12-12 1 site Stand-aloneOther conditions: HypopituitarismView official trial listing → -
Completed NCT NCT01009437
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 28 participants Est. completion 2014-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT01013506
Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2009-12Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01015677
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
Not yet reported Merck Sharp & Dohme LLC 99 participants Est. completion 2010-07-30Other conditions: Moderate to Severe Vasomotor Symptoms in Postmenopausal, WomenView official trial listing → -
Status unknown NCT NCT01022333
The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Not yet reported Women's College Hospital 300 participants Est. completion 2010-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01023178
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure
Not yet reported Stanford University 20 participants Est. completion 2013-06 1 siteOther conditions: Ovarian Failure, PrematureView official trial listing → -
Completed NCT NCT01031355
Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium
Not yet reported Bayer 42 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Contraception, Ovulation InhibitionView official trial listing → -
Status unknown NCT NCT01040182
Polymorphism of Estrogen Genes in Stroke
Taipei Medical University WanFang Hospital 300 participants Est. completion 2010-11 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01040845
A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
Not yet reported Mutual Pharmaceutical Company, Inc. 30 participants Est. completion 2008-02 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT01044056
A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)
Not yet reported Organon and Co 24 participants Est. completion 2004-06Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01044498
A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis
Not yet reported Hoffmann-La Roche 46 participants Est. completion 2012-02 6 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01044862
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
Not yet reported Yale University 900 participants Est. completion 2014-03 14 sitesOther conditions: Pregnancy, Unexplained InfertilityView official trial listing → -
Completed NCT NCT01046578
Aromatase Inhibitor Effects on Ovarian Function During the Follicular and Early Luteal Phase in Women
Not yet reported University of Saskatchewan 41 participants Est. completion 2012-02 1 siteOther conditions: FertilityView official trial listing → -
Completed NCT NCT01046643
Early Menopause Hormone Treatment and Cognition
Not yet reported University of Michigan 30 participants Est. completion 2012-03 1 siteOther conditions: Menopausal SyndromeView official trial listing → -
Completed NCT NCT01047358
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Pfizer 206 participants Est. completion 2014-06 22 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01048606
Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women
Not yet reported Université de Sherbrooke 45 participants Est. completion 2012-11 1 siteOther conditions: OverweightView official trial listing → -
Status unknown NCT NCT01052623
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Not yet reported Johann Wolfgang Goethe University Hospital 24 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: Ataxia Telangiectasia, Growth FailureView official trial listing → -
Completed NCT NCT01056042
Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain
Not yet reported Prince of Songkla University 112 participants Est. completion 2011-10 1 siteOther conditions: EndometriosisView official trial listing → -
Status unknown NCT NCT01058252
Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF
Galaxy Pharma (Pvt) Limited 30 participants Est. completion 2022-03 2 sitesOther conditions: Primary Infertility, Secondary Infertility, Low Responders, Mild to Moderate Male Factor InfertilityView official trial listing → -
Completed NCT NCT01063023
Drug Interaction Oral Contraceptive Pill (OCP)
Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2010-06 1 siteOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT01064453
Angeliq Regulatory Post Marketing Surveillance
Bayer 4078 participants Est. completion 2012-12 1 siteOther conditions: Postmenopausal Period, Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT01065220
Sex Steroids and the Serotonin Transporter
Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 siteOther conditions: TranssexualismView official trial listing → -
Status unknown NCT NCT01069211
Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
Korean Breast Cancer Study Group 876 participants Est. completion 2017-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01070979
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
Not yet reported Warner Chilcott 249 participants Est. completion 2003-09 32 sitesOther conditions: Hormone Replacement TherapyView official trial listing → -
Completed NCT NCT01073865
Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer
Not yet reported AstraZeneca 222 participants Est. completion 2017-11-20 55 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01076582
Comparative Trial in Hormone Withdrawal Associated Symptoms
Not yet reported Bayer 592 participants Est. completion 2011-10 44 sitesOther conditions: Oral ContraceptiveView official trial listing → -
Terminated NCT NCT01079949
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
Not yet reported Merck KGaA, Darmstadt, Germany 93 participants Est. completion 2010-10 1 siteOther conditions: Infertility, Ovulation InductionView official trial listing → -
Completed NCT NCT01081613
Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
University Medical Center Groningen 7 participants Est. completion 2012-02 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01083641
Estrogen for Triple Negative Breast Cancer
Not yet reported University of Wisconsin, Madison 17 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: Female Breast CancerView official trial listing → -
Completed NCT NCT01085877
Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Not yet reported Novo Nordisk A/S 70 participants Est. completion 2010-05 1 siteOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Terminated NCT NCT01087593
Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia
Not yet reported Ostergotland County Council, Sweden 29 participants Est. completion 2007-10 1 siteOther conditions: FibromyalgiaView official trial listing → -
Completed NCT NCT01087879
The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism
Not yet reported University of Oulu 45 participants Est. completion 2011-01 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01088477
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
University Medical Center Groningen 21 participants Est. completion 2014-02 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01089049
Effect of a Natural Health Product on Urinary Estrogen Metabolites
Not yet reported, Not yet reported Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 98 participants Est. completion 2010-05 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01093235
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
Not yet reported Cambridge University Hospitals NHS Foundation Trust 800 participants 1 siteOther conditions: Breast Cancer, Cardiac Toxicity, Perioperative/Postoperative ComplicationsView official trial listing → -
Terminated NCT NCT01096329
A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®
Not yet reported VIVUS LLC 16 participants 1 siteOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT01101438
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Not yet reported Canadian Cancer Trials Group 3649 participants Est. completion 2023-08-18 344 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01103518
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
Not yet reported Fundação Educacional Serra dos Órgãos 100 participants Est. completion 2011-01 1 siteOther conditions: Amenorrhea, Dysmenorrhea, Menstruation Disturbances, HyperandrogenismView official trial listing → -
Status unknown NCT NCT01104571
Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 257 participants Est. completion 2025-09 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01109979
Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function
Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2016-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01112358
Lutropin Alfa in Women at Risk of Poor Response
Not yet reported Merck KGaA, Darmstadt, Germany 58 participants Est. completion 2007-01-30 1 siteOther conditions: Ovarian StimulationView official trial listing → -
Completed NCT NCT01120665
Isolated and Associated Effects of Physical Exercise and Estrogen Therapy on Climactercs Women
Not yet reported University of Sao Paulo General Hospital 62 participants Est. completion 2009-02 Stand-aloneOther conditions: Women's HealthView official trial listing → -
Withdrawn NCT NCT01123135
The Effect of Vaginal Estrogen Cream on Subjective and Objective Symptoms of Urodynamic Stress Incontinence
Not yet reported University of California, Irvine Est. completion 2010-05 1 siteOther conditions: Stress Urinary IncontinenceView official trial listing → -
Status unknown NCT NCT01123538
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile
Not yet reported University Hospital of North Norway 40 participants Est. completion 2012-10 1 siteOther conditions: Pharmacogenomics, Systems BiologyView official trial listing → -
Completed NCT NCT01124695
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Not yet reported ECOG-ACRIN Cancer Research Group 124 participants Est. completion 2022-12 294 sitesOther conditions: Breast Cancer, Stage IV Breast CancerView official trial listing → -
Terminated NCT NCT01126801
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
Not yet reported Massachusetts General Hospital 2 participants Est. completion 2011-02 1 siteOther conditions: Menopausal DepressionView official trial listing → -
Completed NCT NCT01129102
Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
Not yet reported Nobelpharma 215 participants Est. completion 2011-04Other conditions: DysmenorrheaView official trial listing → -
Terminated NCT NCT01129830
The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve
Not yet reported Virginia Center for Reproductive Medicine 200 participants Est. completion 2014-09 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01142401
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2021-01-08 21 sitesOther conditions: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Terminated NCT NCT01147016
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Not yet reported Barbara Ann Karmanos Cancer Institute 8 participants Est. completion 2017-07-26 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01147484
A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer
Not yet reported NCIC Clinical Trials Group 47 participants Est. completion 2015-02-13 9 sitesOther conditions: Recurrent Breast CancerView official trial listing → -
Completed NCT NCT01153581
Sex Hormones and Orthostatic Tolerance
Not yet reported Yale University 109 participants Est. completion 2013-05 1 siteOther conditions: Orthostatic IntoleranceView official trial listing → -
Terminated NCT NCT01155063
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Pfizer 89 participants Est. completion 2011-09Other conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT01157182
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2007-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01160211
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 369 participants Est. completion 2022-06-06 110 sitesOther conditions: Neoplasms, BreastView official trial listing → -
Completed NCT NCT01160718
Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy
Not yet reported Swiss Cancer Institute 46 participants Est. completion 2016-09 17 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01165307
Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia
Not yet reported Abimbola Famuyide 77 participants Est. completion 2015-10 1 siteOther conditions: MenorrhagiaView official trial listing → -
Completed NCT NCT01170390
Oral Contraceptives and Body Mass Index
Not yet reported Oregon Health and Science University 32 participants Est. completion 2011-12 1 siteOther conditions: Body Weight, Contraceptive UsageView official trial listing → -
Status unknown NCT NCT01174225
IUD Insertion Post First Trimester Abortion
Not yet reported University of British Columbia 534 participants Est. completion 2023-06-30 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01174524
Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme
Not yet reported Hospital Geral de Fortaleza 100 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: Quality of Life, Menopause, ContraceptionView official trial listing → -
Status unknown NCT NCT01175759
Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss
Not yet reported EVE Medical Systems Ltd. 40 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Abortion, RecurrentView official trial listing → -
Completed NCT NCT01178125
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 2858 participants Est. completion 2013-01 62 sitesOther conditions: Contraception, Female ContraceptionView official trial listing → -
Completed NCT NCT01181479
Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System
Not yet reported Agile Therapeutics 1504 participants Est. completion 2012-03 80 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01181726
Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions
Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2007-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01182194
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.
Not yet reported Teva Pharmaceuticals USA 32 participants Est. completion 2006-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01182207
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 33 participants Est. completion 2006-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01185678
Data on Oral Contraceptives Compliance in Non Stop Regimen
Bayer 8416 participants Est. completion 2010-11 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01185704
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
Not yet reported Merck KGaA, Darmstadt, Germany 136 participants Est. completion 2012-02 1 siteOther conditions: Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT01186796
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Not yet reported Mayo Clinic 30 participants Est. completion 2013-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01194687
Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses
National Cancer Institute (NCI) 98 participants Est. completion 2018-09-14 1 siteOther conditions: Normal PhysiologyView official trial listing → -
Terminated NCT NCT01194908
Re-expression of ER in Triple Negative Breast Cancers
Not yet reported, Not yet reported Emory University 5 participants Est. completion 2014-01 1 siteOther conditions: Breast Cancer, Breast Tumors, Breast NeoplasmsView official trial listing → -
Terminated NCT NCT01195974
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Not yet reported ViiV Healthcare 13 participants Est. completion 2011-02-09 1 siteOther conditions: Infection, Human Immunodeficiency Virus, HIV InfectionsView official trial listing → -
Completed NCT NCT01197170
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
Not yet reported M.D. Anderson Cancer Center 277 participants Est. completion 2021-01-13 1 siteOther conditions: Solid Tumors, Advanced CancerView official trial listing → -
Withdrawn NCT NCT01200537
Optimizing Ovulation Induction in the Poor Responder
Not yet reported Duke University Est. completion 2012-10 1 siteOther conditions: IVF Poor RespondersView official trial listing → -
Completed NCT NCT01202591
Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients
Not yet reported, Not yet reported AstraZeneca 127 participants Est. completion 2014-10 21 sitesOther conditions: FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast CancerView official trial listing → -
Completed NCT NCT01204190
Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.
Not yet reported Bayer 173 participants Est. completion 2011-08 2 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01204840
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
Not yet reported Ottawa Fertility Centre 38 participants Est. completion 2015-05 1 siteOther conditions: Infertility, Poor Ovarian ReserveView official trial listing → -
Completed NCT NCT01204957
Brown Seaweed as a Breast Cancer Preventive
Not yet reported, Not yet reported University of South Carolina 33 participants Est. completion 1999-03 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01207102
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
Not yet reported Duke University 10 participants Est. completion 2014-06 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01208324
Estrogen and Serotonin on Changing Brain Chemistry
Not yet reported University of Colorado, Denver 47 participants Est. completion 2018-11 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT01208779
Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
AstraZeneca 90 participants Est. completion 2012-11 2 sitesOther conditions: Hormon Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01209143
A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
Not yet reported Genentech, Inc. 52 participants Est. completion 2012-03 3 sitesOther conditions: Solid CancersView official trial listing → -
Terminated NCT NCT01210144
EXpression PRofile Endometrium Samples Study
Not yet reported Merck KGaA, Darmstadt, Germany 27 participants Est. completion 2010-08 1 siteOther conditions: In Vitro FertilizationView official trial listing → -
Completed NCT NCT01216176
A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Not yet reported, Not yet reported Joyce Marie Slingerland, MD 71 participants Est. completion 2018-02-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01216358
Boston Migraine and Contraception Study
Planned Parenthood League of Massachusetts 171 participants Est. completion 2011-12 1 siteOther conditions: HeadacheView official trial listing → -
Terminated NCT NCT01217411
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 5 participants Est. completion 2011-11-30 2 sitesOther conditions: Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma, HER2/Neu Negative, HER2/Neu Positive, Male Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma, Recurrent Melanoma, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IV Lung Non-Small Cell Cancer AJCC v7View official trial listing → -
Completed NCT NCT01218386
Pretreatment With Estradiol Valerate
Not yet reported Universitair Ziekenhuis Brussel 80 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219101
The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination
Not yet reported Royan Institute 95 participants Est. completion 2013-02 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219153
Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET
Not yet reported Cairo University 136 participants Est. completion 2010-12 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01219699
A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Not yet reported Novartis Pharmaceuticals 221 participants Est. completion 2020-04-16 11 sites Stand-aloneOther conditions: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast CancerView official trial listing → -
Terminated NCT NCT01220128
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Not yet reported GlaxoSmithKline 66 participants Est. completion 2014-11-14 36 sitesOther conditions: Neoplasms, BreastView official trial listing → -
Completed NCT NCT01221831
Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2
Not yet reported Estetra 396 participants Est. completion 2011-09 10 sitesOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT01230970
Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer
Not yet reported Ipsen 2 participants Est. completion 2011-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01231659
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 72 participants Est. completion 2017-04-30 7 sitesOther conditions: Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01232075
Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination
Not yet reported Cairo University 214 participants Est. completion 2010-12 2 sitesOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01233947
Study of AFP464 +/- Faslodex in ER + Breast Cancer
Not yet reported Tigris Pharmaceuticals 7 participants Est. completion 2012-08 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT01234857
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
Not yet reported Merck Sharp & Dohme LLC 115 participants Est. completion 2013-10-15Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT01236768
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
Not yet reported Agile Therapeutics 407 participants Est. completion 2011-06 21 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01237327
Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer
Not yet reported Pfizer 84 participants Est. completion 2009-12 7 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01237535
Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates
Not yet reported Rabin Medical Center 400 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Unexplained Infertility, Mild Male FactorView official trial listing → -
Terminated NCT NCT01239745
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
Pfizer 46 participants Est. completion 2011-10 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT01239888
Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study
Not yet reported The Alfred 15 participants 1 siteOther conditions: Depression, Major Depressive DisorderView official trial listing → -
Completed NCT NCT01243580
AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol
Not yet reported Agile Therapeutics 36 participants Est. completion 2009-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01246791
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
Not yet reported Nobelpharma 12 participants Est. completion 2011-05Other conditions: HealthyView official trial listing → -
Completed NCT NCT01248416
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
Not yet reported Nemours Children's Clinic 76 participants Est. completion 2016-09 4 sitesOther conditions: Idiopathic Short StatureView official trial listing → -
Completed NCT NCT01250314
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
Not yet reported Assistance Publique - Hôpitaux de Paris 79 participants Est. completion 2010-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01250717
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
Not yet reported Beth Israel Deaconess Medical Center 28 participants Est. completion 2011-05 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT01251263
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Not yet reported Scott and White Hospital & Clinic 40 participants Est. completion 2012-10 1 siteOther conditions: Menstrual Migraines, Menstrual Bleeding, Menstrual SpottingView official trial listing → -
Terminated NCT NCT01251354
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
Not yet reported Ipsen 6 participants Est. completion 2011-07 9 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT01252186
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Not yet reported Teva Women's Health 265 participants Est. completion 2011-12 24 sitesOther conditions: Hemostasis, Oral ContraceptiveView official trial listing → -
Completed NCT NCT01253174
Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)
Not yet reported Bayer 48 participants Est. completion 2007-07 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01253187
Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)
Not yet reported Bayer 44 participants Est. completion 2007-09 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01253824
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Not yet reported Nobelpharma 14 participants Est. completion 2011-07Other conditions: HealthyView official trial listing → -
Completed NCT NCT01254292
LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Not yet reported Bayer 567 participants Est. completion 2014-05-28 94 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01257984
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
Not yet reported Bayer 508 participants Est. completion 2012-09 43 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01258660
Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate
Not yet reported Bayer 172 participants Est. completion 2008-01 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01260805
A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.
Not yet reported Pfizer 32 participants Est. completion 2010-10 1 siteOther conditions: Bioequivalence, Ethinylestradiol, Gestodene, HarmonetView official trial listing → -
Withdrawn NCT NCT01265017
Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes
Not yet reported Sansum Diabetes Research Institute Est. completion 2020-06 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT01266213
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 siteOther conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos PremenopausalView official trial listing → -
Completed NCT NCT01266408
INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)
Center for Epidemiology and Health Research, Germany 82921 participants Est. completion 2019-10-02 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01268046
Aging and Estrogen on Cortical Function
Not yet reported, Not yet reported Massachusetts General Hospital 38 participants Est. completion 2013-12-02 1 site Stand-aloneOther conditions: Memory Loss, Cognitive Changes, Postmenopausal SymptomsView official trial listing → -
Terminated NCT NCT01272141
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Not yet reported Emory University 5 participants Est. completion 2014-01 3 sitesOther conditions: Breast Neoplasms, Breast Cancer, Cancer of the BreastView official trial listing → -
Completed NCT NCT01273168
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2025-12-19 1 siteOther conditions: Hormone Receptor-Positive Breast, Gynecologic, Desmoid, Hormone Receptor-Positive NeoplasmsView official trial listing → -
Status unknown NCT NCT01278810
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 30 participants Est. completion 2011-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01281137
Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01282164
The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis
Not yet reported The Cleveland Clinic 43 participants Est. completion 2014-07 4 sitesOther conditions: Adult Growth Hormone Deficiency, Hypothalamic-pituitary DisordersView official trial listing → -
Completed NCT NCT01284244
A Randomized Controlled Trial of the Uresta Continence Pessary
Not yet reported Mount Sinai Hospital, Canada 36 participants Est. completion 2014-05 1 siteOther conditions: Stress Urinary IncontinenceView official trial listing → -
Completed NCT NCT01286948
Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG
Not yet reported Population Council 20 participants Est. completion 2014-11 2 sitesOther conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT01291004
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 206 participants Est. completion 2012-03-31 2 sitesOther conditions: Follicle Development, Ovarian Follicle, Follicle Count, Follicle Size, Oral ContraceptiveView official trial listing → -
Completed NCT NCT01292785
Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity
Medical University of Vienna 80 participants Est. completion 2015-04 1 siteOther conditions: Gender Identity DisorderView official trial listing → -
Completed NCT NCT01293032
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sitesOther conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast CancerView official trial listing → -
Completed NCT NCT01293747
Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
Not yet reported Productos Científicos S. A. de C. V. 30 participants Est. completion 2011-10 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT01295892
Chronic Effects of Estrogen in Microcirculation
Not yet reported Rio de Janeiro State University 44 participants Est. completion 2013-04 1 site Stand-aloneOther conditions: Postmenopausal SymptomsView official trial listing → -
Terminated NCT NCT01296555
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sitesOther conditions: Solid Cancers, Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT01297179
A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill
Not yet reported Astellas Pharma Inc 30 participants Est. completion 2009-03 1 siteOther conditions: Healthy Volunteers, Pharmacokinetics of MirabegronView official trial listing → -
Completed NCT NCT01297348
Study Of Lybrel In Relation To Venous Thromboembolism
Pfizer 598682 participants Est. completion 2012-04Other conditions: Venous Thrombosis, Pulmonary Embolism, Sinus Thrombosis, IntracranialView official trial listing → -
Completed NCT NCT01300351
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women
Not yet reported AstraZeneca 249 participants Est. completion 2014-03 15 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01300676
The Effects of Tualang Honey on Postmenopausal Women
Not yet reported, Not yet reported Universiti Sains Malaysia 79 participants Est. completion 2010-06 1 siteOther conditions: Postmenopausal SyndromeView official trial listing → -
Completed NCT NCT01301183
Effects of Anorexia Nervosa on Peak Bone Mass
Not yet reported Massachusetts General Hospital 75 participants Est. completion 2020-03 1 siteObstructive sleep apneaView official trial listing → -
Terminated NCT NCT01303679
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer
Not yet reported ARCAGY/ GINECO GROUP 117 participants Est. completion 2018-05 1 siteOther conditions: First Line Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01308814
Perimenopausal Estrogen Replacement Therapy Study
Not yet reported, Not yet reported University of North Carolina, Chapel Hill 172 participants Est. completion 2016-03 1 siteOther conditions: Perimenopause, Menopause, DepressionView official trial listing → -
Completed NCT NCT01310647
Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders
Not yet reported Instituto de Investigacion Sanitaria La Fe 66 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: Ovarian DiseasesView official trial listing → -
Status unknown NCT NCT01311037
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center 2 participants 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT01313039
Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer
Not yet reported University of Miami 4 participants Est. completion 2014-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01318005
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Not yet reported University of Southern California 82 participants Est. completion 2015-06-30 1 siteOther conditions: Oral ContraceptiveView official trial listing → -
Completed NCT NCT01319968
Postpartum Dyspareunia Resulting From Vaginal Atrophy
Meir Medical Center 117 participants Est. completion 2013-09 2 sitesOther conditions: Vulvovaginal Atrophy, Dyspareunia Among Puerperal WomenView official trial listing → -
Withdrawn NCT NCT01320046
Vulvar Contact Dermatitis Resulting From Urine Incontinence
Meir Medical Center Est. completion 2012-03 1 siteOther conditions: Urinary Incontinence, Vulvar Pruritus, Vulvar Contact DermatitisView official trial listing → -
Withdrawn NCT NCT01320787
18-F-Fluoroacetate as PET Imaging Agent
Not yet reported M.D. Anderson Cancer CenterOther conditions: Brain Cancer, Breast Cancer, Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT01327781
Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sitesOther conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT01328184
Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
Not yet reported Boehringer Ingelheim 18 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01329562
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
Not yet reported Cady, Roger, M.D. 41 participants Est. completion 2012-06 2 sitesOther conditions: Menstrual MigraineView official trial listing → -
Completed NCT NCT01339442
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
Not yet reported Washington University School of Medicine 31 participants Est. completion 2016-12-28 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01340625
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2007-01 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT01344031
MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 31 participants 1 siteOther conditions: Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT01344369
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Not yet reported Teva Pharmaceuticals USA 36 participants Est. completion 2008-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01345786
Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)
Not yet reported Organon and Co 158 participants Est. completion 2010-06Other conditions: Healthy Postmenopausal FemalesView official trial listing → -
Terminated NCT NCT01346579
Biomarkers in Tissue Samples From Older Women With Breast Cancer
Alliance for Clinical Trials in Oncology 505 participants Est. completion 2014-01Other conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT01349322
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Not yet reported Radiation Therapy Oncology Group 2354 participants 415 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01352091
Adjuvant AI Combined With Zoladex
Not yet reported Fudan University 670 participants Est. completion 2018-04 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01353846
Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 70 participants Est. completion 2012-11 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01360996
Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
Not yet reported Woman's 64 participants Est. completion 2015-02 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01361958
Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol
Not yet reported Theramex 38 participants Est. completion 1998-09Other conditions: Suppression of OvulationView official trial listing → -
Completed NCT NCT01367912
Timing of Estrogen Support During the Luteal Phase of in Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycle
Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 301 participants Est. completion 2008-11 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01368263
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Not yet reported Washington University School of Medicine 8 participants Est. completion 2013-05 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Completed NCT NCT01370551
Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients
Not yet reported Medinova AG 16 participants Est. completion 2012-07 2 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Completed NCT NCT01370798
Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications
Not yet reported Hospices Civils de Lyon 244 participants Est. completion 2017-09-18 4 sitesOther conditions: HypospadiasView official trial listing → -
Completed NCT NCT01372293
71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women
Not yet reported Federal University of Rio Grande do Sul 49 participants Est. completion 2010-12Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01373931
A Study of LY2216684 in Healthy Females
Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 siteOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT01377324
Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites
Not yet reported University Medical Center Groningen 16 participants Est. completion 2013-08 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01381016
Estrogen Sensitivity and Ovulatory Dysfunction in Obesity
Not yet reported University of Colorado, Denver 30 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Obesity, InfertilityView official trial listing → -
Completed NCT NCT01381874
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Not yet reported Janssen Research & Development, LLC 297 participants Est. completion 2018-08-08 81 sitesOther conditions: Metastatic ER+ Her2- Breast Cancer, PostmenopausalView official trial listing → -
Status unknown NCT NCT01384331
New Treatments for Troublesome Bleeding in Implanon Users
Not yet reported Family Planning Association New South Wales 200 participants Est. completion 2013-04 1 siteOther conditions: Menstrual ProblemView official trial listing → -
Completed NCT NCT01385137
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy
Not yet reported SWOG Cancer Research Network 262 participants Est. completion 2014-03 292 sitesOther conditions: Arthralgia, Breast Cancer, PainView official trial listing → -
Completed NCT NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01385332
A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors
Not yet reported Parc de Salut Mar 10 participants Est. completion 2012-09 1 siteOther conditions: Stimulation in the OvaryView official trial listing → -
Completed NCT NCT01385618
Gene-polymorphisms Relating to Human Subfertility
Infertility Treatment Center Dortmund 150 participants Est. completion 2015-03 1 siteOther conditions: Estradiol Receptor Polymorphism, Progesterone Receptor Polymorphism, IVF, SubfertilityView official trial listing → -
Completed NCT NCT01388491
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 293 participants Est. completion 2012-09-30 27 sitesOther conditions: Hemostasis, Oral ContraceptiveView official trial listing → -
Completed NCT NCT01389102
Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
Not yet reported Lumara Health, Inc. 454 participants Est. completion 2006-11 43 sitesOther conditions: Hot FlashesView official trial listing → -
Terminated NCT NCT01393119
Phase II, Dose Finding Study of GTx-758
Not yet reported GTx 77 participants Est. completion 2012-12 21 sites Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01394016
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
Not yet reported Eli Lilly and Company 225 participants Est. completion 2022-04-12 3 sitesOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT01399086
Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer
Hellenic Oncology Research Group 140 participants Est. completion 2011-09 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01400776
Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women
Not yet reported Warner Chilcott 722 participants Est. completion 2012-02-27 70 sitesOther conditions: Postmenopausal Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT01402648
Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence
Not yet reported, Not yet reported CM&D Pharma Limited 60 participants Est. completion 2011-04 1 siteOther conditions: Adenocarcinoma of Colon RecurrentView official trial listing → -
Completed NCT NCT01407692
Menstrual Cycle Hormones and Eating Behavior
USDA, Western Human Nutrition Research Center 24 participants Est. completion 2012-12 1 siteOther conditions: Dietary Habits, Food PreferenceView official trial listing → -
Completed NCT NCT01408030
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Not yet reported James Gossage 123 participants Est. completion 2014-09 6 sitesOther conditions: Telangiectasia, Hereditary Hemorrhagic, EpistaxisView official trial listing → -
Status unknown NCT NCT01414530
Oral Contraceptive During Menopausal Transition
Not yet reported Samsung Medical Center 52 participants 1 siteOther conditions: PerimenopauseView official trial listing → -
Completed NCT NCT01418209
MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms
Not yet reported Fred Hutchinson Cancer Center 339 participants Est. completion 2013-01 4 sitesOther conditions: Hot Flashes, Menopause, Vasomotor DisturbanceView official trial listing → -
Completed NCT NCT01419353
Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
Not yet reported Meir Medical Center 63 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT01420185
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NSABP Foundation Inc 1300 participantsOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01421472
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Not yet reported Merrimack Pharmaceuticals 196 participants Est. completion 2014-06 38 sitesOther conditions: ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer PatientsView official trial listing → -
Status unknown NCT NCT01424618
A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs
Not yet reported Kelly, Maureen, M.D. 20 participants 1 siteOther conditions: Implantation, EmbryoView official trial listing → -
Terminated NCT NCT01425294
Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment
AstraZeneca 231 participants Est. completion 2016-01-30 23 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01425541
Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Not yet reported University of Virginia 60 participants Est. completion 2025-08 1 site Stand-aloneOther conditions: Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)View official trial listing → -
Completed NCT NCT01427595
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Not yet reported University of Virginia 25 participants Est. completion 2015-01-17 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome, HyperandrogenismView official trial listing → -
Terminated NCT NCT01428193
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
Not yet reported University of Virginia 4 participants Est. completion 2017-08 1 siteOther conditions: Polycystic Ovary Syndrome, HyperandrogenismView official trial listing → -
Terminated NCT NCT01428245
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Not yet reported University of Virginia 3 participants Est. completion 2013-05-14 1 site Stand-aloneOther conditions: Hyperandrogenemia, Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT01430585
Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer
Not yet reported Pfizer 14 participants Est. completion 2012-12 5 sitesOther conditions: Early Breast Cancer (Phase 2), Advanced Breast Cancer (Phase 1b)View official trial listing → -
Completed NCT NCT01430650
Endometrial Priming for Embryo Transfer
Not yet reported Parc de Salut Mar 140 participants Est. completion 2015-07 1 siteOther conditions: SterilityView official trial listing → -
Completed NCT NCT01431872
Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors
University of Arkansas 17 participants Est. completion 2015-08 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01432028
Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Not yet reported Denusa Wiltgen 90 participants Est. completion 2011-04 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT01436513
A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.
Not yet reported Pfizer 72 participants Est. completion 2012-03 1 siteOther conditions: Primary Ovarian Insufficiency, Vaginitis, Metrorrhagia, MenopauseView official trial listing → -
Completed NCT NCT01437566
Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy
Not yet reported Genentech, Inc. 318 participants Est. completion 2016-04 130 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01439282
Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
Not yet reported Eisai Inc. 77 participants Est. completion 2014-05 23 sitesOther conditions: Estrogen Receptor Positive Tumor, Breast CancerView official trial listing → -
Completed NCT NCT01439711
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Not yet reported Alliance for Clinical Trials in Oncology 108 participants Est. completion 2018-01 32 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01441635
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Not yet reported AbbVie (prior sponsor, Abbott) 271 participants Est. completion 2014-05-17 Stand-aloneOther conditions: Heavy Uterine Bleeding, Uterine FibroidsView official trial listing → -
Completed NCT NCT01441947
Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
Not yet reported Massachusetts General Hospital 68 participants Est. completion 2019-08-09 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01446159
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Not yet reported MedImmune LLC 188 participants Est. completion 2019-06-28 71 sitesOther conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01448291
Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers
Not yet reported Eastern Virginia Medical School 30 participants Est. completion 2013-03 1 siteOther conditions: Vaginosis, BacterialView official trial listing → -
Completed NCT NCT01452373
Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women
Not yet reported EndoCeutics Inc. 238 participants Est. completion 2013-05 15 sitesOther conditions: Vasomotor Symptoms, Hot FlushesView official trial listing → -
Completed NCT NCT01455597
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
Not yet reported Warner Chilcott 309 participants Est. completion 2012-12-03 64 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT01458210
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
Not yet reported Eli Lilly and Company 22 participants Est. completion 2012-02 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT01459445
Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
Not yet reported Iuliu Hatieganu University of Medicine and Pharmacy 26 participants Est. completion 2012-01 1 siteOther conditions: Polycystic Ovary Syndrome, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT01461070
Intestine Bacteria and Breast Cancer Risk
National Cancer Institute (NCI) 175 participants Est. completion 2020-05-22 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01465022
Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Not yet reported University of New Mexico 197 participants Est. completion 2008-06Other conditions: Breast Feeding, ContraceptionView official trial listing → -
Status unknown NCT NCT01466114
Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Not yet reported University of California, Los Angeles 64 participants Est. completion 2022-04 4 sitesOther conditions: Relapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis, Primary-progressive Multiple SclerosisView official trial listing → -
Completed NCT NCT01471106
Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
Not yet reported M.D. Anderson Cancer Center 26 participants Est. completion 2024-05-30 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01471457
Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis
Not yet reported, Not yet reported University of New Mexico 184 participants Est. completion 2014-09 2 sitesOther conditions: Bacterial VaginosisView official trial listing → -
Completed NCT NCT01475513
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Not yet reported Virginia Commonwealth University 47 participants Est. completion 2014-05-28 1 siteOther conditions: Insulin Sensitivity, Cardiovascular Risk, Perimenopausal DisorderView official trial listing → -
Terminated NCT NCT01475565
Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
Virginia Commonwealth University 2 participants Est. completion 2014-08 1 siteOther conditions: Polycystic Ovary Syndrome, Insulin Resistance, Insulin Sensitivity, Obesity, PregnancyView official trial listing → -
Completed NCT NCT01477632
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
Not yet reported Novo Nordisk A/S 24 participants Est. completion 2005-06 1 siteOther conditions: Menopause, HealthyView official trial listing → -
Completed NCT NCT01480778
Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.
Not yet reported Azidus Brasil 62 participants Est. completion 2015-06 1 siteOther conditions: Irregular PeriodsView official trial listing → -
Completed NCT NCT01481883
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
Not yet reported The Alfred 13 participants Est. completion 2019-02 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01482416
Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Unspecified Injury of Brachial Artery, Left Side, Initial EncounterView official trial listing → -
Terminated NCT NCT01484041
Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
Not yet reported, Not yet reported Georgetown University 12 participants Est. completion 2017-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01489852
Estrogen Pretreatment Prior to GnRH Antagonist Protocol
Not yet reported Gemer 472 participants Est. completion 2011-05 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01490190
Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)
Not yet reported Organon and Co 252 participants Est. completion 2012-12-05Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01491737
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
Not yet reported Hoffmann-La Roche 258 participants Est. completion 2019-11-14 82 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01497977
Phytoestrogen Supplementation in Postmenopausal Women
Not yet reported American Medical Academy, Serbia 74 participants Est. completion 2010-06 1 siteOther conditions: Low Serum Lipid LevelsView official trial listing → -
Completed NCT NCT01498861
Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
Not yet reported ViiV Healthcare 16 participants Est. completion 2012-03 1 siteOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Terminated NCT NCT01500473
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
Not yet reported Children's Hospital Los Angeles 1 participants Est. completion 2016-05-11 1 siteOther conditions: Congenital Central Hypoventilation SyndromeView official trial listing → -
Completed NCT NCT01500863
Endometrial Receptivity After GnRH Agonist Triggering
Not yet reported IVI Madrid 35 participants 1 site Stand-aloneOther conditions: Ovarian Hyperstimulation SyndromeView official trial listing → -
Completed NCT NCT01501422
Effect of Estrogen Therapy on Objective Sleep Quality in Postmenopausal Women
Not yet reported Chulalongkorn University 40 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Insomniac Postmenopausal WomenView official trial listing → -
Completed NCT NCT01504139
The Luteal Phase After GnRHa Trigger - a Proof of Concept Study
Not yet reported Regionshospitalet Viborg, Skive 93 participants Est. completion 2014-08 1 siteOther conditions: Progesterone Levels, InfertilityView official trial listing → -
Completed NCT NCT01507454
Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Novo Nordisk A/S 1613 participants Est. completion 2006-11 1 siteOther conditions: Menopause, Postmenopausal Vaginal AtrophyView official trial listing → -
Completed NCT NCT01508858
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
Not yet reported Novo Nordisk A/S 21 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01509625
Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)
Isabel Blancas 272 participants Est. completion 2014-03 7 sitesOther conditions: Malignant Neoplasm of Breast Stage IVView official trial listing → -
Completed NCT NCT01511822
Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
Not yet reported AGUNCO Obstetrics and Gynecology Centre 1 siteOther conditions: PCOS, Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01515800
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
Not yet reported SWOG Cancer Research Network 724 participants Est. completion 2018-02 204 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01518062
Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome
Not yet reported Novo Nordisk A/S 65 participants Est. completion 2003-09 1 siteOther conditions: Genetic Disorder, Turner SyndromeView official trial listing → -
Completed NCT NCT01519401
Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.
Not yet reported Catholic University of the Sacred Heart 50 participants Est. completion 2011-07 1 siteOther conditions: Polycystic Ovary Syndrome, Estro-progestin DrugsView official trial listing → -
Terminated NCT NCT01528345
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Not yet reported Novartis Pharmaceuticals 97 participants Est. completion 2015-04 67 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01535066
S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer
Not yet reported SWOG Cancer Research Network 226 participants Est. completion 2018-07-01 47 sitesOther conditions: Breast Cancer, PainView official trial listing → -
Completed NCT NCT01535820
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2011-07 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01546454
Relationship Between the Menstrual Cycle and Heart Disease in Women
Not yet reported Oregon Health and Science University 5 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT01547741
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Not yet reported NSABP Foundation Inc 4242 participants Est. completion 2025-10-17 915 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01553773
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
Not yet reported Federal University of São Paulo 30 participants Est. completion 2005-03 1 siteOther conditions: AtrophyView official trial listing → -
Completed NCT NCT01556191
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
Not yet reported Intergroupe Francophone de Cancerologie Thoracique 379 participants Est. completion 2020-06-17 61 sitesOther conditions: Stage IV Lung CancerView official trial listing → -
Completed NCT NCT01560416
Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2016-06-26 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01564056
Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
Not yet reported UNICANCER 1989 participants Est. completion 2026-04 84 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01569113
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
Not yet reported HRA Pharma 76 participants Est. completion 2012-08 3 sitesOther conditions: Emergency ContraceptionView official trial listing → -
Completed NCT NCT01569945
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
Not yet reported University Hospital, Gasthuisberg 371 participants Est. completion 2011-12 1 siteOther conditions: SubfertilityView official trial listing → -
Completed NCT NCT01570244
Drug-drug Interaction of BI 201335 and Microgynon
Not yet reported Boehringer Ingelheim 16 participants Est. completion 2012-08 1 siteOther conditions: Hepatitis C, ChronicView official trial listing → -
Completed NCT NCT01573377
Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial
Not yet reported Chongqing Medical University 40 participants Est. completion 2013-02 1 siteOther conditions: Polycystic Ovary Syndrome, Insulin ResistanceView official trial listing → -
Completed NCT NCT01573442
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Not yet reported Alliance for Clinical Trials in Oncology 227 participants Est. completion 2019-09-01 529 sitesOther conditions: Arthralgia, Breast Cancer, Hot Flashes, Musculoskeletal Complications, Sexual DysfunctionView official trial listing → -
Completed NCT NCT01577017
The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)
Not yet reported Nik Hazlina 150 participants Est. completion 2012-03Other conditions: Polycystic Ovarian SyndromeView official trial listing → -
Withdrawn NCT NCT01577199
RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders
Not yet reported Weill Medical College of Cornell University Est. completion 2012-12Other conditions: InfertilityView official trial listing → -
Completed NCT NCT01581814
Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
Not yet reported Catholic University of the Sacred Heart 99 participants Est. completion 2012-03 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01582074
The Ultrasound Study of Tamoxifen
National Cancer Institute (NCI) 247 participants Est. completion 2016-01-01 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01586000
A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
Not yet reported Kimberly Myer 197 participants Est. completion 2015-05 8 sitesOther conditions: Suppression of OvulationView official trial listing → -
Status unknown NCT NCT01588873
Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome
Not yet reported University of Oulu 42 participants Est. completion 2019-12 1 siteOther conditions: Adverse Effect of Oral Contraceptives, SequelaView official trial listing → -
Status unknown NCT NCT01590849
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
Not yet reported Instituto do Coracao 69 participants 1 siteOther conditions: Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood PressureView official trial listing → -
Completed NCT NCT01594216
Ruxolitinib in Estrogen Receptor Positive Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 25 participants Est. completion 2016-04-09 1 siteOther conditions: Estrogen-receptor Positive Invasive Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01595334
Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
Not yet reported Southern Cross Fertility Centre 300 participants Est. completion 2012-11 3 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01596010
Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women
Not yet reported Novo Nordisk A/S 44 participants Est. completion 2007-11 1 siteOther conditions: Menopause, HealthyView official trial listing → -
Completed NCT NCT01597193
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Not yet reported Pfizer 101 participants Est. completion 2018-01-22 17 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01597388
AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Not yet reported AstraZeneca 99 participants Est. completion 2026-01-13 5 sitesOther conditions: Advanced Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01597986
Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone
Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2012-06 1 siteOther conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ethinyl Estradiol and Norethindrone, Healthy VolunteersView official trial listing → -
Completed NCT NCT01598298
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy
Not yet reported SWOG Cancer Research Network 299 participants Est. completion 2018-12-20 714 sitesOther conditions: Breast Cancer, Musculoskeletal Complications, PainView official trial listing → -
Completed NCT NCT01600274
Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest
Not yet reported Pharbil Waltrop GmbH 20 participants Est. completion 2010-02 1 siteOther conditions: Focus: BioequivalenceView official trial listing → -
Completed NCT NCT01602380
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sitesOther conditions: Hormone Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01602770
Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy
Bayer 1 participants Est. completion 2017-10-31 1 siteOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT01603745
Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
Not yet reported Catholic University of the Sacred Heart 10 participants Est. completion 2012-10 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01605071
Timing Estrogen After MenoPaUSe
Not yet reported University of Colorado, Denver 53 participants Est. completion 2017-01 1 siteOther conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT01605396
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)
Not yet reported Merck Sharp & Dohme LLC 80 participants Est. completion 2018-03-15Other conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT01608698
Comparison of Body Weight Change During Contraception With Belara and Yasmin
Not yet reported Mahidol University 100 participants Est. completion 2016-02 1 siteOther conditions: Body Weight ChangesView official trial listing → -
Completed NCT NCT01610284
Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
Not yet reported Novartis Pharmaceuticals 1147 participants Est. completion 2019-04-19 268 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01611038
Methylselenocysteine Effects on Circadian Rhythm
Not yet reported Rutgers, The State University of New Jersey 100 participants Est. completion 2015-06 1 siteOther conditions: Breast Cancer, Prostate CancerView official trial listing → -
Withdrawn NCT NCT01612728
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
Not yet reported Baylor Breast Care Center Est. completion 2014-10Other conditions: Breast Cancer, Arthralgia, Joint PainView official trial listing → -
Withdrawn NCT NCT01612910
Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2014-02Other conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT01613131
Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression
Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-06 1 siteOther conditions: Menopausal and Other Perimenopausal DisordersView official trial listing → -
Status unknown NCT NCT01613170
Premarin Versus Toviaz for Treatment of Overactive Bladder
Not yet reported The Cleveland Clinic 90 participants Est. completion 2018-12 1 siteOther conditions: Overactive BladderView official trial listing → -
Completed NCT NCT01615354
A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers
Not yet reported Hoffmann-La Roche 18 participants Est. completion 2013-01 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Terminated NCT NCT01616758
Phase II Study of GTx024 in Women With Metastatic Breast Cancer
Not yet reported GTx 22 participants Est. completion 2016-03 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01625286
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
Not yet reported, Not yet reported AstraZeneca 148 participants Est. completion 2022-10-03 41 sitesOther conditions: Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01626222
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 301 participants Est. completion 2013-11 84 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01631981
PGL2001 Proof of Concept Study in Symptomatic Endometriosis
Not yet reported PregLem SA 162 participants Est. completion 2014-05 20 sitesOther conditions: EndometriosisView official trial listing → -
Terminated NCT NCT01633060
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Not yet reported Novartis Pharmaceuticals 432 participants Est. completion 2017-09-21 197 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01633528
The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy
Not yet reported Royan Institute 60 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01633814
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
Not yet reported University of Missouri-Columbia 4 participants Est. completion 2015-08 1 siteOther conditions: Menopause, Aging, Blood PressureView official trial listing → -
Terminated NCT NCT01634789
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
Not yet reported Pfizer 2 participants Est. completion 2012-11 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01638767
NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Not yet reported Clinique Ovo 7 participants Est. completion 2014-07 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01638910
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
Not yet reported Bayer 955 participants Est. completion 2014-11 39 sites Stand-aloneOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01638923
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
Not yet reported Bayer 339 participants Est. completion 2015-06 41 sites Stand-aloneOther conditions: MetrorrhagiaView official trial listing → -
Completed NCT NCT01642186
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-07-16 6 sitesOther conditions: Fibrolamellar Carcinoma, Fibrolamellar Liver CancerView official trial listing → -
Completed NCT NCT01645241
Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation
Not yet reported Fundacion Dexeus 15 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: INFERTILITY, Fertility Preservation, Ovulation Induction, Vitrification, Oocyte DonationView official trial listing → -
Terminated NCT NCT01648751
Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse
Not yet reported Pamela Moalli 21 participants Est. completion 2023-03-02 1 site Stand-aloneOther conditions: Pelvic Organ ProlapseView official trial listing → -
Completed NCT NCT01650168
Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)
Center for Epidemiology and Health Research, Germany 101498 participants Est. completion 2020-12 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01653743
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Not yet reported Merck KGaA, Darmstadt, Germany 81 participants Est. completion 2014-12 6 sitesOther conditions: Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction, Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT01654185
Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer
Not yet reported Xichun Hu 60 participants Est. completion 2016-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01654367
Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer
Not yet reported, Not yet reported Tianjin Medical University 300 participants Est. completion 2013-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01655225
A Study of LY3023414 in Participants With Advanced Cancer
Not yet reported Eli Lilly and Company 156 participants Est. completion 2022-02-02 8 sitesOther conditions: Advanced Cancer, Metastatic Cancer, Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Malignant Mesothelioma, Non-small Cell Lung CancerView official trial listing → -
Terminated NCT NCT01656434
Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
Not yet reported Organon and Co 3173 participants Est. completion 2014-02-12Other conditions: ContraceptionView official trial listing → -
Withdrawn NCT NCT01658176
Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer
Not yet reported Pfizer Est. completion 2015-04Other conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT01659008
Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding
Not yet reported Kay I Waud MD PhD 100 participants Est. completion 2016-03 2 sitesOther conditions: Menstrual Cycle and Uterine Bleeding DisordersView official trial listing → -
Status unknown NCT NCT01666171
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
Cancer and Leukemia Group B 458 participantsOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01668056
Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence
Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2014-12 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01668446
Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles
Not yet reported farzaneh hojjat 2 participants Est. completion 2011-02 1 siteOther conditions: Endometrial Preparation, Frozen Embryo TransferView official trial listing → -
Completed NCT NCT01669291
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
Not yet reported Main Line Fertility Center 43 participants Est. completion 2014-05 1 siteOther conditions: FertilityView official trial listing → -
Completed NCT NCT01669343
Aromatase Inhibitor Host Factors Study
Not yet reported Samuel Lunenfeld Research Institute, Mount Sinai Hospital 121 participants Est. completion 2016-12 3 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01670656
A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)
Not yet reported Organon and Co 439 participants Est. completion 2013-09-12Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT01670877
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Not yet reported Washington University School of Medicine 56 participants Est. completion 2021-03-11 17 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1459 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01686828
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
Not yet reported, Not yet reported University of Washington 53 participants Est. completion 2017-12 1 siteType 2 diabetes Other conditions: Insulin Resistance, Obesity, Androgen Deficiency, Metabolic DiseaseView official trial listing → -
Withdrawn NCT NCT01691976
Mild Cognitive Impairment in Men Following Androgen Deprivation
Not yet reported Imperial College London Est. completion 2013-12 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01694225
Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
Not yet reported University of Louisville 87 participants Est. completion 2018-01-28 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01698164
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Not yet reported Peking Union Medical College Hospital 1200 participants 1 site Stand-aloneCardiovascular disease Other conditions: Menopausal Syndrome, Osteoporosis, Breast CancerView official trial listing → -
Completed NCT NCT01698918
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 202 participants Est. completion 2021-01-13 52 sitesOther conditions: Hormone Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01701050
Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
Janssen Diagnostics, LLC 121 participants Est. completion 2016-11-10 20 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01705249
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women
Not yet reported Novo Nordisk A/S 191 participants Est. completion 2003-06-06 19 sitesOther conditions: Menopause, HealthyView official trial listing → -
Completed NCT NCT01709318
A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
Not yet reported Organon and Co 666 participants Est. completion 2013-10-22Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT01709942
Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
Not yet reported Centre for Endocrinology and Reproductive Medicine, Italy 80 participants Est. completion 2015-12 1 siteOther conditions: PCOS, OHSS, INFERTILITYView official trial listing → -
Withdrawn NCT NCT01714128
FES-PET for Patients Treated on NCI Protocol 8762
Not yet reported Washington University School of Medicine Est. completion 2015-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01714193
A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30 participants Est. completion 2008-03Other conditions: HealthyView official trial listing → -
Withdrawn NCT NCT01723579
Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)
Not yet reported Organon and Co Est. completion 2015-05Other conditions: ContraceptionView official trial listing → -
Active, not recruiting NCT NCT01723774
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Not yet reported Washington University School of Medicine 84 participants Est. completion 2027-11-07 4 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01723917
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Not yet reported University of Southern California 71 participants Est. completion 2015-01 1 siteOther conditions: Hot Flashes, Memory LossView official trial listing → -
Withdrawn NCT NCT01724242
Vaginal DHEA for Women After Breast Cancer
Not yet reported, Not yet reported Hadassah Medical Organization Est. completion 2014-12 1 siteOther conditions: Vaginal Dryness, Breast Cancer, Urinary Incontinence, Quality of Life, Sexual SatisfactionView official trial listing → -
Completed NCT NCT01724658
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
Not yet reported Chulalongkorn University 70 participants Est. completion 2013-05 1 siteOther conditions: Female Sexual DysfunctionView official trial listing → -
Completed NCT NCT01726127
Green Vegetables and Women's Health
Not yet reported University of Wisconsin, Madison 66 participants Est. completion 2015-09 1 siteOther conditions: Dietary ModificationView official trial listing → -
Completed NCT NCT01738152
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
Not yet reported Memorial Sloan Kettering Cancer Center 106 participants Est. completion 2021-07-21 1 site Stand-aloneOther conditions: Breast Cancer, Endometrial CancerView official trial listing → -
Completed NCT NCT01740427
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
Not yet reported Pfizer 666 participants Est. completion 2023-11-09 305 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01741974
Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women
Not yet reported Institute for Atherosclerosis Research, Russia 340 participants Est. completion 2012-10Other conditions: Menopausal Syndrome, AtherosclerosisView official trial listing → -
Completed NCT NCT01743560
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2016-08-15 11 sitesOther conditions: Oestrogen Receptor Positive Advanced Breast CancerView official trial listing → -
Completed NCT NCT01746732
A Study of Evacetrapib in Healthy Female Participants
Not yet reported Eli Lilly and Company 23 participants Est. completion 2013-05 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Terminated NCT NCT01753102
Efficacy and Safety Of Spil's Estradiol Vaginal Tablet
Not yet reported Sun Pharmaceutical Industries Limited 49 participants Est. completion 2013-04-30 1 siteOther conditions: Vulvar Atrophy, Vaginal AtrophyView official trial listing → -
Withdrawn NCT NCT01757327
LDE225 in Treating Patients With Stage II-III Estrogen Receptor- and HER2-Negative Breast Cancer
Not yet reported Washington University School of Medicine Est. completion 2019-12Other conditions: Breast NeoplasmsView official trial listing → -
Withdrawn NCT NCT01763541
Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
Not yet reported Massachusetts General Hospital Est. completion 2016-02 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01768247
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2014-01 1 site Stand-aloneOther conditions: Endometrial Thickness, Pregnancy OutcomeView official trial listing → -
Terminated NCT NCT01776008
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2015-05-05 8 sitesOther conditions: Estrogen Receptor Positive, HER2/Neu Negative, Recurrent Breast Carcinoma, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Completed NCT NCT01778985
Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor
Not yet reported University of Texas Southwestern Medical Center 30 participants Est. completion 2013-04 1 siteOther conditions: Pelvic Organ Prolapse, MenopauseView official trial listing → -
Completed NCT NCT01779947
Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo
Not yet reported Amneal Pharmaceuticals, LLC 519 participants Est. completion 2012-12 25 sitesOther conditions: Atrophic Vaginitis Due to MenopauseView official trial listing → -
Status unknown NCT NCT01780558
A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2015-01 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT01780610
The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 670 participants Est. completion 2015-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01783444
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
Not yet reported Novartis Pharmaceuticals 309 participants Est. completion 2018-07-30 83 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01785992
A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.
Not yet reported Imperial College London 27 participants Est. completion 2014-12 9 sitesOther conditions: Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01790282
Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT
Not yet reported Mansoura Integrated Fertility Center 220 participants Est. completion 2015-03 1 siteOther conditions: IVF, InfertilityView official trial listing → -
Status unknown NCT NCT01793038
Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
Not yet reported Mansoura Integrated Fertility Center 160 participants Est. completion 2014-09 1 siteOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT01797120
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Not yet reported PrECOG, LLC. 131 participants Est. completion 2017-09-12 25 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01798836
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
Not yet reported, Not yet reported National and Kapodistrian University of Athens 17 participants Est. completion 2015-02 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT01805817
Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
Not yet reported Istanbul Training and Research Hospital 1 siteOther conditions: Contraceptive Methods ComparisonView official trial listing → -
Completed NCT NCT01810315
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Not yet reported CONRAD 40 participants Est. completion 2014-10 1 siteOther conditions: HIV PreventionView official trial listing → -
Completed NCT NCT01813162
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Not yet reported CONRAD 101 participants Est. completion 2014-12 2 sites Stand-aloneOther conditions: HIV PreventionView official trial listing → -
Completed NCT NCT01814397
Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients
University of Michigan Rogel Cancer Center 50 participants Est. completion 2013-02 1 siteOther conditions: Breast Cancer, Pain, ArthralgiaView official trial listing → -
Withdrawn NCT NCT01814865
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
Not yet reported British Columbia Cancer Agency Est. completion 2013-12 4 sitesOther conditions: Post-menopausal ER+ Stage I-IIIA Primary Operable Breast CancerView official trial listing → -
Completed NCT NCT01816139
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
Not yet reported Warner Chilcott 576 participants Est. completion 2013-11-19 48 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT01817400
Mediators of Abnormal Reproductive Function in Obesity (MARO)
Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Infertility, Female, ObesityView official trial listing → -
Completed NCT NCT01817530
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Not yet reported AbbVie 571 participants Est. completion 2015-12Other conditions: Heavy Uterine Bleeding, Uterine FibroidsView official trial listing → -
Completed NCT NCT01822288
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 siteOther conditions: Menopausal SyndromesView official trial listing → -
Terminated NCT NCT01823835
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Not yet reported, Not yet reported Genentech, Inc. 152 participants Est. completion 2020-03-13 14 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01831076
Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Not yet reported University of Colorado, Denver 36 participants Est. completion 2022-01-06 1 siteOther conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast CancerView official trial listing → -
Completed NCT NCT01833663
Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women
Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Overactive Bladder, Postmenopausal Disorder, Urination DisordersView official trial listing → -
Completed NCT NCT01833858
Human Chorionic Gonadotrophin in an Antagonist Protocol
Not yet reported, Not yet reported Cairo University 60 participants Est. completion 2015-01 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT01842217
Validation of [18F]FES for Imaging of Brain Estrogen Receptors
Not yet reported University Medical Center Groningen 3 participants Est. completion 2016-01 1 siteOther conditions: Psychiatric/Mood Disorder | Patient, Estrogen Receptor Levels, Premenopausal, PostmenopausalView official trial listing → -
Completed NCT NCT01843166
Vaginal Estrogen With Pessary Treatment
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 150 participants Est. completion 2016-12 1 siteOther conditions: Vaginal Infection, Urinary Tract Infection, Quality of LifeView official trial listing → -
Completed NCT NCT01845649
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
Not yet reported Warner Chilcott 550 participants Est. completion 2013-11-20 57 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT01846728
Effects of Estrogen Deficiency on Energy Expenditure
Not yet reported University of Colorado, Denver 6 participants Est. completion 2016-10 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT01850095
The Influence of Peripheral Androgen Conversion at Women Adult Acne
Not yet reported Marco Alexandre Dias da Rocha 60 participants Est. completion 2015-01 1 siteOther conditions: Acne, Quality of LifeView official trial listing → -
Completed NCT NCT01855971
"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome" (TESFX)
Not yet reported Parc de Salut Mar 44 participants Est. completion 2015-10-31 1 siteOther conditions: Fragile X SyndromeView official trial listing → -
Terminated NCT NCT01856036
Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
Not yet reported Saint John's Cancer Institute 2 participants Est. completion 2014-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01862835
Impact of Estradiol Addback
Not yet reported Mayo Clinic 43 participants Est. completion 2018-12-30 1 site Stand-aloneOther conditions: Normal Healthy VolunteersView official trial listing → -
Completed NCT NCT01873170
Quantification of Immune Cells in Women Using Contraception (CHIC II)
University of Pittsburgh 326 participants Est. completion 2020-10 1 siteObstructive sleep apnea Other conditions: HIV, ContraceptionView official trial listing → -
Completed NCT NCT01874184
Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer
Not yet reported University of Washington 17 participants 1 siteOther conditions: Atypical Ductal Breast Hyperplasia, Atypical Lobular Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in SituView official trial listing → -
Terminated NCT NCT01874756
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
Not yet reported Indiana University 95 participants Est. completion 2017-12 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01880086
Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
Not yet reported Weill Medical College of Cornell University 13 participants Est. completion 2017-11 1 siteOther conditions: Hypogonadism, Opioid-Related Disorders, Male InfertilityView official trial listing → -
Completed NCT NCT01881230
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
Not yet reported, Not yet reported Celgene 191 participants Est. completion 2016-10-28 140 sitesOther conditions: Breast Tumor, Breast Cancer, Cancer of the Breast, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Progesterone Receptor- Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer, Triple-negative Metastatic Breast Cancer, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01886794
Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse
Not yet reported The University of Texas Medical Branch, Galveston 7 participants Est. completion 2023-12-11 1 site Stand-aloneOther conditions: Pelvic Floor DisordersView official trial listing → -
Completed NCT NCT01896726
A Study of Baricitinib and Birth Control Pills in Healthy Females
Not yet reported Eli Lilly and Company 20 participants Est. completion 2013-10 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01899079
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay
NanoString Technologies, Inc. 217 participants Est. completion 2014-07 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01902264
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Not yet reported Bayer 34 participants Est. completion 2015-02 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT01903031
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84 participants Est. completion 2016-10-10 21 sitesOther conditions: HIV-1 InfectionView official trial listing → -
Status unknown NCT NCT01907438
Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells
Hadassah Medical Organization 30 participants Est. completion 2015-09 1 siteOther conditions: BRCA1 Gene Mutation, BRCA2 Gene MutationView official trial listing → -
Completed NCT NCT01909141
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
Not yet reported Cairo University 100 participants Est. completion 2014-04 1 siteOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT01916122
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2024-04-03 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01918306
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 11 participants Est. completion 2015-04 16 sitesOther conditions: Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast CancerView official trial listing → -
Completed NCT NCT01921374
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Not yet reported Monica Levy Andersen 60 participants Est. completion 2014-07 1 siteOther conditions: Other Diseases or ConditionsView official trial listing → -
Completed NCT NCT01923298
Estradiol Levels in Patients Treated With Estring
Not yet reported University of Arizona 14 participants Est. completion 2019-04-24 1 siteOther conditions: Estrogen Levels Among Breast Cancer PatientsView official trial listing → -
Status unknown NCT NCT01924078
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
Not yet reported Fudan University 100 participants Est. completion 2015-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01926210
Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders
Not yet reported Huang Rui 500 participants Est. completion 2016-09 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT01928186
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
Not yet reported University of Washington 28 participants Est. completion 2015-07-20 1 siteOther conditions: Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Completed NCT NCT01933204
Acupuncture for Relieving Perimenopausal Symptoms
Not yet reported, Not yet reported Chengdu University of Traditional Chinese Medicine 220 participants Est. completion 2015-08 2 sitesOther conditions: PerimenopauseView official trial listing → -
Completed NCT NCT01940653
Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone
Not yet reported Universitair Ziekenhuis Brussel 300 participants Est. completion 2017-12 1 siteOther conditions: Progesterone SupplementationView official trial listing → -
Withdrawn NCT NCT01941134
Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery
Not yet reported Johns Hopkins University Est. completion 2017-12-06 1 siteOther conditions: Bariatric Surgery Candidate, ContraceptionView official trial listing → -
Terminated NCT NCT01941615
Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel
Not yet reported Boehringer Ingelheim 18 participants Est. completion 2014-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Not yet reported Pfizer 521 participants Est. completion 2022-09-28 247 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01942668
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
Not yet reported TherapeuticsMD 1845 participants Est. completion 2016-10-28 119 sitesOther conditions: MenopauseView official trial listing → -
Completed NCT NCT01942759
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
Bagcilar Training and Research Hospital 43 participants Est. completion 2014-06 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01943812
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
Not yet reported Peter Humaidan 287 participants Est. completion 2020-04 2 sitesOther conditions: Pregnancy Loss, Frozen Embryo TransferView official trial listing → -
Completed NCT NCT01950182
Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer
Not yet reported Sun Yat-sen University 392 participants Est. completion 2020-05-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01953211
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
University of Southern California 64 participants 1 siteOther conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive EfficacyView official trial listing → -
Withdrawn NCT NCT01953445
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer
Not yet reported Washington University School of Medicine Est. completion 2015-07Other conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT01953588
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Not yet reported Alliance for Clinical Trials in Oncology 1473 participants Est. completion 2027-04-01 860 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma, Recurrent Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Withdrawn NCT NCT01953809
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Not yet reported GlaxoSmithKline Est. completion 2015-03Other conditions: Infections, BacterialView official trial listing → -
Terminated NCT NCT01953926
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
Not yet reported Puma Biotechnology, Inc. 582 participants Est. completion 2023-01-02 60 sitesOther conditions: Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsView official trial listing → -
Completed NCT NCT01958073
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
Not yet reported University of California, San Diego 35 participants Est. completion 2017-12 2 sites Stand-aloneOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Terminated NCT NCT01963403
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Not yet reported University of California, Davis 26 participants Est. completion 2015-09 2 sitesOther conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding HeavyView official trial listing → -
Completed NCT NCT01968135
Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study
Not yet reported University of Colorado, Denver 32 participants Est. completion 2014-11 1 siteOther conditions: Uterine Hemorrhage, ContraceptionView official trial listing → -
Completed NCT NCT01971723
Multi-ingredient Supplement for Strength and Power
Not yet reported Florida State University 32 participants Est. completion 2015-12 1 siteOther conditions: SupplementView official trial listing → -
Completed NCT NCT01972984
Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients
Not yet reported Ottawa Hospital Research Institute 20 participants Est. completion 2014-08 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01973816
MEdical Versus SUrgical Treatments of Rectal Endometriosis
Not yet reported University Hospital, Rouen 78 participants Est. completion 2022-10-11 11 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT01980680
The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients
Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 siteOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT01984138
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Not yet reported Polly A. Niravath, MD 33 participants Est. completion 2026-06 1 site Stand-aloneOther conditions: Estrogen Receptor Positive Breast Cancer, Breast CancerView official trial listing → -
Completed NCT NCT01984320
Cabergoline and Coasting to Prevent OHSS
Not yet reported Cairo University 300 participants Est. completion 2015-07 1 siteOther conditions: OHSSView official trial listing → -
Completed NCT NCT01986569
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Not yet reported Asan Medical Center 93 participants Est. completion 2016-11 1 siteOther conditions: Recurrent Breast Cancer, Stage IV Breast CancerView official trial listing → -
Withdrawn NCT NCT01986764
E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
Not yet reported University of Pennsylvania Est. completion 2013-07-01 1 siteOther conditions: Planned RRSOView official trial listing → -
Completed NCT NCT01988324
AR and ER Imaging in Metastatic Breast Cancer
Not yet reported University Medical Center Groningen 24 participants Est. completion 2015-09 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01989780
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
Not yet reported Japan Breast Cancer Research Group 160 participants Est. completion 2019-06 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT01992952
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Not yet reported, Not yet reported Velindre NHS Trust 149 participants Est. completion 2025-12-31 21 sitesOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT01997333
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
Not yet reported Celldex Therapeutics 327 participants Est. completion 2018-08-07 140 sitesOther conditions: Metastatic gpNMB Over-expressing Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT01999569
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2008-05 1 siteOther conditions: Ovulation Disorder, Ovarian CystsView official trial listing → -
Status unknown NCT NCT02000193
Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer
Not yet reported Sun Yat-sen University 58 participants Est. completion 2018-12 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02000596
1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Not yet reported University of Maryland, Baltimore 2 participants Est. completion 2016-01 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02002403
Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
Not yet reported Unity Health Toronto 34 participants Est. completion 2012-04Other conditions: Diabetic Macular EdemaView official trial listing → -
Completed NCT NCT02007512
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Not yet reported Pfizer 247 participants Est. completion 2024-08-23 135 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02019589
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Not yet reported TherapeuticsMD 6 participants Est. completion 2014-10-31 22 sitesOther conditions: Secondary AmenorrheaView official trial listing → -
Status unknown NCT NCT02021097
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
Not yet reported Regenex Pharmaceutical, China 1008 participants Est. completion 2016-02 21 sitesOther conditions: Oral ContraceptiveView official trial listing → -
Completed NCT NCT02026973
Impact of Endogenous E2 on SSI and GH Rebound
Not yet reported Mayo Clinic 62 participants Est. completion 2015-11 1 siteOther conditions: Normal Healthy VolunteersView official trial listing → -
Status unknown NCT NCT02027337
Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Not yet reported Tyumen State Medical Academy 200 participants Est. completion 2015-10 1 siteOther conditions: Polycystic Ovarian Syndrome, Hyperandrogenism, Menstrual IrregularitiesView official trial listing → -
Completed NCT NCT02028364
Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
Not yet reported Jules Bordet Institute 55 participants Est. completion 2021-08-09 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02028507
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
Not yet reported Spanish Breast Cancer Research Group 693 participants Est. completion 2021-01-11 37 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02032797
Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.
Not yet reported Universitair Ziekenhuis Brussel 300 participants Est. completion 2019-09 1 siteOther conditions: Cryopreservation, Embryo Implantation, ProgesteronView official trial listing → -
Completed NCT NCT02033512
TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS
Not yet reported University Potiguar 66 participants Est. completion 2008-04 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02036879
Gender Disparity and Hormones in Cystic Fibrosis
Not yet reported University of Texas Southwestern Medical Center 55 participants Est. completion 2018-08 2 sitesOther conditions: Cystic Fibrosis (CF)View official trial listing → -
Completed NCT NCT02038335
HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
University of Pittsburgh 451 participants Est. completion 2020-12 1 siteObstructive sleep apnea Other conditions: Contraception, HIV, MicrobiotaView official trial listing → -
Completed NCT NCT02040857
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02042196
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Not yet reported University of Colorado, Denver 100 participants Est. completion 2016-05-02 1 site Stand-aloneOther conditions: Menopause, AgingView official trial listing → -
Completed NCT NCT02049957
Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer
Not yet reported Calithera Biosciences, Inc 118 participants Est. completion 2018-06-29 40 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02057029
Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer
Not yet reported Yale University 96 participants Est. completion 2015-06 1 siteOther conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02057133
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02057536
The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.
Not yet reported Christiana Care Health Services 30 participants Est. completion 2015-03 1 siteOther conditions: Women With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and StiffnessView official trial listing → -
Completed NCT NCT02069093
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2016-03 23 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT02072122
Estrogen and the Outer Eye in Women During Fertility Treatment
Meir Medical Center 30 participants Est. completion 2014-07Other conditions: Dry Eye SyndromesView official trial listing → -
Status unknown NCT NCT02072512
The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer
Not yet reported Hospital Affiliated to Military Medical Science, Beijing 180 participants Est. completion 2016-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02077569
AKT Inhibitor in Oestrogen Positive Breast Cancer
Not yet reported University of Nottingham 48 participants Est. completion 2017-02-21 11 sitesOther conditions: Invasive Breast CancerView official trial listing → -
Completed NCT NCT02080468
Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects
Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-04-24 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02086032
The Effect of Different Types of Progestin on Sleeping of Menopausal Women
Not yet reported Chiang Mai University 100 participants Est. completion 2015-07 1 siteOther conditions: Menopausal and Postmenopausal DisordersView official trial listing → -
Status unknown NCT NCT02086318
A New Algorithm to Predict Ovarian Age
University Magna Graecia 720 participants Est. completion 2018-06 1 siteOther conditions: Infertility, Polycystic Ovary Syndrome, Premature Ovarian Failure (POF), Ovarian Cysts, EndometriosisView official trial listing → -
Completed NCT NCT02088684
Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 70 participants Est. completion 2018-04-17 11 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02088710
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Philipps University Marburg 138 participants Est. completion 2020-02 1 siteOther conditions: Female Breast CancerView official trial listing → -
Status unknown NCT NCT02089854
Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Not yet reported Peking Union Medical College Hospital 800 participants 1 siteOther conditions: Female Breast CancerView official trial listing → -
Completed NCT NCT02100553
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
Not yet reported Pfizer 24 participants Est. completion 2014-06 2 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT02103569
Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2014-07Other conditions: Hepatitis CView official trial listing → -
Active, not recruiting NCT NCT02107703
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Not yet reported Eli Lilly and Company 669 participants Est. completion 2027-12 146 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02114645
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes
Not yet reported Zekai Tahir Burak Women's Health Research and Education Hospital 100 participants Est. completion 2015-04 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT02115594
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer
Not yet reported Syndax Pharmaceuticals Est. completion 2016-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02116803
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
Not yet reported, Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2016-11-28 9 sitesOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT02118636
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
Lynn Henry 75 participants Est. completion 2015-09 1 siteOther conditions: Breast Cancer, ArthralgiaView official trial listing → -
Completed NCT NCT02122198
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sitesCardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT02123823
BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer
Not yet reported Boehringer Ingelheim 164 participants Est. completion 2021-12-14 38 sitesOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02127593
A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities
Not yet reported Janssen Research & Development, LLC 101 participants Est. completion 2014-09 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02129114
Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs
Not yet reported Medprin Regenerative Medical Technologies Co., Ltd. 132 participants Est. completion 2015-05 1 siteOther conditions: Neurosurgical RepairsView official trial listing → -
Status unknown NCT NCT02132000
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
Not yet reported, Not yet reported Fengxi Su 3036 participants Est. completion 2020-05 1 siteOther conditions: Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor PositiveView official trial listing → -
Completed NCT NCT02137083
A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer
Not yet reported Fudan University 22 participants Est. completion 2017-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02137837
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Not yet reported SWOG Cancer Research Network 37 participants Est. completion 2019-12-31 223 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT02140437
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
Not yet reported Fudan University Est. completion 2016-06Other conditions: Carcinoma Breast Stage IVView official trial listing → -
Completed NCT NCT02148393
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
Not yet reported Universitair Ziekenhuis Brussel 212 participants Est. completion 2017-02-28 1 siteOther conditions: Infertility, OHSSView official trial listing → -
Terminated NCT NCT02149173
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
Not yet reported University of Washington 29 participants Est. completion 2021-01-13 1 site Stand-aloneOther conditions: Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02157467
Study of Combined Oral Contraceptive Effects in Female Subjects
Not yet reported ViiV Healthcare 46 participants Est. completion 2014-08-25Other conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT02158507
Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer
Not yet reported University of Alabama at Birmingham 20 participants Est. completion 2021-07-22 1 siteOther conditions: Metastatic Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT02158572
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
Not yet reported Agile Therapeutics 2032 participants Est. completion 2016-11Other conditions: HealthyView official trial listing → -
Completed NCT NCT02159131
Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects
Not yet reported ViiV Healthcare 20 participants Est. completion 2014-12 1 siteOther conditions: Infections, Human Immunodeficiency Virus and HepatitisView official trial listing → -
Completed NCT NCT02159326
Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women
Not yet reported Bayer 31 participants Est. completion 2015-07 1 siteOther conditions: Drug InteractionsView official trial listing → -
Completed NCT NCT02161614
Vascular Effect of Estradiol Valerate Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
Not yet reported Federal University of Minas Gerais 60 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Flow-mediated Dilation Evaluation of the Brachial ArteryView official trial listing → -
Completed NCT NCT02170038
Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Not yet reported Bayer 16 participants Est. completion 2015-03 1 siteOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT02175394
Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects
Not yet reported Boehringer Ingelheim 18 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02182791
Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
Not yet reported Boehringer Ingelheim 14 participantsOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT02184364
Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints
Not yet reported Boehringer Ingelheim 161 participantsOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT02186782
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
Not yet reported Maher elesawi kamel elesawi 600 participants Est. completion 2018-08 3 sitesOther conditions: Infertility, AnovulationView official trial listing → -
Completed NCT NCT02187991
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
Not yet reported US Oncology Research 169 participants Est. completion 2024-08-01 1 siteOther conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Malignant Neoplasm of BreastView official trial listing → -
Completed NCT NCT02188745
ER Reactivation Therapy for Breast Cancer
Not yet reported Dartmouth-Hitchcock Medical Center 20 participants Est. completion 2024-07-05 3 sites Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02195986
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
Not yet reported Mylan Pharmaceuticals Inc 366 participants Est. completion 2014-12 21 sitesOther conditions: Atrophic VaginitisView official trial listing → -
Completed NCT NCT02197000
A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers
Not yet reported Rabin Medical Center 23 participants Est. completion 2018-10-10 1 siteOther conditions: BRCA1 Gene Mutation, BRCA2 Gene MutationView official trial listing → -
Completed NCT NCT02197208
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
Not yet reported The University of Hong Kong 300 participants Est. completion 2015-12 2 sitesOther conditions: Subfertility, PregnancyView official trial listing → -
Completed NCT NCT02197897
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Not yet reported Baylor College of Medicine 15 participants Est. completion 2019-06-28 2 sitesOther conditions: Bladder CancerView official trial listing → -
Completed NCT NCT02200952
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
San Carlo Public Hospital, Potenza, Italy 16 participants Est. completion 2014-06-30 1 siteOther conditions: Ovarian Hyperstimulation SyndromeView official trial listing → -
Terminated NCT NCT02202746
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
Not yet reported Clovis Oncology, Inc. 178 participants Est. completion 2017-01-18 33 sitesOther conditions: Breast Cancer, Metastatic Breast Cancer, MBC, HER2 Positive, HER2, Estrogen Receptor Positive, ER, Triple NegativeView official trial listing → -
Completed NCT NCT02206984
Endocrine Response in Women With Invasive Lobular Breast Cancer
Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02210702
Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
Not yet reported The Jones Institute 33 participants 1 siteOther conditions: Postpartum Depressive Mood, Postpartum Sexual FunctionView official trial listing → -
Terminated NCT NCT02213042
Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 42 participants Est. completion 2020-06-04 51 sitesOther conditions: Neoplasms, BreastView official trial listing → -
Terminated NCT NCT02213757
Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)
Not yet reported Medstar Health Research Institute 29 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Microscopic HematuriaView official trial listing → -
Completed NCT NCT02215395
An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women
Not yet reported Population Council 45 participants Est. completion 2015-04 1 siteOther conditions: Antifungal Drug Adverse ReactionView official trial listing → -
Completed NCT NCT02216786
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
Not yet reported Queen Mary University of London 333 participants Est. completion 2021-12-31 79 sitesOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02218463
Treatment of Prepubertal Labial Adhesions
Not yet reported Children's Mercy Hospital Kansas City 43 participants Est. completion 2016-06 1 siteOther conditions: Prepubertal Labial AdhesionsView official trial listing → -
Completed NCT NCT02219789
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Not yet reported Mayo Clinic 10 participants Est. completion 2018-10-01 1 siteOther conditions: Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT02224313
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Not yet reported Intira Sriprasert 20 participants Est. completion 2018-08 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02225080
Duragen® Secure Post Marketing Clinical Follow-up (PMCF)
Integra LifeSciences Corporation 100 participants Est. completion 2016-06 5 sitesOther conditions: Dura Mater Nick Cut or Tear, SurgeryView official trial listing → -
Completed NCT NCT02226302
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
Queensland Centre for Gynaecological Cancer 16 participants Est. completion 2021-08 2 sitesOther conditions: Endometrial CancerView official trial listing → -
Terminated NCT NCT02233621
Assessment of Performance of [18F]-FES for Endometriosis Diagnosis
Not yet reported University Hospital, Angers 31 participants Est. completion 2016-04-06 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02237079
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
Not yet reported Tulane University Health Sciences Center 17 participants Est. completion 2018-04 1 siteOther conditions: Obesity, Glucose Homeostasis, Postmenopausal SymptomsView official trial listing → -
Status unknown NCT NCT02237131
Continuous Versus Cyclic Oral Contraceptives for Endometriosis
Not yet reported University of Athens 50 participants Est. completion 2015-12 1 siteOther conditions: Dysmenorrhea, Pelvic Pain, Dyspareunia, EndometriomaView official trial listing → -
Active, not recruiting NCT NCT02238808
A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers
Not yet reported AHS Cancer Control Alberta 19 participants Est. completion 2028-06 1 siteOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02244580
Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"
Not yet reported BioNTech Diagnostics GmbH 1010 participants Est. completion 2014-08 Stand-aloneOther conditions: Invasive Breast CancerView official trial listing → -
Terminated NCT NCT02245438
Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
Not yet reported Boehringer Ingelheim 52 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02248090
AZD9496 First Time in Patients Ascending Dose Study
Not yet reported AstraZeneca 45 participants Est. completion 2019-04-03 6 sitesOther conditions: ER+ HER2- Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT02251925
Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles
Not yet reported Royan Institute 460 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02255175
Perimenopausal Effects of Estradiol on Reward Responsiveness
Not yet reported University of North Carolina, Chapel Hill 64 participants Est. completion 2018-10-17 1 siteOther conditions: Perimenopausal DepressionView official trial listing → -
Completed NCT NCT02255396
Estradiol and Testosterone Levels in Seminal Plasma of Men With Non-obstructive Azoospermia
University Hospital, Clermont-Ferrand 50 participants Est. completion 2014-06 1 siteOther conditions: Non-obstructive Azoospermia With Testicular Biopsy for Spermatozoa ExtractionView official trial listing → -
Completed NCT NCT02256540
The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women
Not yet reported University of Colorado, Denver 25 participants Est. completion 2016-03-25 1 siteOther conditions: Endothelial DysfunctionView official trial listing → -
Status unknown NCT NCT02257671
Oral Contraceptives and Economic Behaviour
Not yet reported Karolinska University Hospital 400 participants Est. completion 2015-12 1 siteOther conditions: Female ContraceptionView official trial listing → -
Completed NCT NCT02260661
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Not yet reported AstraZeneca 20 participants Est. completion 2016-07 9 sites Stand-aloneOther conditions: Advanced Solid Malignancies, Breast Cancer - ER+, HER2 -, Breast Cancer - ER+, HER2-, PIK3CA Gene MutationView official trial listing → -
Completed NCT NCT02263846
Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer
Affiliated Hospital to Academy of Military Medical Sciences 1183 participants Est. completion 2013-07Other conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02264743
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sitesOther conditions: Venous Thrombosis, Insulin ResistanceView official trial listing → -
Terminated NCT NCT02269670
Phase II Study of Everolimus Beyond Progression
Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT02269826
Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness
Not yet reported Dr. August Wolff GmbH & Co. KG Arzneimittel 117 participants Est. completion 2008-12 6 sitesOther conditions: Vaginal DrynessView official trial listing → -
Completed NCT NCT02271282
Estradiol-Receptor Blockade in Older Men and Women
Not yet reported Mayo Clinic 40 participants Est. completion 2016-05 1 siteOther conditions: Normal Healthy VolunteersView official trial listing → -
Completed NCT NCT02273791
HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
Mansoura University 126 participants Est. completion 2016-04 2 sitesOther conditions: Infertility, Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT02274571
Raising Insulin Sensitivity in Post Menopause
Not yet reported Pennington Biomedical Research Center 8 participants Est. completion 2017-04-11 1 site Stand-aloneOther conditions: MenopauseView official trial listing → -
Withdrawn NCT NCT02292732
A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Not yet reported GlaxoSmithKline Est. completion 2017-05Other conditions: CancerView official trial listing → -
Completed NCT NCT02296801
A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Not yet reported NSABP Foundation Inc 307 participants Est. completion 2019-03 52 sitesOther conditions: Breast Cancer, Breast Carcinoma, Breast TumorsView official trial listing → -
Completed NCT NCT02297438
A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]
Not yet reported Pfizer 340 participants Est. completion 2025-02-24 54 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT02304887
The Relationship Between the Residual Renal Function and Osteoporosis Treatment
Toshihiko Kono 1000 participants Est. completion 2019-01 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT02308904
Reproductive Capacity and Iron Burden in Thalassemia
Not yet reported UCSF Benioff Children's Hospital Oakland 59 participants Est. completion 2020-09-01 1 siteOther conditions: THALASSEMIA MAJORView official trial listing → -
Active, not recruiting NCT NCT02311933
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Not yet reported National Cancer Institute (NCI) 81 participants Est. completion 2027-02-02 559 sitesOther conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT02313415
Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 26 participants Est. completion 2017-08-31 1 siteOther conditions: Infertility, Intrauterine AdhesionsView official trial listing → -
Withdrawn NCT NCT02316249
Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
Not yet reported Northwell Health Est. completion 2015-08 1 siteOther conditions: Atrophy of Vagina, Vaginal Ulceration, VaginitisView official trial listing → -
Completed NCT NCT02316509
A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Not yet reported Genentech, Inc. 43 participants Est. completion 2020-01-10 13 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02322060
In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency
The First Affiliated Hospital of Zhengzhou University 35 participants Est. completion 2021-10 1 siteOther conditions: in Vitro Activation, Dormant Follicle, Primary Ovarian Insufficiency, Ovarian Resistance SyndromeView official trial listing → -
Completed NCT NCT02330250
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment
Not yet reported Oswaldo Cruz Foundation 131 participants Est. completion 2016-06 1 siteOther conditions: Systemic Lupus Erythematosus, Medication AdherenceView official trial listing → -
Status unknown NCT NCT02330757
HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients
Not yet reported Mansoura University 150 participants Est. completion 2024-12-31 2 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02333253
Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase
Not yet reported Cairo University 60 participants Est. completion 2016-01 1 siteOther conditions: Other Complications Associated With Artificial FertilizationView official trial listing → -
Completed NCT NCT02333370
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2022-09-29 15 sitesOther conditions: Hormone Receptor Positive, HER2-negative, Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02338310
Trial of Perioperative Endocrine Therapy - Individualising Care
Not yet reported Institute of Cancer Research, United Kingdom 4486 participants Est. completion 2034-04 128 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02338349
A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
Not yet reported Stemline Therapeutics, Inc. 57 participants Est. completion 2020-04 1 siteOther conditions: Advanced ER+, HER2-Negative Breast CancerView official trial listing → -
Terminated NCT NCT02340221
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
Not yet reported Hoffmann-La Roche 631 participants Est. completion 2021-06-29 157 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02344472
Detect V / CHEVENDO (Chemo vs. Endo)
Not yet reported Prof. Wolfgang Janni 271 participants Est. completion 2025-01-31 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02345772
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
Not yet reported, Not yet reported Western Regional Medical Center 4 participants Est. completion 2015-11 1 siteOther conditions: HER2-positive Breast Cancer, ER-positive Breast CancerView official trial listing → -
Completed NCT NCT02349113
Effects of Acute Estrogen Therapy on Bone Formation
Not yet reported Mayo Clinic 20 participants Est. completion 2012-09 Stand-aloneOther conditions: Bone Loss, Age-relatedView official trial listing → -
Terminated NCT NCT02349386
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
Not yet reported BHR Pharma, LLC 34 participants Est. completion 2018-01-10 12 sitesOther conditions: Cancer of the ProstateView official trial listing → -
Completed NCT NCT02349399
Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases
Bayer 26065 participants Est. completion 2016-03-01 3 sitesOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT02352090
Synthetic vs Natural Estrogen in Combined Oral Contraception
Not yet reported Helsinki University Central Hospital 59 participants Est. completion 2018-12-30 2 sites Stand-aloneOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02352597
Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS
Not yet reported Cairo University 150 participants Est. completion 2015-01Other conditions: Polycystic OvariesView official trial listing → -
Status unknown NCT NCT02353988
AR-inhibitor Bicalutamide in Treating Patients With TNBC
Not yet reported Jinling Hospital, China 60 participants Est. completion 2017-05 Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02354001
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Not yet reported The Alfred 80 participants Est. completion 2019-01 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02362711
Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea
Not yet reported Nobelpharma 248 participants Est. completion 2017-01-28Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT02367833
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
Not yet reported Penn State University 60 participants Est. completion 2018-12 1 siteOther conditions: Bone; Disorder, Development and GrowthView official trial listing → -
Active, not recruiting NCT NCT02367846
Assessing the Impact of Contraceptives on Bone Health Using 41Ca
Not yet reported Penn State University 6 participants Est. completion 2028-12 1 siteOther conditions: Other Disorders of Bone Development and GrowthView official trial listing → -
Active, not recruiting NCT NCT02373709
Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression
KK Women's and Children's Hospital 750 participants Est. completion 2028-12 1 siteOther conditions: Postnatal Depression, Genetic PredispositionView official trial listing → -
Terminated NCT NCT02374099
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant
Not yet reported Celgene 97 participants Est. completion 2017-11-21 35 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02376985
Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
Not yet reported Comprehensive Support Project for Oncology Research 174 participants Est. completion 2018-10-16 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02380755
Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
Not yet reported University of Sao Paulo 78 participants Est. completion 2017-01 1 siteOther conditions: Obesity, HypoandrogenismView official trial listing → -
Status unknown NCT NCT02383030
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
Not yet reported Consorzio Oncotech 156 participants Est. completion 2017-12 20 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT02383823
Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
Not yet reported Herning Hospital Est. completion 2020-12-10 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02384239
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sitesOther conditions: Metastatic Breast Cancer, Hormone Receptor PositiveView official trial listing → -
Completed NCT NCT02384408
Hormone Replacement Therapy on the Postmenopausal Endometrium
Not yet reported Universidade do Vale do Sapucai 100 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT02384746
Phase I Study of the Combination of MLN9708 and Fulvestrant
Not yet reported Dartmouth-Hitchcock Medical Center 9 participants Est. completion 2018-06-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02385448
Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery
Not yet reported The University of Hong Kong 144 participants Est. completion 2019-02 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02385916
The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females
Not yet reported University of British Columbia 120 participants Est. completion 2020-04 1 siteOther conditions: Estrogen ProfileView official trial listing → -
Completed NCT NCT02392611
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer
Not yet reported Gilead Sciences 33 participants Est. completion 2017-10-11 4 sites Stand-aloneOther conditions: Solid Tumors and LymphomasView official trial listing → -
Status unknown NCT NCT02393482
Psychological Impact of Amenorrhea in Women With Endometriosis
Not yet reported University of Cagliari 50 participants Est. completion 2022-06 1 siteOther conditions: Amenorrhea, Endometriosis, Quality of LifeView official trial listing → -
Status unknown NCT NCT02394496
Overcoming Endocrine Resistance in Metastatic Breast Cancer
Not yet reported Consorzio Oncotech 396 participants Est. completion 2017-01 69 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02395627
Reversing Therapy Resistance With Epigenetic-Immune Modification
Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02400801
Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients
Not yet reported Universitaire Ziekenhuizen KU Leuven 166 participants Est. completion 2018-01-26 1 siteOther conditions: Endometriosis, InfertilityView official trial listing → -
Status unknown NCT NCT02404038
A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods
Not yet reported Desmond Tutu HIV Centre 131 participants Est. completion 2020-02-28 1 siteOther conditions: HIVView official trial listing → -
Status unknown NCT NCT02404051
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Not yet reported Consorzio Oncotech 745 participants Est. completion 2019-01 41 sitesOther conditions: Metastatic Breast Cancer, Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Locally Advanced Malignant NeoplasmView official trial listing → -
Completed NCT NCT02406690
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
Reproductive Medicine Associates of New Jersey 1 participants Est. completion 2015-09-17 1 siteOther conditions: Endometrial DysfunctionView official trial listing → -
Completed NCT NCT02406794
Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors
Not yet reported, Not yet reported University of Malaga 156 participants Est. completion 2017-03 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT02414776
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
Not yet reported Western Regional Medical Center 3 participants Est. completion 2015-11 1 siteOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02419729
Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported Faculdade de Medicina do ABC 45 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT02422615
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Not yet reported Novartis Pharmaceuticals 726 participants Est. completion 2023-01-11 174 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT02427386
Homeopathic Treatment of Chronic Pelvic Pain in Women With Endometriosis
Not yet reported University of Sao Paulo General Hospital 50 participants Est. completion 2016-12Other conditions: Endometriosis, Pelvic PainView official trial listing → -
Completed NCT NCT02431689
Delayed Embryo Transfer in Poor Responders
Not yet reported Cairo University 400 participants Est. completion 2018-05 3 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02434562
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
Universitaire Ziekenhuizen KU Leuven 73 participants Est. completion 2016-09-30Other conditions: Hypogonadism, Estrogens, Testosterone, AndrogensView official trial listing → -
Completed NCT NCT02437318
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
Not yet reported Novartis Pharmaceuticals 572 participants Est. completion 2023-06-09 197 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02442895
Biomarkers of Ovarian Reserve and Correlation With IVF Treatments
U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti 236 participants Est. completion 2015-02 1 siteOther conditions: Pregnancy, OvarianView official trial listing → -
Completed NCT NCT02447328
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Not yet reported AstraZeneca 83 participants Est. completion 2020-09-16 9 sitesOther conditions: Locally Advanced or, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02449642
LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation
Rambam Health Care Campus 10 participants Est. completion 2015-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02449902
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
Not yet reported TherapeuticsMD 50 participants Est. completion 2013-09 1 siteOther conditions: Menopause, Vulvovaginal Atrophy, Painful Intercourse, DyspareuniaView official trial listing → -
Completed NCT NCT02449993
Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy
BioNTech Diagnostics GmbH 101 participants Est. completion 2014-10Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT02451228
Indomethacin PK and PD Therapy in Pregnancy
The University of Texas Medical Branch, Galveston 62 participants Est. completion 2018-12-31 6 sitesOther conditions: Premature Labor, Pregnancy, Premature BirthView official trial listing → -
Completed NCT NCT02455453
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Not yet reported Washington University School of Medicine 47 participants Est. completion 2019-01-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02458001
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Not yet reported University College, London 100 participants Est. completion 2017-03Other conditions: Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulval Cancer, Psychosexual DysfunctionsView official trial listing → -
Completed NCT NCT02458404
Effects of Varied Estrogen Doses on Endometrial Receptivity
Reproductive Medicine Associates of New Jersey 19 participants Est. completion 2019-06 1 siteOther conditions: Luteal Phase DefectView official trial listing → -
Completed NCT NCT02458768
Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.
Not yet reported LG Life Sciences 112 participantsOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT02460445
Phlebotomy and Polycystic Ovary Syndrome
Not yet reported Manuel Luque Ramírez 37 participants Est. completion 2020-06 1 siteOther conditions: Hyperandrogenism, Metabolic Cardiovascular SyndromeView official trial listing → -
Completed NCT NCT02463032
Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer
Not yet reported GTx 136 participants Est. completion 2019-03 4 sitesOther conditions: ER+ and AR+ Breast CancerView official trial listing → -
Completed NCT NCT02463383
Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women
Not yet reported Professor Lars Ove Dragsted 25 participants Est. completion 2015-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02467673
Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy
Not yet reported University Potiguar 185 participants Est. completion 2012-07 3 sitesOther conditions: Menopausal SyndromeView official trial listing → -
Status unknown NCT NCT02467686
Breast Cancer, Sexuality and Black Cohosh
Not yet reported Irmandade da Santa Casa de Misericordia de Sao Paulo 60 participants Est. completion 2017-12 1 siteOther conditions: SexualityView official trial listing → -
Completed NCT NCT02475265
Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
Not yet reported Massachusetts General Hospital 11 participants Est. completion 2018-07-30 1 siteObstructive sleep apnea Other conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT02476955
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole
Not yet reported ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41 participants Est. completion 2019-05-07 5 sitesOther conditions: Solid Tumors, Ovarian Cancer, Endometrial CancerView official trial listing → -
No Longer Available NCT NCT02480777
Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair
W. Dalton Dietrich 1 siteOther conditions: Sciatic Nerve InjuryView official trial listing → -
Completed NCT NCT02480881
A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
Not yet reported ViiV Healthcare 26 participants Est. completion 2016-01-11 2 sitesOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Status unknown NCT NCT02480985
The PIT-TBI Pilot Study
Not yet reported CHU de Quebec-Universite Laval 70 participants Est. completion 2018-03 5 sitesOther conditions: Pituitary Disorders, Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT02482753
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Not yet reported Chipscreen Biosciences, Ltd. 365 participants Est. completion 2021-02 22 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT02483871
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Not yet reported Duke University Est. completion 2017-05-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02485821
Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol
Not yet reported, Not yet reported Ain Shams University 200 participants Est. completion 2016-02 1 siteOther conditions: Failed Induction of LaborView official trial listing → -
Completed NCT NCT02486757
Investigation of Female Reproductive Hormone Dynamics During Adolescence
Not yet reported Massachusetts General Hospital 9 participants Est. completion 2016-03-01 1 siteOther conditions: Menstruation DisturbancesView official trial listing → -
Completed NCT NCT02491983
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer
Not yet reported MedSIR 486 participants Est. completion 2020-01 48 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02494297
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Center for Epidemiology and Health Research, Germany 1597 participants Est. completion 2016-10-31 1 siteOther conditions: Hirsutism, Androgenetic Alopecia, Severe Anemia, Seborrhea, PCOSView official trial listing → -
Terminated NCT NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-09-14 1 siteOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02496052
The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions
Not yet reported Beijing Obstetrics and Gynecology Hospital 300 participants Est. completion 2017-06 1 site Stand-aloneOther conditions: Intrauterine AdhesionsView official trial listing → -
No Longer Available NCT NCT02510079
Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.
W. Dalton Dietrich 1 siteOther conditions: Sciatic Nerve InjuryView official trial listing → -
Completed NCT NCT02511639
Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
Not yet reported Istituto Oncologico Veneto IRCCS 110 participants Est. completion 2020-07-31 16 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Active, not recruiting NCT NCT02515110
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
Not yet reported Virginia Commonwealth University 137 participants Est. completion 2028-04-30 2 sitesOther conditions: Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma, Invasive Breast Carcinoma, Lobular Breast Carcinoma In SituView official trial listing → -
Completed NCT NCT02516202
The Vaginal Health Trial
Not yet reported Fred Hutchinson Cancer Center 302 participants Est. completion 2017-07 2 sitesOther conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)View official trial listing → -
Completed NCT NCT02518009
GEnder Dysphoria Treatment in Sweden
Karolinska Institutet 40 participants Est. completion 2022-05 1 siteOther conditions: TranssexualismView official trial listing → -
Terminated NCT NCT02524288
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
Not yet reported Organon and Co 1941 participants Est. completion 2016-09-16Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT02524561
KEEPS Mammographic Density And Breast Health Ancillary Study
Not yet reported Brigham and Women's Hospital 517 participants Est. completion 2013-12 1 siteOther conditions: Mammographic Density, Abnormal MammogramView official trial listing → -
Completed NCT NCT02524769
The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
Not yet reported Loyola University 27 participants Est. completion 2017-06 1 siteOther conditions: Overactive BladderView official trial listing → -
Status unknown NCT NCT02525276
Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause
Not yet reported Copenhagen University Hospital, Rigshospitalet 48 participants Est. completion 2018-08Metabolic syndromeView official trial listing → -
Completed NCT NCT02528383
Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors
Not yet reported Susan Tannenbaum 3 participants Est. completion 2017-05 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02529683
Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya
Not yet reported Centers for Disease Control and Prevention 200 participants Est. completion 2015-08Other conditions: Hormonal ContraceptionView official trial listing → -
Status unknown NCT NCT02530411
Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
Not yet reported Velindre NHS Trust 160 participants Est. completion 2020-12 5 sites Stand-aloneOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02530424
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "
Not yet reported Fondazione Michelangelo 102 participants Est. completion 2019-11 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT02531321
Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics
Not yet reported University of Southern California 17 participants Est. completion 2016-11-01 1 siteOther conditions: Contraception, HIVView official trial listing → -
Completed NCT NCT02533427
Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol
Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 siteOther conditions: HCV InfectionView official trial listing → -
Completed NCT NCT02536742
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 124 participants Est. completion 2022-12-22 19 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02538484
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2020-03-26 2 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02540330
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Not yet reported Atossa Therapeutics, Inc. 3 participants Est. completion 2020-08-13 3 sitesOther conditions: Female Breast Carcinoma, Female Ductal Carcinoma In SituView official trial listing → -
Completed NCT NCT02549430
To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy
Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02550977
Russia/Ukraine Suppression of Ovarian Activity Study
Not yet reported Bayer 91 participants Est. completion 2016-08-15 8 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT02556411
Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Not yet reported University of Cagliari 50 participants Est. completion 2022-06-01Other conditions: Adenomyosis, Chronic Pelvic PainView official trial listing → -
Completed NCT NCT02558426
Estrogen Receptors and Chronic Venous Disease
University of Catanzaro 40 participants Est. completion 2015-09Other conditions: Estrogen Excess, Varicose VeinsView official trial listing → -
Terminated NCT NCT02560051
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Not yet reported The University of Texas Health Science Center, Houston 19 participants Est. completion 2017-09-14 1 siteOther conditions: Prostatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT02564848
Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65
Not yet reported Cedars-Sinai Medical Center 200 participants Est. completion 2029-03 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02569801
A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy
Not yet reported Genentech, Inc. 71 participants Est. completion 2020-02-28 44 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02577601
Impact of Combined Hormonal Contraceptives on UPA
Not yet reported Oregon Health and Science University 36 participants Est. completion 2017-06-17 1 siteOther conditions: ContraceptionView official trial listing → -
Terminated NCT NCT02577913
European Active Surveillance Study Comparing Regimens of Administration in Combined Hormonal Contraception
Center for Epidemiology and Health Research, Germany 2281 participants Est. completion 2019-05-22 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02580448
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)
Not yet reported, Not yet reported Innocrin Pharmaceutical 175 participants Est. completion 2019-01 36 sites Stand-aloneOther conditions: Cancer of the Breast, Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Male Breast Cancer, Triple Negative Breast Cancer, ER+ Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02592083
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Not yet reported Thomas Hatschek 10 participants Est. completion 2029-02 1 siteOther conditions: Early-Stage Breast Carcinoma, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT02598557
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 180 participants Est. completion 2023-02-02 5 sitesOther conditions: Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7View official trial listing → -
Suspended NCT NCT02599077
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
Not yet reported, Not yet reported Fundación Santa Fe de Bogota 50 participants Est. completion 2018-11 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02599714
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer
Not yet reported AstraZeneca 54 participants Est. completion 2023-11-23 7 sitesOther conditions: Advanced and Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02605070
Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia
Not yet reported Instituto de Investigacion Sanitaria La Fe 30 participants Est. completion 2017-06-13 1 siteOther conditions: Male InfertilityView official trial listing → -
Completed NCT NCT02613039
Oral Contraceptive Therapy and Sexuality
Not yet reported University of Florence 10 participants Est. completion 2019-02 1 siteOther conditions: Contraceptive Usage, Sexual Behavior, Mental Health Wellness 1View official trial listing → -
Terminated NCT NCT02616146
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
Not yet reported Organon and Co 2016 participants Est. completion 2016-10-06 14 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT02617108
Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11 Stand-aloneOther conditions: Uterine SeptumView official trial listing → -
Withdrawn NCT NCT02617537
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
Not yet reported Bayer Est. completion 2017-10Other conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT02618148
Hormone Estradiol Replacement Therapy Additional Herbals
Not yet reported Trieu, Nguyen Thi, M.D. 60 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: MenopauseView official trial listing → -
Completed NCT NCT02620124
GnRH Agonist as Luteal Support in FET Cycles
Not yet reported Turku University Hospital 100 participants Est. completion 2015-10 Stand-aloneOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02622087
The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women
Not yet reported The University of New South Wales 90 participants Est. completion 2017-06-15 1 siteOther conditions: Phobia, SpecificView official trial listing → -
Terminated NCT NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
Not yet reported University of Virginia 4 participants Est. completion 2021-09 1 site Stand-aloneObstructive sleep apnea Other conditions: Lymphoma, Childhood Lymphoma, Solid Tumor, Childhood Solid Tumor, Neuroblastoma, Ewing Sarcoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Soft Tissue Sarcoma, Medulloblastoma, Germ Cell Tumor, Wilms Tumor, Brain Neoplasms, Medulloblastoma, Childhood, Neuroectodermal Tumors, PrimitiveView official trial listing → -
Completed NCT NCT02625935
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
NanoString Technologies, Inc. 206 participants Est. completion 2017-10-10 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02626208
Dose Finding Study of Contraceptive Vaginal Ring With Different Estradiol Levels in Combination With Nestorone
Not yet reported Premier Research 65 participants Est. completion 2017-03 7 sitesOther conditions: Suppression of OvulationView official trial listing → -
Status unknown NCT NCT02626507
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Not yet reported Hoffman Oncology 18 participants Est. completion 2022-03-15 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02627703
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
British Columbia Cancer Agency 80 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02630693
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Not yet reported Canadian Cancer Trials Group 180 participants Est. completion 2023-11-29 22 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02632045
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer
Not yet reported Melissa K Accordino 169 participants Est. completion 2022-01-04 13 sitesOther conditions: Metastatic Breast Cancer, Breast CarcinomaView official trial listing → -
Completed NCT NCT02636972
The Progression From Dysmenorrhoea to Chronic Pelvic Pain
University of Adelaide 56 participants Est. completion 2016-01 1 siteOther conditions: Dysmenorrhoea, Pelvic Pain, Chronic PainView official trial listing → -
Status unknown NCT NCT02638922
Evaluation and Treatment of Tall Statured Girls
Copenhagen University Hospital, Rigshospitalet 304 participants Est. completion 2017-12Other conditions: Constitutional Tall StatureView official trial listing → -
Completed NCT NCT02640755
Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase
Not yet reported AstraZeneca 4 participants Est. completion 2017-07-06 1 siteOther conditions: Solid MalignanciesView official trial listing → -
Completed NCT NCT02640976
Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
Not yet reported Cairo University 216 participants Est. completion 2015-08Other conditions: InfertilityView official trial listing → -
Status unknown NCT NCT02646735
Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 148 participants Est. completion 2020-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02648477
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
Not yet reported City of Hope Medical Center 30 participants Est. completion 2023-12-30 6 sites Stand-aloneOther conditions: Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer, Triple-Negative Breast CarcinomaView official trial listing → -
Completed NCT NCT02650817
Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
Not yet reported Stemline Therapeutics, Inc. 16 participants Est. completion 2019-10-18 5 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02652650
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2016-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02654054
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Not yet reported AbbVie 413 participants Est. completion 2018-12-12 96 sitesOther conditions: Uterine Fibroids, Heavy Menstrual BleedingView official trial listing → -
Completed NCT NCT02654119
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Not yet reported University of Nebraska 20 participants Est. completion 2025-12-08 3 sites Stand-aloneOther conditions: HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7View official trial listing → -
Status unknown NCT NCT02655146
the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .
Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02657343
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
Not yet reported, Not yet reported Dana-Farber Cancer Institute 25 participants Est. completion 2022-06-30 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02660294
Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI
Not yet reported, Not yet reported Ain Shams University 30 participants Est. completion 2017-04 1 siteOther conditions: InfertilityView official trial listing → -
Terminated NCT NCT02668783
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Not yet reported Organon and Co 25 participants Est. completion 2016-09-07Other conditions: Moderate to Severe Primary DysmenorrheaView official trial listing → -
Completed NCT NCT02668796
To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.
Not yet reported Glenmark Pharmaceuticals Ltd. India 522 participants Est. completion 2016-09-21 1 siteOther conditions: Vulvar and Vaginal AtrophyView official trial listing → -
Terminated NCT NCT02668822
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
Not yet reported Organon and Co 18 participants Est. completion 2016-09-12Other conditions: DysmenorrheaView official trial listing → -
Terminated NCT NCT02669238
Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis
Not yet reported, Not yet reported Centre Hospitalier Universitaire de la Réunion 2 participants Est. completion 2019-10-10 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT02670785
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported Warner Chilcott 203 participants Est. completion 2016-11-14 20 sitesOther conditions: Vulvovaginal Atrophy, Menopause, DyspareuniaView official trial listing → -
Completed NCT NCT02672826
Description of the Endothelial Phenotypes From the Subcutaneous Abdominal and Gluteo-femoral Adipose Tissues in Women
Not yet reported University Hospital, Toulouse 50 participants Est. completion 2016-12 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT02673606
Impact of Estrogen on Fear Extinction R61
Not yet reported NYU Langone Health 136 participants Est. completion 2019-04-15 1 siteOther conditions: Fear, Fear; Examination, PhobicView official trial listing → -
Completed NCT NCT02675231
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
Not yet reported Eli Lilly and Company 237 participants Est. completion 2023-11-09 93 sitesOther conditions: Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast CancerView official trial listing → -
Status unknown NCT NCT02677259
Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
Not yet reported One Fertility 506 participants Est. completion 2018-06Other conditions: IVFView official trial listing → -
Completed NCT NCT02680366
Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 152 participants Est. completion 2022-07-22 1 site Stand-aloneOther conditions: Infertility, Asherman SyndromeView official trial listing → -
Status unknown NCT NCT02681536
Miniflare Versus Long Protocol in Poor Responders
Not yet reported Woman's Health University Hospital, Egypt 200 participants Est. completion 2016-09 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02684032
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Not yet reported Celcuity Inc 141 participants Est. completion 2022-01-19 41 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02689843
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT02690480
Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer
Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02691494
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Not yet reported AbbVie 378 participants Est. completion 2019-01-23 105 sitesOther conditions: Uterine Fibroids, Heavy Menstrual BleedingView official trial listing → -
Completed NCT NCT02691936
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Not yet reported The Cleveland Clinic 69 participants Est. completion 2018-12 6 sitesOther conditions: Atrophic Vaginitis, MenopauseView official trial listing → -
Completed NCT NCT02692755
Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
Not yet reported, Not yet reported Georgetown University 35 participants Est. completion 2021-03-23 6 sitesOther conditions: Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Terminated NCT NCT02693002
Estrogen Diastolic Heart Failure
Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 siteOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT02697851
Pharmacokinetic Effect of Evotaz/Microgynon Co-administration
Not yet reported St Stephens Aids Trust 13 participants Est. completion 2017-10-31 1 siteOther conditions: HIVView official trial listing → -
Completed NCT NCT02701348
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
Not yet reported NHS Tayside 31 participants Est. completion 2020-12-24 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02701452
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
Not yet reported University Hospital, Lille 1 participants Est. completion 2019-01-01Other conditions: Ovarian Hyperstimulation Syndrome, HypercoagulabilityView official trial listing → -
Completed NCT NCT02710214
A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Not yet reported University of California, San Francisco 24 participants Est. completion 2019-04-24 1 site Stand-aloneOther conditions: Menopause, Multiple SclerosisView official trial listing → -
Completed NCT NCT02710708
YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China
Not yet reported Bayer 1921 participants Est. completion 2018-07-03 38 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02712814
Subtypes of Provoked Vestibulodynia
Meir Medical Center 113 participants Est. completion 2021-08 1 siteOther conditions: Provoked Localized VulvodyniaView official trial listing → -
Status unknown NCT NCT02715232
Effects of Sex Steroids on the Serotonin System
Not yet reported Medical University of Vienna 92 participants Est. completion 2020-12 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Completed NCT NCT02718144
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
Not yet reported, Not yet reported Pantarhei Oncology B.V. 12 participants Est. completion 2019-12-31 2 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02720224
Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol
Not yet reported Estetra 6 participants Est. completion 2016-04 1 siteOther conditions: Contraception, MenopauseView official trial listing → -
Completed NCT NCT02726971
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
Not yet reported, Not yet reported Fu Xing Hospital, Capital Medical University 141 participants Est. completion 2016-08 1 siteOther conditions: Asherman SyndromeView official trial listing → -
Completed NCT NCT02729545
The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome
Not yet reported Beijing Hospital of Integrated Traditional Chinese and Western Medicine 60 participants Est. completion 2018-05 1 siteOther conditions: Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT02729701
Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation
Not yet reported University of Kansas Medical Center 28 participants Est. completion 2019-06 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02730429
Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
Not yet reported Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78 participants Est. completion 2021-12-15 1 siteOther conditions: Endometrial CancerView official trial listing → -
Status unknown NCT NCT02733731
The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis
Not yet reported First Affiliated Hospital, Sun Yat-Sen University 80 participants Est. completion 2016-06 1 siteOther conditions: Atrophic VaginitisView official trial listing → -
Active, not recruiting NCT NCT02734290
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Not yet reported, Not yet reported Providence Health & Services 29 participants Est. completion 2026-12 2 sitesOther conditions: Triple Negative Breast CancerView official trial listing → -
Terminated NCT NCT02734615
Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers
Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2021-09-13 10 sitesOther conditions: Advanced or Metastatic ER+ Breast CancerView official trial listing → -
Completed NCT NCT02736032
Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sitesOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02737800
Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients
Not yet reported Kasr El Aini Hospital 88 participants Est. completion 2017-08 1 siteOther conditions: EndometriomaView official trial listing → -
Active, not recruiting NCT NCT02738866
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants Est. completion 2026-12 5 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02744131
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
Not yet reported Kar Clinic & Hospital Pvt. Ltd. 100 participants Est. completion 2019-12 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT02751385
Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
Not yet reported Boehringer Ingelheim 2 participants Est. completion 2017-11-28 1 siteOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Status unknown NCT NCT02752568
Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure
Not yet reported Kasr El Aini Hospital 300 participants Est. completion 2016-12Other conditions: Recurrent Implantation FailureView official trial listing → -
Completed NCT NCT02752893
Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts
Dartmouth-Hitchcock Medical Center 10 participants Est. completion 2019-04-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02753686
Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sitesOther conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT02755038
Scalp Hair Estradiol and Progesterone Level Determination in Women (Proof of Concept Study)
Bnai Zion Medical Center 40 participants Est. completion 2017-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02756364
Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
Not yet reported Calithera Biosciences, Inc 141 participants Est. completion 2019-11-25 53 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Withdrawn NCT NCT02757287
Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors
Not yet reported Fundacion Dexeus Est. completion 2018-12-01 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT02757469
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
Not yet reported Navy General Hospital, Beijing 20 participants Est. completion 2021-05 1 siteOther conditions: Primary Ovarian Insufficiency, Menopause, PrematureView official trial listing → -
Completed NCT NCT02758431
Cardiovascular Outcomes of Low Testosterone
Not yet reported University of Colorado, Denver 232 participants Est. completion 2023-01-04 1 siteOther conditions: HypogonadismView official trial listing → -
Completed NCT NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
Not yet reported Ohio State University Comprehensive Cancer Center 14 participants Est. completion 2025-08-31 3 sitesOther conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast CancerView official trial listing → -
Terminated NCT NCT02761694
Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)
Not yet reported ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 78 participants Est. completion 2021-03-10 6 sitesOther conditions: Cancer, Solid TumorsView official trial listing → -
Active, not recruiting NCT NCT02763566
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Not yet reported Eli Lilly and Company 463 participants Est. completion 2028-03 45 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02767661
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 263 participants Est. completion 2023-08-25 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02769104
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
Not yet reported Zhejiang Cancer Hospital 120 participants Est. completion 2019-12 1 siteOther conditions: Neoadjuvant TherapyView official trial listing → -
Completed NCT NCT02770365
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
Not yet reported Padagis LLC 695 participants Est. completion 2016-11 1 siteOther conditions: AtrophyView official trial listing → -
Completed NCT NCT02770469
Culturally Tailored Educational and Support Program to Increase Quality of Life Among Korean Breast Cancer Survivors
Not yet reported University of Maryland, College Park 86 participants Est. completion 2016-06 Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02773784
Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.
Peking University 314 participants Est. completion 2016-09 1 siteOther conditions: Invasive Breast CancerView official trial listing → -
Completed NCT NCT02779855
Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 50 participants Est. completion 2025-08-26 1 siteOther conditions: Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma, Invasive Ductal Breast CarcinomaView official trial listing → -
Terminated NCT NCT02780791
Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary
Not yet reported Insel Gruppe AG, University Hospital Bern 1 participants Est. completion 2020-07-31 1 siteOther conditions: Infertility, Ovarian Failure, PrematureView official trial listing → -
Withdrawn NCT NCT02792153
Estradiol and Fear Extinction in Anorexia Nervosa (AN)
Not yet reported Johns Hopkins University Est. completion 2018-08-22 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT02792465
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
Not yet reported University Health Network, Toronto 52 participants Est. completion 2025-06-12 3 sitesOther conditions: Advanced Solid Cancers, Breast CancerView official trial listing → -
Completed NCT NCT02792517
Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females
Not yet reported Amgen 41 participants Est. completion 2016-09-09 4 sites Stand-aloneOther conditions: Headache, MigraineView official trial listing → -
Completed NCT NCT02793089
Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF
IVI Vigo 578 participants Est. completion 2016-05Other conditions: Ectopic PregnancyView official trial listing → -
Completed NCT NCT02795039
Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects
Not yet reported Fresenius Kabi 266 participants Est. completion 2017-03-03 3 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT02817841
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
Not yet reported Estetra 2148 participants Est. completion 2018-11-16 2 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT02820961
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Not yet reported Syndax Pharmaceuticals 61 participants Est. completion 2021-07-12 3 sitesOther conditions: Breast Cancer, Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02821702
Fertility Post Placenta Accrete
Not yet reported Sheba Medical Center 135 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: FertilityView official trial listing → -
Terminated NCT NCT02823262
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Not yet reported Beth Israel Deaconess Medical Center 65 participants Est. completion 2022-03 2 sites Stand-aloneOther conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Completed NCT NCT02832180
The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects
Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2016-10 2 sitesOther conditions: ArthritisView official trial listing → -
Completed NCT NCT02834312
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
Not yet reported Donesta Bioscience 260 participants Est. completion 2018-01-22 1 siteOther conditions: Hot FlushesView official trial listing → -
Completed NCT NCT02835846
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
Not yet reported Loyola University 35 participants Est. completion 2018-05 1 site Stand-aloneOther conditions: Overactive Bladder, Incontinence, NocturiaView official trial listing → -
Status unknown NCT NCT02838576
Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women
Not yet reported Hospital de Clinicas de Porto Alegre 72 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: ArthralgiaView official trial listing → -
Completed NCT NCT02841202
The Effect of Oral Contraceptive Pills On Eyes
Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2016-07Other conditions: Adverse Effect of Oral Contraceptives, Subsequent EncounterView official trial listing → -
Completed NCT NCT02845219
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
Not yet reported Novo Nordisk A/S 25 participants Est. completion 2016-12 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02845388
Sildenafil Citrate in Frozen Embryo Transfer
Not yet reported Omar Ahmed El Sayed Saad 90 participants Est. completion 2016-06Other conditions: InfertilityView official trial listing → -
Completed NCT NCT02846142
Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers
Not yet reported Proteostasis Therapeutics, Inc. 94 participants Est. completion 2017-03 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT02847806
Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man
Not yet reported University Hospital, Caen 6 participants Est. completion 2016-08 1 siteOther conditions: HypogonadismView official trial listing → -
Withdrawn NCT NCT02853071
Efficacy and Safety of Estracyt® in Metastatic Breast Cancer
Not yet reported Centre Hospitalier Universitaire de Besancon Est. completion 2020-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02855294
The Effect of Oral Contraceptives on Women Balance
Not yet reported Cairo University 100 participants Est. completion 2016-07 1 siteOther conditions: Joint StabiliotyView official trial listing → -
Status unknown NCT NCT02855632
The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Sir Run Run Shaw Hospital 240 participants Est. completion 2019-12 1 siteOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT02859285
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
Not yet reported ProHealth Care, Inc 30 participants Est. completion 2020-03-10 1 siteOther conditions: Hypoactive Sexual Desire DisorderView official trial listing → -
Completed NCT NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer
Not yet reported Mayo Clinic 96 participants Est. completion 2025-02-14 8 sitesOther conditions: Estrogen Receptor Status, HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Withdrawn NCT NCT02860897
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
Not yet reported University Hospitals Cleveland Medical Center Est. completion 2017-07 1 site Stand-aloneOther conditions: Estrogen, Menopause, Pelvic Floor Disorders, SurgeryView official trial listing → -
Completed NCT NCT02866786
The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS
Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2017-08-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT02866955
Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.
Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02871791
Palbociclib With Everolimus + Exemestane In BC
Not yet reported, Not yet reported Dana-Farber Cancer Institute 41 participants Est. completion 2021-09 1 siteOther conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor (HR)-Positive Breast CancerView official trial listing → -
Status unknown NCT NCT02871986
Pubertal Induction in Individuals With Hypogonadism
University College, London 24 participants Est. completion 2020-03 1 siteOther conditions: Primary Amenorrhoea, Hypothalamic Amenorrhoea, Hypogonadotrophic Hypogonadism, Hypopituitarism, Turner's Syndrome, Primary Ovarian InsufficiencyView official trial listing → -
Completed NCT NCT02872818
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Not yet reported Kayseri Education and Research Hospital 40 participants Est. completion 2015-03 1 siteOther conditions: Apoptotic Signal Pathways in Endometrial HyperplasiaView official trial listing → -
Completed NCT NCT02874248
E4/DRSP Single and Multiple Dose PK and Early QT Study
Not yet reported Estetra 55 participants Est. completion 2016-11-21Other conditions: ContraceptionView official trial listing → -
Completed NCT NCT02885454
To Evaluate the Effects of Odalasvir and AL-335 With Simeprevir on the Single-Dose Pharmacokinetics of Ethinylestradiol and Drospirenone in Healthy Female Participants
Not yet reported Janssen Research & Development, LLC 24 participants Est. completion 2016-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02887885
Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women
Insel Gruppe AG, University Hospital Bern 32 participants Est. completion 2020-04-10 1 siteOther conditions: Atrophy of Vagina, PostmenopauseView official trial listing → -
Completed NCT NCT02892214
The Reciprocal Relations Between Psychosocial Characteristics and the Progression of Vestibulodynia
Meir Medical Center 113 participants Est. completion 2021-12 1 siteOther conditions: Localized Provoked VulvodyniaView official trial listing → -
Completed NCT NCT02892942
NATural Ovarian Stimulation
Not yet reported Assistance Publique - Hôpitaux de Paris 129 participants Est. completion 2019-02-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02894398
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Completed NCT NCT02900664
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Not yet reported Novartis Pharmaceuticals 283 participants Est. completion 2021-03-17 23 sitesOther conditions: Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaView official trial listing → -
Status unknown NCT NCT02909361
Fulvestrant 500mg in Patients With Advanced Breast Cancer
Fudan University 500 participants Est. completion 2022-10 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02910050
Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
Not yet reported Xu fei 58 participants Est. completion 2018-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02911844
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
Not yet reported University of Pennsylvania 5 participants Est. completion 2018-12-05 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT02915380
Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage
Dr. Rita Bertuetti 50 participants Est. completion 2018-01Other conditions: Thyroid Disfunction, Subarachnoid Haemorrhage From Cerebral Aneurism Rupture, Pituitary DisfunctionView official trial listing → -
Completed NCT NCT02920671
Muscle OXPHOS and Nutrient Homeostasis
University of Pennsylvania 45 participants Est. completion 2024-08-28 2 sitesOther conditions: Mitochondrial Diseases, ObesityView official trial listing → -
Completed NCT NCT02922127
Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation
Not yet reported Columbia University 29 participants Est. completion 2019-10-21 2 sitesOther conditions: ContraceptionView official trial listing → -
Withdrawn NCT NCT02922348
Hormone Replacement for Premature Ovarian Insufficiency
Not yet reported University of Pennsylvania Est. completion 2018-12-01 1 siteOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Completed NCT NCT02925494
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported AbbVie 433 participants Est. completion 2019-03-22 124 sitesOther conditions: Uterine Fibroids, Heavy Menstrual BleedingView official trial listing → -
Completed NCT NCT02927392
Brown Adipose Tissue Activity in Pre- and Postmenopausal Women
Not yet reported University of Colorado, Denver 69 participants Est. completion 2023-05-02 1 siteOther conditions: Menopause, ObesityView official trial listing → -
Completed NCT NCT02931695
Ventricular Repolarization During the Pregnancy-to-Postpartum Transition (QuTe)
French Cardiology Society 90 participants Est. completion 2026-02-03 1 siteOther conditions: Pregnancy, Long QT SyndromeView official trial listing → -
Terminated NCT NCT02936206
Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.
Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02939898
Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles
Not yet reported, Not yet reported Sven O. Skouby 33 participants Est. completion 2018-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02946684
Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment
Not yet reported, Not yet reported Sven O. Skouby 129 participants Est. completion 2018-10-30 4 sitesOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT02947685
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Not yet reported Alliance Foundation Trials, LLC. 518 participants Est. completion 2026-07-31 106 sitesOther conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02951949
Estrogen Exposure and Atherosclerosis in Postmenopausal Women
University of Valencia 92 participants Est. completion 2015-12 1 siteOther conditions: Atherosclerosis, Menopause, Estrogens, Carotid Intima-media Thickness, Coronary Stenoses, WomenView official trial listing → -
Completed NCT NCT02953860
Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Not yet reported University of Colorado, Denver 32 participants Est. completion 2020-04-10 3 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02955394
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Not yet reported University of Colorado, Denver 61 participants Est. completion 2027-02 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02957630
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
Not yet reported, Not yet reported Estetra 101 participants Est. completion 2017-10-09 1 siteOther conditions: Contraception, Liver Metabolism, Hemostasis ParameterView official trial listing → -
Completed NCT NCT02958852
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02964507
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Not yet reported GlaxoSmithKline 124 participants Est. completion 2021-07-19 38 sitesOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02967510
Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
Not yet reported ITF Research Pharma, S.L.U. 283 participants Est. completion 2018-05 23 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Completed NCT NCT02969590
Regulation of Cervical Mucus Secretion
Not yet reported Oregon Health and Science University 5 participants Est. completion 2017-08-23 1 siteOther conditions: Fertility, ContraceptionView official trial listing → -
Completed NCT NCT02970682
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
Not yet reported Evgen Pharma 60 participants Est. completion 2019-03 10 sitesOther conditions: Breast NeoplasmView official trial listing → -
Status unknown NCT NCT02983071
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported G1 Therapeutics, Inc. 102 participants Est. completion 2023-10 8 sitesOther conditions: Carcinoma, Ductal, Breast, Breast Cancer, Breast NeoplasmView official trial listing → -
Terminated NCT NCT02983604
GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Not yet reported, Not yet reported Gilead Sciences 14 participants Est. completion 2018-07-19 6 sitesOther conditions: Advanced Estrogen Receptor Positive HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT02984696
Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea
Not yet reported Catholic University of the Sacred Heart 20 participants Est. completion 2017-12 1 siteOther conditions: Hypothalamic AmenorrheaView official trial listing → -
Completed NCT NCT02988986
TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer
Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2019-03-30 3 sites Stand-aloneOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02995694
A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis
Not yet reported Alvogen Pine Brook LLC 535 participants Est. completion 2016-12Other conditions: Atrophic VaginitisView official trial listing → -
Completed NCT NCT02995772
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02996760
Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.
Not yet reported IVI Bilbao 22 participants Est. completion 2021-12-31 1 site Stand-aloneOther conditions: Endometrial DevelopmentView official trial listing → -
Completed NCT NCT02997995
Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Not yet reported UNICANCER 61 participants Est. completion 2020-08-28 29 sitesOther conditions: Breast Cancer, Estrogen Receptor Positive Tumor, Menopause, Hormone AntagonistView official trial listing → -
Terminated NCT NCT03003949
The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood
Not yet reported University of North Carolina, Chapel Hill 82 participants Est. completion 2020-05-10 2 sitesOther conditions: Perimenopausal Disorder, Stress, EmotionalView official trial listing → -
Withdrawn NCT NCT03005275
A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women
Not yet reported Vietnam National University Est. completion 2017-04Other conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT03006172
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Not yet reported Genentech, Inc. 200 participants Est. completion 2026-12-31 12 sitesOther conditions: Breast Cancer, Solid TumorView official trial listing → -
Completed NCT NCT03007979
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Not yet reported Washington University School of Medicine 55 participants Est. completion 2023-03-31 2 sitesOther conditions: Breast Cancer, Breast Carcinoma, Cancer of Breast, Malignant Tumor of BreastView official trial listing → -
Terminated NCT NCT03018106
Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction
Not yet reported Emory University 1 participants Est. completion 2017-09-29 4 sites Stand-aloneOther conditions: Sexual Dysfunction, PhysiologicalView official trial listing → -
Completed NCT NCT03018366
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
Not yet reported Cedars-Sinai Medical Center 29 participants Est. completion 2023-02-01 1 siteCardiovascular disease Other conditions: Estrogen Deficiency, Functional Hypothalamic Amenorrhea, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT03020953
The Anabolic Effects of Estrogen on Skeletal Muscles
Not yet reported University of Aarhus 31 participants Est. completion 2018-02-15 1 site Stand-aloneOther conditions: Estrogen SupplementationView official trial listing → -
Status unknown NCT NCT03024580
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
Not yet reported Instituto Nacional de Cancer, Brazil 20 participants Est. completion 2020-09 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Status unknown NCT NCT03033160
Vaginal Estrogen for Asymptomatic Microscopic Hematuria
Not yet reported Boston Urogynecology Associates 68 participants Est. completion 2020-12-30 1 siteOther conditions: Asymptomatic Microscopic HematuriaView official trial listing → -
Status unknown NCT NCT03037944
Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri
Not yet reported Ain Shams Maternity Hospital 32 participants Est. completion 2018-12-01 1 site Stand-aloneOther conditions: AdenomyosisView official trial listing → -
Completed NCT NCT03041129
Post-Prandial Liver Glucose Metabolism in PCOS
University of Colorado, Denver 19 participants Est. completion 2018-09-29 1 siteOther conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic SteatosisView official trial listing → -
Completed NCT NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Not yet reported Iris Sommer 110 participants Est. completion 2021-07-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOSView official trial listing → -
Completed NCT NCT03043924
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
Not yet reported University Hospital, Lille 52 participants Est. completion 2022-04-15 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT03047330
Menopausal Sleep Fragmentation and Body Fat Gain
Not yet reported Brigham and Women's Hospital 41 participants Est. completion 2022-08-01 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT03049735
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported Myovant Sciences GmbH 388 participants Est. completion 2020-08-24 110 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidView official trial listing → -
Completed NCT NCT03056755
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2024-11-12 94 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03060304
The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.
Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06Other conditions: EndometriumView official trial listing → -
Completed NCT NCT03063684
Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus
Not yet reported Hadassah Medical Organization 16 participants Est. completion 2019-04-28 1 site Stand-aloneOther conditions: Vaginal Atrophy, Lichen SclerosusView official trial listing → -
Withdrawn NCT NCT03069781
The Effects of 17β-estradiol on Skeletal Muscle
Not yet reported McMaster University Est. completion 2018-08-14 1 siteOther conditions: Muscle AtrophyView official trial listing → -
Completed NCT NCT03074045
LCS16 vs. COC User Satisfaction and Tolerability Study
Not yet reported Bayer 145 participants Est. completion 2022-08-05 9 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03075956
Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
Not yet reported Estetra 31 participants Est. completion 2017-08-02 1 siteOther conditions: Contraception, MenopauseView official trial listing → -
Completed NCT NCT03077555
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception
Not yet reported Mahidol University 69 participants Est. completion 2018-02-28 1 siteOther conditions: Ovulation InhibitionView official trial listing → -
Terminated NCT NCT03077698
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Not yet reported Xenetic Biosciences, Inc. 25 participants Est. completion 2020-07-17 25 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT03077711
Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
Not yet reported Endeavor Health 92 participants Est. completion 2019-06-21 1 siteOther conditions: Urinary Tract Infections, RecurrentView official trial listing → -
Completed NCT NCT03078751
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2020-03-09 33 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03079011
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
Not yet reported UNICANCER 1017 participants Est. completion 2025-09-22 82 sites Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03081130
Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium
Kaohsiung Veterans General Hospital. 60 participants Est. completion 2018-03-31 1 siteOther conditions: Endometrium, LaserView official trial listing → -
Withdrawn NCT NCT03081234
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer
Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT03091595
E4/DRSP Ovarian Function Inhibition Study
Not yet reported Estetra 82 participants Est. completion 2018-06-08 1 siteOther conditions: Prevention of PregnancyView official trial listing → -
Completed NCT NCT03096847
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 502 participants Est. completion 2020-02-06 84 sitesOther conditions: Advanced Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03097120
The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
Not yet reported Wake Forest University Health Sciences 309 participants Est. completion 2001-01 1 siteOther conditions: Heart DiseaseView official trial listing → -
Completed NCT NCT03099174
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer
Not yet reported Boehringer Ingelheim 133 participants Est. completion 2024-05-16 30 sitesOther conditions: Neoplasms, Breast NeoplasmsView official trial listing → -
Completed NCT NCT03101085
S-Equol in Alzheimer's Disease 2 Trial
Not yet reported, Not yet reported Russell Swerdlow 40 participants Est. completion 2021-03-01 2 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03111511
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)
Not yet reported Janssen Sciences Ireland UC 18 participants Est. completion 2017-08-23 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03111615
HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer
Not yet reported Centro Hospitalar Lisboa Ocidental 90 participants Est. completion 2020-05-01 1 siteOther conditions: Hormone Dependent Neoplasms, Breast Cancer FemaleView official trial listing → -
Completed NCT NCT03116022
Use of Estriol at Distal Third of Vagina Improving Coital Pain in Post-menopause Women
Not yet reported University of Sao Paulo 125 participants Est. completion 2024-01-31 1 siteOther conditions: Dyspareunia, Menopause, Sexual DysfunctionView official trial listing → -
Status unknown NCT NCT03120715
Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer
Not yet reported Nanfang Hospital, Southern Medical University 342 participants Est. completion 2017-09-05 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT03120728
Application for the Etonogestrel/Ethinyl Estradiol Ring
Not yet reported University of Southern California 36 participants Est. completion 2018-07-01 2 sitesOther conditions: Emergency Contraception, Healthy, Reproductive Age WomenView official trial listing → -
Completed NCT NCT03124524
Treatment Choice in Primary Dysmenorrhea
Not yet reported Adana Numune Training and Research Hospital 99 participants Est. completion 2016-10-10Other conditions: Primary DysmenorrheaView official trial listing → -
Terminated NCT NCT03126097
A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females
Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2017-05-26 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03126773
A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia
Bayer 1570 participants Est. completion 2020-06-18 1 siteOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT03137693
Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 20 participants Est. completion 2020-01-27 1 siteOther conditions: Breast Cancer, Breast Cancer Female, Breast AdenocarcinomaView official trial listing → -
Completed NCT NCT03155048
The Effects of Estrogen on Artificial Endometrium
Not yet reported Memorial Sisli Hospital, Istanbul 317 participants Est. completion 2018-09-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03161873
Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
University of Zurich 194 participants Est. completion 2020-11 1 siteOther conditions: Fertility Disorders, Early PregnancyView official trial listing → -
Status unknown NCT NCT03162809
Needle-Free Monitoring for IVF Patient Cycles
Boston IVF 300 participants Est. completion 2021-06 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT03167749
Effect of Liver Cirrhosis on Semen Parameters and Reproductive Hormones
Assiut University 90 participants Est. completion 2019-03Other conditions: Male InfertilityView official trial listing → -
Status unknown NCT NCT03168074
Phase II Study of Single Agent Lenvatinib
Not yet reported National University Hospital, Singapore 30 participants Est. completion 2021-03-28 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT03169738
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Non-small Cell Lung CancerView official trial listing → -
Withdrawn NCT NCT03169764
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Withdrawn NCT NCT03169777
QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Colorectal CancerView official trial listing → -
Terminated NCT NCT03172533
Estrogen Replacement in Anorexia Nervosa
Not yet reported University of Erlangen-Nürnberg Medical School 11 participants Est. completion 2019-01-15 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT03174691
Early Luteal Progesterone Profile in IVF Patients Triggered With hCG
Not yet reported Vietnam National University 161 participants Est. completion 2017-08-08 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03176238
Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sitesOther conditions: Post Menopausal Breast CancerView official trial listing → -
Completed NCT NCT03178695
Inovium Ovarian Rejuvenation Trials
Not yet reported Ascendance Biomedical 200 participants Est. completion 2018-05-01 1 siteOther conditions: Perimenopausal Disorder, Menopause, Menopause, Premature, Menopause Related Conditions, Menopause Premature Symptomatic, Menopause Premature Asymptomatic, Premature Ovarian Failure, Premature Ovarian Failure, Familial, Premature Ovarian Failure 2A, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 1, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 9, Premature Ovarian Failure 8, Infertility, Infertility, Female, Infertility UnexplainedView official trial listing → -
Completed NCT NCT03179904
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Not yet reported Mayo Clinic 17 participants Est. completion 2026-03-13 3 sitesOther conditions: Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2-positive Breast CancerView official trial listing → -
Status unknown NCT NCT03182634
The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
Not yet reported Institute of Cancer Research, United Kingdom 1150 participants Est. completion 2023-11 19 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT03183102
The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.
Not yet reported Colorado State University 30 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT03192293
Metformin and Simvastatin in Addition to Fulvestrant
Not yet reported National University Hospital, Singapore 28 participants Est. completion 2019-01-20 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT03197584
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28Other conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT03201913
Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy
Not yet reported TTC Oncology, LLC 15 participants Est. completion 2020-04-30 4 sitesOther conditions: Metastatic ER+ Breast CancerView official trial listing → -
Status unknown NCT NCT03202862
The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer
Not yet reported Fudan University 50 participants Est. completion 2019-08-01Other conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT03204318
SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Not yet reported Myovant Sciences GmbH 638 participants Est. completion 2021-04-08 123 sitesOther conditions: Endometriosis Related PainView official trial listing → -
Completed NCT NCT03204331
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Not yet reported Myovant Sciences GmbH 623 participants Est. completion 2021-05-31 91 sitesOther conditions: Endometriosis Related PainView official trial listing → -
Completed NCT NCT03210246
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
Not yet reported Bayer 71 participants Est. completion 2019-01-23 2 sitesOther conditions: Clinical Trial ,Phase IView official trial listing → -
Completed NCT NCT03213457
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Not yet reported AbbVie 681 participants Est. completion 2023-12-06 197 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03219476
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
Not yet reported Medical College of Wisconsin 37 participants Est. completion 2025-03-20 1 siteOther conditions: Breast Cancer, Invasive Breast CancerView official trial listing → -
Terminated NCT NCT03220178
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
Not yet reported Palleos Healthcare GmbH 532 participants Est. completion 2021-12-07 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT03232281
Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
Not yet reported Ipsen 300 participants Est. completion 2019-11-16 24 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03236545
Menopause Effects on Vascular Function
Not yet reported University of Delaware 48 participants Est. completion 2022-11-01 1 site Stand-aloneOther conditions: Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT03236740
OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
Not yet reported S.C.B. Medical College and Hospital 101 participants Est. completion 2018-03-15 1 siteOther conditions: PCOSView official trial listing → -
Completed NCT NCT03236974
Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.
Not yet reported AstraZeneca 49 participants Est. completion 2019-02-12 12 sitesOther conditions: Postmenopausal Women With ER+ HER2- Primary Breast CancerView official trial listing → -
Status unknown NCT NCT03237117
Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program
Not yet reported Competence Centre on Health Technologies 105 participants Est. completion 2017-12-31 1 siteOther conditions: Female InfertilityView official trial listing → -
Status unknown NCT NCT03238092
Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort
Not yet reported Hospital de Clinicas de Porto Alegre 26 participants Est. completion 2018-03Other conditions: Fertility DisordersView official trial listing → -
Completed NCT NCT03240081
Treating Postmenopausal Dyspareunia Where it Hurts
Not yet reported Oregon Health and Science University 50 participants Est. completion 2019-11-21 1 siteOther conditions: DyspareuniaView official trial listing → -
Status unknown NCT NCT03240159
Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix
Not yet reported Assisting Nature 120 participants Est. completion 2021-06-30 1 siteOther conditions: Pregnancy, OvarianView official trial listing → -
Terminated NCT NCT03241810
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Not yet reported Elevation Oncology 22 participants Est. completion 2018-11-30 59 sites Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03249402
A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants
Not yet reported Janssen-Cilag International NV 24 participants Est. completion 2017-11-24 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03250676
Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer
Not yet reported, Not yet reported Eisai Inc. 151 participants Est. completion 2023-10-26 39 sitesOther conditions: Breast Neoplasms, Breast Cancer, Estrogen-receptor Positive Breast Cancer, Cancer, Breast, Breast Cancer Female, Breast Adenocarcinoma, Estrogen Receptor Positive Tumor, ER PositiveView official trial listing → -
Completed NCT NCT03258307
Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy
Not yet reported Istanbul Training and Research Hospital 25 participants Est. completion 2018-12-31 1 siteOther conditions: Gynecologic CancerView official trial listing → -
Completed NCT NCT03259711
Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase
Groupe Hospitalier Pitie-Salpetriere 20000 participants Est. completion 2017-08-14 1 siteOther conditions: Cardiac AffectionsView official trial listing → -
Completed NCT NCT03262727
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Not yet reported Bristol-Myers Squibb 49 participants Est. completion 2017-12-19 1 siteOther conditions: Systemic Lupus Erythematosus, Arthritic Psoriasis, Psoriasis, Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT03262740
The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2018-01-30 2 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT03264781
The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users
Not yet reported, Not yet reported Chulalongkorn University 44 participants Est. completion 2017-12 1 siteOther conditions: Uterine BleedingView official trial listing → -
Withdrawn NCT NCT03266562
Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography
Not yet reported Mayo Clinic Est. completion 2019-04-30 1 siteOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT03266926
Does the Use of Bupivacaine Soaked Vaginal Packing Following Vaginal Surgery Decrease Postoperative Pain?
Sunnybrook Health Sciences Centre 140 participants Est. completion 2018-03-01 1 siteOther conditions: Pelvic Organ Prolapse, Postoperative PainView official trial listing → -
Status unknown NCT NCT03269916
Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease
Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 80 participants Est. completion 2018-08-01 1 site Stand-aloneOther conditions: Fertility Disorders, Ovarian Reserve Function, Pregnancy OutcomesView official trial listing → -
Completed NCT NCT03271489
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Not yet reported AbbVie 478 participants Est. completion 2024-06-28 157 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidsView official trial listing → -
Completed NCT NCT03280563
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 144 participants Est. completion 2024-09-26 22 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT03281902
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
Mayo Clinic 68 participants Est. completion 2028-03-04 3 sitesOther conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Status unknown NCT NCT03283345
Effect of Menstrual Cycle on Traumatic Systemic Response
Not yet reported Kocaeli University 89 participants Est. completion 2018-11Other conditions: Systemic Inflammatory Response SyndromeView official trial listing → -
Terminated NCT NCT03284957
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Not yet reported, Not yet reported Sanofi 136 participants Est. completion 2024-11-08 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03289559
Effects of Testosterone and Fat Utilization
Not yet reported University of Colorado, Denver 13 participants Est. completion 2014-01-01Other conditions: Healthy, VolunteersView official trial listing → -
Terminated NCT NCT03294694
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2020-10-14 3 sitesOther conditions: Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian CancerView official trial listing → -
Completed NCT NCT03295487
ToT and Estrogen in Postmenopausal Females
Not yet reported, Not yet reported Kasr El Aini Hospital 210 participants Est. completion 2020-11-30 1 siteOther conditions: Stress Urinary Incontinence, Postmenopausal DisorderView official trial listing → -
Completed NCT NCT03300518
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 552 participants Est. completion 2021-08-18 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03301233
Effect Sildenafil and Estradiiol Valerate on Endometrial Thickness in Infertile Women
Not yet reported Ain Shams University 90 participants Est. completion 2018-07-30 1 site Stand-aloneOther conditions: Endometrial ThicknessView official trial listing → -
Completed NCT NCT03310541
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2023-05-03 3 sitesOther conditions: Breast Cancer, Prostate Cancer, Advanced Solid TumorsView official trial listing → -
Completed NCT NCT03312738
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor
Not yet reported Novartis Pharmaceuticals 159 participants Est. completion 2022-04-25 15 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT03318263
CIrCuLAting Dna ESr1 Gene Mutations Analysis
Not yet reported Institut de Cancérologie de Lorraine 146 participants Est. completion 2022-12-22 10 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03321981
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.
Not yet reported Merus B.V. 105 participants Est. completion 2023-07-26 25 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Terminated NCT NCT03322215
HR+/HER2- Advanced Breast Cancer and Endocrine Resistance
Not yet reported Theodoros Foukakis 42 participants Est. completion 2023-10-31 9 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT03324061
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration
Not yet reported Eagle Pharmaceuticals, Inc. 600 participants Est. completion 2018-07-12 12 sitesOther conditions: PharmacokineticsView official trial listing → -
Status unknown NCT NCT03329898
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
Not yet reported Beijing Obstetrics and Gynecology Hospital 200 participants Est. completion 2018-11-25 1 site Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT03332303
Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy
Not yet reported Prasco LLC 540 participants Est. completion 2018-03-15 27 sitesOther conditions: Vulvar and Vaginal AtrophyView official trial listing → -
Active, not recruiting NCT NCT03332797
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Not yet reported Genentech, Inc. 181 participants Est. completion 2027-07-31 23 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03333564
Effect of Vitamin D3 and Omega-3FA on Estradiol
Not yet reported Applied Science Private University 116 participants Est. completion 2017-02Other conditions: Vitamin D DeficiencyView official trial listing → -
Completed NCT NCT03336437
Estrogen and the Urogenital Microbiome in GSM
Not yet reported Oregon Health and Science University 40 participants Est. completion 2019-08-23 1 siteOther conditions: MenopauseView official trial listing → -
Terminated NCT NCT03343067
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
Not yet reported AbbVie 11 participants Est. completion 2018-10-23 37 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT03343912
Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings
Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 36 participants Est. completion 2018-02-15 1 siteOther conditions: PregnancyView official trial listing → -
Completed NCT NCT03344536
A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2021-08-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03346317
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-05-20 1 site Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Status unknown NCT NCT03351062
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
Not yet reported Chinese Anti-Cancer Association 844 participants Est. completion 2025-12 21 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT03351205
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
Not yet reported Beijing Obstetrics and Gynecology Hospital 100 participants Est. completion 2018-11-22 1 site Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT03353857
Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam
Not yet reported Bayer 68 participants Est. completion 2019-02-19 2 sitesOther conditions: Biological AvailabilityView official trial listing → -
Status unknown NCT NCT03353883
Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?
Not yet reported, Not yet reported Benha University 200 participants Est. completion 2018-08 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03355157
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03355651
Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction
Not yet reported OPKO Health, Inc. 80 participants Est. completion 2017-03-03Other conditions: ACL ReconstructionView official trial listing → -
Status unknown NCT NCT03357640
Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?
Not yet reported, Not yet reported Benha University 118 participants Est. completion 2018-06 1 siteOther conditions: Ovary CystView official trial listing → -
Completed NCT NCT03358823
Study on the Brain Network of Angelman Syndrome
Fudan University 150 participants Est. completion 2019-05-20 1 siteOther conditions: Angelman SyndromeView official trial listing → -
Completed NCT NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Not yet reported Pantarhei Oncology B.V. 63 participants Est. completion 2020-05-15 6 sitesOther conditions: Prostatic NeoplasmView official trial listing → -
Completed NCT NCT03363828
The Temporo-spatial Dynamics of Genital Tract Microbiota
Peter Humaidan 27 participants Est. completion 2021-01-08 2 sitesOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03363997
Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days
Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 31 participants Est. completion 2017-06-06 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT03368898
Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 104 participants Est. completion 2019-12-30 1 siteOther conditions: Heavy Menstrual BleedingView official trial listing → -
Status unknown NCT NCT03373149
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
Not yet reported Riyadh Fertility and Reproductive Health center 228 participants Est. completion 2020-11 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Withdrawn NCT NCT03377101
Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer
Not yet reported National Cancer Institute (NCI) Est. completion 2018-08-07Other conditions: Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT03382834
Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 31 participants Est. completion 2023-07-27 15 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT03385551
Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
Instituto Palacios 120 participants Est. completion 2020-09-30 2 sitesOther conditions: Vulvovaginal AtrophyView official trial listing → -
Terminated NCT NCT03386162
SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer
Not yet reported UNICANCER 31 participants Est. completion 2022-11-18 14 sitesOther conditions: Breast Cancer, PI3K, AlpelisibView official trial listing → -
Completed NCT NCT03390608
Prognostic and Predictive Factors for Small Breast Tumors
Karolinska Institutet 35002 participants Est. completion 2016-07-30 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03393845
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Not yet reported Nancy Chan, MD 47 participants Est. completion 2027-09-01 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03394027
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2021-10-07 1 site Stand-aloneOther conditions: Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast CancerView official trial listing → -
Terminated NCT NCT03395288
Nutraceutical Efficacy for rUTI
Not yet reported, Not yet reported Washington University School of Medicine 61 participants Est. completion 2020-04-25 1 siteOther conditions: Urinary Tract InfectionsView official trial listing → -
Completed NCT NCT03395665
Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer
Fundacion Dexeus 299 participants Est. completion 2018-01 1 siteOther conditions: Infertility, Preimplantation Genetic Diagnosis/Screening, MiscarriageView official trial listing → -
Completed NCT NCT03395756
Depot Medroxyprogesterone Acetate as Emergency Contraception
Not yet reported University of Southern California 30 participants Est. completion 2020-10-30 1 siteOther conditions: Emergency Contraception, ContraceptionView official trial listing → -
Completed NCT NCT03412890
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Not yet reported Myovant Sciences GmbH 477 participants Est. completion 2021-01-13 150 sitesOther conditions: Heavy Menstrual Bleeding, Uterine FibroidView official trial listing → -
Status unknown NCT NCT03416764
Estradiol-mediated Neural Plasticity as Potential Mediator of Neurofeedback Treatment Change for Traumatized Women
Not yet reported Tel-Aviv Sourasky Medical Center 100 participants Est. completion 2022-02-20 1 site Stand-aloneOther conditions: Posttraumatic Stress Disorder (PTSD)View official trial listing → -
Completed NCT NCT03418363
How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills
Not yet reported Oregon Health and Science University 15 participants Est. completion 2019-12-11 1 siteOther conditions: Contraceptive Usage, CoagulationView official trial listing → -
Completed NCT NCT03418831
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
Not yet reported Shanghai Mental Health Center 45 participants Est. completion 2019-07-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03421639
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Not yet reported Centre for Endocrinology and Reproductive Medicine, Italy 300 participants Est. completion 2024-09-30 3 sitesOther conditions: Uterine Adenomyosis, Recurrent Implantation Failure, Menstrual PainView official trial listing → -
Completed NCT NCT03422809
Cyclic Variation in Micronutrient Concentrations and Plasma Volume
Alison Gernand 47 participants Est. completion 2018-11-20 1 siteOther conditions: Plasma Volume, Micronutrients, Menstrual CycleView official trial listing → -
Active, not recruiting NCT NCT03425838
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sitesOther conditions: Breast Neoplasm FemaleView official trial listing → -
Completed NCT NCT03426228
In Vitro Fertilization Impact on Metabolic Parameters
University of Warwick 344 participants Est. completion 2020-01-05 1 siteOther conditions: GDM, Insulin Resistance, Glucose Intolerance, PCOS, ObesityView official trial listing → -
Status unknown NCT NCT03430024
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer
Maidstone & Tunbridge Wells NHS Trust 120 participants Est. completion 2020-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03432416
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
Not yet reported Premier Research 385 participants Est. completion 2021-12-14 11 sitesOther conditions: Healthy Women, Female ContraceptionView official trial listing → -
Status unknown NCT NCT03436303
The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome
Not yet reported Peking Union Medical College Hospital 120 participants Est. completion 2018-12-01 1 siteOther conditions: Menopause SyndromeView official trial listing → -
Completed NCT NCT03436992
Estrogen and Diabetes
Not yet reported Augusta University 143 participants Est. completion 2023-12-31 2 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT03439046
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant
Not yet reported Novartis Pharmaceuticals 287 participants Est. completion 2023-12-11 41 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03442504
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
Not yet reported Institut Cancerologie de l'Ouest 57 participants Est. completion 2024-06 4 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03443089
Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate
Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 24 participants Est. completion 2017-08-01 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03447132
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Not yet reported International Cancer Research Group, United Arab Emirates 354 participants Est. completion 2021-07-20 14 sitesOther conditions: Breast Neoplasm FemaleView official trial listing → -
Completed NCT NCT03450135
Neurophysiology, Estrogen, and Stress Exposure in the Emergence of Depression in Adolescent Girls
University of North Carolina, Chapel Hill 53 participants Est. completion 2020-06-30 1 siteOther conditions: Adolescent Development, Stress, Emotional DisturbancesView official trial listing → -
Completed NCT NCT03451110
Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects
Not yet reported Eisai Inc. 50 participants Est. completion 2018-03-23 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Active, not recruiting NCT NCT03452878
Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients
Hospital Sirio-Libanes 4 participants Est. completion 2026-12-31Other conditions: AggressionView official trial listing → -
Completed NCT NCT03455270
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
Not yet reported G1 Therapeutics, Inc. 107 participants Est. completion 2022-09-29 15 sitesOther conditions: Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Neoplasm, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Stage IV Breast CancerView official trial listing → -
Status unknown NCT NCT03458221
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Not yet reported, Not yet reported Gynaecologisch Oncologisch Centrum Zuid 148 participants Est. completion 2026-10-01 6 sites Stand-aloneOther conditions: Recurrent Ovarian Cancer, Signal Transduction Pathway Deregulation, Therapy-Associated CancerView official trial listing → -
Completed NCT NCT03462251
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
Not yet reported iOMEDICO AG 41 participants Est. completion 2022-11-30 27 sitesOther conditions: Breast Cancer, Hormone Receptor Positive Tumor, HER 2 Negative Breast CancerView official trial listing → -
Completed NCT NCT03470610
Administration of Vaginal and Rectal Progesterone During FET Cycles
Thor Haahr 277 participants Est. completion 2019-09-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03477396
Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported City of Hope Medical Center 2 participants Est. completion 2023-06-05 9 sitesOther conditions: Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT03478020
Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study
Not yet reported Aquinox Pharmaceuticals (Canada) Inc. 32 participants Est. completion 2018-04-05 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT03479879
Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage
Not yet reported, Not yet reported Ain Shams University 200 participants Est. completion 2018-12-20 1 siteOther conditions: MiscarriageView official trial listing → -
Terminated NCT NCT03480659
Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
HKGepitherapeutics 165 participants Est. completion 2021-09-01 1 siteOther conditions: Breast Cancer, Breast Cancer FemaleView official trial listing → -
Completed NCT NCT03481998
A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 104 participants Est. completion 2022-07-30 4 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT03489473
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
Radboud University Medical Center 40 participants Est. completion 2021-12-01Other conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT03493126
Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
Not yet reported Ohio State University 59 participants Est. completion 2020-09-01 1 siteOther conditions: Vaginal AtrophyView official trial listing → -
Status unknown NCT NCT03497702
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
Not yet reported National Cancer Center, Korea 114 participants Est. completion 2024-01 1 siteOther conditions: Breast Cancer, Invasive Breast CancerView official trial listing → -
Completed NCT NCT03498313
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
Not yet reported University of Illinois at Chicago 60 participants Est. completion 2021-05-09 1 siteOther conditions: Suicidal IdeationView official trial listing → -
Completed NCT NCT03505736
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Wake Forest University Health Sciences 25 participants Est. completion 2020-03-05 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Premenopausal, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8View official trial listing → -
Withdrawn NCT NCT03506399
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
Not yet reported Eli Lilly and Company Est. completion 2018-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03507088
Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer
Not yet reported Zhimin Shao 36 participants Est. completion 2018-07-01 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03518528
Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer
University Hospital, Angers 100 participants Est. completion 2018-12 1 siteOther conditions: Embryo Transfer, InfertilityView official trial listing → -
Terminated NCT NCT03519178
A Study of PF-06873600 in People With Cancer
Not yet reported, Not yet reported Pfizer 155 participants Est. completion 2024-10-30 54 sitesOther conditions: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerView official trial listing → -
Terminated NCT NCT03531437
Comparison of Coagulation Profiles Between Zoely and Minidoz: RCT
Not yet reported Mahidol University 112 participants Est. completion 2018-04-18Other conditions: Contraception, HypercoagulabilityView official trial listing → -
Active, not recruiting NCT NCT03531645
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2027-09-30 1 siteOther conditions: Malignant Neoplasms of Female Genital OrgansView official trial listing → -
Status unknown NCT NCT03540979
Endometrial Preparation in Frozen Embryo Transfer Cycles
Not yet reported Meir Medical Center 100 participants Est. completion 2019-12Other conditions: Reproductive BehaviorView official trial listing → -
Withdrawn NCT NCT03544073
GnRH Agonist at Embryo Transfer: IVF Outcomes
Not yet reported Maimonides Medical Center Est. completion 2021-06-30 1 site Stand-aloneOther conditions: Infertility, Infertility, Female, Infertility, MaleView official trial listing → -
Status unknown NCT NCT03544762
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
Not yet reported National Taiwan University Hospital 60 participants Est. completion 2020-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03547024
A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol
Not yet reported Janssen-Cilag International NV 14 participants Est. completion 2018-08-30 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03554044
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
Not yet reported University of California, San Francisco 20 participants Est. completion 2023-12-31 1 siteOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Breast CarcinomaView official trial listing → -
Completed NCT NCT03555877
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2022-07-21 1 siteOther conditions: Breast Cancer MetastaticView official trial listing → -
Status unknown NCT NCT03556800
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 siteOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT03557619
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
Not yet reported AbbVie 12 participants Est. completion 2026-03-21 4 sitesOther conditions: Hematologic MalignanciesView official trial listing → -
Status unknown NCT NCT03558399
Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis
Not yet reported Shady Grove Fertility Reproductive Science Center 800 participants Est. completion 2021-09-23 1 siteOther conditions: Implantation Failure, Infertility, FemaleView official trial listing → -
Completed NCT NCT03560531
A Study of ZN-c5 in Subjects With Breast Cancer
Not yet reported, Not yet reported Zeno Alpha Inc. 181 participants Est. completion 2022-12-22 38 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03560856
A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer
Not yet reported Assistance Publique - Hôpitaux de Paris 54 participants Est. completion 2022-06-01Other conditions: Breast Cancer, HR+/HER2-negative Breast Cancer, MetastasisView official trial listing → -
Terminated NCT NCT03566485
Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer
Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 12 participants Est. completion 2020-12-10 1 siteOther conditions: Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Estrogen Receptor-positive, HER2/Neu NegativeView official trial listing → -
Completed NCT NCT03568708
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
Not yet reported Children's Hospital Medical Center, Cincinnati 19 participants Est. completion 2023-01-05 1 site Stand-aloneOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Active, not recruiting NCT NCT03573648
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03578172
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 186 participants Est. completion 2019-11-20 1 siteOther conditions: Infertility, Female, Intrauterine AdhesionView official trial listing → -
Status unknown NCT NCT03581201
The Relationship of the Intestinal Microbiome and the Menstrual Cycle
Medical University of Vienna 20 participants Est. completion 2020-07-01 1 siteOther conditions: Sex Hormones, Microbial ColonizationView official trial listing → -
Status unknown NCT NCT03582865
Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Assiut University 100 participants Est. completion 2020-12Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT03584009
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
Not yet reported Hoffmann-La Roche 103 participants Est. completion 2021-05-06 40 sitesOther conditions: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03584971
Estrogen and Cooperation, Competitiveness, and Risk Preferences
RWTH Aachen University 80 participants Est. completion 2021-12-30 1 siteOther conditions: Behavioral Correlates of EstradiolView official trial listing → -
Completed NCT NCT03585712
Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill
Not yet reported HRA Pharma 52 participants Est. completion 2020-04-07 2 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT03591549
Fulvestrant in Metastatic Breast Cancer
Not yet reported Assiut University 30 participants Est. completion 2021-10-01Other conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03608241
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
Not yet reported Pfizer 12 participants Est. completion 2018-11-23 2 sitesOther conditions: Healthy FemalesView official trial listing → -
Terminated NCT NCT03619044
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
Not yet reported Institut Claudius Regaud 4 participants Est. completion 2021-07-09 6 sitesOther conditions: HER2-positive Breast CancerView official trial listing → -
Completed NCT NCT03620643
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
Not yet reported Royal Marsden NHS Foundation Trust 33 participants Est. completion 2024-08-30 5 sitesOther conditions: Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer, CDH1 Gene MutationView official trial listing → -
Status unknown NCT NCT03620929
Estrogen in the Prevention of Adhesion Reformation
Not yet reported Fu Xing Hospital, Capital Medical University 186 participants Est. completion 2022-12-01 1 site Stand-aloneOther conditions: Asherman SyndromeView official trial listing → -
Completed NCT NCT03628066
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Not yet reported NSABP Foundation Inc 24 participants Est. completion 2021-01-30 15 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT03631680
The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause
Pennington Biomedical Research Center 2 participants Est. completion 2022-11-11 1 siteOther conditions: Menopause Surgical, Estrogen Deficiency, AdiposityView official trial listing → -
Completed NCT NCT03633331
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 93 participants Est. completion 2026-02-27 447 sitesOther conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Active, not recruiting NCT NCT03640624
Multidisciplinary Treatment of Chronic Vulvar Pain
Not yet reported Norwegian University of Science and Technology 106 participants Est. completion 2027-06 1 siteOther conditions: Vulvodynia, Chronic PainView official trial listing → -
Completed NCT NCT03642665
Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer
Not yet reported Universitaire Ziekenhuizen KU Leuven 554 participants Est. completion 2024-11-01 1 siteOther conditions: Embryo TransferView official trial listing → -
Completed NCT NCT03643510
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 27 participants Est. completion 2026-03-12 7 sitesOther conditions: Adenocarcinoma of EndometriumView official trial listing → -
Status unknown NCT NCT03651427
Cross-sex Hormone Therapy and Neuronal Plasticity
Not yet reported Hospital de Clinicas de Porto Alegre 30 participants Est. completion 2019-03-30 1 site Stand-aloneOther conditions: Gender DysphoriaView official trial listing → -
Completed NCT NCT03652623
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study
Not yet reported, Not yet reported Hektoen Institute for Medical Research 49 participants Est. completion 2023-11-30 1 siteOther conditions: HIV/AIDS, Gender, Behavior and Behavior MechanismsView official trial listing → -
Completed NCT NCT03654274
SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain
Not yet reported Myovant Sciences GmbH 802 participants Est. completion 2023-01-31 169 sitesOther conditions: EndometriosisView official trial listing → -
Withdrawn NCT NCT03658213
To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.
Not yet reported AstraZeneca Est. completion 2021-11-04 11 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03662516
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
Not yet reported Pfizer 17 participants Est. completion 2019-01-19 1 siteOther conditions: Healthy FemalesView official trial listing → -
Completed NCT NCT03663075
Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women
Not yet reported Vastra Gotaland Region 370 participants Est. completion 2020-11-06 1 site Stand-aloneOther conditions: Women's Health, Quality of Life, Mental Health, Menopause, Primary Health Care, Sick LeaveView official trial listing → -
Active, not recruiting NCT NCT03663543
Intravenous Estrogen in Kidney Transplant Study
Not yet reported, Not yet reported University of Pennsylvania 30 participants Est. completion 2027-05-01 1 siteOther conditions: Ischemia Reperfusion InjuryView official trial listing → -
Completed NCT NCT03675581
A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Not yet reported Boehringer Ingelheim 17 participants Est. completion 2019-10-10 10 sitesOther conditions: Scleroderma, SystemicView official trial listing → -
Completed NCT NCT03681691
The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women
Not yet reported Wake Forest University Health Sciences 12 participants Est. completion 2021-07-19 1 siteOther conditions: Diabetes Type 2, DementiaView official trial listing → -
Completed NCT NCT03684096
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
Not yet reported University Hospital, Ghent 69 participants Est. completion 2023-01-31 1 siteOther conditions: Breast Cancer, Hot Flashes, Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT03685331
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 siteOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 MutationView official trial listing → -
Completed NCT NCT03689543
Estrogen Receptor Beta and Mood
Not yet reported National Institute of Mental Health (NIMH) 74 participants Est. completion 2024-09-09 1 site Stand-aloneOther conditions: Perimenopause-Related DepressionView official trial listing → -
Completed NCT NCT03691493
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT03703492
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2024-01-02 1 site Stand-aloneOther conditions: Breast Cancer, Ductal Carcinoma in Situ - CategoryView official trial listing → -
Terminated NCT NCT03709082
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Not yet reported, Not yet reported University of Kansas Medical Center 3 participants Est. completion 2021-02-03 5 sitesOther conditions: HER2-positive Breast Cancer, Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT03718494
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
Mayo Clinic 299 participants Est. completion 2022-09-01 6 sitesOther conditions: Alzheimer DementiaView official trial listing → -
Completed NCT NCT03719495
Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer
Duke University 68 participants Est. completion 2023-07-31 1 siteOther conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HealthyView official trial listing → -
Completed NCT NCT03720847
Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality
Not yet reported University of North Carolina, Chapel Hill 30 participants Est. completion 2017-11 1 siteOther conditions: Suicidal IdeationView official trial listing → -
Withdrawn NCT NCT03724955
Pilot E2 for Hypogonadal Women With CFBD
Not yet reported Emory University Est. completion 2021-06 1 siteOther conditions: Cystic Fibrosis Related Bone DiseaseView official trial listing → -
Active, not recruiting NCT NCT03725059
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03725436
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2026-03-11 1 siteOther conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Malignant Solid Neoplasm, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Recurrent Breast Carcinoma, TP53 wt Allele, Unresectable Malignant Solid NeoplasmView official trial listing → -
Terminated NCT NCT03725696
The Effect of Bariatric Surgery on Spermatogenesis
The Cleveland Clinic 25 participants Est. completion 2020-12-31 1 siteOther conditions: Bariatric Surgery Candidate, Sexual Function and Fertility DisordersView official trial listing → -
Completed NCT NCT03726931
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
Not yet reported Amsterdam UMC, location VUmc 40 participants Est. completion 2023-01-29 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03740009
Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
Not yet reported University of North Carolina, Chapel Hill 20 participants Est. completion 2021-05-17 1 site Stand-aloneOther conditions: Perimenopausal Disorder, DepressionView official trial listing → -
Active, not recruiting NCT NCT03740204
The Role of Estrogen in the Neurobiology of Eating Disorders
Not yet reported Massachusetts General Hospital 120 participants Est. completion 2026-12-31 1 siteOther conditions: Eating Disorders, HypoestrogenemiaView official trial listing → -
Completed NCT NCT03747198
Methylsulfonylmethane on Knee Laxity
Not yet reported University of California, Davis 32 participants Est. completion 2019-10-01 1 site Stand-aloneOther conditions: Ligament Injury, Ligament; Laxity, Tendon Rupture, Tendon InjuriesView official trial listing → -
Withdrawn NCT NCT03749733
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate
Not yet reported Grünenthal GmbH Est. completion 2019-12 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT03751800
A Study Run at Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also be Used to Assess Changes of Severity of HMB in Women With HMB Who Are Treated During 12 Months With a Chronic Hormonal Treatment
Bayer 422 participants Est. completion 2021-05-18 1 siteOther conditions: MenorrhagiaView official trial listing → -
Completed NCT NCT03755037
Clomiphene Citrate, Estradiol and Sildenafil for Induction of Ovulation in Unexplained Infertility
Not yet reported Nesreen Abdel Fattah Abdullah Shehata 150 participants Est. completion 2018-04-30 1 siteOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT03757117
Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade
Not yet reported Asociación Civil Impacta Salud y Educación, Peru 220 participants Est. completion 2018-03-31 1 site Stand-aloneOther conditions: HIV-1-infectionView official trial listing → -
Completed NCT NCT03767335
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Not yet reported Menarini Group 62 participants Est. completion 2024-02-23 27 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT03772353
Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
Not yet reported, Not yet reported Fudan University 59 participants Est. completion 2025-12-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03773263
New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome
Not yet reported Sun Yat-sen University 300 participants Est. completion 2020-03 5 sitesOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT03774472
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2024-04-17 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT03778931
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Not yet reported Stemline Therapeutics, Inc. 478 participants Est. completion 2024-08-22 244 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03779633
Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse
Not yet reported Medical University of Vienna 120 participants Est. completion 2020-08-27 2 sitesOther conditions: Pelvic Organ ProlapseView official trial listing → -
Completed NCT NCT03781063
Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Not yet reported Sermonix Pharmaceuticals Inc. 100 participants Est. completion 2025-05-08 51 sites Stand-aloneOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03783897
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
Not yet reported Enanta Pharmaceuticals, Inc 43 participants Est. completion 2019-06-18 1 siteMASHView official trial listing → -
Completed NCT NCT03786393
Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome
Nigde Omer Halisdemir University 200 participants Est. completion 2021-05-15 1 siteOther conditions: FibromyalgiaView official trial listing → -
Completed NCT NCT03786952
Stress, Sex, and the Generalization of Fear
Not yet reported Ohio Northern University 606 participants Est. completion 2022-06-30 1 siteOther conditions: Psychological StressView official trial listing → -
Status unknown NCT NCT03788681
Luteal Phase Support With Estradiol In Poor Responders Undergoing In Vitro Fertilization
Not yet reported Ain Shams University 170 participants Est. completion 2019-09-01 1 siteOther conditions: ICSIView official trial listing → -
Status unknown NCT NCT03789123
Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma
Not yet reported Bagcilar Training and Research Hospital 710 participants Est. completion 2019-12-01 1 site Stand-aloneOther conditions: Ovarian ReserveView official trial listing → -
Completed NCT NCT03798197
Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers
Not yet reported Donesta Bioscience 28 participants Est. completion 2019-04-06 1 siteOther conditions: Food-effectView official trial listing → -
Completed NCT NCT03803228
Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders
Not yet reported Centre Hospitalier Intercommunal Creteil 88 participants Est. completion 2021-11-24 4 sites Stand-aloneOther conditions: Fertility DisordersView official trial listing → -
Withdrawn NCT NCT03803761
A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) Est. completion 2022-02-19 7 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT03809546
Individual Differences in Drug Response
Not yet reported University of Chicago 60 participants Est. completion 2021-06-01 1 siteOther conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)View official trial listing → -
Completed NCT NCT03809988
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of BreastView official trial listing → -
Completed NCT NCT03815929
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
Not yet reported Mayo Clinic 35 participants Est. completion 2023-08-28 1 siteOther conditions: Cardiovascular Risk ReductionView official trial listing → -
Terminated NCT NCT03816839
Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)
Not yet reported Sanofi 10 participants Est. completion 2024-12-26 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03819140
Continuous Versus Cyclical OCP Use in PCOS
Not yet reported University of California, San Francisco 51 participants Est. completion 2022-10-16 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Active, not recruiting NCT NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sites Stand-aloneOther conditions: Breast Cancer RecurrentView official trial listing → -
Completed NCT NCT03831711
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Not yet reported, Not yet reported Andrei Iagaru 5 participants Est. completion 2021-11-15 1 siteOther conditions: Breast Carcinoma, Estrogen Receptor PositiveView official trial listing → -
Status unknown NCT NCT03832894
Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .
Not yet reported Cairo University 2 participants Est. completion 2020-01-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03832972
Performance During Menstrual Cycle
University of Aarhus 40 participants Est. completion 2022-04-01 1 siteOther conditions: PerformanceView official trial listing → -
Completed NCT NCT03837015
Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women
Not yet reported McMaster University 50 participants Est. completion 2021-12-14 1 siteOther conditions: HIV-1-infection, Bacterial VaginosesView official trial listing → -
Completed NCT NCT03837626
ENAC Blockade and Arterial Stiffness
Not yet reported, Not yet reported University of Missouri-Columbia 137 participants Est. completion 2025-04-30 1 siteOther conditions: Overweight and Obesity, Insulin ResistanceView official trial listing → -
Completed NCT NCT03843346
The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Cancer Trials Ireland 87 participants Est. completion 2021-02-02 10 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03843736
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2020-12-31 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT03844412
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
Not yet reported Duke University 209 participants Est. completion 2024-05-30 2 sitesOther conditions: Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome, Irritable Bowel Syndrome, Migraines, Tension Headache, Endometriosis, Interstitial Cystitis, Back Pain, Chronic Fatigue SyndromeView official trial listing → -
Completed NCT NCT03844685
Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88 participants Est. completion 2016-02-23 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT03846583
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
Not yet reported Dana-Farber Cancer Institute Est. completion 2020-09-22 Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03854175
Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles
Not yet reported Cairo University 80 participants Est. completion 2020-01 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT03854903
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
Not yet reported Georgetown University 19 participants Est. completion 2025-01-09 1 siteOther conditions: Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast CancerView official trial listing → -
Withdrawn NCT NCT03856268
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
Pennington Biomedical Research Center Est. completion 2022-11-11 1 siteOther conditions: Menopause Surgical, Estrogen Deficiency, Adiposity, Follicle-Stimulating Hormone Deficiency, Hormone DeficiencyView official trial listing → -
Completed NCT NCT03856970
Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers
Not yet reported Ironwood Pharmaceuticals, Inc. 87 participants Est. completion 2019-07-03 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT03860636
The Accuracy of Endometrial Ultrasound to Predict Implantation
University of Nottingham 155 participants Est. completion 2022-04-13 1 siteOther conditions: Infertility, SubfertilityView official trial listing → -
Status unknown NCT NCT03868202
Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol
Not yet reported Eastern Virginia Medical School 10 participants Est. completion 2020-01 1 siteOther conditions: Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio, Estradiol EffectView official trial listing → -
Completed NCT NCT03870399
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sitesOther conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive TumorView official trial listing → -
Status unknown NCT NCT03873428
Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES
Not yet reported Centre Georges Francois Leclerc 25 participants Est. completion 2025-10-18 2 sitesOther conditions: FES TEP in Detection of Estrogen ReceptorsView official trial listing → -
Terminated NCT NCT03875313
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Not yet reported, Not yet reported Calithera Biosciences, Inc 33 participants Est. completion 2020-07-29 9 sites Stand-aloneOther conditions: Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer, Colorectal Cancer, CRC, RCC, ccRCCView official trial listing → -
Completed NCT NCT03876145
The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome
Not yet reported Royan Institute 120 participants Est. completion 2020-11-20 1 siteOther conditions: Polycystic Ovary Syndrome, Ovarian Hyperstimulation SyndromeView official trial listing → -
Completed NCT NCT03878823
Safety and Pharmacokinetics of ODM-209
Not yet reported, Not yet reported Orion Corporation, Orion Pharma 38 participants Est. completion 2024-01-09 4 sitesOther conditions: Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03886389
Breast Cancer Diet Intervention Study
Not yet reported Helse Stavanger HF 80 participants Est. completion 2017-07-07Other conditions: Early-stage Breast Cancer, Carbohydrate Engorgement, Proliferation, Insulin Resistance, Estrogen Receptor-positive Breast CancerView official trial listing → -
Completed NCT NCT03887728
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles
ART Fertility Clinics LLC 124 participants Est. completion 2020-12-14 1 siteOther conditions: Endometrial ReceptivityView official trial listing → -
Completed NCT NCT03890042
Dienogest for Treatment of Adenomyotic Uteri
Not yet reported Assiut University 100 participants Est. completion 2020-08-01 1 siteOther conditions: AdenomyosisView official trial listing → -
Status unknown NCT NCT03898401
Effect of PRP Injection in Releiving of Symptoms of Senile Vaginitis
Not yet reported Ain Shams University 30 participants Est. completion 2019-10-30 2 sites Stand-aloneOther conditions: Senile VaginitisView official trial listing → -
Completed NCT NCT03901131
PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.
Bayer 296 participants Est. completion 2022-02-17 1 siteOther conditions: ContraceptiveView official trial listing → -
Withdrawn NCT NCT03905941
Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
Not yet reported University of Virginia Est. completion 2024-11-25 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Status unknown NCT NCT03910712
Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
Not yet reported Peking Union Medical College Hospital 250 participants Est. completion 2023-12-01Other conditions: Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Breast Diseases, Hormone Receptor Positive TumorView official trial listing → -
Status unknown NCT NCT03913208
Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles
Not yet reported Tanta University 1000 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Infertility, IVF, ICSI, CryopreservationView official trial listing → -
Completed NCT NCT03915054
Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.
Not yet reported Mỹ Đức Hospital 30 participants Est. completion 2020-01-31 1 siteOther conditions: PCOS, IVMView official trial listing → -
Completed NCT NCT03916744
A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer
Not yet reported Genentech, Inc. 75 participants Est. completion 2021-05-25 15 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03917082
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
Not yet reported British Columbia Cancer Agency 290 participants Est. completion 2029-05-01 1 siteOther conditions: Breast Cancer Female, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT03921710
CAPA-IVM Versus STANDARD IVM
Not yet reported Mỹ Đức Hospital 80 participants Est. completion 2018-10-10 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT03921736
Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.
Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17 Stand-aloneOther conditions: Hypertension, Hyperuricemia, MenopauseView official trial listing → -
Status unknown NCT NCT03925233
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital 300 participants Est. completion 2021-12-15 1 siteOther conditions: Breast Cancer OrganoidsView official trial listing → -
Completed NCT NCT03926936
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study
Not yet reported Frederic Amant 17 participants Est. completion 2022-12-27 14 sitesObstructive sleep apnea Other conditions: Endometrial Stromal Sarcoma, Endometrial Cancer, Sex Cord Stromal Tumor, Serous Ovarian TumorView official trial listing → -
Status unknown NCT NCT03927456
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 357 participants Est. completion 2022-12-30 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT03930706
SHorter Treatment of Replacement Therapy for Frozen Embryo Transfer (FET)
Not yet reported Universitair Ziekenhuis Brussel 150 participants Est. completion 2021-03-31 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT03939897
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2027-07-31 14 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma, Recurrent Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT03941730
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Not yet reported Mayo Clinic 8 participants Est. completion 2026-12-31 9 sitesOther conditions: Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Recurrent Breast CarcinomaView official trial listing → -
Terminated NCT NCT03943823
Postmenopausal Pessary Users: Estrogen Versus Trimosan
Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2021-04-08 1 siteOther conditions: Vaginosis, Vaginosis, Bacterial, Vaginal DischargeView official trial listing → -
Active, not recruiting NCT NCT03944434
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
Not yet reported Fondazione Sandro Pitigliani 116 participants Est. completion 2025-11-27 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03945513
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
Not yet reported Insud Pharma 1034 participants Est. completion 2023-09-08 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT03945812
Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer
Not yet reported Wael Elbanna Clinic 665 participants Est. completion 2023-03-08 1 siteOther conditions: Infertility, Frozen Embryo Transfer (FET)View official trial listing → -
Status unknown NCT NCT03946722
Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.
Not yet reported University College, London 162 participants Est. completion 2024-05-17 1 siteOther conditions: AdenomyosisView official trial listing → -
Completed NCT NCT03949985
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
University Hospital, Geneva 103 participants Est. completion 2020-09-14 1 siteOther conditions: Venous Thromboembolism, ContraceptionView official trial listing → -
Terminated NCT NCT03954587
What is the Optimal Cycle Regimen for Frozen- Thawed Embryo Transfer Cycles
ART Fertility Clinics LLC 4 participants Est. completion 2020-07-30 1 siteOther conditions: Infertility, Female Infertility, Pregnancy EarlyView official trial listing → -
Active, not recruiting NCT NCT03959891
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
Not yet reported Massachusetts General Hospital 77 participants Est. completion 2027-08 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03961880
Impact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer Patients
University Hospital Tuebingen 270 participants Est. completion 2025-06-30 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT03967457
Comprehensive Study on the Quality of Life in Cervical Cancer Patients
Lei Li 10000 participants Est. completion 2023-06-01 1 siteOther conditions: Quality of Life, Cervical Cancer, Urodynamics, Rectum Dynamics, Sex Dysfunction, Pelvic Floor Disorders, Ovarian Reserve Function, Survivorship, Disease-free Survival, Overall SurvivalView official trial listing → -
Completed NCT NCT03973229
Neuroendocrine Risk for PTSD in Women
Not yet reported Emory University 127 participants Est. completion 2025-04-30 1 siteOther conditions: PTSD, TraumaView official trial listing → -
Status unknown NCT NCT03981341
Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea
Not yet reported Laval University 36 participants Est. completion 2023-12-01 1 siteOther conditions: Sleep Apnea, Post Menopausal, Oxidative StressView official trial listing → -
Completed NCT NCT03984825
Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive
Not yet reported ViiV Healthcare 23 participants Est. completion 2019-08-16 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT03994432
Effect of Mediterranean Diet and Physical Activity in Patients With Endometriosis
Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 140 participants Est. completion 2023-11-20 1 siteOther conditions: EndometriosisView official trial listing → -
Withdrawn NCT NCT03996057
Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention
Not yet reported Washington University School of Medicine Est. completion 2022-02-11 Stand-aloneOther conditions: UTI, Female Urogenital Diseases, UTI - Lower Urinary Tract InfectionView official trial listing → -
Completed NCT NCT03996603
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
Not yet reported University of Alabama at Birmingham 25 participants Est. completion 2021-01-14 1 siteOther conditions: Female Urogenital Diseases, Vaginal Atrophy, Postmenopausal Atrophic Vaginitis, Genitourinary Disease, Postmenopausal SymptomsView official trial listing → -
Completed NCT NCT03998761
Progesterone Versus Progesterone Plus Dydrogesterone in FET
Not yet reported Mỹ Đức Hospital 1364 participants Est. completion 2021-01-31 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT04002635
Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)
Not yet reported CRG UZ Brussel Est. completion 2022-04-01Other conditions: Infertility, Female, Polycystic Ovary Syndrome, IVF, Ovulation DisorderView official trial listing → -
Completed NCT NCT04002934
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
Not yet reported Riley Bove, MD 63 participants Est. completion 2025-05-20 1 siteOther conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-RemittingView official trial listing → -
Completed NCT NCT04006626
18F-FES PET/CT's Additional Clinical Value in ER+ BC
Fudan University 19 participants Est. completion 2019-06-20 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04007874
Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
Not yet reported Leiden University Medical Center 360 participants Est. completion 2024-12 1 siteOther conditions: Migraine, Migraine;MenstrualView official trial listing → -
Status unknown NCT NCT04009473
Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation
Not yet reported, Not yet reported Forever Young d.o.o. 100 participants Est. completion 2021-12 3 sitesOther conditions: Menopause, Menopause Ovarian Failure, Ovarian Failure, Premature Ovarian Failure, Premature Ovarian Failure 1, Premature Ovarian Failure 2A, Premature Ovarian Failure 2B, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 8, Premature Ovarian Failure 9, Premature Ovarian Failure 10, Premature Ovarian Failure 11, Premature Ovarian Failure 12, Premature Ovarian Failure 13, Premature Ovarian Failure 14, Ovarian Insufficiency, Ovarian Failure Secondary, Ovarian Failure, Premature, Ovarian Insufficiency, Primary, Menopause, PrematureView official trial listing → -
Status unknown NCT NCT04012918
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04013438
Luteal Phase Support During Frozen Embryo Transfer Cycle
Not yet reported Royan Institute 60 participants Est. completion 2019-04-30 1 site Stand-aloneOther conditions: Infertility, Female, Frozen Embryo TransferView official trial listing → -
Completed NCT NCT04016753
A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 32 participants Est. completion 2020-02-21 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT04018274
Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids
Not yet reported Pfizer 29 participants Est. completion 2019-10-16 2 sitesOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT04021017
PRE-GAiN Bone Health Pilot Study
Not yet reported University of Saskatchewan Est. completion 2022-12-13 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Terminated NCT NCT04024436
A Study of TAS-120 in Patients With Metastatic Breast Cancer
Not yet reported Taiho Oncology, Inc. 64 participants Est. completion 2023-09-06 37 sitesOther conditions: Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 AmplificationView official trial listing → -
Terminated NCT NCT04031885
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Not yet reported Eli Lilly and Company 4 participants Est. completion 2020-08-11 61 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04033172
Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )
Not yet reported Chinese Academy of Medical Sciences 40 participants Est. completion 2021-09-01 1 siteOther conditions: Breast Cancer, HER2-positive Breast CancerView official trial listing → -
Status unknown NCT NCT04034589
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46 participants Est. completion 2022-07-06 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04036500
Transgender Estradiol
Not yet reported Medical College of Wisconsin 11 participants Est. completion 2020-07-13 1 siteOther conditions: Transgender PersonsView official trial listing → -
Withdrawn NCT NCT04038489
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
Not yet reported University of Virginia Est. completion 2023-04-30 1 siteOther conditions: Breast Cancer, Estrogen Receptor-positive Breast CancerView official trial listing → -
Completed NCT NCT04039204
Elagolix for Fertility Enhancement Clinical Trial
Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2023-08-09 1 site Stand-aloneOther conditions: Endometriosis, Unexplained InfertilityView official trial listing → -
Active, not recruiting NCT NCT04045379
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
Not yet reported Federal University of São Paulo 195 participants Est. completion 2025-08 1 siteOther conditions: Postmenopausal Atrophic Vaginitis, Postmenopausal Symptoms, Genitourinary SymptomsView official trial listing → -
Status unknown NCT NCT04046159
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
Not yet reported National Taiwan University Hospital 810 participants Est. completion 2025-12-31 1 siteOther conditions: Breast Ductal Carcinoma in SituView official trial listing → -
Status unknown NCT NCT04050592
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Not yet reported Hanna Savolainen-Peltonen 150 participants Est. completion 2022-12 1 siteCardiovascular disease Other conditions: Menopause, Atherosclerosis, Estrogen Replacement TherapyView official trial listing → -
Completed NCT NCT04051320
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
Not yet reported University of North Carolina, Chapel Hill 23 participants Est. completion 2022-07-19 1 siteOther conditions: Perinatal Depression, Post Partum Depression, Depression, Postpartum, DepressionView official trial listing → -
Active, not recruiting NCT NCT04052555
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2027-02-24 14 sitesOther conditions: Bilateral Breast Carcinoma, HER2-Negative Breast Carcinoma, Localized Breast Carcinoma, Recurrent Breast Carcinoma, Triple-Negative Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT04053322
Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.
Not yet reported UNICANCER 172 participants Est. completion 2027-08 2 sitesOther conditions: ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusView official trial listing → -
Completed NCT NCT04055129
Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control
University of St. Augustine for Health Sciences 52 participants Est. completion 2023-08-01 1 siteOther conditions: Hormone Influence on Ligament Laxity and Motor ControlView official trial listing → -
Terminated NCT NCT04059484
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Terminated NCT NCT04060862
A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer
Not yet reported Hoffmann-La Roche 20 participants Est. completion 2023-08-29 20 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04066283
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
University of Colorado, Denver 29 participants Est. completion 2023-12-31 1 siteOther conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive BehaviorView official trial listing → -
Completed NCT NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Arvinas Estrogen Receptor, Inc. 219 participants Est. completion 2026-03-05 16 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04079218
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
Not yet reported Kerry Murphy 60 participants Est. completion 2023-08-09 1 siteOther conditions: HIV Infection, Vaginal Atrophy, Menopause, Menopause Related Conditions, Aging, Premature Aging, Atrophic Vaginitis, Dysbiosis, VaginitisView official trial listing → -
Completed NCT NCT04080297
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Not yet reported Que Oncology 21 participants Est. completion 2014-07-28Other conditions: Vasomotor Symptoms (VMS)View official trial listing → -
Withdrawn NCT NCT04088032
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
Not yet reported Alison Stopeck Est. completion 2020-12-31 1 siteOther conditions: Breast Cancer Female, Locally Advanced Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of BreastView official trial listing → -
Status unknown NCT NCT04088110
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
Not yet reported Fuzhou General Hospital 77 participants Est. completion 2023-11 1 siteOther conditions: Breast Cancer Female, HER2-positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer, Breast Diseases, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT04090957
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
Not yet reported Estetra 1015 participants Est. completion 2022-08-18 117 sitesOther conditions: Vasomotor Symptoms, Menopausal SymptomsView official trial listing → -
Status unknown NCT NCT04092673
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
Not yet reported, Not yet reported Effector Therapeutics 30 participants Est. completion 2025-03-31 14 sitesOther conditions: Solid Tumor, AdultView official trial listing → -
Status unknown NCT NCT04093518
Estradiol as add-on to Antipsychotics
Not yet reported Tangent Data 100 participants Est. completion 2020-11-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisordersView official trial listing → -
Status unknown NCT NCT04100655
The Effect of the GM-CSF Gel on the Endometrial Thickness in Infertile Women With Thin Endometrium
Not yet reported Sir Run Run Shaw Hospital 96 participants Est. completion 2020-12 1 siteOther conditions: Thin EndometriumView official trial listing → -
Status unknown NCT NCT04101656
Accelerated Partial Irradiation of the Breast: New Altered Fractionation
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 174 participants Est. completion 2026-06-15 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04103476
Advancing Postmenopausal Preventive Therapy
Not yet reported University of Southern California 385 participants Est. completion 2026-12-31 1 siteOther conditions: Atherosclerosis, Cognitive DeclineView official trial listing → -
Completed NCT NCT04109066
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
Not yet reported Bristol-Myers Squibb 521 participants Est. completion 2023-12-27 240 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04112368
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
Not yet reported University of Illinois at Chicago 124 participants Est. completion 2024-08-01 1 siteOther conditions: Suicidal IdeationView official trial listing → -
Completed NCT NCT04114500
The Association Between Serum E2 and P on the Day of FET and the Pregnancy Outcome
Al Baraka Fertility Hospital 402 participants Est. completion 2019-05-05 1 siteOther conditions: Frozen Embryo TransferView official trial listing → -
Terminated NCT NCT04131517
A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants
Not yet reported UCB Biopharma SRL 14 participants Est. completion 2020-05-22 1 siteOther conditions: Healthy Female ParticipantsView official trial listing → -
Status unknown NCT NCT04137640
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Not yet reported Shengjing Hospital 152 participants Est. completion 2026-05-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04142762
A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults
Not yet reported Assembly Biosciences 80 participants Est. completion 2020-01-29 1 siteOther conditions: Chronic Hepatitis BView official trial listing → -
Completed NCT NCT04150731
16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer
Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2023-06-28 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04152057
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 site Stand-aloneOther conditions: Breast Cancer, HER2 Positive, Combination ChemotherapyView official trial listing → -
Withdrawn NCT NCT04159493
A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy
Not yet reported Aspen USA Inc Est. completion 2023-05-15Other conditions: Vaginal AtrophyView official trial listing → -
Status unknown NCT NCT04163380
Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle
Not yet reported Southern Illinois University Edwardsville 25 participants Est. completion 2021-12 1 siteOther conditions: Women's HealthView official trial listing → -
Completed NCT NCT04172987
A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-02-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04176757
A Study of ZN-c5 in Participants With Breast Cancer
Not yet reported Zeno Alpha Inc. 35 participants Est. completion 2021-05-25 10 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04185311
Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted
Not yet reported Jonsson Comprehensive Cancer Center 6 participants Est. completion 2023-05-17 1 siteOther conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, HER2/Neu Negative, Invasive Ductal Carcinoma, Not Otherwise Specified, Progesterone Receptor Negative, Prognostic Stage 0 Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Triple-Negative Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT04188548
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Not yet reported Eli Lilly and Company 379 participants Est. completion 2027-12 74 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial CancerView official trial listing → -
Terminated NCT NCT04190056
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
Not yet reported University of California, San Francisco 1 participants Est. completion 2023-06-15 1 siteOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT04190927
A New Hormone Replacement Paradigm: Physiologic Restoration Study
Not yet reported Women's Hormone Network 100 participants Est. completion 2023-08-01Other conditions: Menopause, Perimenopausal Disorder, Menopause Related ConditionsView official trial listing → -
Active, not recruiting NCT NCT04191499
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 325 participants Est. completion 2027-11-15 135 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04192266
Estrogen and Fear in PTSD
Not yet reported The University of Texas Health Science Center, Houston 83 participants Est. completion 2024-12-02 2 sites Stand-aloneOther conditions: PTSDView official trial listing → -
Completed NCT NCT04193852
Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2019-11-25 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04194905
Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2020-12-15 1 siteOther conditions: BioequivalenceView official trial listing → -
Enrolling by invitation NCT NCT04202094
Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems
Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2030-12 1 siteOther conditions: Childhood Cancer, Hematological DisordersView official trial listing → -
Completed NCT NCT04209881
Ovarian Reserve and Ankylosing Spondylitis
Kanuni Sultan Suleyman Training and Research Hospital 50 participants Est. completion 2020-05-19 1 siteOther conditions: Ovarian Diseases, Ankylosing Spondylitis, Anti-Mullerian Hormone DeficiencyView official trial listing → -
Status unknown NCT NCT04212702
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04214288
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
Not yet reported AstraZeneca 240 participants Est. completion 2027-06-16 85 sitesOther conditions: Advanced ER-Positive HER2-Negative Breast CancerView official trial listing → -
Completed NCT NCT04224272
Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant
Not yet reported Jazz Pharmaceuticals 51 participants Est. completion 2025-06-30 13 sitesOther conditions: HER2+/HR+ Breast CancerView official trial listing → -
Completed NCT NCT04225221
Neurobiology of Bulimia Nervosa
Not yet reported University of North Carolina, Chapel Hill 10 participants Est. completion 2022-04-04 1 siteObstructive sleep apneaView official trial listing → -
Terminated NCT NCT04227327
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
Not yet reported University of Milano Bicocca 31 participants Est. completion 2024-07-25 39 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT04230070
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2020-11-17 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04232813
Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
Not yet reported Instituto Palacios 120 participants Est. completion 2020-11-30 1 siteOther conditions: Vulvovaginal AtrophyView official trial listing → -
Completed NCT NCT04240106
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Not yet reported MedSIR 14 participants Est. completion 2023-11-17 10 sitesOther conditions: Breast Cancer, Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT04247126
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Not yet reported Syros Pharmaceuticals 105 participants Est. completion 2023-03-30 16 sites Stand-aloneOther conditions: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer, Pancreatic CancerView official trial listing → -
Status unknown NCT NCT04247204
Assessment of Endometrial and Sub-endometrial Vascularity Before and After PRP Infusion in Frozen Embryo Transfer Cycles
Not yet reported Hatem AbuHashim 30 participants Est. completion 2020-10-05 Stand-aloneOther conditions: Frozen Embryo TransferView official trial listing → -
Terminated NCT NCT04252859
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Not yet reported University of Utah 44 participants Est. completion 2024-12-07 1 site Stand-aloneOther conditions: Invasive Lobular Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT04255160
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
Not yet reported University of Delaware 80 participants Est. completion 2026-10-31 1 siteOther conditions: Perimenopause, Vasodilation, EstrogenView official trial listing → -
Completed NCT NCT04255277
To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.
Not yet reported Viatris Innovation GmbH 97 participants Est. completion 2021-10-18 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Status unknown NCT NCT04256200
Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
Not yet reported, Not yet reported American University of Beirut Medical Center 100 participants Est. completion 2021-12 1 siteOther conditions: EndometriosisView official trial listing → -
Terminated NCT NCT04256941
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
Not yet reported M.D. Anderson Cancer Center 4 participants Est. completion 2023-09-22 1 siteOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Completed NCT NCT04257500
Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS
Not yet reported Andrea Roe, MD, MPH 22 participants Est. completion 2025-08-22 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT04258163
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 760 participants Est. completion 2019-07-01 3 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT04258410
Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency
Not yet reported Wake Forest University Health Sciences Est. completion 2024-01Other conditions: Menopause Related ConditionsView official trial listing → -
Completed NCT NCT04259996
Impact of Serum Progesterone in Modified Natural Cycles and Stimulated Cycles on Ongoing Pregnancy Rate
Instituto Valenciano de Infertilidad, IVI VALENCIA 488 participants Est. completion 2023-07-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT04267250
Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids
Not yet reported Pfizer 18 participants Est. completion 2020-11-06 2 sitesOther conditions: Healthy Female VolunteersView official trial listing → -
Status unknown NCT NCT04268927
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
Not yet reported Cairo University 106 participants Est. completion 2020-04-20 2 sitesOther conditions: InfertilityView official trial listing → -
Active, not recruiting NCT NCT04270149
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer
Not yet reported Herbert Lyerly 8 participants Est. completion 2027-08-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04272008
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
Not yet reported TherapeuticsMD 21 participants Est. completion 2021-06-08 2 sitesOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT04276272
D4 Choline Breast PET/CT
Imperial College London 6 participants Est. completion 2023-11-03 1 siteOther conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04278053
Evaluation of Sports Supplements on Blood Flow
Not yet reported University of Arkansas, Fayetteville 24 participants Est. completion 2019-05-08 1 siteOther conditions: Determine the Effects of Nitrosigine and Citrulline-malate on Flow-mediated Dilation Among Young AdultsView official trial listing → -
Terminated NCT NCT04278755
Binge Eating & Birth Control
Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2022-05-17 1 siteObstructive sleep apnea Other conditions: Binge Eating, Eating Disorders, Binge-Eating DisorderView official trial listing → -
Withdrawn NCT NCT04280523
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH
Vanderbilt University Medical Center Est. completion 2023-12-31 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT04282031
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
Not yet reported, Not yet reported Beta Pharma (Suzhou) Co., Ltd. 224 participants Est. completion 2025-06-30 1 siteOther conditions: Advanced Solid Tumor, HR+/HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT04283435
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
Not yet reported Cairo University 100 participants Est. completion 2022-03-01 1 site Stand-aloneOther conditions: IVF, Endometrial ReceptivityView official trial listing → -
Completed NCT NCT04283656
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
Not yet reported Thomas Jefferson University 8 participants Est. completion 2022-12-30 1 siteOther conditions: Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT04285892
Embryo Developmental Potential in a Novel 2-step IVM System
Not yet reported Universitair Ziekenhuis Brussel 23 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: In Vitro Maturation of OocytesView official trial listing → -
Active, not recruiting NCT NCT04288089
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer
Not yet reported Eisai Inc. 31 participants Est. completion 2027-03-31 8 sitesOther conditions: Receptors, Estrogen, Genes, Erbb-2, Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT04289974
Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer
Chinese Academy of Medical Sciences 100 participants Est. completion 2022-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04290390
Annovera™ Drug-Drug Interaction Study
Not yet reported TherapeuticsMD 67 participants Est. completion 2021-01-06 1 siteOther conditions: Women, ContraceptionView official trial listing → -
Completed NCT NCT04294225
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
Not yet reported Mayo Clinic 161 participants Est. completion 2022-12-12 3 sitesOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8View official trial listing → -
Terminated NCT NCT04296942
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2021-10-22 1 site Stand-aloneOther conditions: Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer, Hormone Receptor Negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04300790
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04301934
Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection
Not yet reported Mayo Clinic 12 participants Est. completion 2023-04-30 1 siteOther conditions: Urinary Tract InfectionsView official trial listing → -
Completed NCT NCT04305093
Data Mining: Precision Analytical Retrospective Data Correlation
Precision Analytical, Inc. 144561 participants Est. completion 2023-03-28 1 siteOther conditions: Obesity; Endocrine, Hormone DisturbanceView official trial listing → -
Terminated NCT NCT04305236
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
Not yet reported University of California, Irvine 1 participants Est. completion 2022-02-16 1 siteOther conditions: Breast Neoplasm, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT04305496
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
Not yet reported AstraZeneca 818 participants Est. completion 2026-06-22 215 sitesOther conditions: Locally Advanced (Inoperable) or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04309643
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
Not yet reported Concert Pharmaceuticals 21 participants Est. completion 2020-07-08 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Withdrawn NCT NCT04316169
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Not yet reported Medical College of Wisconsin Est. completion 2028-01 1 siteOther conditions: Solid Tumor, Advanced Breast CancerView official trial listing → -
Completed NCT NCT04330677
Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin
Not yet reported University Hospital, Bonn 487 participants Est. completion 2020-01-25 1 site Stand-aloneOther conditions: Oxytocin, Estrogen, Fear Extinction, Emotion Processing, MemoryView official trial listing → -
Status unknown NCT NCT04334330
Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China
Not yet reported Sun Yat-sen University 34 participants Est. completion 2024-12-31 2 sitesOther conditions: Breast Cancer, Brain MetastasesView official trial listing → -
Completed NCT NCT04336891
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
University of Florence 81 participants Est. completion 2020-03-31 1 siteOther conditions: Hypoactive Sexual Desire Disorder, Vulvovaginal Disease, Menopause Related Conditions, Dyspareunia (Female Excluding Psychogenic), Hypoestrogenism, Arousal Disorders, SexualView official trial listing → -
Status unknown NCT NCT04337658
Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 493 participants Est. completion 2026-04-30 2 sitesOther conditions: HER2-positive Breast CancerView official trial listing → -
Withdrawn NCT NCT04347135
Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI
Not yet reported, Not yet reported Annie (Annie) T. Packard Est. completion 2024-04-30 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT04352777
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
Not yet reported Duke University 18 participants Est. completion 2025-06-25 1 siteOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive TumorView official trial listing → -
Status unknown NCT NCT04355520
A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42 participants Est. completion 2021-09 4 sitesOther conditions: HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerView official trial listing → -
Terminated NCT NCT04359329
Estrogen Patch for COVID-19 Symptoms
Not yet reported Sharon Nachman 2 participants Est. completion 2020-07-30 1 siteOther conditions: COVIDView official trial listing → -
Status unknown NCT NCT04359576
Frozen-thawed Embryo Transfers and Hormone Substitution on Thrombotic Risk Markers
Horsens Hospital 50 participants Est. completion 2024-12 1 siteOther conditions: Frozen Embryo TransferView official trial listing → -
Completed NCT NCT04374773
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
Not yet reported University of Washington 14 participants Est. completion 2026-02-28 1 siteOther conditions: Pregnancy Related, Cannabis UseView official trial listing → -
Terminated NCT NCT04379024
Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms
Not yet reported Carol Fabian, MD 11 participants Est. completion 2021-07-31 1 siteOther conditions: Focus of Study is Healthy Women at Risk for Breast CancerView official trial listing → -
Status unknown NCT NCT04393194
The Effect of Intra-vaginal Conjugated Estrogen Cream on Ring Pessary Use for Pelvic Organ Prolapse
Not yet reported Peking Union Medical College Hospital 420 participants Est. completion 2022-09-01 Stand-aloneOther conditions: Pelvic Floor ProlapseView official trial listing → -
Completed NCT NCT04417569
A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
ART Fertility Clinics LLC 10 participants Est. completion 2021-06-30 1 siteOther conditions: Infertility, Infertility, Female, IVF, hCGView official trial listing → -
Completed NCT NCT04418908
Estrogen, Diabetes, and Endothelial Function
Not yet reported University of Colorado, Denver 40 participants Est. completion 2018-10-22Other conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT04419727
Estrogen Receptors and Peripheral Artery Disease
University of Catanzaro 40 participants Est. completion 2020-11-02 1 siteOther conditions: Estrogen Deficiency, Peripheral Artery DiseaseView official trial listing → -
Completed NCT NCT04420598
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
Not yet reported MedSIR 41 participants Est. completion 2023-04-04 16 sites Stand-aloneOther conditions: Advanced Breast Cancer, HER2-positive Breast Cancer, Brain Metastases, Leptomeningeal MetastasisView official trial listing → -
Completed NCT NCT04423068
Inpatient Adolescent Contraception
Not yet reported Children's Mercy Hospital Kansas City 25 participants Est. completion 2023-04-04 1 siteOther conditions: Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior, PregnancyView official trial listing → -
Completed NCT NCT04424173
Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women
Karadeniz Technical University 45 participants Est. completion 2008-08-30Other conditions: CRP, MenopauseView official trial listing → -
Status unknown NCT NCT04433897
Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women
University Hospital, Ghent 300 participants Est. completion 2025-12-31 1 siteOther conditions: NocturiaView official trial listing → -
Completed NCT NCT04436744
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)
Not yet reported Hoffmann-La Roche 221 participants Est. completion 2021-11-24 65 sitesOther conditions: Early Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04443348
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
Not yet reported Laura M. Spring, MD 120 participants Est. completion 2026-12-31 10 sitesOther conditions: Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph Node(s)View official trial listing → -
Completed NCT NCT04445025
Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
Not yet reported Colorado Center for Reproductive Medicine 30 participants Est. completion 2024-12-30 1 siteOther conditions: Infertility, EndometriosisView official trial listing → -
Status unknown NCT NCT04447872
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
Not yet reported Northwell Health 142 participants Est. completion 2025-06 1 siteOther conditions: Infertility, Diminished Ovarian Reserve, IVFView official trial listing → -
Status unknown NCT NCT04453332
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
Not yet reported Hospital de Clinicas de Porto Alegre 60 participants Est. completion 2021-12 1 siteOther conditions: Menopause, Hormone Replacement TherapyView official trial listing → -
Terminated NCT NCT04454749
Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes
ART Fertility Clinics LLC 3 participants Est. completion 2021-03-04 1 siteOther conditions: Endometrial Disorder, Infertility, Female, IVF, Pregnancy EarlyView official trial listing → -
Completed NCT NCT04458662
Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise
Universidad Politecnica de Madrid 103 participants Est. completion 2020-06-01 1 siteOther conditions: Iron-deficiency, Inflammation, Exercise Induced Iron-deficiency, Exercise Induced Muscle Damage, Regulation of Sex Hormones on Hepcidin, Regulation of Sex Hormones on Muscle Damage, Iron Metabolism DisordersView official trial listing → -
Terminated NCT NCT04460807
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer
Not yet reported Ente Ospedaliero Ospedali Galliera 23 participants Est. completion 2023-04-27 47 sitesOther conditions: Ovarian CancerView official trial listing → -
Status unknown NCT NCT04468438
Role of Estrogen in the Flarring up of Lupus Nepheritis
Assiut University 100 participants Est. completion 2021-03-01Other conditions: Activity of Lupus NepheritisView official trial listing → -
Completed NCT NCT04471805
4 mA tDCS, Estrogen, and Leg Muscle Fatigability
Not yet reported University of Iowa 10 participants Est. completion 2021-11-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04478760
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
King's College Hospital NHS Trust 250 participants Est. completion 2024-05-14 1 siteOther conditions: Transgender Persons, Hormone Replacement Therapy, Reference ValuesView official trial listing → -
Completed NCT NCT04482920
Effect of Hormone Therapy on Renal Function
University of Colorado, Denver 22 participants Est. completion 2023-08-31 1 siteOther conditions: Transgenderism, Kidney Diseases, Kidney InjuryView official trial listing → -
Completed NCT NCT04483505
Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.
Not yet reported Fundacion CRIS de Investigación para Vencer el Cáncer 9 participants Est. completion 2023-04-04 8 sitesOther conditions: Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of BreastView official trial listing → -
Active, not recruiting NCT NCT04485013
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Not yet reported Tizona Therapeutics, Inc 240 participants Est. completion 2027-06-01 41 sites Stand-aloneOther conditions: CancerView official trial listing → -
Withdrawn NCT NCT04487392
Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.
Not yet reported University of Nove de Julho Est. completion 2021-12-30Other conditions: Vulvovaginal AtrophyView official trial listing → -
Status unknown NCT NCT04488107
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
Not yet reported, Not yet reported Ahon Pharmaceutical Co., Ltd. 78 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Enrolling by invitation NCT NCT04488614
Prospective Breast Cancer Biobanking
Helse Stavanger HF 1200 participants Est. completion 2030-07-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT04498520
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
Not yet reported Pamela Munster Est. completion 2025-06-30Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Endometrioid Adenocarcinoma, Metastatic Fallopian Tube Carcinoma, Metastatic HER2 Negative Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Refractory Breast Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Fallopian Tube Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Primary Peritoneal Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Fallopian Tube Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Primary Peritoneal Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8View official trial listing → -
Completed NCT NCT04499131
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 109 participants Est. completion 2025-12-31 1 siteOther conditions: Infertility, Female, ENDOMETRIAL RECEPTIVITYView official trial listing → -
Withdrawn NCT NCT04503161
The Effect of an ASC-seeded Collagen Hydrogel on Cerebrospinal Fluid Leak Rates Following Skull Base Surgery
Not yet reported Stanford University Est. completion 2022-09Other conditions: CSF LeakView official trial listing → -
Status unknown NCT NCT04503915
Estrogen Supplementation Mode in HRT-FET Cycle: a RCT
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 784 participants Est. completion 2023-12-01 Stand-aloneOther conditions: Hormone Replacement Therapy, Estrogen, Live Birth RateView official trial listing → -
Completed NCT NCT04505826
A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer
Not yet reported, Not yet reported Olema Pharmaceuticals, Inc. 153 participants Est. completion 2024-07-30 19 sites Stand-aloneOther conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast CancerView official trial listing → -
Completed NCT NCT04507022
The Outcome of Two Protocols Used to Prepare Endometrium for Frozen Embryo Transfer
Not yet reported Rahem Fertility Center 112 participants Est. completion 2021-02-05 1 site Stand-aloneOther conditions: Infertility, Infertility, Female, Infertility, MaleView official trial listing → -
Completed NCT NCT04508582
Cardiac and Immune Cell Function in Preeclampsia
Queen Mary University of London 86 participants Est. completion 2024-03-06 1 siteCardiovascular disease Other conditions: Preeclampsia, Hypertension, Pregnancy Induced Hypertension, Pregnancy Related, Cardiovascular Risk Factor, Heart DiseasesView official trial listing → -
Status unknown NCT NCT04513405
Estrogens Levels and Receptors Status and Skin Tears
Not yet reported University of Catanzaro 1200 participants Est. completion 2022-09-01 1 siteOther conditions: Skin Tear, Estrogen DeficiencyView official trial listing → -
Completed NCT NCT04514159
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
Not yet reported Zeno Alpha Inc. 14 participants Est. completion 2022-10-24 5 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04515472
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2025-03-17 1 siteOther conditions: Transgender PersonsView official trial listing → -
Active, not recruiting NCT NCT04524000
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2027-02-27 15 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT04524026
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2
Not yet reported Nicholas Macklon 25 participants Est. completion 2020-11-30 2 sitesOther conditions: IVFView official trial listing → -
Completed NCT NCT04524728
Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy
Istituti Clinici Scientifici Maugeri SpA 191 participants Est. completion 2020-06 1 siteOther conditions: Breast, Neoplasm Malignant, FemaleView official trial listing → -
Withdrawn NCT NCT04531748
Selective Estrogen Modulation and Melatonin in Early COVID-19
Not yet reported Reena Mehra, MD Est. completion 2022-09Other conditions: Covid19View official trial listing → -
Completed NCT NCT04531943
Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women
Emory University 285 participants Est. completion 2024-04-04 1 siteOther conditions: HIV PreventionView official trial listing → -
Completed NCT NCT04537078
Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
Not yet reported El Shatby University Hospital for Obstetrics and Gynecology 90 participants Est. completion 2021-09-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Status unknown NCT NCT04539626
Estrogen Therapy in Non-severe COVID-19 Patients
Not yet reported CMN "20 de Noviembre" 44 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Covid-19View official trial listing → -
Active, not recruiting NCT NCT04544189
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 69 participants Est. completion 2027-01-29 24 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04544475
A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
Not yet reported NYU Langone Health 49 participants Est. completion 2022-10-03 1 siteOther conditions: Genitourinary Syndrome of Menopause (GSM)View official trial listing → -
Active, not recruiting NCT NCT04546009
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
Not yet reported Hoffmann-La Roche 992 participants Est. completion 2027-07-31 255 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04546347
A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833
Not yet reported AstraZeneca 32 participants Est. completion 2021-01-07 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Terminated NCT NCT04551144
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
St. Louis University 4 participants Est. completion 2023-01-18 1 siteOther conditions: Gender Incongruence, TransgenderismView official trial listing → -
Active, not recruiting NCT NCT04551807
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
Not yet reported JHSPH Center for Clinical Trials 788 participants Est. completion 2026-04-01 15 sitesOther conditions: Pregnancy Related, Pre-EclampsiaView official trial listing → -
Active, not recruiting NCT NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy
Not yet reported Pfizer 157 participants Est. completion 2026-12-31 22 sitesOther conditions: Small Cell Lung Cancer, Ovarian Cancer, Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
Not yet reported AstraZeneca 138 participants Est. completion 2027-06-01 37 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Not yet reported Pfizer 362 participants Est. completion 2027-11-23 39 sitesObstructive sleep apnea Other conditions: Prostate Cancer, Breast Neoplasms, Adenocarcinoma of LungView official trial listing → -
Status unknown NCT NCT04558268
Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
Not yet reported, Not yet reported Soroka University Medical Center 242 participants Est. completion 2021-10 1 site Stand-aloneOther conditions: Recurrent Pregnancy Loss(RPL), Recurrent MiscarriageView official trial listing → -
Completed NCT NCT04564378
Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure
State University of New York at Buffalo 43 participants Est. completion 2023-09-01 1 siteOther conditions: Fuchs DystrophyView official trial listing → -
Active, not recruiting NCT NCT04567420
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Not yet reported Criterium, Inc. 70 participants Est. completion 2028-12-31 19 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04568902
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Not yet reported Eisai Co., Ltd. 33 participants Est. completion 2025-10-01 2 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04572295
A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer
Not yet reported Eisai Co., Ltd. 51 participants Est. completion 2026-06-18 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04574999
Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.
Not yet reported Italfarmaco S.A 167 participants Est. completion 2009-02-23 12 sitesOther conditions: Vaginal AtrophyView official trial listing → -
Active, not recruiting NCT NCT04576455
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Not yet reported Hoffmann-La Roche 303 participants Est. completion 2027-08-25 81 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04579380
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Not yet reported Seagen, a wholly owned subsidiary of Pfizer 217 participants Est. completion 2026-12-31 108 sitesOther conditions: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms, Urologic Neoplasms, Carcinoma, Non-Small-Cell Lung, HER2 Mutations Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT04584255
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
Not yet reported Dana-Farber Cancer Institute 66 participants Est. completion 2029-07-17 8 sites Stand-aloneOther conditions: Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Breast Cancer, HER2-negative Breast Cancer, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Deleterious PALB2 Gene MutationView official trial listing → -
Completed NCT NCT04588298
A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer
Not yet reported AstraZeneca 135 participants Est. completion 2023-06-19 12 sitesOther conditions: HER2-negative Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04590417
Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women
Not yet reported Thai Red Cross AIDS Research Centre 20 participants Est. completion 2025-10-01 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT04595682
Estradiol Effects on Alcohol Across the Menstrual Cycle
Not yet reported Mark Fillmore 100 participants Est. completion 2024-11-06 1 siteOther conditions: Alcohol Use, UnspecifiedView official trial listing → -
Status unknown NCT NCT04597099
Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion
Not yet reported University of Virginia 10 participants Est. completion 2025-10-01 1 siteOther conditions: PCOS, Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT04603183
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
Not yet reported MedSIR 162 participants Est. completion 2025-06-30 31 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Withdrawn NCT NCT04606550
MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study
Not yet reported Mount Sinai Hospital, Canada Est. completion 2022-07-01Other conditions: Breast Cancer Female, Genitourinary Syndrome of MenopauseView official trial listing → -
Completed NCT NCT04607382
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
Bayer 397 participants Est. completion 2021-06-30 1 siteOther conditions: DysmenorrheaView official trial listing → -
Completed NCT NCT04615767
D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum
Not yet reported AGUNCO Obstetrics and Gynecology Centre 10 participants Est. completion 2020-12-16 1 siteOther conditions: Low Serum Testosterone Levels in ManView official trial listing → -
Completed NCT NCT04616417
Investigational Oocyte Cryopreservation for Medical and Non Medical Indications
Not yet reported University of Illinois at Chicago 29 participants Est. completion 2023-03-20 1 siteOther conditions: Infertility, Female, Deferred ChildbearingView official trial listing → -
Status unknown NCT NCT04616729
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 30 participants Est. completion 2025-12-31 2 sitesOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT04619914
the Effect of Clomiphene Citrate Plus Estradiol Valerate Versus Letrozole on Endometrial Thickness and Pregnancy Rate in Infertile Women
Not yet reported Laylay Mohammed Khalleefah Alhibshi 160 participants Est. completion 2019-08-10 1 site Stand-aloneOther conditions: Endometrial Thickness, Pregnancy RateView official trial listing → -
Completed NCT NCT04629846
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
Not yet reported Qilu Pharmaceutical Co., Ltd. 517 participants Est. completion 2023-10-24 2 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04631835
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 54 participants Est. completion 2023-08-31 3 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04639661
Predictors of Periodontal Outcomes Post-sanative Therapy
Brock University 12 participants Est. completion 2021-10-20 2 sitesOther conditions: Periodontal Diseases, Periodontal PocketView official trial listing → -
Completed NCT NCT04641624
sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency
Cengiz Gokcek Women's and Children's Hospital 90 participants Est. completion 2021-08-30 1 siteOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Completed NCT NCT04647487
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery
Not yet reported Eli Lilly and Company 87 participants Est. completion 2022-11-11 19 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04650581
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
Not yet reported Canadian Cancer Trials Group 250 participants Est. completion 2026-12-31 39 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04657536
Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.
Not yet reported Peking University People's Hospital 200 participants Est. completion 2021-12 1 siteOther conditions: Postmenopausal Vulvovaginal AtrophyView official trial listing → -
Status unknown NCT NCT04666805
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04669587
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
Not yet reported, Not yet reported EnhancedBio USA Inc. 106 participants Est. completion 2024-01-31 8 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04671966
Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
Not yet reported The University of Texas at Arlington 100 participants Est. completion 2024-12 1 site Stand-aloneOther conditions: Heart Diseases, Left Ventricular DysfunctionView official trial listing → -
Terminated NCT NCT04675827
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
Not yet reported Jules Bordet Institute 139 participants Est. completion 2024-11-26 85 sitesOther conditions: HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer, Node-negative Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04692103
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
Not yet reported University of Washington 2 participants Est. completion 2041-04-30 1 site Stand-aloneOther conditions: Estrogen Receptor Positive, Primary or Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT04707196
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Not yet reported Eli Lilly and Company 200 participants Est. completion 2023-01-09 15 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT04709094
A Drug Interaction Study of Danicopan
Not yet reported Alexion Pharmaceuticals, Inc. 52 participants Est. completion 2020-04-17 1 siteOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT04711252
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
Not yet reported AstraZeneca 1371 participants Est. completion 2029-02-01 263 sitesOther conditions: ER-Positive HER2-Negative Breast CancerView official trial listing → -
Completed NCT NCT04713904
Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 38 participants Est. completion 2021-02-02 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT04714554
A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men
Not yet reported Myovant Sciences GmbH 43 participants Est. completion 2021-03-29 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04718636
A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants
Not yet reported Celgene 28 participants Est. completion 2021-08-03 3 sitesOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04719273
Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer
Not yet reported Thomas Jefferson University 14 participants Est. completion 2025-12-17 2 sites Stand-aloneOther conditions: Refractory Endometrial Adenocarcinoma, Refractory Endometrial Carcinoma, Refractory Endometrial Clear Cell Adenocarcinoma, Refractory Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Mixed Cell Adenocarcinoma, Refractory Endometrial Serous Adenocarcinoma, Refractory Endometrial Undifferentiated CarcinomaView official trial listing → -
Status unknown NCT NCT04721522
The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
Zagazig University 356 participants Est. completion 2024-06-01 1 siteOther conditions: Embryo Implantation, ARTView official trial listing → -
Terminated NCT NCT04726332
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
Not yet reported Exelixis 52 participants Est. completion 2024-05-02 5 sitesOther conditions: Neoplasm Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate CancerView official trial listing → -
Completed NCT NCT04733235
the Effect of Endometrial Compaction Caused by Progesterone Effect on Pregnancy Outcomes
Akdeniz University 205 participants Est. completion 2021-07-15 1 siteOther conditions: Infertility, Female Infertility, Frozen-thawed Embryo TransferView official trial listing → -
Terminated NCT NCT04738292
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sitesOther conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic CancerView official trial listing → -
Completed NCT NCT04746313
Prevalence of Hyperprolactinemia in Systemic Scleroderma
University Hospital, Lille 71 participants Est. completion 2021-05-12 1 siteOther conditions: Sclerosis, Systemic, Scleroderma, HyperprolactinemiaView official trial listing → -
Status unknown NCT NCT04753177
The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Not yet reported, Not yet reported Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120 participants Est. completion 2024-01-28 1 siteOther conditions: The Neoadjuvant TherapyView official trial listing → -
Completed NCT NCT04756037
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
Not yet reported Sumitomo Pharma Switzerland GmbH 1164 participants Est. completion 2026-03-31 112 sitesOther conditions: ContraceptionView official trial listing → -
Active, not recruiting NCT NCT04759248
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 55 participants Est. completion 2027-07-01 15 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04760691
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
Not yet reported Johns Hopkins University 13 participants Est. completion 2025-03-24 1 site Stand-aloneOther conditions: HIV, Prophylaxis, TransgenderView official trial listing → -
Active, not recruiting NCT NCT04762979
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sitesOther conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04767451
Levels of Selected Microelements in Premature Ovarian Insufficiency
Cengiz Gokcek Women's and Children's Hospital 100 participants Est. completion 2021-10-30 1 siteOther conditions: Premature Ovarian FailureView official trial listing → -
Completed NCT NCT04769401
Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle
Not yet reported Bezmialem Vakif University 238 participants Est. completion 2021-11-21 2 sitesOther conditions: Infertility, IVF, ProgesteroneView official trial listing → -
Completed NCT NCT04777929
The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia
Second Affiliated Hospital of Wenzhou Medical University 60 participants Est. completion 2022-10-31 1 siteOther conditions: Phthalate Exposure, Preeclampsia, Estrogen, ProgestinView official trial listing → -
Completed NCT NCT04778514
A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Not yet reported Population Council 30 participants Est. completion 2023-09-11 1 siteOther conditions: HIV Infections, ContraceptionView official trial listing → -
Terminated NCT NCT04778982
Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 4 participants Est. completion 2023-03-15 1 siteOther conditions: HER2-positive Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04796623
A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122 participants Est. completion 2024-05-24 17 sitesOther conditions: HR-positive, HER2-negative Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT04797338
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
Not yet reported Assaf-Harofeh Medical Center 100 participants Est. completion 2021-09-30 1 siteOther conditions: Pregnancy Early, Miscarriage, Ovarian Hyperstimulation SyndromeView official trial listing → -
Completed NCT NCT04800146
A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study
Ilaria Colombo 177 participants Est. completion 2023-03-21 1 siteOther conditions: Covid19, CancerView official trial listing → -
Status unknown NCT NCT04800705
Levels of Selected Macroelements in Premature Ovarian Insufficiency
Cengiz Gokcek Women's and Children's Hospital 140 participants Est. completion 2021-12-30 1 siteOther conditions: Premature Ovarian FailureView official trial listing → -
Completed NCT NCT04804020
Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.
Not yet reported Mỹ Đức Hospital 1428 participants Est. completion 2023-12-31 1 siteOther conditions: IVF, Frozen Embryo TransferView official trial listing → -
Completed NCT NCT04818632
AZD9833 China PK Study
Not yet reported AstraZeneca 28 participants Est. completion 2023-09-07 4 sitesOther conditions: ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04819906
Effect of Estetrol Monohydrate (E4) on QTc Interval
Not yet reported Estetra 32 participants Est. completion 2021-07-14 1 siteOther conditions: Prolonged QTc IntervalView official trial listing → -
Active, not recruiting NCT NCT04821141
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Not yet reported University of Kansas Medical Center 120 participants Est. completion 2027-07-31 6 sitesOther conditions: Risk Reduction, Breast CancerView official trial listing → -
Completed NCT NCT04821375
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
Not yet reported Carol Fabian, MD 16 participants Est. completion 2024-12-31 1 siteOther conditions: Increased Risk for Development of Breast CancerView official trial listing → -
Status unknown NCT NCT04822012
Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid
Meir Medical Center 50 participants Est. completion 2021-06-01 1 siteOther conditions: SARS-CoV-2View official trial listing → -
Completed NCT NCT04822857
The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension
Polish Mother Memorial Hospital Research Institute 86 participants Est. completion 2020-12-30 1 siteOther conditions: Hypertension, MenopauseView official trial listing → -
Completed NCT NCT04828824
Premature Discontinuation of Contraceptive Implants
Not yet reported University of Colorado, Denver 600 participants Est. completion 2025-11-12 1 siteOther conditions: Contraception BehaviorView official trial listing → -
Status unknown NCT NCT04831151
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Not yet reported Inonu University 42 participants Est. completion 2023-06 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Active, not recruiting NCT NCT04833140
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
Not yet reported Massachusetts General Hospital 50 participants Est. completion 2027-07-09 1 siteMASHView official trial listing → -
Completed NCT NCT04841499
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
Not yet reported University of South Alabama 40 participants Est. completion 2021-07-15 1 siteOther conditions: MenopauseView official trial listing → -
Active, not recruiting NCT NCT04851613
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Not yet reported Laekna Limited 256 participants Est. completion 2026-12-30 55 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04852081
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center 1000 participants Est. completion 2021-12-01 1 siteOther conditions: Breast Cancer Stage IVView official trial listing → -
Status unknown NCT NCT04853069
Oestrogen Treatment for COVID-19 Symptoms
Not yet reported Hamad Medical Corporation 2000 participants Est. completion 2022-03-31 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04855383
Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles
Not yet reported Royan Institute 200 participants Est. completion 2023-06-20 1 siteOther conditions: Embryo ImplantationView official trial listing → -
Status unknown NCT NCT04856306
Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L
Medstar Health Research Institute 300 participants Est. completion 2025-08-30 1 siteOther conditions: Heavy Menstrual Bleeding, Fibroid UterusView official trial listing → -
Status unknown NCT NCT04856371
Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer
Not yet reported Haihe Biopharma Co., Ltd. 228 participants Est. completion 2022-12Other conditions: Advanced Breast CancerView official trial listing → -
Terminated NCT NCT04862143
Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2022-09-19 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04862663
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Not yet reported AstraZeneca 893 participants Est. completion 2029-08-14 225 sitesOther conditions: Locally Advanced (Inoperable) or Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT04865029
Estradiol and Progesterone in Hospitalized COVID-19 Patients
Not yet reported Tulane University 10 participants Est. completion 2022-01-25 1 siteOther conditions: Covid19View official trial listing → -
Terminated NCT NCT04869943
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
Not yet reported Veru Inc. 52 participants Est. completion 2024-01-09 54 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT04883814
18F-fluoroestradiol (FES) PET/CT for Breast Cancer
Not yet reported Hoag Memorial Hospital Presbyterian 124 participants Est. completion 2023-12-15 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04891926
Hormonal Influences on Diuresis
Not yet reported University Hospital, Ghent 70 participants Est. completion 2018-09-30 Stand-aloneOther conditions: Nocturia, Menopause, LUTS, DiuresisView official trial listing → -
Active, not recruiting NCT NCT04895358
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
Not yet reported Merck Sharp & Dohme LLC 342 participants Est. completion 2027-12-18 256 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT04899349
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
Not yet reported Novartis Pharmaceuticals 2 participants Est. completion 2023-05-10 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04899778
Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
Not yet reported Cedars-Sinai Medical Center 73 participants Est. completion 2024-06-30 1 siteOther conditions: Ligament InjuryView official trial listing → -
Withdrawn NCT NCT04901299
Fulvestrant + Neratinib In Breast Cancer
Not yet reported Massachusetts General Hospital Est. completion 2025-07-01 2 sitesOther conditions: Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer, HER2-negative Breast Cancer, Invasive Breast CancerView official trial listing → -
Completed NCT NCT04901377
A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest
Bayer 255 participants Est. completion 2023-04-20 1 siteOther conditions: Oral ContraceptionView official trial listing → -
Completed NCT NCT04916509
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
Pfizer 258 participants Est. completion 2022-12-27 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT04920708
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
Not yet reported Royal Marsden NHS Foundation Trust 57 participants Est. completion 2027-06 13 sitesOther conditions: Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast CancerView official trial listing → -
Completed NCT NCT04923867
Suturable DuraGen™ PMCF Study
Integra LifeSciences Corporation 106 participants Est. completion 2024-07-31 3 sitesOther conditions: Cerebrospinal Fluid LeakView official trial listing → -
Completed NCT NCT04930224
Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients
Kahramanmaras Sutcu Imam University 120 participants Est. completion 2020-04-25 1 siteOther conditions: Diabetes Mellitus, Diabetic Retinopathy, HormonesView official trial listing → -
Withdrawn NCT NCT04933240
Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial
Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sitesOther conditions: Vaginal BleedingView official trial listing → -
Completed NCT NCT04934696
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
Not yet reported Bristol-Myers Squibb 25 participants Est. completion 2022-01-25 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Status unknown NCT NCT04942015
Honghuaruyi Wan for Endometriosis Dysmenorrhea
Not yet reported Beijing University of Chinese Medicine 164 participants Est. completion 2023-12-31 Stand-aloneOther conditions: Endometriosis, DysmenorrheaView official trial listing → -
Active, not recruiting NCT NCT04961996
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 622 sitesOther conditions: Early Breast CancerView official trial listing → -
Status unknown NCT NCT04962386
Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD
Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2022-03-06 2 sitesOther conditions: Meibomian Gland DysfunctionView official trial listing → -
Status unknown NCT NCT04962789
Endometrial Compaction in Assissted Reproduction
Assiut University 145 participants Est. completion 2023-10-01 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT04964193
Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers
Not yet reported PT Sydna Farma 24 participants Est. completion 2019-09-26 1 siteOther conditions: Drug UseView official trial listing → -
Active, not recruiting NCT NCT04964934
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
Not yet reported AstraZeneca 315 participants Est. completion 2028-09-01 264 sitesOther conditions: ER-Positive HER2-Negative Breast CancerView official trial listing → -
Terminated NCT NCT04965688
Biology Guided Therapy for Breast Cancer for ER Positive
Not yet reported Inova Health Care Services 2 participants Est. completion 2024-03-13 1 siteOther conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Terminated NCT NCT04967248
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
Novartis Pharmaceuticals 4 participants Est. completion 2024-10-18Other conditions: Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationView official trial listing → -
Status unknown NCT NCT04972032
Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis
Not yet reported Limin Feng 246 participants Est. completion 2025-03 1 site Stand-aloneOther conditions: Intrauterine AdhesionView official trial listing → -
Completed NCT NCT04972396
Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sitesMASHView official trial listing → -
Active, not recruiting NCT NCT04975308
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
Not yet reported Eli Lilly and Company 874 participants Est. completion 2027-08 243 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT04979091
Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients
Universitätsklinikum Hamburg-Eppendorf 100 participants Est. completion 2021-05-31 1 siteOther conditions: Covid19, Critical IllnessView official trial listing → -
Status unknown NCT NCT04984070
Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety
Not yet reported Fudan University 100 participants Est. completion 2024-12-31 1 siteOther conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Depression, AnxietyView official trial listing → -
Completed NCT NCT04989348
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
Not yet reported Shanghai First Maternity and Infant Hospital 240 participants Est. completion 2024-02-20 1 siteOther conditions: IVFView official trial listing → -
Completed NCT NCT04997525
Estradiol and Progesterone Levels Following Frozen Embryo Transfer
Not yet reported Copenhagen University Hospital at Herlev 305 participants Est. completion 2024-12-06 1 siteOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT04999540
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
Not yet reported Guangdong Women and Children Hospital 73 participants Est. completion 2024-12-30Other conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05000736
Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC
Chinese Academy of Medical Sciences 600 participants Est. completion 2022-09-01 1 siteOther conditions: Hormone Receptor Positive Advanced Breast CancerView official trial listing → -
Completed NCT NCT05002738
Desogestrel-containing COCP Pharmacokinetic Validation Study
Not yet reported University of Colorado, Denver 22 participants Est. completion 2022-11-28 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT05010707
Transgender Estradiol Affirming Therapy
Not yet reported Washington University School of Medicine 39 participants Est. completion 2024-01-01 1 siteOther conditions: TransgenderismView official trial listing → -
Completed NCT NCT05012644
Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone
Pfizer 197 participants Est. completion 2021-12-09 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05021094
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
Not yet reported Affiliated Hospital of Nantong University 120 participants Est. completion 2023-12-31 6 sites Stand-aloneOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Status unknown NCT NCT05021861
Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen
Postgraduate Institute of Dental Sciences Rohtak 150 participants Est. completion 2022-09-30 1 siteOther conditions: Periodontitis, Polycystic Ovary Syndrome, GingivitisView official trial listing → -
Completed NCT NCT05022342
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Novartis Pharmaceuticals 595 participants Est. completion 2025-02-11 28 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05026502
A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
AbbVie 23 participants Est. completion 2022-08-30 1 siteOther conditions: Heavy Menstrual Bleeding, Uterine FibroidsView official trial listing → -
Completed NCT NCT05030038
Oral Aromatase Inhibitors Modify the Gut Microbiome
Wake Forest University Health Sciences 24 participants Est. completion 2025-07-28 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05033574
The State of Sexual Development in Children With Inherited Epidermolysis Bullosa
National Medical Research Center for Children's Health, Russian Federation 50 participants Est. completion 2023-06-01 1 siteObstructive sleep apnea Other conditions: Dermatologic Disease, Kindler Syndrome, Puberty Disorders, Hormone DisturbanceView official trial listing → -
Active, not recruiting NCT NCT05038735
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
Not yet reported Novartis Pharmaceuticals 210 participants Est. completion 2027-02-26 68 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05043506
European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies
Pfizer 1939 participants Est. completion 2023-11-02 64 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05047848
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
Not yet reported Liaoning Cancer Hospital & Institute 82 participants Est. completion 2023-09-18 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05050981
Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life
Faculdade de Medicina do ABC 74 participants Est. completion 2022-02-28 1 siteOther conditions: MenopauseView official trial listing → -
Withdrawn NCT NCT05051293
Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension
Methodist Health System Est. completion 2024-08-17Other conditions: Hypotension, CirrhosisView official trial listing → -
Completed NCT NCT05054374
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 6 participants Est. completion 2023-10-26 4 sites Stand-aloneOther conditions: Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer, Solid Carcinoma, MEK1 Gene Mutation, MEK2 Gene Mutation, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05054751
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported Genor Biopharma Co., Ltd. 275 participants Est. completion 2024-03-30 54 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT05059626
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
Not yet reported Penn State University 28 participants Est. completion 2026-12-31 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT05061472
A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity
University of Colorado, Denver 20 participants Est. completion 2023-08-23 2 sitesOther conditions: Contraceptive Usage, Overweight or Obesity, Body Weight Changes, Appetitive Behavior, Eating BehaviorView official trial listing → -
Active, not recruiting NCT NCT05063786
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
Not yet reported Spanish Breast Cancer Research Group 27 participants Est. completion 2026-06 106 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05064332
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
Not yet reported Pfizer 10 participants Est. completion 2021-12-16 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT05065411
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05069038
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
Not yet reported University of Nebraska 51 participants Est. completion 2032-09 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT05073237
Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans
Not yet reported VA Office of Research and Development Est. completion 2024-04-08 1 sitePrediabetes Other conditions: Menopause, ObesityView official trial listing → -
Status unknown NCT NCT05075512
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
Not yet reported Zhejiang Cancer Hospital 40 participants Est. completion 2026-08-31 1 siteOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT05076695
Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Not yet reported Fudan University 37 participants Est. completion 2024-10-15 1 siteOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05077449
A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 300 participants Est. completion 2029-11 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Withdrawn NCT NCT05079360
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Not yet reported Veru Inc. Est. completion 2024-05-26 26 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05080842
A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer
Not yet reported Accutar Biotechnology Inc 21 participants Est. completion 2024-04-04 5 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05082025
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
Not yet reported M.D. Anderson Cancer Center 7 participants Est. completion 2025-12-12 1 siteOther conditions: Endometrial Cancer, Ovarian CancerView official trial listing → -
Terminated NCT NCT05085002
A Study of Lerociclib in Participants With Advanced Breast Cancer
Not yet reported EQRx, Inc. 100 participants Est. completion 2023-11-29 21 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05090358
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-10-08 9 sitesOther conditions: Breast Cancer, Breast Cancer Stage IV, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05093205
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
Not yet reported Pfizer 35 participants Est. completion 2022-07-06 1 siteOther conditions: Healthy AdultsView official trial listing → -
Completed NCT NCT05095597
Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)
Not yet reported Fundación IVI 15 participants Est. completion 2025-01-27 1 site Stand-aloneOther conditions: Asherman Syndrome, Endometrial AtrophyView official trial listing → -
Status unknown NCT NCT05096065
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
Not yet reported Enteris BioPharma Inc. 16 participants Est. completion 2022-05 4 sitesOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT05098574
Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
Not yet reported St. Joseph's Healthcare Hamilton 17 participants Est. completion 2024-04-11 1 siteOther conditions: Premenstrual Dysphoric Disorder, Bipolar DisorderView official trial listing → -
Active, not recruiting NCT NCT05105854
Hand Osteoarthritis: Investigating Pain Trajectories and Association With Biomarkers Including Estrogen Cohort
University of Oxford 120 participants Est. completion 2029-02-07 2 sitesOsteoarthritisView official trial listing → -
Completed NCT NCT05107804
Energy Restriction and Hormones in Premenopausal Women
Not yet reported Penn State University 47 participants Est. completion 2006-11Other conditions: Menstruation Disturbances, Luteal Phase DefectView official trial listing → -
Completed NCT NCT05109676
Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer.
Not yet reported University Hospital, Toulouse 300 participants Est. completion 2022-06-03 1 siteOther conditions: IVFView official trial listing → -
Status unknown NCT NCT05112692
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Not yet reported Mansoura University 200 participants Est. completion 2023-12Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesView official trial listing → -
Status unknown NCT NCT05118685
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
Not yet reported Fayoum University 100 participants Est. completion 2023-09 2 sitesOther conditions: Atrophic Vaginitis, Postmenopausal Atrophic VaginitisView official trial listing → -
Status unknown NCT NCT05133674
Therapeutic Dose Monitoring (TDM) of Tamoxifen
Not yet reported Karolinska University Hospital 40 participants Est. completion 2023-03-01 1 siteOther conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Cancer of Breast, Malignant Neoplasm of BreastView official trial listing → -
Status unknown NCT NCT05135013
The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study
NewGiza University 200 participants Est. completion 2022-03-31Other conditions: Observational StudyView official trial listing → -
Status unknown NCT NCT05135104
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Asociatia Oncohelp - Centrul de Oncologie Oncohelp 650 participants Est. completion 2024-05-25 7 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05139121
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
Not yet reported Mylan Technologies Inc. 1320 participants Est. completion 2025-01-15 100 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT05140655
Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
Dr. Reddy's Laboratories SAS 40 participants Est. completion 2022-08-19 1 siteOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT05143723
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
Not yet reported Kuban State Medical University 102 participants Est. completion 2022-06-10 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT05153564
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Not yet reported Novo Nordisk A/S 27 participants Est. completion 2022-09-01 1 siteType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT05154487
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Not yet reported GOG Foundation 51 participants Est. completion 2028-11-01 21 sites Stand-aloneOther conditions: Endometroid Endometrial CancerView official trial listing → -
Status unknown NCT NCT05156814
Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women
Not yet reported Scientific Research Institute of Public Health, Russian Federation 150 participants Est. completion 2023-05 1 siteOther conditions: Perimenopausal Disorder, Hot FlashesView official trial listing → -
Status unknown NCT NCT05156879
Aspirin for the Management of Endometriosis-associated Pelvic Pain
Not yet reported Women's Hospital School Of Medicine Zhejiang University 220 participants Est. completion 2025-06 1 siteOther conditions: Pelvic PainView official trial listing → -
Active, not recruiting NCT NCT05161195
Roll-over Study to Allow Continued Access to Ribociclib
Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05161338
Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study.
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 100 participants Est. completion 2023-04-30 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Withdrawn NCT NCT05168865
Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.
Not yet reported Dubai Fertility Center Est. completion 2024-04-01Other conditions: Frozen Embryo Transfer, Polycystic Ovarian Disease, Letrozole, Hormone Replacement Therapy, Live Birth, MiscarriageView official trial listing → -
Active, not recruiting NCT NCT05169567
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
Not yet reported Eli Lilly and Company 368 participants Est. completion 2027-12 138 sitesOther conditions: Breast Neoplasm, Neoplasm MetastasisView official trial listing → -
Terminated NCT NCT05176080
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Not yet reported, Not yet reported Henan Cancer Hospital 46 participants Est. completion 2024-07-03 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05177432
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer
Not yet reported National University Hospital, Singapore 26 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05183828
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
Not yet reported University of Washington 62 participants Est. completion 2026-05-13 1 siteOther conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Adenocarcinoma, Invasive Breast Carcinoma of No Special TypeView official trial listing → -
Completed NCT NCT05184777
Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 120 participants Est. completion 2023-02-20 1 siteOther conditions: Infertility, Female, Reproductive SterilityView official trial listing → -
Status unknown NCT NCT05186545
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sitesOther conditions: Breast Cancer, Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05189145
Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles
Not yet reported Alexandria University 600 participants Est. completion 2021-10-01 1 site Stand-aloneOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT05189873
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Not yet reported Tehran University of Medical Sciences 128 participants Est. completion 2022-01-03 1 siteOther conditions: Polycystic Ovary Syndrome, Infertility, FemaleView official trial listing → -
Withdrawn NCT NCT05191004
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Not yet reported, Not yet reported Nuvation Bio Inc. Est. completion 2026-09 5 sitesOther conditions: Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer, Breast Carcinoma, Cancer of the Breast, Cancer of Breast, Malignant Tumor of Breast, Breast TumorView official trial listing → -
Completed NCT NCT05195164
The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women
University of Colorado, Denver 17 participants Est. completion 2023-12-31 1 siteOther conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Insulin Sensitivity, Blood Pressure, Lipid Disorder, Appetitive BehaviorView official trial listing → -
Completed NCT NCT05197374
Effect of Estradiol Pretreatment on Antagonist ICSI Cycles
Not yet reported Alexandria University 114 participants Est. completion 2021-11-15 1 site Stand-aloneOther conditions: Female InfertilityView official trial listing → -
Terminated NCT NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05226871
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
Not yet reported Pfizer 35 participants Est. completion 2029-12-31 23 sitesOther conditions: Breast Cancer, Head and Neck CancerView official trial listing → -
Status unknown NCT NCT05227391
Live Birth After Letrozole-stimulated Cycles Versus Hormone Replacement Treatment Cycles for the First Frozen Embryo Transfer in Women With PCOS
Not yet reported Reproductive & Genetic Hospital of CITIC-Xiangya 1078 participants Est. completion 2024-12-31 1 siteOther conditions: PCOSView official trial listing → -
Active, not recruiting NCT NCT05230810
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
Not yet reported, Not yet reported Criterium, Inc. 40 participants Est. completion 2026-06-30 4 sitesOther conditions: HER2-positive Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05232344
Sexual Intercourse and Vaginal Absorption of Progesterone
Not yet reported University Hospital, Montpellier 40 participants Est. completion 2024-02-29 1 siteOther conditions: InfertilityView official trial listing → -
Withdrawn NCT NCT05238831
SMMART Adaptive Clinical Treatment (ACT) Trial
Not yet reported OHSU Knight Cancer Institute Est. completion 2026-05-31Other conditions: Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Sarcoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Recurrent Adult Soft Tissue Sarcoma, Recurrent Breast Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Active, not recruiting NCT NCT05238922
Study of INCB123667 in Subjects With Advanced Solid Tumors
Not yet reported Incyte Corporation 291 participants Est. completion 2027-08-31 41 sitesOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT05243823
Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy
Novo Nordisk A/S 500000 participants Est. completion 2022-07-31 1 siteOther conditions: Postmenopausal Vaginal AtrophyView official trial listing → -
Status unknown NCT NCT05244811
Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills
Not yet reported Sohag University 60 participants Est. completion 2023-01Other conditions: Ovarian NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT05251714
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
Not yet reported, Not yet reported Treadwell Therapeutics, Inc 44 participants Est. completion 2026-08 4 sitesOther conditions: Advanced Solid Tumor, Breast CancerView official trial listing → -
Terminated NCT NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumors
Not yet reported Blueprint Medicines Corporation 50 participants Est. completion 2025-07-04 23 sitesObstructive sleep apnea Other conditions: Advanced Solid Tumors, HR+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer, Ovarian Cancer, Endometrial Cancer, Gastric Cancer, Esophageal AdenocarcinomaView official trial listing → -
Active, not recruiting NCT NCT05262400
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
Not yet reported, Not yet reported Pfizer 235 participants Est. completion 2027-02-26 44 sitesOther conditions: Breast Cancer, Solid TumorsView official trial listing → -
Terminated NCT NCT05264506
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
Not yet reported Organon and Co 3055 participants Est. completion 2024-01-26 103 sitesOther conditions: ContraceptionView official trial listing → -
Status unknown NCT NCT05264649
Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer
Not yet reported Show Chwan Memorial Hospital 72 participants Est. completion 2023-03-03 1 siteOther conditions: ArthralgiaView official trial listing → -
Active, not recruiting NCT NCT05266105
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
Not yet reported Olema Pharmaceuticals, Inc. 60 participants Est. completion 2026-03 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05282940
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 36 participants Est. completion 2022-04-08 1 siteOther conditions: Therapeutic EquivalencyView official trial listing → -
Active, not recruiting NCT NCT05293964
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 214 participants Est. completion 2025-09-08 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05296746
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 1100 participants Est. completion 2031-12-01 51 sitesOther conditions: Breast Cancer Stage IIView official trial listing → -
Active, not recruiting NCT NCT05296798
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
Not yet reported Hoffmann-La Roche 922 participants Est. completion 2030-12-31 202 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05300841
The Effect of Pretreatment With Dydrogesterone Vs Combined Estradiol Valerate and Dydrogestrone on Clinical Pregnancy Outcome of ICSI in PCOS Patients"
Not yet reported Sohag University 500 participants Est. completion 2023-05-01Other conditions: PCOS, ICSIView official trial listing → -
Status unknown NCT NCT05302726
Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
Not yet reported Copenhagen University Hospital, Rigshospitalet 20 participants Est. completion 2023-06-01 1 siteOther conditions: Adrenal Insufficiency, Hypogonadism FemaleView official trial listing → -
Active, not recruiting NCT NCT05306340
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Not yet reported Genentech, Inc. 373 participants Est. completion 2026-10-15 136 sitesOther conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05306405
Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream
Not yet reported, Not yet reported Ain Shams University 120 participants Est. completion 2022-08-30 1 siteOther conditions: Cervix; PregnancyView official trial listing → -
Status unknown NCT NCT05308342
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
Not yet reported Li-jun Ding 66 participants Est. completion 2023-12-01 1 site Stand-aloneOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Active, not recruiting NCT NCT05309655
Cardiac Outcomes With Near-Complete Estrogen Deprivation
Not yet reported Duke University 90 participants Est. completion 2028-12-01 3 sites Stand-aloneOther conditions: Breast Cancer, Triple Negative Breast Cancer, Cardiovascular ComplicationsView official trial listing → -
Terminated NCT NCT05317364
Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery
Not yet reported University of Alabama at Birmingham 38 participants Est. completion 2026-02-13 1 siteOther conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary IncontinenceView official trial listing → -
Completed NCT NCT05318989
Genetic Aspects of Vaginal Aging
Żelazna Medical Centre, LLC 120 participants Est. completion 2023-07-10 1 siteOther conditions: Genitourinary AgentsView official trial listing → -
Active, not recruiting NCT NCT05319873
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
Not yet reported, Not yet reported Jonsson Comprehensive Cancer Center 18 participants Est. completion 2028-04-01 1 siteOther conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Locally Advanced HER2-Positive Breast Carcinoma, Metastatic HER2-Positive Breast Carcinoma, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT05328440
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)
Not yet reported Henan Cancer Hospital 120 participants Est. completion 2026-01-01 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT05332106
Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 10 participants Est. completion 2022-03-22 1 site Stand-aloneOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT05340010
Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles
Not yet reported Alexandria University 180 participants Est. completion 2022-07-30 1 site Stand-aloneOther conditions: hCG, FET, Frozen-thawed Embryo Transfe, Human Chorionic GonadotrophinView official trial listing → -
Completed NCT NCT05346159
Effects of Adrenal Androgens on Gender-typed Behavior in Girls With Turner Syndrome
Sohag University 78 participants Est. completion 2023-05-31 1 siteOther conditions: Turner SyndromeView official trial listing → -
Status unknown NCT NCT05358678
Cesarean Section Scar Niche: The Impact on ART Outcome
Rahem Fertility Center 266 participants Est. completion 2023-05 1 siteOther conditions: Cesarean Section, ARTView official trial listing → -
Completed NCT NCT05360550
A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females
Not yet reported Lupin Research Inc 26 participants Est. completion 2023-01-12 1 siteOther conditions: Pregnancy PreventionView official trial listing → -
Completed NCT NCT05360576
An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study
Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 siteOther conditions: Pregnancy PreventionView official trial listing → -
Completed NCT NCT05361655
Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor
Pfizer 2888 participants Est. completion 2021-09-01 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05367973
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
Not yet reported, Not yet reported Daré Bioscience, Inc. 21 participants Est. completion 2023-03-23 2 sitesOther conditions: Vulvovaginal Atrophy, Vasomotor SymptomsView official trial listing → -
Completed NCT NCT05377879
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization
Not yet reported Stochastic Research Technologies LLC 44 participants Est. completion 2022-07-01 1 site Stand-aloneOther conditions: IVFView official trial listing → -
Terminated NCT NCT05384119
Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
Not yet reported Tvardi Therapeutics, Incorporated 6 participants Est. completion 2024-05-06 6 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT05387577
Coagulation and Fibrinolysis of Estradiol in Transwomen
Not yet reported Medical College of Wisconsin 6 participants Est. completion 2022-11-23 1 siteOther conditions: Transgenderism, Clotting DisorderView official trial listing → -
Completed NCT NCT05388656
Estrogen Variability and Irritability During the Menopause Transition
Not yet reported University of North Carolina, Chapel Hill 40 participants Est. completion 2025-01-17 1 siteOther conditions: Menopause, Irritable MoodView official trial listing → -
Active, not recruiting NCT NCT05392608
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sitesOther conditions: Neoplasm, Breast, Congenital, Familial and Genetic DisordersView official trial listing → -
Completed NCT NCT05392985
Detection and Analysis of MBC With Heterogeneous ER Expression
Fudan University 51 participants Est. completion 2022-12-15 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05411380
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.
Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05418426
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Not yet reported Daré Bioscience, Inc. 34 participants Est. completion 2022-01-27 2 sitesOther conditions: Vulvovaginal Atrophy, Vasomotor SymptomsView official trial listing → -
Completed NCT NCT05427617
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
Hunan Cancer Hospital 223 participants Est. completion 2021-06-30Other conditions: Metastatic Breast Cancer, Circulating Tumor DNA, Gene AbnormalityView official trial listing → -
Terminated NCT NCT05428215
Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients
Not yet reported MaineHealth 2 participants Est. completion 2023-07-20 1 siteOther conditions: Gender DysphoriaView official trial listing → -
Status unknown NCT NCT05433480
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer
Not yet reported Betta Pharmaceuticals Co., Ltd. 274 participants Est. completion 2025-07-31 64 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05443282
Ovarian Reserve and Matrix Metalloproteinases
Ankara City Hospital Bilkent 133 participants Est. completion 2022-03-07 1 siteOther conditions: Oxidative Stress, Ovarian Insufficiency, Primary, Ovarian Failure, PrematureView official trial listing → -
Completed NCT NCT05448924
Isolated Growth Hormone Deficiency and Amennorrhea
Universitas Padjadjaran 1 participants Est. completion 2022-01-31 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Terminated NCT NCT05458375
Vaginal Estradiol Use in Pessary Care
Not yet reported University of South Florida 11 participants Est. completion 2023-04-26 1 site Stand-aloneOther conditions: Pelvic Organ Prolapse, Urinary Incontinence, Pessary Ulcer of Vagina, Vaginal AtrophyView official trial listing → -
Active, not recruiting NCT NCT05463601
Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05464654
Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause
Not yet reported Hospital Regional 1o de Octubre 136 participants Est. completion 2022-12-31 1 siteOther conditions: Genitourinary Syndrome of Menopause, Postmenopausal Disorder, Menopause, Vagina AtrophyView official trial listing → -
Completed NCT NCT05469204
Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet reported University of Washington 22 participants Est. completion 2025-07-30 1 siteOther conditions: Transgender PersonsView official trial listing → -
Completed NCT NCT05472779
Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
Not yet reported Stephanie Wang Zuo 114 participants Est. completion 2025-06-25 4 sites Stand-aloneOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Completed NCT NCT05478746
Effects of Flourish HEC on Localized Provoked Vulvodynia
Not yet reported Vaginal Biome Science 7 participants Est. completion 2024-01-15 1 siteOther conditions: Vulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar Vestibulitis, Vulvar PainView official trial listing → -
Not yet recruiting NCT NCT05483634
Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause
Mackay Memorial Hospital 40 participants Est. completion 2027-06-30 1 siteOther conditions: Menopause, Platelet-rich Plasma, Estrogen Replacement Therapy, Vaginal AtrophyView official trial listing → -
Terminated NCT NCT05489679
A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported Accutar Biotechnology Inc 6 participants Est. completion 2023-09-28 3 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05492487
A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore
Not yet reported KK Women's and Children's Hospital 60 participants Est. completion 2023-03-31 3 sites Stand-aloneOther conditions: Endometrial Hyperplasia, Fertility Issues, Disease Regression, Treatment Side EffectsView official trial listing → -
Completed NCT NCT05493202
Superovulation And Urinary Concentration of Estrone
Olive Fertility Centre 30 participants Est. completion 2022-07-30 1 siteOther conditions: in Vitro Fertilization, Hormone TestingView official trial listing → -
Completed NCT NCT05501769
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Not yet reported Arvinas Estrogen Receptor, Inc. 32 participants Est. completion 2025-08-25 9 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05501886
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
Not yet reported Celcuity Inc 701 participants Est. completion 2026-12-31 235 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05504213
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 224 participants Est. completion 2025-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05505162
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
Not yet reported AstraZeneca 24 participants Est. completion 2023-01-10 1 siteOther conditions: Healthy Female ParticipantsView official trial listing → -
Active, not recruiting NCT NCT05508906
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Not yet reported Olema Pharmaceuticals, Inc. 190 participants Est. completion 2028-01-31 16 sites Stand-aloneOther conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Breast Cancer, Locally Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05509790
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
Not yet reported Eli Lilly and Company 17 participants Est. completion 2026-12 4 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT05531357
Physiologic Mechanisms Underlying Ovarian Follicular Waves During the Menstrual Cycle
University of Saskatchewan 50 participants Est. completion 2024-03-26 1 siteOther conditions: Reproductive IssuesView official trial listing → -
Withdrawn NCT NCT05538689
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)
Not yet reported University of Chicago Est. completion 2024-10-24 6 sitesOther conditions: Metrorrhagia, Pelvic Pain, Menorrhagia, LeiomyomaView official trial listing → -
Completed NCT NCT05549505
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Not yet reported Arvinas Inc. 152 participants Est. completion 2024-07-25 49 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05551897
A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole
Not yet reported AstraZeneca 14 participants Est. completion 2022-12-28 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Terminated NCT NCT05554354
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2025-04-04 196 sitesOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast CarcinomaView official trial listing → -
Status unknown NCT NCT05556317
Effect of Resistive Exercise on Insomnia in Post Menopausal Women
Not yet reported Cairo University 56 participants Est. completion 2022-11-15 1 siteOther conditions: Sleep Disturbances and InsomniaView official trial listing → -
Terminated NCT NCT05560685
SMART-ER: Symptom Monitoring With Patient-reported Outcomes
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10 participants Est. completion 2025-05-06 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05562518
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
Not yet reported University Hospital, Ghent 31 participants Est. completion 2026-03-02 1 siteOther conditions: Vulvovaginal Atrophy, Breast CancerView official trial listing → -
Completed NCT NCT05564702
An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice
Not yet reported Stochastic Research Technologies LLC 93 participants Est. completion 2023-03-15 1 site Stand-aloneOther conditions: InfertilityView official trial listing → -
Status unknown NCT NCT05569577
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
Not yet reported Fudan University 46 participants Est. completion 2025-12-31 2 sites Stand-aloneOther conditions: Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic HypogonadismView official trial listing → -
Status unknown NCT NCT05574881
Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer
Not yet reported, Not yet reported Fudan University 72 participants Est. completion 2025-01-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05576740
Influence of Menstrual Cycle Stages on Female Athletes
Universitat Jaume I 41 participants Est. completion 2022-07-15 1 siteOther conditions: Menstrual Cycle, SportsView official trial listing → -
Completed NCT NCT05579574
A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2023-06-01 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT05586711
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
Not yet reported Angelica Lindén Hirschberg 170 participants Est. completion 2024-12-15 1 siteOther conditions: Vulvovaginal Atrophy, Genitourinary Syndrome of MenopauseView official trial listing → -
Status unknown NCT NCT05587920
Effect of Oestrogen on Musculoskeletal Outcomes
Army Health Branch, British Army 100 participants Est. completion 2024-06-01 1 siteOther conditions: Contraception, Estrogen Deficiency, Estrogen ExcessView official trial listing → -
Active, not recruiting NCT NCT05596409
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study
Not yet reported Stemline Therapeutics, Inc. 61 participants Est. completion 2027-11 22 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05607004
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Not yet reported Atossa Therapeutics, Inc. 87 participants Est. completion 2027-04 14 sitesOther conditions: Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05607303
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
University of Colorado, Denver 138 participants Est. completion 2027-06-30 1 siteOther conditions: Headache, Gender IdentityView official trial listing → -
Completed NCT NCT05613777
A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 19 participants Est. completion 2023-10-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT05617820
Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy
Not yet reported Teva Pharmaceuticals USA 1050 participants Est. completion 2024-03-15 48 sitesOther conditions: DyspareuniaView official trial listing → -
Terminated NCT NCT05618613
Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Context Therapeutics Inc. 4 participants Est. completion 2023-06-23 3 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05620355
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
Not yet reported Bio Genuine (Shanghai) Biotech Co., Ltd. 312 participants Est. completion 2025-03 29 sitesOther conditions: Uterine Fibroids, Heavy Menstrual BleedingView official trial listing → -
Completed NCT NCT05623397
A Deep Learning Method to Evaluate QT on Ribociclib
CMC Ambroise Paré 70 participants Est. completion 2025-10-08 4 sitesOther conditions: Breast Cancer, RibociclibView official trial listing → -
Active, not recruiting NCT NCT05625087
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
Not yet reported UNICANCER 162 participants Est. completion 2030-06 44 sitesOther conditions: Breast Cancer Stage IVView official trial listing → -
Completed NCT NCT05631795
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2025-06-12 12 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT05640778
Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2025-10-31 1 siteOther conditions: Luminal B/HER2-negative Breast CancerView official trial listing → -
Completed NCT NCT05645393
Effect of Estradiol Topical Products
Not yet reported University of Maryland, Baltimore 4 participants Est. completion 2025-03-30 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT05645406
Estrogen Hormone Products
Not yet reported University of Maryland, Baltimore 8 participants Est. completion 2025-06-15 1 siteOther conditions: MenopauseView official trial listing → -
Status unknown NCT NCT05651087
Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient
Not yet reported Gun Oh Chong 60 participants Est. completion 2023-02-28Other conditions: Hormone Receptor-positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05654532
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
Not yet reported Accutar Biotechnology Inc 100 participants Est. completion 2026-05-31 9 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
Not yet reported Pfizer 624 participants Est. completion 2028-05-15 312 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT05657171
"Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis
Postgraduate Institute of Dental Sciences Rohtak 47 participants Est. completion 2023-12-30 1 siteOther conditions: Periodontal DiseasesView official trial listing → -
Terminated NCT NCT05658874
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
Not yet reported Jocelyn Fitzgerald 26 participants Est. completion 2025-12-30 1 site Stand-aloneOther conditions: Interstitial Cystitis, Levator Spasm, Bladder Pain SyndromeView official trial listing → -
Completed NCT NCT05659563
Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%
Not yet reported MedSIR 92 participants Est. completion 2025-01-30 18 sitesOther conditions: Breast Cancer, Breast Cancer, Early-OnsetView official trial listing → -
Status unknown NCT NCT05660356
Growth Hormone Deficiency in Mild Traumatic Brain Injury
Not yet reported University of Calgary 20 participants Est. completion 2025-02 Stand-aloneOther conditions: Growth Hormone Treatment, Growth Hormone Deficiency, Concussion, Mild, Concussion Post SyndromeView official trial listing → -
Status unknown NCT NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
Not yet reported Maple Leaf Research 45 participants Est. completion 2025-01 1 site Stand-aloneOther conditions: Hiv, TransgenderismView official trial listing → -
Status unknown NCT NCT05673694
To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 70 participants Est. completion 2026-01-02 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05678192
Effect of Menopausal Hormone Therapy on Immune System Parameters
Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 40 participants Est. completion 2023-03-01 1 siteOther conditions: Last Period Not Earlier Than 6 Months AgoView official trial listing → -
Status unknown NCT NCT05683119
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
Not yet reported Western University, Canada 20 participants Est. completion 2024-12 1 siteOther conditions: Menstrual Cycle, Oral ContraceptivesView official trial listing → -
Status unknown NCT NCT05692297
Denosumab Treatment in CKD Patients at High Risk of Fracture
Not yet reported Capital Medical University 102 participants Est. completion 2025-12-31 1 siteChronic kidney disease Other conditions: Fracture, Bone Density, Low, End Stage Renal DiseaseView official trial listing → -
Status unknown NCT NCT05699356
Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases
Sohag University 150 participants Est. completion 2023-03-28 1 siteOther conditions: Poly Cystic Ovary Treatment for InfertilityView official trial listing → -
Completed NCT NCT05700006
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
University of Michigan 94 participants Est. completion 2026-02-26 1 siteOther conditions: Breast Neoplasm Female, Arthralgia, AgingView official trial listing → -
Completed NCT NCT05706753
A Study of Milvexian in Healthy Adult Females
Not yet reported Janssen Pharmaceutica N.V., Belgium 20 participants Est. completion 2023-07-20 1 siteOther conditions: Healthy FemaleView official trial listing → -
Terminated NCT NCT05716139
Natural Cycle vs Programmed Cycle Frozen Embryo Transfer
Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 siteOther conditions: Infertility, Frozen Embryo Transfer, Preeclampsia and EclampsiaView official trial listing → -
Status unknown NCT NCT05716152
Hormonal Associations in Male Patients With Psoriasis Vulgaris
Sohag University 102 participants Est. completion 2024-08-01Other conditions: Psoriasis VulgarisView official trial listing → -
Active, not recruiting NCT NCT05723601
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
Not yet reported Wake Forest University Health Sciences 21 participants Est. completion 2027-01 1 siteOther conditions: Recurrent Urinary Tract InfectionView official trial listing → -
Status unknown NCT NCT05724407
Molecular Signature for Breast Cancer
Assistance Publique - Hôpitaux de Paris 220 participants Est. completion 2023-12Other conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05730647
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
Consorzio Oncotech 600 participants Est. completion 2032-07-31 40 sitesOther conditions: Early Breast CancerView official trial listing → -
Status unknown NCT NCT05734950
Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer
Royal Marsden NHS Foundation Trust 100 participants Est. completion 2023-08-31 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT05737329
Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency
Not yet reported, Not yet reported Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 80 participants Est. completion 2023-04 1 siteOther conditions: Primary Ovarian InsufficiencyView official trial listing → -
Active, not recruiting NCT NCT05739136
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Sumitomo Pharma Switzerland GmbH 530 participants Est. completion 2027-05 1 siteOther conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High RiskView official trial listing → -
Active, not recruiting NCT NCT05741060
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
Not yet reported Akira Sekikawa 369 participants Est. completion 2027-01-30 3 sitesOther conditions: Arterial Stiffness, White Matter Lesions, Cognitive DeclineView official trial listing → -
Completed NCT NCT05753098
Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility
Not yet reported Beni-Suef University 148 participants Est. completion 2023-01-31 1 site Stand-aloneOther conditions: Subfertility, FemaleView official trial listing → -
Completed NCT NCT05759949
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Not yet reported Relay Therapeutics, Inc. 41 participants Est. completion 2025-04-11 7 sitesOther conditions: PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Solid Tumor, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT05762042
Comparison of the Efficacy and Tolerability of Femal Versus Placebo
Not yet reported Azienda Ospedaliera Ordine Mauriziano di Torino 34 participants Est. completion 2022-04-01 2 sitesOther conditions: Breast Cancer, MenopauseView official trial listing → -
Status unknown NCT NCT05769712
A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity
Guangdong Second Provincial General Hospital 361 participants Est. completion 2023-11-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT05774405
Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients
Not yet reported Istanbul University - Cerrahpasa 9169 participants Est. completion 2021-07-31 1 siteOther conditions: COVID-19, Hormone Replacement TherapyView official trial listing → -
Status unknown NCT NCT05780489
Evaluation of Salivary ELISA for Hormone Monitoring in Donors
Not yet reported Instituto Valenciano de Infertilidad, IVI VALENCIA 200 participants Est. completion 2024-12 2 sitesOther conditions: Infertility, Female, Reproductive SterilityView official trial listing → -
Completed NCT NCT05781685
The Influence of Testosterone on Experimental Pain Perception
Not yet reported University of New Mexico 20 participants Est. completion 2018-07-17 1 siteOther conditions: Acute PainView official trial listing → -
Completed NCT NCT05782725
Subclinical Hypothyroidism and Normogonadotropic Anovulation
Jagiellonian University 300 participants Est. completion 2024-01-10 1 siteOther conditions: Polycystic Ovary Syndrome, Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)View official trial listing → -
Completed NCT NCT05783479
Pharmacological Preparation of the Cervix for Hysteroscopy
Not yet reported Jagiellonian University 96 participants Est. completion 2023-01-31 1 siteOther conditions: Uterine Polyp, Uterine Bleeding, Endometrium; SenilityView official trial listing → -
Status unknown NCT NCT05788952
The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometriosis
Universidade Nova de Lisboa 60 participants Est. completion 2024-12-01 1 siteOther conditions: EndometriosisView official trial listing → -
Status unknown NCT NCT05792410
A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Not yet reported, Not yet reported Jiangsu HengRui Medicine Co., Ltd. 300 participants Est. completion 2025-02-27Other conditions: HER2 Low Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05797987
Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor
Fudan University 52 participants Est. completion 2023-08-01 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05800197
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 siteOther conditions: Breast Cancer, Neoadjuvant Endocrine TherapyView official trial listing → -
Status unknown NCT NCT05801705
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700 participants Est. completion 2023-12-30 1 siteOther conditions: Hormone-receptor-positive Breast Cancer, Premenopausal Breast Cancer, Breast Cancer Patients at Intermediate to High Risk, Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenView official trial listing → -
Status unknown NCT NCT05802277
Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.
Not yet reported EZUS-LYON 1 130 participants Est. completion 2024-04-01 1 siteOther conditions: Menstrual Cycle, Oral Contraceptive UseView official trial listing → -
Terminated NCT NCT05802303
Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation
Not yet reported Indira IVF Hospital Pvt Ltd 172 participants Est. completion 2024-03-26 1 siteOther conditions: Frozen Embryo Transfer, Infertility, FemaleView official trial listing → -
Status unknown NCT NCT05806671
Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy
Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05826964
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
Not yet reported University of Miami 24 participants Est. completion 2029-07-31 1 site Stand-aloneOther conditions: Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05835089
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Sohag University 50 participants Est. completion 2024-05 1 siteChronic kidney diseaseView official trial listing → -
Status unknown NCT NCT05863975
Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
Not yet reported Qianfoshan Hospital 150 participants Est. completion 2025-12-31Other conditions: HPV InfectionView official trial listing → -
Completed NCT NCT05865262
Protocol TRANS and QT Repolarization
University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 siteOther conditions: Transgender Individuals, QTc IntervalView official trial listing → -
Active, not recruiting NCT NCT05870579
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2032-05-27 13 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05872425
Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS
Not yet reported Guangdong Women and Children Hospital 120 participants Est. completion 2024-04-01 1 siteOther conditions: PCOSView official trial listing → -
Completed NCT NCT05877235
Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:
Not yet reported InCor Heart Institute 60 participants Est. completion 2024-06-23 1 siteCardiovascular disease Other conditions: MenopauseView official trial listing → -
Status unknown NCT NCT05880394
Study of Dotatate Imaging in Breast Cancer
Not yet reported Hoag Memorial Hospital Presbyterian 30 participants Est. completion 2024-07-31 1 siteOther conditions: Breast Cancer Stage IVView official trial listing → -
Status unknown NCT NCT05890287
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 siteOther conditions: HR Positive HER2 Negative Advanced Breast CancerView official trial listing → -
Completed NCT NCT05891262
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 15 participants Est. completion 2023-08-25 1 siteOther conditions: Healthy Female VolunteersView official trial listing → -
Completed NCT NCT05894954
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Not yet reported Alzheimer's Prevention and Reversal Project, Inc. 73 participants Est. completion 2026-02-09 6 sitesOther conditions: Mild Cognitive Impairment, Dementia, MildView official trial listing → -
Completed NCT NCT05896384
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 32 participants Est. completion 2025-03-26 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05903716
The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
Marmara University 40 participants Est. completion 2023-06-30 1 siteOther conditions: Acne VulgarisView official trial listing → -
Completed NCT NCT05903820
Rhythmic Estradiol and Bone Health
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48 participants Est. completion 2024-10-28 1 siteOther conditions: Osteoporosis Risk, MenopauseView official trial listing → -
Withdrawn NCT NCT05905341
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.
Not yet reported Pfizer Est. completion 2028-04-13Obstructive sleep apnea Other conditions: Breast Cancer, Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), Endometrial, Solid TumorsView official trial listing → -
Active, not recruiting NCT NCT05909397
Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
Not yet reported Pfizer 59 participants Est. completion 2026-12-30 29 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05914792
Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery
University of Pittsburgh 49 participants Est. completion 2026-07-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05928650
Comparison of Menstrual Function Among Sprinters, Long Marathon Runners, and Non-Athletic Females
Cairo University 42 participants Est. completion 2023-07-31 1 siteOther conditions: Menstruation DisturbancesView official trial listing → -
Terminated NCT NCT05932667
Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Not yet reported Institut Curie 1 participants Est. completion 2023-11-30 6 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05932771
Resistance Exercise and Hydrolyzed Collagen Supplementation
Not yet reported Rob Erskine 21 participants Est. completion 2023-04-30 1 site Stand-aloneOther conditions: Diet, Food, and NutritionView official trial listing → -
Terminated NCT NCT05934942
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 29 participants Est. completion 2024-02-08 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05951413
The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles
Not yet reported, Not yet reported Beni-Suef University 110 participants Est. completion 2023-09-30 1 siteOther conditions: IVFView official trial listing → -
Active, not recruiting NCT NCT05952557
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Not yet reported AstraZeneca 5511 participants Est. completion 2037-05-06 661 sitesOther conditions: Breast Cancer, Early Breast CancerView official trial listing → -
Completed NCT NCT05963984
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
Not yet reported Carrick Therapeutics Limited 60 participants Est. completion 2025-08-28 32 sitesOther conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast CancerView official trial listing → -
Suspended NCT NCT05980091
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
Not yet reported ART Fertility Clinics LLC 316 participants Est. completion 2026-12-30 2 sitesOther conditions: Infertility, Fertility Issues, Infertility, FemaleView official trial listing → -
Status unknown NCT NCT05982470
Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI
Not yet reported Beijing Tiantan Hospital 328 participants Est. completion 2025-10-01 1 siteOther conditions: Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment, White Matter HyperintensityView official trial listing → -
Completed NCT NCT05985590
A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants
Not yet reported Bristol-Myers Squibb 37 participants Est. completion 2023-12-11 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Not yet recruiting NCT NCT05986071
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers
Not yet reported, Not yet reported Institut Paoli-Calmettes 57 participants Est. completion 2027-10-15 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05994599
Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring
Not yet reported Evestra Inc. 36 participants Est. completion 2023-12-11 1 siteOther conditions: Healthy Women, Female, ContraceptionView official trial listing → -
Active, not recruiting NCT NCT06001762
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sites Stand-aloneOther conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast CarcinomaView official trial listing → -
Terminated NCT NCT06005610
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 93 participants Est. completion 2025-08-21 18 sitesOther conditions: HIV I InfectionView official trial listing → -
Status unknown NCT NCT06014398
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
Not yet reported Royal College of Surgeons, Ireland 50 participants Est. completion 2025-09-01 2 sitesOther conditions: Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain TumorView official trial listing → -
Active, not recruiting NCT NCT06016738
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Not yet reported Olema Pharmaceuticals, Inc. 510 participants Est. completion 2028-02-29 233 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast CarcinomaView official trial listing → -
Status unknown NCT NCT06026553
Assessing Ketorolac (Toradol) at Oocyte Retrieval
Not yet reported Shady Grove Fertility Reproductive Science Center 400 participants Est. completion 2025-01 2 sitesOther conditions: Infertility, Infertility, Female, Oocyte Retrieval, Postoperative Pain, Embryo TransferView official trial listing → -
Status unknown NCT NCT06031493
A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)
Not yet reported Hospital Clinic of Barcelona 122 participants Est. completion 2025-04 2 sitesOther conditions: Cervical Cancer, Sexual Dysfunction, Quality of LifeView official trial listing → -
Completed NCT NCT06039826
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Not yet reported Eli Lilly and Company 46 participants Est. completion 2024-07-11 2 sitesOther conditions: OverweightView official trial listing → -
Active, not recruiting NCT NCT06043310
Estrogen and Microvascular Function
Medical College of Wisconsin 45 participants Est. completion 2031-12 1 siteCardiovascular disease Other conditions: Estrogen, Microvasculature, Oral Contraceptive UseView official trial listing → -
Completed NCT NCT06047184
Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
Not yet reported BeBetter Med Inc 100 participants Est. completion 2024-01-30 2 sitesOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06053827
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Clinique Ovo 1207 participants Est. completion 2024-07-18 1 siteOther conditions: Fertility DisordersView official trial listing → -
Completed NCT NCT06057896
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Lo.Li.Pharma s.r.l 200 participants Est. completion 2023-08-15 1 siteMetabolic syndrome Other conditions: Menopause, Climacteric SyndromeView official trial listing → -
Withdrawn NCT NCT06058728
A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie Est. completion 2026-08 1 siteOther conditions: Uterine Fibroids (UF)View official trial listing → -
Active, not recruiting NCT NCT06065748
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sitesOther conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT06067217
Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users
Not yet reported Department of Medical Services Ministry of Public Health of Thailand 52 participants Est. completion 2024-08-30 2 sitesOther conditions: Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen, Depot Medroxyprogesterone AcetateView official trial listing → -
Status unknown NCT NCT06067256
A Multicentre, Prospective, Open-label, Non-comparative Study
Not yet reported Italfarmaco 228 participants Est. completion 2024-06 1 siteOther conditions: ContraceptionView official trial listing → -
Completed NCT NCT06071442
Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine
Not yet reported Alexion Pharmaceuticals, Inc. 60 participants Est. completion 2024-04-12 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Terminated NCT NCT06074055
PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer
Not yet reported Reproductive Medicine Associates of New Jersey 9 participants Est. completion 2024-10-21 2 sitesOther conditions: Infertility, FemaleView official trial listing → -
Completed NCT NCT06074757
Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study
Not yet reported Kashiv BioSciences, LLC 48 participants Est. completion 2023-10-01 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT06083935
Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
Not yet reported Ain Shams University 120 participants Est. completion 2024-12-01Other conditions: Poly Cystic Ovary SyndromeView official trial listing → -
Completed NCT NCT06086340
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer 779 participants Est. completion 2024-01-24 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06105632
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Not yet reported Pfizer 333 participants Est. completion 2028-01-21 48 sitesOther conditions: Advanced or Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT06109623
Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women
RenJi Hospital 1226 participants Est. completion 2023-12-01Other conditions: Urinary Incontinence,StressView official trial listing → -
Active, not recruiting NCT NCT06110793
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 56 participants Est. completion 2027-11 7 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06115577
Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes
Pirogov Russian National Research Medical University 92 participants Est. completion 2022-08-01Other conditions: Endometrial Hyperplasia Without Atypia, Endometrial Hyperplasia With Atypia, Endometrial Cancer, Peripheral Blood Mononuclear Cells, Postmenopause, Estrogen Receptor, Progesterone ReceptorView official trial listing → -
Completed NCT NCT06116201
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
Not yet reported Chulalongkorn University 60 participants Est. completion 2021-07-31 1 siteOther conditions: Transgender WomenView official trial listing → -
Completed NCT NCT06132620
Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons
Not yet reported Yun Chen 60 participants Est. completion 2018-06-30 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT06136208
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women
Not yet reported Science Valley Research Institute 20 participants Est. completion 2025-07-30 1 siteOther conditions: Climacteric Syndrome, Menopause, HypoestrogenismView official trial listing → -
Completed NCT NCT06148129
Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients
Not yet reported Zagazig University 96 participants Est. completion 2022-03-01 1 siteOther conditions: Endometrial CancerView official trial listing → -
Status unknown NCT NCT06172322
A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 42 participants Est. completion 2025-07 1 siteOther conditions: HR Positive/HER-2 Negative Breast CancerView official trial listing → -
Status unknown NCT NCT06181305
Endometrial Preparation in Frozen Embryo Transfer Cycles
Not yet reported Rahem Fertility Center 210 participants Est. completion 2024-12-25 1 site Stand-aloneOther conditions: IVFView official trial listing → -
Completed NCT NCT06188026
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.
Not yet reported Novo Nordisk A/S 34 participants Est. completion 2024-12-30 1 siteOther conditions: Healthy Volunteers (Non-alcoholic Steatohepatitis)View official trial listing → -
Terminated NCT NCT06191289
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
Not yet reported University of Illinois at Chicago 11 participants Est. completion 2024-12-01 1 siteOther conditions: SuicideView official trial listing → -
Status unknown NCT NCT06195202
Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)
Sun Yat-sen University 2000 participants Est. completion 2026-08-31 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT06195280
SUPerficial ENDometriosis In Magnetic Resonance Imaging
Not yet reported GCS Ramsay Santé pour l'Enseignement et la Recherche Est. completion 2026-03 1 site Stand-aloneOther conditions: EndometriosisView official trial listing → -
Status unknown NCT NCT06204016
Estradiol and Stress Reactivity in Women
International Research Training Group 2804 74 participants Est. completion 2025-12 1 siteOther conditions: Stress vs. Control, Estradiol vs. PlaceboView official trial listing → -
Status unknown NCT NCT06214442
Effects of the Menstrual Cycle on Triceps Surae Properties in Women
Marco Aurélio Vaz, PhD 40 participants Est. completion 2024-12-31 1 siteOther conditions: Menstrual Cycle, Achilles TendonView official trial listing → -
Status unknown NCT NCT06220266
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
Not yet reported, Not yet reported Dhurakij Pundit University 10 participants Est. completion 2024-11 1 siteOther conditions: Dyslipidemias, Hypertriglyceridemia, Hypercholesterolemia, Hyper-LDL-cholesterolemia, Hypo HDL Cholesterolaemia, Postmenopausal SymptomsView official trial listing → -
Status unknown NCT NCT06233058
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®
Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-27Other conditions: Healthy SubjectsView official trial listing → -
Status unknown NCT NCT06233071
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®
Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-02 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT06236659
Acute Resistance Exercise and Hydrolyzed Collagen Supplementation
Not yet reported Rob Erskine 10 participants Est. completion 2023-09-30 1 siteOther conditions: Diet, Food, NutritionView official trial listing → -
Active, not recruiting NCT NCT06239467
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Not yet reported OnKure, Inc. 200 participants Est. completion 2027-08-01 33 sitesOther conditions: Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene MutationView official trial listing → -
Status unknown NCT NCT06243432
Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600 participants Est. completion 2025-03-01 1 siteOther conditions: Advanced Breast CarcinomaView official trial listing → -
Active, not recruiting NCT NCT06247995
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
Not yet reported, Not yet reported Novartis Pharmaceuticals 20 participants Est. completion 2027-04-14 23 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06250205
Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib
Not yet reported NewAmsterdam Pharma 30 participants Est. completion 2024-04-26 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT06253195
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported BeOne Medicines 33 participants Est. completion 2026-04-23 7 sitesOther conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Hormone-receptor-positive Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, HER2-negative Breast CancerView official trial listing → -
Completed NCT NCT06253702
Brain Blood Flow Responses to Stress: Sex Differences
Not yet reported University of Wisconsin, Madison 22 participants Est. completion 2025-05-31 1 siteOther conditions: Cerebrovascular DisordersView official trial listing → -
Active, not recruiting NCT NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Not yet reported BeiGene 103 participants Est. completion 2026-08-31 24 sitesOther conditions: Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer, Hormone-receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, Prostate Cancer, TNBC - Triple-Negative Breast Cancer, GastroEsophageal Cancer, Bladder CancerView official trial listing → -
Not yet recruiting NCT NCT06271551
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy
Not yet reported Central Finland Hospital District 310 participants Est. completion 2029-12 Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Withdrawn NCT NCT06279195
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Not yet reported Endeavor Health Est. completion 2025-11-02 1 siteOther conditions: Pelvic PainView official trial listing → -
Not yet recruiting NCT NCT06306404
Sleeping Through Menopause
Not yet reported VU University of Amsterdam 222 participants Est. completion 2030-01-01 Stand-aloneOther conditions: Menopause, InsomniaView official trial listing → -
Completed NCT NCT06308614
Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
Not yet reported Estetra 82 participants Est. completion 2025-04-21 24 sitesOther conditions: Sexual Dysfunction, PhysiologicalView official trial listing → -
Completed NCT NCT06310616
A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants
Not yet reported ViiV Healthcare 26 participants Est. completion 2024-08-15 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT06312033
Estradiol's Effect on Brain Volume and Connectivity
Not yet reported International Research Training Group 2804 32 participants Est. completion 2021-12-31 1 site Stand-aloneOther conditions: Emotion Regulation, EstradiolView official trial listing → -
Completed NCT NCT06316180
The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation
Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sitesOther conditions: Endometrial Polyp, Endometrial DiseasesView official trial listing → -
Completed NCT NCT06316206
The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sitesOther conditions: Endometrial Polyp, Endometrial DiseasesView official trial listing → -
Completed NCT NCT06316219
The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation
Not yet reported University of Palermo 80 participants Est. completion 2024-03-01 2 sitesOther conditions: Endometrial Polyp, Endometrial DiseasesView official trial listing → -
Not yet recruiting NCT NCT06318403
Estradiol Supplementation and Rotator Cuff Repair
Not yet reported University of Utah 58 participants Est. completion 2030-12 Stand-aloneOther conditions: Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome, Menopause Related Conditions, MenopauseView official trial listing → -
Completed NCT NCT06324851
The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Not yet reported University of Palermo 150 participants Est. completion 2024-03-01 2 sitesOther conditions: Endometrial Polyp, Endometrial DiseasesView official trial listing → -
Status unknown NCT NCT06341283
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
The Affiliated Hospital of Qingdao University 200 participants Est. completion 2025-07-01 1 siteOther conditions: Breast Cancer, Neoplasms, Breast DiseasesView official trial listing → -
Completed NCT NCT06344767
Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor
Fudan University 19 participants Est. completion 2024-05-05 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06346457
Breast Cancer & Antiestrogenic Therapy & Brain
International Research Training Group 2804 180 participants Est. completion 2026-04-01 1 siteOther conditions: Breast Cancer Female, Healthy Female, Menopause, Anti-estrogenic TherapyView official trial listing → -
Active, not recruiting NCT NCT06353269
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
Not yet reported University of California, Irvine 111 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: Recurrent Urinary Tract Infection, HypoestrogenismView official trial listing → -
Completed NCT NCT06354257
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Not yet reported GlaxoSmithKline 20 participants Est. completion 2024-07-01 1 siteOther conditions: TuberculosisView official trial listing → -
Status unknown NCT NCT06358014
Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Not yet reported Xiao Wang 40 participants Est. completion 2024-12-30 1 site Stand-aloneOther conditions: Postmenopausal Depression, EstrogenView official trial listing → -
Completed NCT NCT06363812
Probability of OncotypeDx to Reallocate As Low or High Risk of Recurrence Breast Cancer Patients with Uncertain Biology
Fondazione Sandro Pitigliani 258 participants Est. completion 2024-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06369363
Estrogen Deficiency on Cardiovascular Risk
Not yet reported Milton S. Hershey Medical Center 20 participants Est. completion 2028-11Cardiovascular disease Other conditions: Postmenopausal SymptomsView official trial listing → -
Status unknown NCT NCT06370221
The Effect of Psoriatic Arthritis on Female Sexual Dysfunction
Egymedicalpedia 180 participants Est. completion 2024-12-30 1 siteOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT06375707
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 74 participants Est. completion 2026-05-30 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06380205
A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
Not yet reported Incyte Corporation 24 participants Est. completion 2024-06-07 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06396208
"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Not yet reported Chulalongkorn University 40 participants Est. completion 2024-10-20 1 site Stand-aloneOther conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal ProfileView official trial listing → -
Completed NCT NCT06396221
"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Not yet reported Chulalongkorn University 36 participants Est. completion 2024-09-30 1 siteOther conditions: Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal ProfileView official trial listing → -
Status unknown NCT NCT06405243
Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients
Not yet reported Beni-Suef University 100 participants Est. completion 2024-12-31 2 sites Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT06408168
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2025-12-08 1 siteOther conditions: Hormone Receptor-positive Human Epidermal Growth Factor 2-negative, Metastatic Invasive LObular CarcinomaView official trial listing → -
Terminated NCT NCT06419855
Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair
Top Health S.A.P.I DE C.V. 2 participants Est. completion 2025-02-18 4 sitesOther conditions: Cerebrospinal Fluid LeakageView official trial listing → -
Completed NCT NCT06425978
Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit
Not yet reported Fundación Santiago Dexeus Font 192 participants Est. completion 2026-03-23 1 siteOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Completed NCT NCT06426771
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital 90 participants Est. completion 2024-11-10 1 siteOther conditions: AMH, Diet Habit, Ovarian Failure, Polycystic Ovary SyndromeView official trial listing → -
Active, not recruiting NCT NCT06428396
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06440967
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sitesOther conditions: Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT06447623
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
Not yet reported Fudan University 184 participants Est. completion 2029-02-01 1 siteOther conditions: Advanced Breast Cancer, HR+/HER2- Breast CancerView official trial listing → -
Status unknown NCT NCT06454084
Investigation of Endothelium-dependent Vasodilation in Human Gingiva
Not yet reported Semmelweis University 80 participants Est. completion 2025-12-31 1 siteOther conditions: Vasodilation, Oral Soft Tissue ConditionsView official trial listing → -
Completed NCT NCT06461039
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
Not yet reported Novo Nordisk A/S 43 participants Est. completion 2025-04-04 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT06467942
Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection
Not yet reported Peking University People's Hospital 240 participants Est. completion 2024-12-31 1 siteOther conditions: Human Papilloma Virus InfectionView official trial listing → -
Status unknown NCT NCT06474988
Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients
European Institute of Oncology 150 participants Est. completion 2025-05-31 1 siteOther conditions: Breast Cancer, Estrogen Receptor Positive TumorView official trial listing → -
Not yet recruiting NCT NCT06480682
Relative Energy Deficiency in Sport and Dance
University of Wolverhampton 200 participants Est. completion 2029-07-30 1 siteOther conditions: Relative Energy Deficiency in Sport, Bone Stress ReactionView official trial listing → -
Active, not recruiting NCT NCT06494150
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 siteOther conditions: Low Grade Ovarian Serous AdenocarcinomaView official trial listing → -
Active, not recruiting NCT NCT06495164
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Pfizer 1 participants Est. completion 2026-12-30 1 siteOther conditions: Breast Cancer, Malignant Neoplasm of BreastView official trial listing → -
Active, not recruiting NCT NCT06497270
A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3 participants Est. completion 2027-06-01 1 siteOther conditions: BRCA Mutation, Estrogen Deficiency, Surgical Menopause, Menopause Related Conditions, Menopause, Premature, Ovarian CancerView official trial listing → -
Completed NCT NCT06504953
Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy
Not yet reported Centre Hospitalier Universitaire de Nice 72 participants Est. completion 2026-06-17 1 site Stand-aloneOther conditions: Women, Tibial Translation, HormoneView official trial listing → -
Active, not recruiting NCT NCT06506955
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Not yet reported, Not yet reported Taiho Oncology, Inc. 15 participants Est. completion 2027-04-30 9 sitesOther conditions: Advanced/Metastatic CancerView official trial listing → -
Completed NCT NCT06508944
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women
Not yet reported Mahidol University 86 participants Est. completion 2024-10-31 1 siteOther conditions: Lower Urinary Tract Symptoms, Female Genitourinary Disease, Urinary Stress Incontinence, Urinary Urge Incontinence, Nocturia, Quality of Life, Voiding Disorders, Vagina Atrophy, Urethral Atrophy, Overactive Bladder, Overactive Bladder Syndrome, Bladder, OveractiveView official trial listing → -
Completed NCT NCT06525675
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
MedSIR 419 participants Est. completion 2024-09-02 36 sitesOther conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Luminal Breast Cancer, HER2-negative Breast Cancer, ER-positive Breast CancerView official trial listing → -
Status unknown NCT NCT06531668
A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women
Not yet reported Scale Media Inc 50 participants Est. completion 2024-09-07 1 siteOther conditions: Hormone RegulationView official trial listing → -
Status unknown NCT NCT06546397
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Not yet reported Women's Hospital School Of Medicine Zhejiang University 200 participants Est. completion 2025-12-31 1 siteOther conditions: Pregnancy ComplicationsView official trial listing → -
Completed NCT NCT06547164
A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants
Not yet reported AstraZeneca 40 participants Est. completion 2025-08-20 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Status unknown NCT NCT06561022
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
Not yet reported Fudan University 260 participants Est. completion 2026-06-30 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06577181
Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer
Assiut University 50 participants Est. completion 2026-05-10 1 siteOther conditions: IVFView official trial listing → -
Status unknown NCT NCT06577974
Role of Medical Treatment in Endometriosis Patients Undergoing ICSI
Not yet reported Cairo University 129 participants Est. completion 2025-03-01 2 sitesOther conditions: EndometriosisView official trial listing → -
Active, not recruiting NCT NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Not yet reported Circle Pharma 220 participants Est. completion 2027-03-14 10 sitesOther conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer, Lung Cancer, Triple Negative Breast Cancer, Breast Neoplasms, Neuroendocrine Tumors, Neuroendocrine Carcinoma, RB1 Gene MutationView official trial listing → -
Status unknown NCT NCT06580535
Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas
Assiut University 100 participants Est. completion 2025-12Other conditions: Bipolar DisorderView official trial listing → -
Active, not recruiting NCT NCT06590857
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Not yet reported, Not yet reported RayzeBio, Inc. 16 participants Est. completion 2033-11 31 sitesOther conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast CancerView official trial listing → -
Completed NCT NCT06608186
Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!
Not yet reported, Not yet reported Ahmed Saad 50 participants Est. completion 2025-01-19 1 siteOther conditions: PCOS (Polycystic Ovary Syndrome)View official trial listing → -
Withdrawn NCT NCT06613516
Effect of Capivasertib on ctDNA in ER Positive Breast Cancer
Not yet reported Imperial College London Est. completion 2025-09-16 1 siteOther conditions: Breast Cancer, Oestrogen Receptor Positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06623903
Early Changes in Metabolic Health in Breast Cancer Patients Initiating Endocrine Therapy
Aarhus University Hospital 112 participants Est. completion 2025-07-31 1 siteOther conditions: Early Breast Cancer, Metabolic Health, Estrogen Receptor Positive Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT06629233
Evaluation of a Novel Technique for the Discovery of New, Tumor-specific Targets for the Deployment of Innovative Immunotherapeutics Against Cancer.
Not yet reported University Ghent 36 participants Est. completion 2025-12-31 2 sitesOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT06633705
Changes in Neighbouring Microbiota in Genitourinary Syndrome
Not yet reported Koc University Hospital 31 participants Est. completion 2024-07-10 1 siteOther conditions: Genitourinary Syndrome of MenopauseView official trial listing → -
Active, not recruiting NCT NCT06635447
Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
Not yet reported AstraZeneca 293 participants Est. completion 2027-01-10 76 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06637189
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Not yet reported Ginefiv 144 participants Est. completion 2025-12-31 Stand-aloneOther conditions: Stimulation in the Ovary, Embryo, Oocyte, Oocyte Retrieval, Fertilization in Vitro, Blastocyst, PGT-AView official trial listing → -
Completed NCT NCT06654570
Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial
Not yet reported Helsinki University Central Hospital 20 participants Est. completion 2024-10-10 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06657105
A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential
Not yet reported AstraZeneca 22 participants Est. completion 2025-02-03 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT06671405
An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions
Not yet reported AstraZeneca 59 participants Est. completion 2025-02-17 1 siteOther conditions: DyslipidaemiaView official trial listing → -
Active, not recruiting NCT NCT06680921
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06691035
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 18 participants Est. completion 2027-11 1 site Stand-aloneOther conditions: Breast Cancer Metastatic Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT06691815
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
Not yet reported Hospital de Niños R. Gutierrez de Buenos Aires 48 participants Est. completion 2026-09 1 siteOther conditions: Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)View official trial listing → -
Completed NCT NCT06695039
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer
Not yet reported Asan Medical Center 71 participants Est. completion 2025-10-02 1 siteOther conditions: Breast Cancer InvasiveView official trial listing → -
Active, not recruiting NCT NCT06702618
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2026-12 13 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06706414
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
Not yet reported, Not yet reported Martin Blomberg Jensen 16 participants Est. completion 2026-08 1 siteOther conditions: Infertility, MaleView official trial listing → -
Active, not recruiting NCT NCT06715514
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
Not yet reported Lia Bally 96 participants Est. completion 2026-12-31 1 siteType 2 diabetes Other conditions: MenopauseView official trial listing → -
Active, not recruiting NCT NCT06760637
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Not yet reported Pfizer 1035 participants Est. completion 2037-12-29 463 sitesOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT06764186
A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain
Not yet reported AstraZeneca 101 participants Est. completion 2027-12-31 17 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06773429
Estradiol and Brain Age
International Research Training Group 2804 32 participants Est. completion 2019-07-31 1 siteOther conditions: Estradiol (E2) Vs. Placebo (PLAC), EstradiolView official trial listing → -
Completed NCT NCT06778733
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
Not yet reported University of Athens 22 participants Est. completion 2024-04-30 2 sitesOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT06783192
A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)
Not yet reported Merck Sharp & Dohme LLC 14 participants Est. completion 2023-10-11 1 siteOther conditions: Human Immunodeficiency Virus (HIV), HIV Pre-Exposure ProphylaxisView official trial listing → -
Completed NCT NCT06799884
A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives
Not yet reported Idorsia Pharmaceuticals Ltd. 19 participants Est. completion 2025-02-21 1 siteOther conditions: Drug Drug InteractionView official trial listing → -
Completed NCT NCT06800690
Impact of Menstrual Phase on Oral Glucose Sensitivity
Rutgers, The State University of New Jersey 22 participants Est. completion 2024-12-10 1 siteOther conditions: Ovulation, MenstruationView official trial listing → -
Completed NCT NCT06802211
CBG Normalization After Discontinuation of COC's
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2025-11-18 1 siteOther conditions: Combined Oral Contraceptive CessationView official trial listing → -
Active, not recruiting NCT NCT06805084
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80 participants Est. completion 2031-12 1 siteOther conditions: Breast Adenocarcinoma, Luminal B Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06806072
BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY
Not yet reported Parc de Salut Mar 96 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Not yet recruiting NCT NCT06808347
Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women
Not yet reported Walter Reed National Military Medical Center 110 participants Est. completion 2025-09-30Other conditions: Postmenopausal Atrophic Vaginitis, Genitourinary Syndrome of MenopauseView official trial listing → -
Withdrawn NCT NCT06810765
Trifecta Research Study
Not yet reported Johns Hopkins University Est. completion 2027-12 1 site Stand-aloneOther conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Trauma, Brain InjuriesView official trial listing → -
Completed NCT NCT06816355
Exogenous Sex Hormones and PONV
Riverside University Health System Medical Center 7348 participants Est. completion 2025-02-04 1 siteOther conditions: Postoperative Nausea and Vomiting, Sex Hormone, TransgenderView official trial listing → -
Completed NCT NCT06820307
Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants
Not yet reported Vertex Pharmaceuticals Incorporated 50 participants Est. completion 2025-04-29 1 siteOther conditions: PainView official trial listing → -
Completed NCT NCT06830486
Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)
University of Colorado, Denver 40 participants Est. completion 2023-10-31 1 siteOther conditions: Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT06847386
Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF
Not yet reported Shanghai First Maternity and Infant Hospital 200 participants Est. completion 2025-06-30 1 site Stand-aloneOther conditions: Recurrent Implantation Failure, T-Shaped UterusView official trial listing → -
Terminated NCT NCT06851442
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8 participants Est. completion 2025-11-20 17 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06879002
Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
ART Fertility Clinics LLC 252 participants Est. completion 2027-12-30 2 sitesOther conditions: Stimulation in the Ovary, IVF OutcomeView official trial listing → -
Not yet recruiting NCT NCT06882499
Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
Not yet reported Peter MacCallum Cancer Centre, Australia 74 participants Est. completion 2032-11-01Other conditions: Breast Cancer, Metastatic, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06908941
The Cardiovascular Benefits of Resistance Training and Dark Chocolate in Female Adults
Not yet reported National Cheng Kung University 31 participants Est. completion 2024-07-31 1 siteOther conditions: Vascular Function in Healthy VolunteersView official trial listing → -
Not yet recruiting NCT NCT06913075
FET in Adenomyosis
Not yet reported Indira IVF Hospital Pvt Ltd 700 participants Est. completion 2026-12-23 1 siteOther conditions: AdenomyosisView official trial listing → -
Completed NCT NCT06924229
Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment
Not yet reported Sohag University 40 participants Est. completion 2025-01-01 1 siteOther conditions: Braest Cancer, Dry EyeView official trial listing → -
Not yet recruiting NCT NCT06929325
Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 312 participants Est. completion 2027-12 1 siteOther conditions: HR+/HER2- Advanced/Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06929416
Estrogen and Propofol Injection Pain
Konya City Hospital 90 participants Est. completion 2025-09-10 1 siteOther conditions: Pain, Estradiol, Assisted Reproductive TechniquesView official trial listing → -
Withdrawn NCT NCT06938711
A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Context Therapeutics Inc. Est. completion 2023-12 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06941142
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 382 participants Est. completion 2028-06Other conditions: Advanced Breast CancerView official trial listing → -
Completed NCT NCT06942936
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
Not yet reported AstraZeneca 51 participants Est. completion 2026-01-28 2 sitesOther conditions: Healthy ParticipantsView official trial listing → -
Active, not recruiting NCT NCT06957379
Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78 participants Est. completion 2025-12 1 siteOther conditions: HR+/HER2- Advanced/Metastatic Breast CancerView official trial listing → -
Completed NCT NCT06958965
Resistance Exercise Training on Vascular and Physical Function in Postmenopausal Women
Not yet reported National Yang Ming Chiao Tung University 32 participants Est. completion 2025-11-03 1 siteOther conditions: Postmenopausal WomenView official trial listing → -
Active, not recruiting NCT NCT06963840
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
Not yet reported Wellizen Australia 16 participants Est. completion 2025-08 1 siteOther conditions: Polycystic Ovarian Syndrome (PCOS)View official trial listing → -
Withdrawn NCT NCT06978478
An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6
Not yet reported Queen Mary University of London Est. completion 2020-07-27 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06996093
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
Not yet reported Fudan University 2508 participants Est. completion 2034-06-01 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07003373
Comparison of Two Protocols in Frozen Embryo Transfer
Not yet reported Malihe Mahmoudinia 112 participants Est. completion 2026-07-05 Stand-aloneOther conditions: IVF OutcomesView official trial listing → -
Completed NCT NCT07007416
Impact of Supraphysiological Estradiol on ECG in IVF Patients
Konya City Hospital 62 participants Est. completion 2025-01-31 1 siteOther conditions: In Vitro Fertilization, Estradiol, Cardiac Electrophysiology, Electrocardiography (ECG), Reproductive EndocrinologyView official trial listing → -
Not yet recruiting NCT NCT07020429
Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency
Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 276 participants Est. completion 2030-07-30 1 site Stand-aloneOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Not yet recruiting NCT NCT07021664
Health, Imaging, and Cognition Across the Menopausal Transition
Université de Sherbrooke 45 participants Est. completion 2026-07-01 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT07027332
Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
Bezmialem Vakif University 36 participants Est. completion 2025-03-08 1 siteOther conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver DiseaseView official trial listing → -
Withdrawn NCT NCT07038070
Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study
Not yet reported NYU Langone Health Est. completion 2026-05-01 1 site Stand-aloneOther conditions: Genitourinary Syndrome of Menopause (GSM)View official trial listing → -
Active, not recruiting NCT NCT07038369
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Not yet reported Atavistik Bio, Inc 134 participants Est. completion 2029-01-31 8 sitesOther conditions: Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Neoplasms, ER Positive Breast Cancer, Cervical Cancers, Cervical Neoplasms, Cervical Carcinoma, Triple Negative Breast Cancer, Gynecologic Cancers, Gynecologic Neoplasm, Endometrial Cancer, Endometrial Neoplasm, Endometrial Carcinoma (EC), Fallopian Cancer, Ovarian Carcinoma, Ovarian Cancer, Ovarian Neoplasms, Prostate Cancers, Prostate Carcinoma, Solid Tumors, Neoplasms, Neoplasms by Site, Breast Diseases, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07041814
A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases
Not yet reported Universiti Kebangsaan Malaysia Medical Centre 24 participants Est. completion 2029-10-31 1 siteOther conditions: Turner SyndromeView official trial listing → -
Not yet recruiting NCT NCT07060391
A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's Disease
Not yet reported Shanghai Jiao Tong University School of Medicine 186 participants Est. completion 2027-01-31Other conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT07074327
Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants
Not yet reported Vertex Pharmaceuticals Incorporated 74 participants Est. completion 2026-02-27 1 siteOther conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)View official trial listing → -
Not yet recruiting NCT NCT07078435
Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis
Not yet reported University Hospital, Grenoble 40 participants Est. completion 2027-09-30 1 siteOther conditions: Endometriosis, Immunity, MicrobiotaView official trial listing → -
Completed NCT NCT07096024
A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market
Pfizer 95637 participants Est. completion 2025-02-07 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT07103603
MHT and Liver Function in Postmenopausal Women
Not yet reported Ipek B. Ozcivit Erkan, MD 44 participants Est. completion 2025-12-30 1 siteOther conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic SteatosisView official trial listing → -
Completed NCT NCT07157930
Prenatal Hormonal Markers and Sleep Characteristics in Young Adults With Joint Hypermobility
Nigde Omer Halisdemir University 180 participants Est. completion 2025-12-17 1 siteOther conditions: Joint Hypermobility, Healty Controls, Sleep, Androgen Effect, HormonalView official trial listing → -
Not yet recruiting NCT NCT07163481
A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors
Not yet reported Hunan Cancer Hospital 12 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Stage IV (Metastatic) Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07173556
A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 96 participants Est. completion 2028-10Other conditions: Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07176143
hBMSC Uterine Artery Infusion for Severe IUA-Related Infertility
Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 60 participants Est. completion 2028-12-30 Stand-aloneOther conditions: Intrauterine AdhesionsView official trial listing → -
Not yet recruiting NCT NCT07179939
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 siteOther conditions: HER2-positive Breast CancerView official trial listing → -
Completed NCT NCT07181343
A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)
Not yet reported Hansoh BioMedical R&D Company 18 participants Est. completion 2025-08-19 1 siteOther conditions: Psoriasis (PsO)View official trial listing → -
Completed NCT NCT07190430
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
Not yet reported Pfizer 16 participants Est. completion 2025-12-15 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Not yet recruiting NCT NCT07201259
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
West China Second University Hospital 40 participants Est. completion 2026-10-10 1 siteOther conditions: Malignant TumorsView official trial listing → -
Active, not recruiting NCT NCT07204093
Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 138 participants Est. completion 2026-02 1 siteOther conditions: EndometriosisView official trial listing → -
Not yet recruiting NCT NCT07212712
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
Not yet reported University of British Columbia 50 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Cerebral Blood Flow, Cerebral Blood Flow Regulation, Sex Differences, Exercise, VascularView official trial listing → -
Terminated NCT NCT07214662
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
Not yet reported Genentech, Inc. 3 participants Est. completion 2026-06-24 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT07215806
Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2022-11-25 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT07229209
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
Not yet reported Benha University 166 participants Est. completion 2025-11-01 1 siteOther conditions: Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine ScarView official trial listing → -
Not yet recruiting NCT NCT07235618
A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer
Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 siteOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT07235774
A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants
Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2026-03-13 1 siteOther conditions: Healthy Adult Female ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07245316
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
Not yet reported Jeong Eon Lee 340 participants Est. completion 2032-12-31 1 siteOther conditions: Ductal Carcinoma in Situ of the BreastView official trial listing → -
Not yet recruiting NCT NCT07260825
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
Not yet reported, Not yet reported TriHealth Inc. 44 participants Est. completion 2026-08 2 sitesOther conditions: Vulvodynia, Dyspareunia, Lichen Sclerosus of VulvaView official trial listing → -
Completed NCT NCT07269327
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 24 participants Est. completion 2026-03-09 1 siteOther conditions: FertilityView official trial listing → -
Completed NCT NCT07272889
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Not yet reported Atea Pharmaceuticals, Inc. 24 participants Est. completion 2026-02-17 1 siteOther conditions: Healthy Volunteer StudyView official trial listing → -
Enrolling by invitation NCT NCT07275463
[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression
Not yet reported Tomsk National Research Medical Center of the Russian Academy of Sciences 40 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Primary Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07317895
Sensitivity to Ovarian Hormones and Depression in Adolescents
University of Calgary 94 participants Est. completion 2027-08-31 1 siteOther conditions: DepressedView official trial listing → -
Completed NCT NCT07318337
Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2025-06-30 1 siteOther conditions: PCOS (Polycystic Ovary Syndrome)View official trial listing → -
Not yet recruiting NCT NCT07328789
Factors Influencing Cardiac Rehabilitation Success
Pomeranian Medical University Szczecin 150 participants Est. completion 2029-07-01Other conditions: RehabilitationView official trial listing → -
Not yet recruiting NCT NCT07333937
Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer
Not yet reported Xijing Hospital 35 participants Est. completion 2028-11-20Other conditions: Brest CancerView official trial listing → -
Not yet recruiting NCT NCT07340619
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
Not yet reported UNICANCER 51 participants Est. completion 2029-11-18 8 sitesOther conditions: Metastatic (Stage IV) MelanomaView official trial listing → -
Completed NCT NCT07346287
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
Not yet reported Stratpharma AG 11 participants Est. completion 2026-02-19 1 site Stand-aloneOther conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)View official trial listing → -
Not yet recruiting NCT NCT07366632
A Study of Single Dose of BL0175 in Postmenopausal Women
Not yet reported Shanghai Best-Link Bioscience, LLC 27 participants Est. completion 2026-12-21 Stand-aloneOther conditions: Postmenopausal WomenView official trial listing → -
Not yet recruiting NCT NCT07378241
Effects of Patients' Hormone Levels on Sedoanalgesia
Izmir City Hospital 100 participants Est. completion 2026-04-30Other conditions: Consumption of Anaesthetic Agents, SedoanalgesiaView official trial listing → -
Completed NCT NCT07379502
Endometrial Response in Polyendocrine Metabolic Ovarian Syndrome (PMOS) Treated With Letrozole Alone or With Added Estradiol Valerate
Not yet reported CMH Kharian Medical College 60 participants Est. completion 2026-08-31 1 site Stand-aloneOther conditions: Polyendocrine Metabolic Ovarian Syndrome (PMOS)View official trial listing → -
Not yet recruiting NCT NCT07381569
To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion
Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2026-08-31 1 siteOther conditions: Abortion, InducedView official trial listing → -
Completed NCT NCT07388511
A Study of Elenestinib in Healthy Adult Female Participants
Not yet reported Blueprint Medicines Corporation 20 participants Est. completion 2026-04-02 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07393321
A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
Not yet reported Nanjing Chia-tai Tianqing Pharmaceutical 210 participants Est. completion 2031-08-31Other conditions: HR Positive/HER2 Negative Advanced or Metastatic Breast CancerView official trial listing → -
Completed NCT NCT07398924
Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction
Not yet reported Yuzuncu Yil University 90 participants Est. completion 2023-06-23 1 siteOther conditions: Female Infertility, Anovulatory Infertility, Unexplained InfertilityView official trial listing → -
Terminated NCT NCT07408089
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
Not yet reported Boundless Bio, Inc. 8 participants Est. completion 2026-07-28 8 sites Stand-aloneOther conditions: Breast Cancer, Metastatic Breast Cancer, Advanced Breast CancerView official trial listing → -
Completed NCT NCT07414784
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
Not yet reported AbbVie 20 participants Est. completion 2026-08-04 2 sitesOther conditions: Healthy VolunteerView official trial listing → -
Active, not recruiting NCT NCT07416578
Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions
Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 60 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Intrauterine Adhesions, ExosomesView official trial listing → -
Not yet recruiting NCT NCT07420218
Menopausal Hormones and Sympathetic Activation
Not yet reported University of Delaware 80 participants Est. completion 2030-12-31 Stand-aloneOther conditions: Perimenopausal WomenView official trial listing → -
Not yet recruiting NCT NCT07423611
ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer
Not yet reported Fudan University 388 participants Est. completion 2030-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT07450300
Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients
Clinique Mathilde 1831 participants Est. completion 2026-01-31 1 siteOther conditions: Infertility, FemaleView official trial listing → -
Not yet recruiting NCT NCT07455773
Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium
Not yet reported Azienda Sanitaria Locale di Asti 80 participants Est. completion 2027-12 Stand-aloneOther conditions: Recurrent Implantation Failure, Endometrial Receptivity Disorders, Embryo Implantation, Platelet-Rich Plasma, Platelet-rich Plasma (PRP), Infertility, FemaleView official trial listing → -
Not yet recruiting NCT NCT07462663
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer
Not yet reported Hospital Universitari de Bellvitge 80 participants Est. completion 2035-01Other conditions: Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Obesity & Overweight, BMI>40, Obesity, Obesity Grade IIIView official trial listing → -
Not yet recruiting NCT NCT07466498
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Not yet reported Fred Hutchinson Cancer Center 60 participants Est. completion 2029-06-01 1 site Stand-aloneOther conditions: Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8View official trial listing → -
Not yet recruiting NCT NCT07480681
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Not yet reported Shanghai Henlius Biotech 138 participants Est. completion 2028-06Other conditions: Advanced/Metastatic Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07496294
Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy
Not yet reported Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 200 participants Est. completion 2027-10 1 site Stand-aloneOther conditions: Menopausal Women, Menopausal Symptom Relief, Hormone Therapy, Menopausal Hormone TherapyView official trial listing → -
Not yet recruiting NCT NCT07499999
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
Not yet reported Dana-Farber Cancer Institute 140 participants Est. completion 2028-08-31 2 sites Stand-aloneOther conditions: Breast Cancer, Ductal Carcinoma, Estrogen-receptor-positive Breast Cancer, Atypical Lobular Hyperplasia, BRCA2 Mutation, CHEK2 Gene Mutation, Ataxia Telangiectasia Mutated Gene MutationView official trial listing → -
Completed NCT NCT07502417
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Not yet reported AbbVie 15 participants Est. completion 2026-07-02 1 siteOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT07509411
Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI
Not yet reported Benha University 145 participants Est. completion 2026-08-07 1 siteOther conditions: EndometriosisView official trial listing → -
Completed NCT NCT07513480
Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH
Not yet reported Mst.Sumyara Khatun 68 participants Est. completion 2026-02-20 1 siteOther conditions: PCOSView official trial listing → -
Active, not recruiting NCT NCT07523711
Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity
Not yet reported Amgen 49 participants Est. completion 2026-11-18 2 sitesOther conditions: Overweight, ObesityView official trial listing → -
Active, not recruiting NCT NCT07525791
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
Not yet reported Novo Nordisk A/S 41 participants Est. completion 2027-06-18 1 siteOther conditions: Overweight, ObesityView official trial listing → -
Completed NCT NCT07526207
Estradiol 8 vs 12 mg for Endometrial Preparation in HRT-FET
Not yet reported Cairo University 850 participants Est. completion 2026-02-26 2 sitesOther conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Frozen Embryo Transfer (FET), Endometrial Preparation, Clinical Pregnancy RatesView official trial listing → -
Not yet recruiting NCT NCT07526948
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Not yet reported Albert Einstein College of Medicine 62 participants Est. completion 2029-10-14 1 siteOther conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, PerimenopauseView official trial listing → -
Not yet recruiting NCT NCT07527806
Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
Not yet reported Peking University Cancer Hospital & Institute 156 participants Est. completion 2029-12-31Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07535905
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
Not yet reported University Health Network, Toronto 96 participants Est. completion 2030-10 1 site Stand-aloneOther conditions: Hypogonadism, Prostate CancerView official trial listing → -
Not yet recruiting NCT NCT07542964
Transgender Analysis of Nephrological Studies Focused on Renal Metrics
Amsterdam UMC, location VUmc 60 participants Est. completion 2028-09 1 siteOther conditions: Kidney Disease, Kidney Injury, Transgender IndividualsView official trial listing → -
Not yet recruiting NCT NCT07544966
Teen Vulnerability to Irritability: Brain and Estrogen Changes
Not yet reported University of North Carolina, Chapel Hill 50 participants Est. completion 2029-04 2 sitesOther conditions: Depression - Major Depressive Disorder, IrritabilityView official trial listing → -
Enrolling by invitation NCT NCT07568574
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 siteOther conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesView official trial listing → -
Withdrawn NCT NCT07570966
Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Not yet reported, Not yet reported Novartis Pharmaceuticals Est. completion 2031-08-01Other conditions: Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer (mCRPC)View official trial listing → -
Completed NCT NCT07581054
Super-Resolution Ultrasound Microvascular Mapping for Non-Invasive Breast Cancer Molecular Subtyping: A Validated Nomogram
Anhui Provincial Cancer Hospital 94 participants Est. completion 2026-01-26 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07581288
Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
University of British Columbia 50 participants Est. completion 2026-09 1 siteOther conditions: Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Menstrual Cycle, Reproductive EndocrinologyView official trial listing → -
Not yet recruiting NCT NCT07596212
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
Not yet reported, Not yet reported University of Illinois at Chicago 100 participants Est. completion 2031-09 1 siteOther conditions: Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder, Hormone Receptor Positive Breast Carcinoma, Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07618039
MOving Forward With MENopause Treatment Through Pharmacists' Expanded Roles in Hormone Health
Dalhousie University 200 participants Est. completion 2027-12-31Other conditions: Menopause, PharmacistsView official trial listing → -
Not yet recruiting NCT NCT07618390
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 160 participants Est. completion 2028-12Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07618923
Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer
Not yet reported Tang-Du Hospital 20 participants Est. completion 2029-01Other conditions: Breast Cancer, HR Positive/HER2 Low Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07619066
A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.
Not yet reported MedSIR 25 participants Est. completion 2028-11-28Other conditions: Advanced Breast Cancer, Hormone Receptor Positive / HER2-negative Breast Cancer, HER2 MutationView official trial listing → -
Not yet recruiting NCT NCT07624903
Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
Not yet reported Kafrelsheikh University 70 participants Est. completion 2027-07 1 siteOther conditions: Ectopic PregnancyView official trial listing → -
Not yet recruiting NCT NCT07634601
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2029-12-18 1 siteOther conditions: Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Cancer, Stage IV Endometrial CancerView official trial listing → -
Not yet recruiting NCT NCT07635017
Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation
Not yet reported Carnegie Mellon University 25 participants Est. completion 2028-07-01 1 site Stand-aloneOther conditions: Cortical Excitability, Healthy, TMS, Menstrual Cycle, MenopauseView official trial listing → -
Not yet recruiting NCT NCT07642700
GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET
Guoxia Yang 150 participants Est. completion 2028-06-01Other conditions: Chronic EndometritisView official trial listing → -
Suspended NCT NCT07656792
A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood
Not yet reported Boehringer Ingelheim 36 participants Est. completion 2026-11-26 1 siteOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT07657442
Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 649 participants Est. completion 2032-12-31 1 siteOther conditions: Early Stage Breast Carcinoma, Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07658183
A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer
Not yet reported Shanghai Best-Link Bioscience, LLC 120 participants Est. completion 2028-05-31 Stand-aloneOther conditions: Breast Cancer (Locally Advanced or Metastatic)View official trial listing → -
Not yet recruiting NCT NCT07676331
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Not yet reported Universitaire Ziekenhuizen KU Leuven 168 participants Est. completion 2028-05-01Other conditions: Hormone-receptor-positive Breast Cancer, Early Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07679269
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2032-04-20Other conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Breast Neoplasms (Including Advanced or Metastatic Breast Cancer With PIK3CA Mutation)View official trial listing → -
Not yet recruiting NCT NCT07714616
Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)
Not yet reported Eurofarma Laboratorios S.A. 1600 participants Est. completion 2030-05-31Other conditions: ContraceptionView official trial listing → -
Not yet recruiting NCT NCT07716046
Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast Cancer
Not yet reported Fudan University 240 participants Est. completion 2032-12-31Other conditions: Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor-positive Breast Cancer, HR+/HER2+ Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07724145
Association Between Female Hormonal Profile and Wound Healing
University Hospital, Geneva 84 participants Est. completion 2028-12 1 siteOther conditions: Wound Healing, Wound Healing Complication, EstradiolView official trial listing → -
Completed NCT NCT07727863
Effect of Estradiol Pretreatment on Follicular Synchronization and IVF Outcomes in Women With Polycystic Ovary Syndrome Undergoing ICSI Using GnRH Antagonist Protocol
Not yet reported Cairo University 61 participants Est. completion 2026-06-21 1 siteOther conditions: PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles, IVF OutcomesView official trial listing → -
Not yet recruiting NCT NCT07729046
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 siteOther conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07732452
Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 100 participants Est. completion 2029-01Cardiovascular disease Other conditions: Menopause, Perimenopause, Vasomotor Symptoms, Menopausal Hormone Therapy, Cardiac Remodeling, Myocardial Fibrosis, Microvascular Dysfunction, Cognitive Function AssessmentView official trial listing → -
Not yet recruiting NCT NCT07736261
Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI
Not yet reported, Not yet reported Ahmed Saad 100 participants Est. completion 2027-11 1 siteOther conditions: Poor Ovarian Reserve, Infertility (IVF Patients)View official trial listing → -
Completed NCT NCT07739589
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System
Not yet reported Insud Pharma 28 participants Est. completion 2021-11-16 1 siteOther conditions: Residual Drug Amount of EE and LNGView official trial listing → -
Not yet recruiting NCT NCT07748208
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Not yet reported Hoffmann-La Roche 40 participants Est. completion 2029-09-30Other conditions: Breast Cancer, Diabetes Type IIView official trial listing → -
Not yet recruiting NCT NCT07753954
Medical Imaging to Re-evaluate Elacestrant Clinical Usage
Not yet reported Jules Bordet Institute 160 participants Est. completion 2031-08-19Other conditions: ER+ / HER2- Advanced Breast CancerView official trial listing → -
Active, not recruiting NCT NCT07754630
Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric Women
Not yet reported Nutrindo Ideais Research Center 50 participants Est. completion 2027-10-01 1 siteOther conditions: Menopause, Hypoestrogenism, Hormonal TherapyView official trial listing → -
Completed NCT NCT07763847
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 siteOther conditions: EndometriomaView official trial listing → -
Not yet recruiting NCT NCT07766369
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants
Not yet reported Eisai Inc. 93 participants Est. completion 2026-11-12 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Not yet recruiting NCT NCT07767474
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
Not yet reported, Not yet reported Antares Therapeutics, Inc 343 participants Est. completion 2030-01-31Other conditions: Advanced Solid TumorsView official trial listing → -
Completed NCT NCT07770594
Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-04-16 1 siteOther conditions: EndometriomaView official trial listing → -
Not yet recruiting NCT NCT07782840
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
Not yet reported Hebei Medical University Fourth Hospital 40 participants Est. completion 2028-12-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07784036
JYP0035 Capsules Plus Fulvestrant in PIK3CA-Mutant HR+/HER2- Advanced Breast Cancer
Not yet reported Chengdu JOYO pharma Co., Ltd. 171 participants Est. completion 2029-06-30Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07784582
Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome
Not yet reported Children's National Research Institute 15 participants Est. completion 2027-06 1 siteOther conditions: Turner Syndrome, Primary Ovarian InsufficiencyView official trial listing → -
Not yet recruiting NCT NCT07787520
A Study of LAE118 as Monotherapy and in Combination With Antitumor Agents in Advanced Solid Tumors
Not yet reported Laekna Limited 150 participants Est. completion 2029-12 6 sites Stand-aloneOther conditions: Patients With Advanced Solid TumorsView official trial listing → -
Not yet recruiting NCT NCT07791173
Evaluation of Temporomandibular Disorders During Pregnancy
Zeynep Serra Kalkan 60 participants Est. completion 2027-05 1 siteOther conditions: Temporomandibular Disorders (TMD), PregnancyView official trial listing → -
Not yet recruiting NCT NCT07791394
Does Estrogen Blunt the Effects of Exercise Training on Glycemic Control
Not yet reported University of Waterloo 24 participants Est. completion 2027-04 1 site Stand-aloneOther conditions: To Determine Whether Estrogen Influences the Effects of Training on Glycemic Control and Insulin SensitivityView official trial listing → -
Not yet recruiting NCT NCT07795606
An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes
Bayer 456000 participants Est. completion 2026-12-31 2 sitesOther conditions: Estrogen TherapyView official trial listing → -
Not yet recruiting NCT NCT07799246
Brain and Blood Vessel Health Following Endometriosis Treatment in People With Endometriosis
Not yet reported Colorado State University 45 participants Est. completion 2029-06-30Other conditions: Endometriosis, Endometriosis and Dysmenorrhea, Endometriosis (Diagnosis)View official trial listing → -
Not yet recruiting NCT NCT07802626
Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA Testing
Not yet reported SWOG Cancer Research Network 1084 participants Est. completion 2035-10-30Other conditions: HR Positive/HER-2 Negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07805382
Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD
Duke University 30 participants Est. completion 2027-08 1 siteOther conditions: ADHDView official trial listing → -
Not yet recruiting NCT NCT07806968
Effect of Postural Correction Exercises on Pelvic Floor Dysfunction in Postmenopausal Osteoporotic Women
Not yet reported Cairo University 60 participants Est. completion 2027-03-31 1 site Stand-aloneOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Not yet recruiting NCT NCT07808060
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Not yet reported Eli Lilly and Company 34 participants Est. completion 2027-06 2 sitesOther conditions: Obesity, OverweightView official trial listing → -
Not yet recruiting NCT NCT07811232
A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers
Not yet reported, Not yet reported Advenchen Pharmaceuticals, LLC. 138 participants Est. completion 2031-09-01 1 site Stand-aloneOther conditions: Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast NeoplasmsView official trial listing → -
Not yet recruiting NCT NCT07818278
Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)
Not yet reported University Hospital, Ghent 70 participants Est. completion 2029-08-31 1 site Stand-aloneOther conditions: Fertility, Implantation, EmbryoView official trial listing → -
Active, not recruiting NCT NCT07821086
Effects of Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women
Not yet reported Khyber Medical University Peshawar 30 participants Est. completion 2026-09-20 1 site Stand-aloneOther conditions: Female HypogonadismView official trial listing → -
Not yet recruiting NCT NCT07827573
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
Not yet reported Hoffmann-La Roche 1500 participants Est. completion 2032-11-30Other conditions: Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07833501
Estradiol Levels According to Body Mass Index in Premenopausal Patients With Breast Cancer
D'Or Institute for Research and Education 172 participants Est. completion 2027-05-30Other conditions: Hormone Receptor-Positive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07840443
Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma
Not yet reported University Health Network, Toronto 30 participants Est. completion 2028-10-26 6 sitesOther conditions: Estrogen Receptor-positive, Early Stage Endometrial CancerView official trial listing → -
Active, not recruiting NCT NCT07851649
A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants
Not yet reported Corium Innovations, Inc. 68 participants Est. completion 2026-09-26 1 siteOther conditions: Healthy Female Participants, PostmenopauseView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Estrone, Estrogen, Arthcal ESTROGEN, BiEST 5.0 Estrogen Cream - 3.6oz, 3.6oz BiEST 2.5 Estrogen Cream, Bealions Estrogen, Estradiol Valerate
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
